<SEC-DOCUMENT>0001193125-17-125303.txt : 20170417
<SEC-HEADER>0001193125-17-125303.hdr.sgml : 20170417
<ACCEPTANCE-DATETIME>20170417090100
ACCESSION NUMBER:		0001193125-17-125303
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20170523
FILED AS OF DATE:		20170417
DATE AS OF CHANGE:		20170417
EFFECTIVENESS DATE:		20170417

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		17763639

	BUSINESS ADDRESS:	
		STREET 1:		311 ENTERPRISE DRIVE
		CITY:			PLAINSBORO
		STATE:			NJ
		ZIP:			08536
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		311 ENTERPRISE DRIVE
		CITY:			PLAINSBORO
		STATE:			NJ
		ZIP:			08536

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d333443ddef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section 14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act
of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp; ) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material under <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>INTEGRA LIFESCIENCES HOLDINGS CORPORATION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified In Its Charter) </B></FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box): </FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT></FONT></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
<FONT STYLE="white-space:nowrap">0-11</FONT> (set forth the amount on which the filing fee is calculated and state how it was determined):</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-before:always">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right">


<IMG SRC="g333443g72r19.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>311 ENTERPRISE DRIVE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>PLAINSBORO, NEW JERSEY, 08536 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>TO BE HELD ON MAY&nbsp;23, 2017 </B></FONT></P> <P STYLE="margin-top:10px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the
Stockholders of Integra LifeSciences Holdings Corporation: </FONT></P> <P STYLE="margin-top:10px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE IS HEREBY GIVEN that the 2017 Annual Meeting of
Stockholders (the &#147;Meeting&#148;) of Integra LifeSciences Holdings Corporation (the &#147;Company&#148;) will be held as, and for the purposes, set forth below: </FONT></P> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE="margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">TIME </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="2">5:00 p.m. local time on Tuesday, May&nbsp;23, 2017 </FONT></TD></TR></TABLE> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE="margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">PLACE </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="2">Integra LifeSciences Holdings Corporation, 11101 Metric Boulevard, Austin, Texas 78758 </FONT></TD></TR></TABLE> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE="margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">ITEMS OF BUSINESS </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="2">1. To elect nine directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified. </FONT></TD></TR></TABLE>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="2">2. To ratify the appointment of PricewaterhouseCoopers LLP as the Company&#146;s independent registered public accounting firm for the fiscal year 2017. </FONT></TD></TR></TABLE>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="25%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">3. To approve the Company&#146;s 2018 Performance Incentive Compensation Plan. </FONT></TD></TR></TABLE>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="25%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">4. To approve the Company&#146;s Fourth Amended and Restated 2003 Equity Incentive Plan. </FONT></TD></TR></TABLE>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="25%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">5. To vote on a <FONT STYLE="white-space:nowrap">non-binding</FONT> resolution to approve the compensation of our named executive officers. </FONT></TD></TR></TABLE>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="25%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">6. To vote on a <FONT STYLE="white-space:nowrap">non-binding</FONT> Proposal on the frequency of the advisory vote on the compensation of our named executive officers.
</FONT></TD></TR></TABLE> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="2">7. To act upon any other matters properly coming before the Meeting or any adjournment or postponement thereof. </FONT></TD></TR></TABLE>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE="margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">RECORD DATE </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="2">Holders of record of the Company&#146;s common stock at the close of business on March&nbsp;31, 2017 are entitled to notice of, and to vote at, the Meeting and any adjournment or postponement
thereof. A complete list of stockholders entitled to vote at the Meeting will be available for inspection by any stockholder for any purpose germane to the Meeting for ten days prior to the Meeting during ordinary business hours at the
Company&#146;s headquarters located at 311 Enterprise Drive, Plainsboro, New Jersey. </FONT></TD></TR></TABLE> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE="margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">ANNUAL REPORT </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2016 Annual Report of Integra LifeSciences Holdings Corporation is being mailed simultaneously herewith. The Annual Report is not to be considered part of the proxy solicitation materials.
</FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE="margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">IMPORTANT </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to avoid additional soliciting expense to the Company, please MARK, SIGN, DATE and MAIL your proxy PROMPTLY in the return envelope provided, even if you plan to attend the Meeting. If
you attend the Meeting and wish to vote your shares in person, arrangements will be made for you to do so. </FONT></TD></TR></TABLE> <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">By order of the Board of Directors,</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/&nbsp;&nbsp;&nbsp;&nbsp;R<SMALL>ICHARD</SMALL> D. G<SMALL>ORELICK</SMALL></FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Corporate Vice President, General Counsel,</I></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:0.90em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Administration and Secretary</I></FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Plainsboro, New Jersey </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;17, 2017 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If you do not vote your shares on the Election of
Directors, your brokerage firm may not vote them for you; your shares will remain unvoted. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Therefore, it is very
important that you vote your shares for all proposals, including the Election of Directors (Proposal 1), the approval of the Company&#146;s 2018 Performance Incentive Plan (Proposal 3), the approval of the Company&#146;s Fourth Amended and Restated
2003 Equity Incentive Plan (Proposal 4), the <FONT STYLE="white-space:nowrap">non-binding</FONT> resolution to approve the compensation of our named executive officers (Proposal 5), and the <FONT STYLE="white-space:nowrap">non-binding</FONT>
proposal on the frequency of the advisory vote on the compensation of our named executive officers (Proposal 6), each of which are viewed as <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> matters for which brokerage firms may not
vote for you without your instructions. </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_1">Purpose of Meeting</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_2">Record Date</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_3">Voting and Revocability of Proxies</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_4">Proposal 1: Election of Directors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_5">Information Concerning Meetings, Executive Sessions and Certain Committees</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_6">Director Qualifications</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_7">Board Leadership Structure</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_8">The Board&#146;s Role in Risk Oversight</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_9">Risk Assessment Regarding Compensation Policies and Practices</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_10">Director Attendance at Annual Meetings: Shareholder Communications with Directors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_11">Information About Executive Officers</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_12">Proposal 2: Ratification of Independent Registered Public Accounting Firm</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_13">Proposal 3: Approval of the Company&#146;s 2018 Performance Incentive Compensation
Plan</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_14">Proposal 4: Approval of the Company&#146;s Fourth Amended and Restated 2003 Equity Incentive
Plan</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_15">Proposal 5: Advisory Vote on Named Executive Officer Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_16">Proposal 6: Advisory Vote on the Frequency of the Advisory Vote on Named Executive Officer
Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_17">Compensation Discussion and Analysis</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_18">Compensation Committee Report</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_19">Compensation of Executive Officers</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_20">Director Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_21">Equity Compensation Plan Information</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_22">Compensation Committee Interlocks and Insider Participation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">86</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_23">Certain Relationships and Related Transactions</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">86</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_24">Audit Committee Report</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">88</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_25">Principal Stockholders</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">89</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_26">Section 16(a) Beneficial Ownership Reporting Compliance</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_27">Stockholder Proposals</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_28">Other Matters</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_29">Appendix A&nbsp;&#151;&nbsp;2018 Performance Incentive Compensation Plan</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">A-1</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_30">Appendix B&nbsp;&#151;&nbsp;Fourth Amended and Restated 2003 Equity Incentive Plan</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">B-1</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc333443_31">Appendix C&nbsp;&#151;&nbsp;
Reconciliations of <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">C-1</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">i </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:48px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">(This page intentionally left blank) </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>INTEGRA LIFESCIENCES HOLDINGS CORPORATION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>311 ENTERPRISE DRIVE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>PLAINSBORO, NEW JERSEY 08536 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:18%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>PROXY
STATEMENT </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:18%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>TO BE HELD ON MAY&nbsp;23, 2017 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>IMPORTANT NOTICE REGARDING THE
AVAILABILITY OF PROXY MATERIALS FOR THE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>STOCKHOLDER MEETING TO BE HELD ON MAY&nbsp;23, 2017. The proxy statement and
annual </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>report to security holders are available on our internet site at </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>http://investor.integralife.com/financials.cfm </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_1"></A>PURPOSE OF MEETING </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are providing this Proxy
Statement to holders of our common stock in connection with the solicitation by the Board of Directors of Integra LifeSciences Holdings Corporation (the &#147;Company&#148;) of proxies to be voted at the Company&#146;s 2017 Annual Meeting of
Stockholders (the &#147;Meeting&#148;) and at any adjournments or postponements thereof. The Meeting will begin at 5:00 p.m. local time on Tuesday, May&nbsp;23, 2017 at the Company&#146;s Austin Facility, 11101 Metric Boulevard, Austin, Texas 78758.
We are first mailing this Proxy Statement, the Notice of Annual Meeting of Stockholders and the form of proxy to stockholders of the Company on or about April&nbsp;17, 2017. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At the Meeting, we will ask the stockholders of the Company to consider and vote upon: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(i) the election of nine directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified (see &#147;Proposal 1. Election of Directors&#148;);
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(ii) the ratification of the appointment of PricewaterhouseCoopers LLP as the Company&#146;s independent
registered public accounting firm for the fiscal year 2017 (see &#147;Proposal 2. Ratification of Independent Registered Public Accounting Firm&#148;); </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(iii) the approval of the 2018 performance incentive compensation plan (see &#147;Proposal 3. Approval of 2018 Performance Incentive Compensation Plan&#148;); </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(iv) the approval of the fourth amended and restated 2003 equity incentive plan (see &#147;Proposal 4. Approval of The
Fourth Amended and Restated 2003 Equity Incentive Plan&#148;); </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(v) a
<FONT STYLE="white-space:nowrap">non-binding</FONT> resolution to approve the compensation of our named executive officers (see &#147;Proposal 5. Advisory Vote on Named Executive Officer Compensation&#148;); and </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(vi) a <FONT STYLE="white-space:nowrap">non-binding</FONT> proposal of the frequency of an advisory vote on the
compensation of our named executive officers (see &#147;Proposal 6. Advisory Vote on the Frequency of the Advisory Vote on Named Executive Officer Compensation&#148;). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We know of no other matters that will be presented for consideration at the Meeting. If any other matters are properly presented at the Meeting or any postponement or adjournment thereof, the persons
named in the enclosed proxy will have authority to vote on such matters in accordance with their best judgment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_2">
</A>RECORD DATE </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of March&nbsp;31, 2017, the record date for the Meeting, 75,256,383 shares of our common stock were
outstanding. Only holders of record of our common stock as of the close of business on the record date are entitled to notice of, and to vote at, the Meeting or at any adjournment or postponement thereof. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_3"></A>VOTING AND REVOCABILITY OF PROXIES </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each share of our common stock entitles the holder of record thereof to one vote. Each stockholder may vote in person or by proxy on all
matters that properly come before the Meeting and any adjournment or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
postponement thereof. The presence, in person or by proxy, of stockholders entitled to vote a majority of the shares of common stock outstanding on the record date will constitute a quorum for
purposes of voting at the Meeting. Shares abstaining from voting and shares present but not voting, including broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> are counted as &#147;present&#148; for purposes of determining the existence of a
quorum. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are shares held by a broker or nominee for which an executed proxy is received by the Company, but which are not voted as to one or more proposals because timely instructions have not
been received from the beneficial owners or persons entitled to vote and the broker or nominee does not have discretionary voting power to vote such shares. Brokers and other nominees have discretionary voting power to vote generally only on routine
proposals. At our annual meeting, the only proposal over which brokers will have discretionary authority to vote without having received specific voting instructions from the beneficial owner of the shares is the proposal to ratify the appointment
of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our 2017 fiscal year (Proposal 2). In all other instances, brokers and other shareowners of record who serve as nominees for a beneficial owner may not vote on a
proposal without having voting instructions from the beneficial owner. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we fail to obtain a quorum for the Meeting or a
sufficient number of votes to approve a proposal, we may adjourn the Meeting for the purpose of obtaining additional proxies or votes or for any other purpose. At any subsequent reconvening of the Meeting, all proxies will be voted in the same
manner as they would have been voted at the original Meeting (except for any proxies that have theretofore effectively been revoked or withdrawn). Proxies voting against a proposal set forth herein will not be used to adjourn the Meeting to obtain
additional proxies or votes with respect to such proposal. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors is soliciting the enclosed proxy for use in
connection with the Meeting and any postponement or adjournment thereof. All properly executed proxies received prior to or at the Meeting or any postponement or adjournment thereof and not revoked in the manner described below will be voted in
accordance with any instructions indicated on such proxies. For Proposals 1, 2, 3, 4, and 5 you may vote &#147;FOR,&#148; &#147;AGAINST&#148; or &#147;ABSTAIN.&#148; For Proposal&nbsp;4, you may vote to indicate whether you would prefer an advisory
vote on executive compensation once every &#147;ONE YEAR&#148;, &#147;TWO YEARS&#148; or &#147;THREE YEARS&#148; or &#147;ABSTAIN&#148;. If you sign your proxy card or broker voting instruction card with no further instructions, your shares will be
voted in accordance with the recommendations of the Board of Directors. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may revoke your proxy by (a)&nbsp;delivering to
the Secretary of the Company at or before the Meeting a written notice of revocation bearing a later date than the proxy, (b)&nbsp;duly executing a subsequent proxy relating to the same shares of common stock and delivering it to the Secretary of
the Company at or before the Meeting or (c)&nbsp;attending the Meeting and voting in person (although attendance at the Meeting will not in and of itself constitute revocation of a proxy). Any written notice revoking a proxy should be delivered at
or prior to the Meeting to: Integra LifeSciences Holdings Corporation, 311 Enterprise Drive, Plainsboro, New Jersey 08536, Attention: Corporate Vice President, General Counsel, Administration and Secretary. Beneficial owners of our common stock who
are not holders of record and wish to revoke their proxy should contact their bank, brokerage firm or other custodian, nominee or fiduciary to inquire about how to revoke their proxy, and may not revoke their proxy by one of the methods set forth
above. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will bear all expenses of this solicitation, including the cost of preparing and mailing this Proxy Statement. In
addition to solicitation by use of the mail, proxies may be solicited by telephone, facsimile or personally by our directors, officers and employees, who will receive no extra compensation for their services. In addition, the Company has retained
D.F. King&nbsp;&amp; Co., Inc. to assist in the solicitation of proxies and will pay such firm a fee of $8,500 plus reasonable expenses. We will also reimburse banks, brokerage firms and other custodians, nominees and fiduciaries for reasonable
expenses incurred by them in sending proxy soliciting materials to beneficial owners of shares of common stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_4"></A>PROPOSAL 1. ELECTION OF DIRECTORS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has nominated the following nine persons for election as directors who will serve until the next annual meeting of
stockholders and until their successors are duly elected and qualified: Peter J. Arduini, Keith Bradley, Ph.D., Stuart M. Essig, Ph.D., Barbara B. Hill, Lloyd W. Howell, Jr., Donald E. Morel, Jr., Ph.D., Raymond G. Murphy, Christian S. Schade and
James M. Sullivan, each of whom are currently directors of the Company. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If any nominee should be unable to serve as director,
an event not now anticipated, the shares of common stock represented by proxies would be voted for the election of such substitute as the Board of Directors may nominate. Set forth below is certain information with respect to the persons nominated
as directors of the Company. See &#147;Principal Stockholders&#148; for information regarding the security holdings of our director nominees. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>PETER J. ARDUINI</I> is Integra&#146;s President and Chief Executive Officer and a director. He joined Integra in November 2010 as President and Chief Operating Officer and was appointed Chief
Executive Officer and a director in January 2012. Before joining Integra, Mr.&nbsp;Arduini was Corporate Vice President and President of Medication Delivery, Baxter Healthcare, which he joined in 2005. Mr.&nbsp;Arduini was responsible for a
$4.8&nbsp;billion global division of Baxter focused on inpatient pharmaceuticals and devices. Prior to joining Baxter, Mr.&nbsp;Arduini worked for General Electric Healthcare, where he spent much of his 15 years in a variety of management roles for
domestic and global businesses, culminating in leading the global functional imaging business. Prior to joining General Electric Healthcare, he spent four years with Procter and Gamble in sales and marketing. Mr.&nbsp;Arduini serves on the Board of
Directors and a member of the audit committee of Bristol-Myers Squibb Company. He serves on the Board of Directors of ADVAMED, the Advanced Medical Technology Association, the Medical Device Innovation Consortium, and the National Italian American
Foundation. Mr.&nbsp;Arduini received his bachelor&#146;s degree in marketing from Susquehanna University and a master&#146;s in management from Northwestern University&#146;s Kellogg School of Management. Mr.&nbsp;Arduini is 52 years old.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>KEITH BRADLEY, PH.D.,</I> has been a director of the Company since 1992. Between 1996 and 2003, he was a director of
Highway Insurance plc, an insurance company listed on the London Stock Exchange, and has been a consultant to a number of business, government and international organizations. Dr.&nbsp;Bradley was formerly a visiting professor at the Harvard
Business School, Wharton and UCLA, a visiting fellow at Harvard&#146;s Center for Business and Government and a professor of international management and management strategy at the Open University and Cass Business School, U.K. Dr.&nbsp;Bradley has
taught at the London School of Economics and was the director of the School&#146;s Business Performance Group for more than six years. He received B.A., M.A. and Ph.D. degrees from British universities. Dr.&nbsp;Bradley is an adviser to RPH Capital,
Canada. He currently serves as a director and member of the compensation committee of SeaSpine Holdings Corporation. In addition, he previously served as a director and chair of North Star Capital Management Limited and GRS Financial Solutions
Limited. Dr.&nbsp;Bradley is 72 years old. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>STUART M. ESSIG, PH.D.,</I> is Integra&#146;s Chairman of the Board of
Directors. He has been our Chairman since January 2012 and a director since he joined Integra in December 1997. He also served as our Chief Executive Officer from December 1997 until January 2012. In addition, he served as our President from
December 1997 until November 2010. He currently serves as Managing Director of Prettybrook Partners LLC. Before joining Integra, Dr.&nbsp;Essig supervised the medical technology practice at Goldman, Sachs&nbsp;&amp; Co. as a Managing Director.
Dr.&nbsp;Essig had ten years of broad health care experience at Goldman Sachs serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients.
Dr.&nbsp;Essig has chaired Audit, Compensation and Nominating and Governance Committees and served on the boards of several NASDAQ and NYSE listed companies ranging in size from several hundred million dollars to $20&nbsp;billion in market
capitalization. Dr.&nbsp;Essig currently serves on the Board of Directors of SeaSpine Holdings Corporation, and Owens&nbsp;&amp; Minor, Inc., and as Chairman of the Board of Directors of Breg, Inc. He previously served on the Board of St. Jude
Medical Corporation prior to its sale to Abbott Laboratories. He is a founding investor member of Tigerlabs, a <FONT STYLE="white-space:nowrap">Princeton-based</FONT> business accelerator. He is an Executive in Residence at Cardinal Partners and a
Venture Partner at Wellington Partners Advisory AG, both venture capital firms and serves as a Senior Advisor to TowerBrook Capital Partners and Water Street Healthcare Partners. From March 2005 until August 2008, he served on the Board of Directors
of Zimmer </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Holdings, Inc., and from 1998 to 2002 he served on the Board of Directors of Vital Signs, Inc. Dr.&nbsp;Essig has also served on the executive committee, nominating and governance committee and
as treasurer of ADVAMED, the Advanced Medical Technology Association. Dr.&nbsp;Essig is also involved in several <FONT STYLE="white-space:nowrap">non-profit</FONT> charitable organizations, including from time to time having served on the boards of
such organizations. Dr.&nbsp;Essig also serves on the Leadership Council, School of Engineering and Applied Sciences, Princeton University, and as a member of the Compensation Committee Chain Advisory Council of the National Association of Corporate
Directors (NACD). Dr.&nbsp;Essig received an A.B. degree, and graduated with magna cum laude honors, from the Woodrow Wilson School of Public and International Affairs at Princeton University and an M.B.A. and Ph.D. in Financial Economics from the
University of Chicago, Graduate School of Business. Dr.&nbsp;Essig is 55 years old. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>BARBARA B. HILL</I> has been a director
of the Company since May 2013. Ms.&nbsp;Hill is currently an Operating Partner of NexPhase Capital, a private equity firm, where she focuses on healthcare related investments and providing strategic operating support for its healthcare portfolio
companies. Ms.&nbsp;Hill has served as an Operating Partner of NexPhase Capital since January 2016. Prior to that, Ms.&nbsp;Hill served as an Operating Partner of Moelis Capital Partners, a private equity firm, where she focused on <FONT
STYLE="white-space:nowrap">healthcare-related</FONT> investments and providing strategic operating support for its healthcare portfolio companies. She served as an Operating Partner of Moelis Capital Partners from March 2011 to January 2016. From
March 2006 to September 2010, Ms.&nbsp;Hill served as Chief Executive Officer and a director of ValueOptions, Inc., a managed behavioral health company, and FHC Health Systems, Inc., its parent company. Prior to that, from August 2004 to March 2006,
she served as Chairman and Chief Executive Officer of Woodhaven Health Services, an institutional pharmacy company. In addition, from 2002 to 2003, Ms.&nbsp;Hill served as President and a director of Express Scripts, Inc., a pharmacy benefits
management company. In previous positions, Ms.&nbsp;Hill was responsible for operations nationally for Cigna HealthCare, and also served as the CEO of health plans owned by Prudential, Aetna and the Johns Hopkins Health System. She was active with
the boards or committees of the Association of Health Insurance Plans and other health insurance industry groups. Currently, she serves as a board member as well as a member of the compensation committee of Owens and Minor, a healthcare product
distribution company. In addition, Ms.&nbsp;Hill serves as a board member and a member of the compensation committee of Omega Healthcare Investors, Inc., a Maryland real estate investment trust. Until 2017, Ms.&nbsp;Hill also served as a board
member of Revera Inc., a Canadian company operating seniors&#146; facilities throughout Canada, Great Britain, and the United States, and as a board member of St. Jude Medical Corporation, a medical device company. Ms.&nbsp;Hill received B.A and
M.S. degrees from the Johns Hopkins University. She is 64 years old. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>LLOYD W. HOWELL, JR.</I> has been a director of the
Company since March 2013. Mr.&nbsp;Howell is an Executive Vice President at Booz Allen Hamilton, where he has held a variety of leadership positions since originally joining the firm in 1988 as a consultant. He currently serves as the Chief
Financial Officer and Treasurer of Booz Allen Hamilton. From April 2009 to April 2013, Mr.&nbsp;Howell served as the Client Service Officer of the Financial Services Account in the Civil Market at Booz Allen Hamilton where he led the business in
delivering the firm&#146;s strategic, technology and analytics capabilities and service offerings to both the federal and private sectors. From April 2005 to April 2009, he served as the Strategy and Organization&#146;s Capability Leader at Booz
Allen Hamilton, a group that he has been a member of since 1995. Prior to that, from 1993 to 1995, he worked at Goldman Sachs as an Associate in their Investment Banking Division. Currently, Mr.&nbsp;Howell is a board member of the Partnership for
Public Service, Capital Partners for Education, the University of Pennsylvania&#146;s Engineering School, and a member of the Executive Leadership Council. Mr.&nbsp;Howell received a B.S. in Electrical Engineering from the University of Pennsylvania
and an M.B.A. from Harvard University. Mr.&nbsp;Howell is 50 years old. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>DONALD E. MOREL, JR., PH.D.,</I> has been a
director of the Company since August 2013. Dr.&nbsp;Morel, until April 2015, was the Chief Executive Officer and, until June 2015, was Chairman of the Board of Directors of West Pharmaceutical Services, Inc., a manufacturer of components and systems
for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. Dr.&nbsp;Morel served as the Chief Executive Officer of West Pharmaceutical Services, Inc.
from April 2002 to April 2015, Chairman of the Board of Directors of West Pharmaceutical Services, Inc. from March 2003 to June 2015 and a director of West Pharmaceutical Services, Inc. from March 2002 to June 2015. In addition, he served as
President of West Pharmaceutical Services, Inc. from April 2002 to June 2005. Dr.&nbsp;Morel served as a director of Kensey Nash Corporation, a medical device product development and manufacturing
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
company, from March 2010 to June 2012 as well as a member of its audit and compensation committees. He serves on the Board of Directors of Catalent, Inc. He serves as Chairman of the Board of
Directors of the American Oncologic Hospital of the Fox Chase Cancer Center and as Chairman of the Board of Trustees of The Franklin Institute and a Trustee of Lafayette College. Dr.&nbsp;Morel received a B.S. in Engineering from Lafayette College
and an M.S. and Ph.D. in Materials Science from Cornell University. Dr.&nbsp;Morel is 59 years old. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>RAYMOND G. MURPHY</I>
has been a director of the Company since April 2009. Between 2004 and 2008, he was Senior Vice President&nbsp;&amp; Treasurer of Time Warner, Inc., responsible for all U.S. and international corporate finance, project (real estate and film) finance,
cash management, foreign exchange and interest rate risk management, public debt and equity financing, real estate financing, securitization financing, banking relationships and financings, and relationships with rating agencies, as well as
corporate wide real estate activities and the property/casualty risk management program. Between 2001 and 2004, he was Vice President&nbsp;&amp; Treasurer of Time Warner Inc. From 1999 until 2001, he was Senior Vice President&nbsp;&amp; Treasurer of
America Online, Inc. Between 1993 and 1999, he was Senior Vice President, Finance&nbsp;&amp; Treasurer of Marriott International, Inc. Prior to Marriott, he held executive positions at Manor Care, Inc., Ryder System Inc. and W R Grace&nbsp;&amp;
Company. Since 2005, he has been a member of the Finance Committee of The Advertising Council Inc. and from 2007 until 2009, he served as Chair of such committee. Between 2004 and 2009, he served on the Board of Directors of The Advertising Council,
Inc. and between 2007 and 2009, he served on its Executive Committee. He received a B.S. from Villanova University and an M.B.A. from Columbia University Graduate School of Business. Mr.&nbsp;Murphy is 69 years old. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>CHRISTIAN S. SCHADE</I> has been a director of the Company since 2006. He currently serves as the President and Chief Executive Officer
of Aprea Therapeutics AB, a privately held, clinical-stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53 position he has held since April 2016. Prior to that, Mr.&nbsp;Schade was the Chief
Executive Officer of Novira Therapeutics, Inc., an antiviral drug discovery company focused on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> therapeutics for chronic HBV infection from March 2014 to
December 2015 until it was acquired by Johnson&nbsp;&amp; Johnson. Before joining Novira Therapeutics, Inc., he served as Executive Vice President and Chief Financial Officer of Omthera Pharmaceuticals, Inc. from September 2011 to July 2013. Omthera
was an emerging specialty pharmaceuticals company focused on the clinical development of therapies for dyslipidemia until it was purchased by AstraZeneca Plc in July 2013. From April 2010 to September 2011, Mr.&nbsp;Schade served as Executive Vice
President and Chief Financial Officer at NRG Energy, a NYSE listed, S&amp;P 500 wholesale power generation company based in Princeton, NJ. While there, he was responsible for corporate financial functions, including Treasury, Accounting, Tax, Risk,
Credit Management and Insurance. Prior to joining NRG, he was Senior Vice President Administration and Chief Financial Officer at Medarex Inc., a NASDAQ listed, <FONT STYLE="white-space:nowrap">Princeton-based</FONT> biopharmaceutical company. He
also helped Medarex to grow to become a leading pharmaceutical development company, raising capital through a series of public capital market and asset monetization transactions. While there, he also oversaw the manufacturing of multiple
development/clinical programs and was responsible for the business development team. Before joining Medarex in 2000, Mr.&nbsp;Schade served as Managing Director at Merrill Lynch in London, where he was head of the European Corporate Funding Group
and was responsible for certain capital markets activities of Merrill Lynch&#146;s European corporate clients. He also held various corporate finance and capital markets positions in New York and London for both Merrill Lynch and JP Morgan
Chase&nbsp;&amp; Co. Mr.&nbsp;Schade currently serves on the Board of Directors of Indivior, a UK listed spinoff of the pharmaceutical division of the consumer products conglomerate, Reckitt Benckiser. Mr.&nbsp;Schade received an A.B. degree from
Princeton University, and received an M.B.A. from the Wharton School at the University of Pennsylvania. Mr.&nbsp;Schade is 56 years old. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>JAMES M. SULLIVAN</I> has been a director of the Company since 1992. He is a <FONT STYLE="white-space:nowrap">Co-Founder</FONT> of, and currently the Principal Advisor to, the Clover Investment Group.
Between 1986 and April 2009, he held several positions with Marriott International, Inc. (and its predecessor, Marriott Corp.), including Vice President of Mergers and Acquisitions and Executive Vice President of Lodging Development. From 1983 to
1986, Mr.&nbsp;Sullivan was Chairman, President and Chief Executive Officer of Tenly Enterprises, Inc., a privately held company operating 105 restaurants. Prior to 1983, he held senior management positions with Marriott Corp., Harrah&#146;s
Entertainment, Inc., Holiday Inns, Inc., Kentucky Fried Chicken Corp. and Heublein, Inc. He also was employed as a senior </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
auditor with Arthur Andersen&nbsp;&amp; Co. and served as a director of Classic Vacation Group, Inc. until its acquisition by Expedia, Inc. in March 2002. Mr.&nbsp;Sullivan currently serves as a
member of the Board of Directors of SeaSpine Holdings Corporation. He serves as a member of SeaSpine Holdings Corporation&#146;s audit committee and nominating and corporate governance committee. Mr.&nbsp;Sullivan received a B.S. degree in
Accounting from Boston College and an M.B.A. degree from the University of Connecticut. Mr.&nbsp;Sullivan is 73 years old. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Required Vote
for Approval and Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors are to be elected by the majority of the votes cast
with respect to that director in uncontested elections. Thus, the number of shares voted &#147;FOR&#148; a director must exceed the number of votes cast &#147;AGAINST&#148; that director. Under our Bylaws, any director who fails to be elected must
offer to tender his or her resignation to the Board of Directors. The Nominating and Corporate Governance Committee would then make a recommendation to the Board of Directors whether to accept or reject the resignation, or whether other action
should be taken. The Board of Directors will act on the Nominating and Corporate Governance Committee&#146;s recommendation and publicly disclose its decision and the rationale behind it within 90 days from the date the election results are
certified. The director who tenders his or her resignation will not participate in the Board&#146;s decision. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of this proposal. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors hereby recommends that the stockholders of the Company </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>vote &#147;FOR&#148; the election of each nominee for director. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_5"></A>INFORMATION CONCERNING MEETINGS, EXECUTIVE SESSIONS AND CERTAIN
COMMITTEES </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors held five regularly scheduled meetings during 2016. The Company&#146;s independent
directors meet at least twice a year in executive session without management present. The Board of Directors has determined that all of the Company&#146;s directors, except for Mr.&nbsp;Arduini, are independent, as defined by the applicable NASDAQ
Stock Market listing standards and the rules of the Securities and Exchange Commission. In making this decision with respect to Dr.&nbsp;Caruso, the Board of Directors considered that the Company leases certain production equipment from an entity
controlled by Dr.&nbsp;Caruso and leases a manufacturing facility that is 50% owned by a subsidiary of Provco Industries. Provco&#146;s stockholders are trusts whose beneficiaries include the children of Dr.&nbsp;Caruso. Dr.&nbsp;Caruso is the
President of Provco. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company has standing Audit, Nominating and Corporate Governance, Compensation and Finance Committees
of its Board of Directors. Each committee operates pursuant to a written charter. Copies of these charters are available on our website at www.integralife.com through the &#147;Investors Relations&#148; link under the heading &#147;Corporate
Governance.&#148; During 2016, each incumbent director, other than Mr.&nbsp;Howell, attended in person or by teleconference at least 75% of the total number of meetings of the Board of Directors and of each committee of the Board of Directors on
which he or she served. Mr.&nbsp;Howell did not attend at least 75% of the total meetings because of his promotion to Chief Financial Officer of Booz Allen Hamilton, Inc. and his preparation for that role. Mr.&nbsp;Howell attended 71% of the
meetings. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>COMMITTEE COMPOSITION </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="6%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Audit</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nominating and
Corporate</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Governance</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Finance</B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stuart M. Essig, Ph.D.


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">



<IMG SRC="g333443g95p98.jpg" ALT="LOGO">
</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Keith Bradley, Ph.D.


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g25b38.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard E. Caruso, Ph.D.


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Barbara B. Hill


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lloyd W. Howell, Jr.


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Donald E. Morel, Jr., Ph.D.


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Raymond G. Murphy


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g25b38.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christian S. Schade


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g25b38.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8px">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">James M. Sullivan


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
 ,<B># </B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g25b38.jpg" ALT="LOGO">
</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:1px" align="left"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">


<IMG SRC="g333443g95p98.jpg" ALT="LOGO">
 = Chairman of the Board


<IMG SRC="g333443g25b38.jpg" ALT="LOGO">
 = Chair


<IMG SRC="g333443g88f37.jpg" ALT="LOGO">
 = Member


<IMG SRC="g333443g17u52.jpg" ALT="LOGO">
 = Independent Under NASDAQ Listing Standards #=Presiding Director </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Audit Committee. </I>The
members of the Audit Committee are Mr.&nbsp;Murphy (chair), Mr.&nbsp;Howell, Mr.&nbsp;Schade and Mr.&nbsp;Sullivan. The Committee met six times in 2016. The purpose of the Audit Committee is to oversee the Company&#146;s accounting and financial
reporting process and the audits of the Company&#146;s financial statements. The Board of Directors has determined that all of the members of the Audit Committee are independent within the meaning of the rules of the Securities and Exchange
Commission and the applicable NASDAQ Stock Market listing standards. The Board of Directors has also determined that Mr.&nbsp;Murphy, Mr.&nbsp;Howell, Mr.&nbsp;Schade and Mr.&nbsp;Sullivan are &#147;audit committee financial experts,&#148; as
defined under Item 407(d) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> and that each of them is &#147;financially sophisticated&#148; in accordance with NASDAQ Stock Market listing standards. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Nominating and Corporate Governance Committee. </I>The members of the Nominating and Corporate Governance Committee are
Mr.&nbsp;Sullivan (chair), Dr.&nbsp;Bradley and Ms.&nbsp;Hill. The Committee met five times in </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
2016. The purpose of the Nominating and Corporate Governance Committee is to assist the Board of Directors in the identification of qualified candidates to become directors, the selection of
nominees for election as directors at the stockholders meeting, the selection of candidates to fill any vacancies on the Board of Directors, the development and recommendation to the Board of Directors of a set of corporate governance guidelines and
principles applicable to the Company, the oversight of the evaluation of the Board of Directors and otherwise taking a leadership role in shaping the corporate governance of the Company. The Board of Directors has determined that all of the members
of the Nominating and Corporate Governance Committee are independent, as defined by the applicable NASDAQ Stock Market listing standards. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">When considering a candidate for nomination as a director, the Nominating and Corporate Governance Committee may consider, among other things it deems appropriate, the candidate&#146;s personal and
professional integrity, ethics and values, experience in corporate management and a general understanding of sales, marketing, finance, operations, compliance and other elements relevant to the success of a publicly traded company in today&#146;s
business environment, experience in the Company&#146;s industry and with relevant social policy concerns, experience as a board member of another publicly held company, academic expertise in an area of the Company&#146;s business, and practical and
mature business judgment, including the ability to make independent analytical inquiries. The Nominating and Corporate Governance Committee applies the same criteria to nominees recommended by stockholders that it does to other new nominees. In
addition, for candidates who are currently serving as directors, the Committee considers the director&#146;s past attendance at meetings and participation in and contributions to the activities of the Board. The Nominating and Corporate Governance
Committee does not have a formal policy on diversity. However, both the Nominating and Corporate Governance Committee and the Board of Directors evaluate each individual candidate for nomination as a director in the context of the Board as a whole,
with the objective of assembling a group that can best perpetuate the success of the business and represent stockholder interests through the exercise of sound business judgment using its diversity of experience and background. The Nominating and
Corporate Governance Committee and the Board consider a broad range of experience and attributes for this purpose. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Nominating and Corporate Governance Committee will consider <FONT STYLE="white-space:nowrap">stockholder-nominated</FONT> candidates for director, provided that the nominating stockholder identifies the candidate&#146;s principal occupation or
employment, the number of shares of the Company&#146;s common stock that such candidate beneficially owns, a description of all arrangements or understandings between the nominating stockholder and such candidate and any other person or persons
(naming such person or persons) pursuant to which the nominations are to be made by the stockholder, detailed biographical data, qualifications and information regarding any relationships between the candidate and the Company within the past three
years, and any other information relating to such nominee that is required to be disclosed in solicitations of proxies for election of directors, or is otherwise required, in each case pursuant to Regulation 14A of the Securities Exchange Act of
1934, as amended (the &#147;Exchange Act&#148;), or under our Bylaws. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A stockholder&#146;s recommendation must also set forth
the name and address, as they appear on the Company&#146;s books, of the stockholder making such recommendation, the class and number of shares of the Company&#146;s common stock that the stockholder beneficially owns and the date the stockholder
acquired such shares, any material interest of the stockholder in such nomination, any other information that is required to be provided by the stockholder pursuant to Regulation 14A under the Exchange Act or under our Bylaws, in its capacity as a
proponent of a stockholder proposal, a statement from the recommending stockholder in support of the candidate, references for the candidate, and an indication of the candidate&#146;s willingness to serve, if elected. Recommendations for candidates
to the Board of Directors must be submitted in writing to Integra LifeSciences Holdings Corporation, 311 Enterprise Drive, Plainsboro, New Jersey 08536, Attention: Corporate Vice President, General Counsel, Administration and Secretary. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Committee. </I>The members of the Compensation Committee are Dr.&nbsp;Bradley (chair), Ms.&nbsp;Hill and Dr.&nbsp;Morel.
The Committee met six times in 2016. The Compensation Committee makes decisions concerning salaries and incentive compensation, including the issuance of equity awards, for executive officers of the Company. The Compensation Committee also
administers the Company&#146;s 2000 Equity Incentive Plan, the Company&#146;s 2001 Equity Incentive Plan, the Company&#146;s 2003 Equity Incentive Plan, and the Company&#146;s Employee Stock Purchase Plan (collectively, the &#147;Approved
Plans&#148;). Each member of the Compensation Committee is an &#147;outside&#148; director as defined in Section 162(m) of the Internal Revenue Code of 1986, as </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
amended (the &#147;Code&#148;), and a <FONT STYLE="white-space:nowrap">&#147;non-employee&#148;</FONT> director within the meaning of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the
Exchange Act. The Board of Directors has determined that each of the members of the Compensation Committee is independent, as defined by the applicable NASDAQ Stock Market listing standards. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee may delegate any or all of its responsibilities, except that it shall not delegate its responsibilities
regarding (i)&nbsp;the annual review and approval of all elements of compensation of executive officers, (ii)&nbsp;the management, review and approval of annual bonus, long-term incentive compensation, stock option, employee pension and welfare
benefit plans, (iii)&nbsp;any matters that involve executive officer compensation or (iv)&nbsp;any matters where it has determined such compensation is intended to comply with Section 162(m) of the Code by virtue of being approved by a committee of
&#147;outside directors&#148; or is intended to be exempt from Section 16(b) under the Exchange Act pursuant to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> by virtue of being approved by a committee of
<FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> directors.&#148; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has delegated authority
for making equity awards to <FONT STYLE="white-space:nowrap">non-executive</FONT> officer employees under the Approved Plans to a Special Award Committee, consisting of the Chief Executive Officer. The authority to grant equity to executive
officers, employees who are, or could be, a &#147;covered employee&#148; within the meaning of Section 162(m) of the Code or employees whose grants would result in their receiving more than 5,000 shares of common stock during the previous 12 months,
however, remains with the Compensation Committee. On an annual basis, the Compensation Committee establishes the aggregate number of awards that the Special Award Committee may make. The Compensation Committee authorized the Special Award Committee
to grant a maximum of 300,000 shares of awards during the <FONT STYLE="white-space:nowrap">one-year</FONT> period beginning May&nbsp;24, 2016. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s Chief Executive Officer provides significant input on the compensation, including annual merit adjustments and equity awards, of his direct reports and the other executive officers. As
discussed below in &#147;Executive Compensation&nbsp;&#151;&nbsp;Compensation Discussion and Analysis&nbsp;&#151;&nbsp;Oversight and Authority Over Executive Compensation&nbsp;&#151;&nbsp;Role of Chief Executive Officer and Management in Executive
Compensation,&#148; the Compensation Committee approves the compensation of these officers, taking into consideration the recommendations of the Chief Executive Officer. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has established a process for considering the independence of compensation consultants, outside counsel and other advisers (other than
<FONT STYLE="white-space:nowrap">in-house</FONT> legal counsel) who serve as compensation advisers before the Compensation Committee selects or receives advice from such compensation advisers. Currently, no conflict of interest issues have been
raised regarding such compensation advisers. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2017, the Compensation Committee of the Board of Directors engaged Willis
Towers Watson (formerly Towers Watson) to provide consulting services on (i)&nbsp;the Compensation Discussion and Analysis and Say on Pay Proposal, and the Say on Pay frequency Proposal (ii)&nbsp;shareholder advisory matters, (iii) 2018 Performance
Incentive Compensation Plan and the Fourth Amended&nbsp;&amp; Restated 2003 Equity Incentive Plan and (iv)&nbsp;compensation arrangements for the Chief Executive Officer, Chief Financial Officer and other executive officers for 2016. During 2016,
the Compensation Committee of the Board of Directors engaged Willis Towers Watson to provide consulting services on (i)&nbsp;the Compensation Discussion and Analysis and Say on Pay (ii)&nbsp;shareholder advisory matters, and (iii)&nbsp;compensation
arrangements for the Chief Executive Officer, Chief Financial Officer and other executives officers for 2015. During 2015, the Compensation Committee of the Board of Directors engaged Towers Watson to provide consulting services on (i)&nbsp;the
Compensation Discussion and Analysis, Say on Pay Proposal, and Third Amended and Restated 2003 Equity Incentive Plan Proposal, (ii)&nbsp;shareholder advisory matters, (iii)&nbsp;compensation arrangements for the Chief Executive Officer for 2014, and
(iv)&nbsp;compensation analysis of the Company&#146;s <FONT STYLE="white-space:nowrap">spin-off</FONT> spine business&#146; Chief Executive Officer, Chief Financial Officer, Chairman of the Board, and
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors, (v)&nbsp;analysis of the equity treatment of the Company in relation to the <FONT STYLE="white-space:nowrap">spin-off</FONT> of its spine business, and
<FONT STYLE="white-space:nowrap">(vi)&nbsp;non-employee</FONT> director compensation in 2015. During 2014, the Compensation Committee of the Board of Directors engaged Towers Watson to provide consulting services on (i)&nbsp;the Compensation
Discussion and Analysis and the Say on Pay proposal, (ii)&nbsp;shareholder advisory matters, (iii)&nbsp;compensation arrangements for the Chief Executive Officer and Chief Financial Officer for 2013, and (iv)&nbsp;the design of the Company&#146;s
annual and long-term incentive plans. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Finance Committee. </I>The members of the Finance Committee are Mr.&nbsp;Schade
(chair), Mr.&nbsp;Howell and Mr.&nbsp;Murphy. The Committee met six times in 2016. The purpose of the Finance Committee is to advise </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
management on matters related to financing strategy, as well as the Company&#146;s capital structure and capital allocation initiatives. The Board of Directors has determined that each of the
members of the Finance Committee is independent, as defined by the applicable NASDAQ Stock Market listing standards. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_6">
</A>DIRECTOR QUALIFICATIONS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As indicated above under &#147;Information Concerning Meetings, Executive Sessions and Certain
Committees&nbsp;&#151;&nbsp;Nominating and Corporate Governance Committee,&#148; the Board of Directors has an objective, for its Board membership composition, to assemble a group of directors that can support the business in achieving its goals and
represent stockholder interests through the exercise of sound business judgment using its diversity of experience and background. Both the Nominating and Corporate Governance Committee and the Board consider a broad range of diversity for this
purpose. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In identifying appropriate candidates to serve as directors, the Board believes that individuals with experience as
chief executive officers, chief financial officers or senior executives have demonstrated leadership skills and experience to provide sound business judgment and insights to assist the Company in addressing the issues that the Company faces. In
addition, the Board considers public company experience when evaluating director candidates. While the Board values experience in the medical device or life sciences industries, it also seeks to include a broad range of experiences such as academic,
financial and international experience. Further, the Board reviews the overall business acumen and experience of each director and considers how that individual could work together with the rest of the Board in serving the Company and its
stockholders. Each of our Board members has particular attributes, skills and experiences that contribute to a well-rounded Board. We describe below the particular experiences, qualifications, attributes or skills that led the Board to conclude that
each of our directors should serve as a member of our Board. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Arduini has served as our President and Chief Executive
Officer and as a director since January 2012. He joined the Company in November 2010 as President and Chief Operating Officer. He has experience as a director of Bristol Myers Squibb, a company listed on the NASDAQ. Before joining the Company,
Mr.&nbsp;Arduini was Corporate Vice President and President of Medication Delivery, Baxter Healthcare, which he joined in 2005. Mr.&nbsp;Arduini was responsible for a $4.8&nbsp;billion global division of Baxter. Prior to joining Baxter,
Mr.&nbsp;Arduini worked for General Electric Healthcare, where he spent much of his 15 years in a variety of management roles for domestic and global businesses. Prior to joining General Electric Healthcare, he spent four years with Procter and
Gamble in sales and marketing. The Board greatly values his significant experience and knowledge of the medical device and life sciences industries with a public company, leadership skills, operating skills, international and human resources
experience and business acumen. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Bradley has been a director of the Company since 1992. He has experience as a
director of SeaSpine Holdings Corporation, a medical device company listed on the NASDAQ and Highway Insurance plc, a company listed on the London Stock Exchange, and as a consultant to a number of business, government and international
organizations and significant international academic experience and outside board and chair experience. Dr.&nbsp;Bradley&#146;s experience and knowledge of the Company, his international business, accounting and executive compensation experience,
consulting and teaching background in management and management strategy, as well as outside board experience, enable him to make significant contributions to the Board. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As indicated below under &#147;Board Leadership Structure,&#148; Dr.&nbsp;Essig has served as Chairman of the Board of Directors since January 2012 and has been a director since 1997. He served as both
President and CEO of the Company from 1997 until 2010 and then as CEO from 2010 to 2012. Prior to joining the Company, he was a managing director at Goldman, Sachs&nbsp;&amp; Co. where he supervised the medical technology practice. In addition, he
serves as a board member of Owens&nbsp;&amp; Minor, Inc., an NYSE-listed company as well as SeaSpine Holdings Corporation, a NASDAQ listed company. Previously he served on the board of directors of St. Jude Medical, prior to its acquisition by
Abbott Laboratories, Zimmer Holdings, Inc., a NYSE-listed medical device company, and ADVAMED, a trade association that represents the medical device industry. Dr.&nbsp;Essig&#146;s significant experience in serving as an investment banker for
numerous medical device companies, his finance, business development, management, leadership and risk assessment skills, his knowledge of the Company, and his broad knowledge of, and strategic perspective in, the medical device industry, as well as
his manufacturing, compliance, public company and outside board experience, make him a highly valued Chairman of the Board. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Hill is an Operating Partner of NexPhase Capital, a private equity firm. She
previously served as an Operating Partner of Moelis Capital Partners, a private equity firm. In addition, she previously served as Chief Executive Officer and a director of ValueOptions, Inc., as Chief Executive Officer and Chairman of the Board of
Woodhaven Health Services, and as President and a director of Express Scripts. She also serves as a board member of Omega Healthcare Investors, Inc., a NYSE-listed real estate investment trust. Her experience in the healthcare and medical device
industry, in leadership and management and her outside board experience provides valuable contributions to the Board. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Howell is an Executive Vice President as well as the Chief Financial Officer at Booz Allen Hamilton, where he has held a variety
of leadership positions since joining the firm in 1988. At Booz Allen Hamilton, Mr.&nbsp;Howell has led the business in delivering the firm&#146;s capabilities and service offerings to both the federal and private sectors. The Board believes that it
benefits greatly by having a director who is a seasoned senior executive with extensive business expertise. His management and leadership experience provide valuable contributions to the Board. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Morel was the Chief Executive Officer of West Pharmaceutical Services, Inc., a manufacturer of components and systems for the
packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical, healthcare and consumer products industries between April 2002 and April 2015. He has significant biomedical and pharmaceutical experience with
over 20 years of experience developing and managing programs involving advanced materials for aerospace, biomedical and pharmaceutical applications. In addition, having served in a variety of increasingly responsible roles at West Pharmaceutical
Services, Inc., including Chief Operating Officer, head of the drug delivery division and Vice President of Research and Development, Dr.&nbsp;Morel has considerable experience identifying and implementing strategic priorities. Dr.&nbsp;Morel&#146;s
experience as the Chief Executive Officer of a publicly held life sciences company and as a director of public companies as well as his leadership and management experience make him well qualified to serve on the Board. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Murphy was Senior Vice President&nbsp;&amp; Treasurer of Time Warner Inc. between 2004 and 2008. He also served in various other
leadership positions at Time Warner and at America Online, Inc., Marriott International, Inc., Manor Care, Inc., Ryder System Inc. and WR Grace&nbsp;&amp; Company. His financial, accounting, treasury, business development and risk management
expertise, public company experience, leadership skills and outside board experience enable him to make valuable contributions to the Board. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Schade currently serves as the President and Chief Executive Officer of Aprea AB, a privately held, clinical-stage biopharmaceutical company developing novel anticancer therapies targeting the
tumor suppressor protein p53, positions he has held since June 2016. Prior to that he was the Chief Executive Officer of Novira Therapeutics, Inc., an antiviral drug discovery company, from March 2014 to December 2015 until it was acquired by
Johnson&nbsp;&amp; Johnson. In addition, he served as Executive Vice President and Chief Financial Officer of Omthera Pharmaceuticals, Inc., a former public company that is an emerging specialty pharmaceuticals company from September 2011 to July
2013. Prior to that time, he served as Executive Vice President and Chief Financial Officer of NRG Energy, Inc., a NYSE-listed company, since May 2010. He was formerly the Senior Vice President, Finance and Administration, and Chief Financial
Officer of Medarex, Inc., a <FONT STYLE="white-space:nowrap">NASDAQ-listed</FONT> life sciences company prior to its acquisition by <FONT STYLE="white-space:nowrap">Bristol-Myers</FONT> Squibb Company. He also served in various other leadership
positions at Medarex and Merrill Lynch. The Board greatly values his expertise in corporate management, finance, manufacturing, accounting and human resources, his management, leadership, business development and risk management skills, as well as
his international experience and significant knowledge and experience in the life sciences industry with a public company. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Sullivan has been a director since 1992. He is the Senior Advisor to the Clover Investment Group. He has held several top
leadership positions with Marriott International, Inc., Tenly Enterprises, Inc., Marriott Corp., Harrah&#146;s Entertainment, Inc., Holiday Inns, Inc., Kentucky Fried Chicken Corp. and Heubein, Inc. and was a senior auditor for Arthur
Andersen&nbsp;&amp; Co. He has experience as a director of SeaSpine Holdings Corporation, a medical device company listed on the NASDAQ. His experience and knowledge of the Company, financial expertise and experience in corporate management,
business development, risk assessment and international business, his background in accounting and auditing, his public company experience with global companies, as well as his outside board experience, are highly valued qualifications. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For additional information on the background and experience of each of our directors, see
&#147;Proposal 1. Election of Directors.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_7"></A>BOARD LEADERSHIP STRUCTURE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company currently has ten members of the Board of Directors, who will serve until the next annual meeting of stockholders and until
their successors are duly elected and qualified. The current directors are Peter J. Arduini, Keith Bradley, Ph.D., Richard E. Caruso, Ph.D., Stuart M. Essig, Ph.D., Barbara B. Hill, Lloyd W. Howell, Jr., Donald E. Morel, Jr., Ph.D., Raymond G.
Murphy, Christian S. Schade and James M. Sullivan. All current members of the Board are nominees for election to the Board at the 2017 annual meeting of stockholders except for Dr.&nbsp;Caruso, who will become Chairman Emeritus and Director
Emeritus. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As indicated above, Mr.&nbsp;Arduini has served as both President and Chief Executive Officer and as a director of
the Company since January 2012 and as both President and Chief Operating Officer from November 2010 until January 2012. His position is separate from that of the Executive Chairman of the Board. We view having the Chairman position separate from the
CEO as putting the Company in the best position to oversee all executives of the Company and set a <FONT STYLE="white-space:nowrap">pro-stockholder</FONT> agenda without presenting potential conflicts that having the two positions combined might
pose. This separation of roles, in turn, leads to a more effective board of directors. As a result, we believe that it is a good corporate governance practice to have separate Chairman and Chief Executive Officer positions. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stuart M. Essig, Ph.D. has served as <FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairman of the Board of Directors since June
2012 and has been a director since 1997. He served as Executive Chairman of the Board from January 2012 to June 2012 as well as President from 1997 to 2010 and as Chief Executive Officer from 1997 to 2012. As a result, he has significant experience
with, and knowledge of, the Company, its operations, products and history. In addition, he is a significant stockholder of the Company. We believe that we benefit greatly by having a Chairman with significant experience and knowledge of the Company
and whose interests are strongly aligned with those of our stockholders. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors appointed Mr.&nbsp;Sullivan
Presiding Director, effective as of May&nbsp;17, 2012. He has been a director since 1992. Accordingly, he has significant experience with, and knowledge of, the Company, its operations, products and history. We believe that we benefit greatly by
having a Presiding Director with significant experience and knowledge of the Company. In addition, the presence of an active and independent Presiding Director ensures independent oversight of the Board of Directors and its responsibilities.
Further, we believe that having a separate Presiding Director to, among other things, serve as the primary liaison between the independent directors and the CEO, counsel the CEO on key board governance issues and preside over board meetings if the
Chairman of the Board is absent leads to a more effective board of directors. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that the mix of backgrounds,
experience, attributes and skills of our directors provides a good balance for the Board composition. See &#147;Director Qualifications&#148; above for a description of the specific experience, qualifications, attributes or skills of each of our
director nominees that the Nominating and Corporate Governance Committee considered relevant in nominating them and &#147;Proposal 1. Election of Directors&#148; for each director nominee&#146;s biographical information. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, we believe that the size of the Board and Board Committees is appropriate, given the size, nature, structure and complexity
of the Company. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accordingly, we believe that our Board leadership structure is appropriate at this time. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_8"></A>THE BOARD&#146;S ROLE IN RISK OVERSIGHT </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In general, the Board of Directors has overall responsibility for the oversight of risk management at the Company. The Board of Directors
has delegated responsibility for the oversight of certain areas of risk management to various Committees of the Board, as described below. Each Board Committee reports to the full Board following each Committee meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee oversees the accounting and financial reporting processes of the Company
and the audits of our financial statements. Management meets regularly with the Audit Committee to discuss and review the financial risk management processes. These discussions address compliance with
<FONT STYLE="white-space:nowrap">Sarbanes-Oxley</FONT> (including discussions regarding internal controls and procedures), disclosure controls and procedures and accounting and reporting compliance, as well as tax, treasury and compliance matters.
Our internal audit team&#146;s responsibilities include providing an annual audit assessment of the Company&#146;s processes and controls, developing an annual audit plan using risk-based methodology, implementing the annual audit plan, coordinating
with other control and monitoring functions, issuing periodic reports to the Audit Committee and management summarizing the results of audit activities, assisting with investigations of significant suspected fraudulent activities within the
organization and notifying management and the Audit Committee of the results. Management also regularly discusses with the Audit Committee liquidity, capital, funding needs and other financial matters. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee oversees risk relating to executive compensation programs. The Compensation Committee considers compensation
risk during its deliberations on the design of our executive compensation programs with the goal of appropriately balancing short-term objectives and long-term performance without encouraging excessive and unnecessary risk-taking behaviors.
Management recently conducted a review and risk assessment of the Company&#146;s 2017 incentive compensation programs (which cover the executive officers and certain other employees in the United States, Australia, Canada, Europe, New Zealand, Asia
Pacific and Latin America regions, Mexico and Puerto Rico) and presented a report to the Board on this subject at its February 2017 meeting. The Compensation Committee reviewed this report and approved the conclusions that (i)&nbsp;our compensation
programs are designed with an appropriate balance of risk and reward in relation to our overall business strategy and do not encourage excessive or unnecessary risk-taking behavior and (ii)&nbsp;we do not believe that risks relating to our
compensation programs are reasonably likely to have a material adverse effect on the Company. See &#147;Risk Assessment Regarding Compensation Policies and Practices&#148; below. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Corporate Governance Committee has oversight of corporate governance matters. These matters include evaluation of the
performance of the Board, its Committees and members, as well as establishing policies and procedures for good corporate governance. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Finance Committee has oversight on matters related to financing strategy, as well as the Company&#146;s capital structure and capital allocation initiatives. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each year management presents a detailed report to the Board on the Company&#146;s processes in place for assessing and addressing risks,
providing periodic reports on compliance regimens and reporting material information to the Board. This report assists the Board in its evaluation of the Company&#146;s risk management practices. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our President and Chief Executive Officer, who functions as our chief risk officer, has responsibility for ensuring that management
provides periodic updates to the Board or Board Committees regarding risks in many areas, among them accounting, treasury, information systems, legal, governance, legislative (including reimbursement), general compliance (including sales and
marketing compliance), quality, regulatory, corporate development, operations and sales and marketing. Both formal reports and less formal communications derive from a continual flow of communication throughout the Company regarding risk and
compliance. We believe that our Board and senior management team promote a culture that actively identifies and manages risk, including effective communication throughout the entire organization and to the Board and Committees. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Finance Department and the internal audit team meet with our senior leadership annually to determine whether there is a need to
conduct a formal enterprise risk assessment for the Company. This assessment involves many members of management and obtains management&#146;s views of all the business risks facing the Company. Management reports to, and discusses with, the Board
the results of this enterprise risk assessment. This annual discussion, along with our annual processes for creating and reviewing with the Board our strategic plan, our budget and our internal audit plans, as well as regular processes and
communications throughout the Company and periodic updates to the Board and Committees on a broad range of risks, combine to ensure that the Company continually addresses its business risks in a disciplined fashion. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_9"></A>RISK ASSESSMENT REGARDING COMPENSATION POLICIES AND PRACTICES
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We recently conducted a risk assessment of our compensation policies and programs, including our executive compensation
programs. We reviewed and discussed the findings of the assessment with the Compensation Committee and the full Board of Directors and concluded that our compensation programs are designed with an appropriate balance of risk and reward in relation
to our overall business strategy and do not encourage excessive or unnecessary risk-taking behavior. As a result, we do not believe that risks relating to our compensation programs are reasonably likely to have a material adverse effect on the
Company. The Compensation Committee reviewed management&#146;s report on the review and assessment of such compensation programs and approved these conclusions. In conducting this review, we considered the following attributes of our programs:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mix of base salary, annual bonus opportunities and long-term equity compensation; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Balance between annual and long-term performance opportunities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alignment of annual and long-term incentives to ensure that the awards encourage consistent behaviors and achievable performance results, without
encouraging excessive or unnecessary risk-taking; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ability to use <FONT STYLE="white-space:nowrap">non-financial</FONT> and other qualitative performance factors in determining actual compensation
payouts; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Use of equity awards that vest over time, discouraging excessive or unnecessary risk-taking by senior leadership; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Generally providing senior executives with long-term <FONT STYLE="white-space:nowrap">equity-based</FONT> compensation on an annual basis. We believe
that as executives accumulate awards over a period of time, they are encouraged to take actions that promote the long-term sustainability of our business; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock ownership guidelines, with holding periods until guidelines are achieved, that are reasonable and align the interests of the executive officers
with those of our stockholders while discouraging executive officers from focusing on short-term results without regard for long-term consequences; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective systems and processes in place to identify and assess risk. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Compensation Committee considered the risk implications of our compensation practices during its deliberations on the design of our
2017 executive compensation programs, with the goal of appropriately balancing short-term incentives and long-term performance. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_10"></A>DIRECTOR ATTENDANCE AT ANNUAL MEETINGS; SHAREHOLDER </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>COMMUNICATIONS WITH DIRECTORS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">It is our policy to encourage our directors to attend the annual meeting of stockholders. Seven of our incumbent nominee directors attended the 2016 Annual Meeting of Stockholders, two of our directors,
Barbara B. Hill and Lloyd W. Howell, Jr., were unable to attend. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders may communicate with our Board of Directors, any
of its constituent committees or any member thereof by means of a letter addressed to the Board of Directors, its constituent committees or individual directors and sent care of Integra LifeSciences Holdings Corporation, 311 Enterprise Drive,
Plainsboro, NJ 08536, Attention: Corporate Vice President, General Counsel, Administration and Secretary. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_11"></A>INFORMATION ABOUT EXECUTIVE OFFICERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Set forth below is the name, age, position and a brief account of the business experience of each of our current executive officers:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="63%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:27pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer and Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth Burhop, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, Chief Scientific Officer</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn G. Coleman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President and Chief Financial Officer</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert T. Davis, Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">58</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, President&nbsp;&#151; Specialty Surgical Solutions</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lisa Evoli</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">47</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, Chief Human Resources Officer</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">56</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, General Counsel, Administration and Secretary</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Mooradian</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, Global Operations and Supply Chain</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Judith E. O&#146;Grady</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, Global Regulatory Affairs</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dan Reuvers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, President&nbsp;&#151; International</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph Vinhais</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, Global Quality Assurance</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>PETER J. ARDUINI</I> is Integra&#146;s President and Chief Executive Officer and a director. He joined
Integra in November 2010 as President and Chief Operating Officer and was appointed Chief Executive Officer and a director in January 2012. Before joining Integra, Mr.&nbsp;Arduini was Corporate Vice President and President of Medication Delivery,
Baxter Healthcare, which he joined in 2005. Mr.&nbsp;Arduini was responsible for a $4.8&nbsp;billion global division of Baxter focused on inpatient pharmaceuticals and devices. Prior to joining Baxter, Mr.&nbsp;Arduini worked for General Electric
Healthcare, where he spent much of his 15 years in a variety of management roles for domestic and global businesses, culminating in leading the global functional imaging business. Prior to joining General Electric Healthcare, he spent four years
with Procter and Gamble in sales and marketing. Mr.&nbsp;Arduini serves on the Board of Directors of Bristol-Myers Squibb Company. He serves on the Board of Directors of ADVAMED, the Advanced Medical Technology Association, the Medical Device
Innovation Consortium and the National Italian American Foundation. Mr.&nbsp;Arduini received his bachelor&#146;s degree in marketing from Susquehanna University and a master&#146;s in management from Northwestern University&#146;s Kellogg School of
Management. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>KENNETH BURHOP, PH.D. </I>is Integra&#146;s Corporate Vice President, Chief Scientific Officer. Dr.&nbsp;Burhop
is responsible for setting Integra&#146;s strategic scientific vision and roadmap, as well as leading the Company&#146;s portfolio prioritization and management and the scientific evaluation of corporate development and new product opportunities. He
joined Integra in February 2014 as Senior Vice President, Chief Scientific Officer and was appointed Corporate Vice President in March 2014. Prior to joining Integra, Dr.&nbsp;Burhop served as Chief Scientific Officer at Sangart, Inc., from January
2011 to October 2013. Prior to joining Sangart, Inc., he spent 24 years with Baxter Healthcare Corporation, from 1986 through 2010, in a series of leadership roles such as Vice President, R&amp;D, Baxter Pharmaceutical Technologies and Vice
President, Global Scientific Lead for Baxter&#146;s Medication Delivery Division, a business with over $4&nbsp;billion in annual sales. Dr.&nbsp;Burhop received his Ph.D. and M.S. in Veterinary Science from the University of Wisconsin-Madison, and
his B.A. in Zoology from the University of Wisconsin-Milwaukee. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>GLENN G. COLEMAN</I> is Integra&#146;s Corporate Vice
President, Chief Financial Officer and Principal Accounting Officer. Mr.&nbsp;Coleman is responsible for the Company&#146;s finance department, including accounting and financial reporting, budgeting, internal audit, tax, treasury, investor
relations, and information technology. Mr.&nbsp;Coleman is also responsible for running the commercial operations of the international business. He joined Integra in May 2014 as Corporate Vice President, Chief Financial Officer and Principal
Accounting Officer, and has 25 years of experience in financial management positions with leading global businesses. Prior to joining the Company, from 2008 to May 2014, Mr.&nbsp;Coleman served as Vice President Finance, Corporate Controller at
Curtiss-Wright Corporation, a $2.5&nbsp;billion global company headquartered in Charlotte, North Carolina that delivers highly-engineered, critical function products and services to the commercial, industrial, defense and energy markets. Prior to
joining Curtiss-Wright in 2008, Mr.&nbsp;Coleman worked at Alcatel-Lucent from 1997 to </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
2007, in various finance executive leadership positions, including Vice President for the Wireless and Wireline Business Groups, Controller for the Americas region, Vice President of Internal
Audit and Finance Director of External and Internal Reporting. Mr.&nbsp;Coleman was also instrumental in several significant corporate strategic projects at Alcatel-Lucent, including a multi-billion dollar restructuring program, <FONT
STYLE="white-space:nowrap">spin-off</FONT> of an $8&nbsp;billion publicly traded entity, and numerous acquisitions. Prior to that, Mr.&nbsp;Coleman began his career at PricewaterhouseCoopers LLP where he spent 8 years. Mr.&nbsp;Coleman received his
B.S. degree from Montclair State University and has also been a CPA in New Jersey for more than 20 years. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>ROBERT T. DAVIS,
JR.</I> is Integra&#146;s Corporate Vice President, President, Orthopedics and Tissue Technologies. Mr.&nbsp;Davis is responsible for the management of the Orthopedics and Tissue Technologies global division, which includes the orthopedic extremity
implants, and regenerative tissue products. His responsibilities include leadership of sales, commercial operations, marketing and strategy, product development, regulatory affairs, quality assurance, manufacturing, and business development,
worldwide. Mr.&nbsp;Davis joined Integra in July 2012 as President of the Global Neurosurgery business and was appointed Integra&#146;s Corporate Vice President in December 2012 and President&nbsp;&#151;&nbsp;Specialty Surgical Solutions in 2014. He
brings more than 25 years of executive management experience in the global healthcare industry. Prior to joining Integra, Mr.&nbsp;Davis was the General Manager for the Global Anesthesia&nbsp;&amp; Critical Care business at Baxter Healthcare, from
2009 to 2012, and held various general management positions at GE Healthcare in the areas of interventional therapeutics, cardiovascular imaging and diagnostic ultrasound from 1997 to 2009. Mr.&nbsp;Davis earned his B.S. in Sports Medicine from the
University of Delaware, a Master&#146;s degree in Exercise&nbsp;&amp; Cardiovascular Physiology from Temple University, and an M.B.A. from Drexel University. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>LISA EVOLI</I> is Integra&#146;s Corporate Vice President, Chief Human Resources Officer. Ms.&nbsp;Evoli is responsible for providing leadership in developing and executing human resources strategy in
support of the overall business plan and strategic direction of the organization. She joined Integra as Corporate Vice President, Chief Human Resources Officer in January 2016. Ms.&nbsp;Evoli brings significant global Human Resources leadership
experience. Prior to joining Integra, she served as Vice President, Human Resources for the Data&nbsp;&amp; Devices division of TE Connectivity (formerly Tyco Electronics) from September 2012 through December 2015. Prior to working for TE
Connectivity, Ms.&nbsp;Evoli held senior global human resources leadership positions with Johnson&nbsp;&amp; Johnson from 2004 through December 2011 in both the Pharmaceutical and Consumer sectors. She held various global human resources leadership
roles at Motorola specifically in their Broadband Communications and Automotive groups from 1997 through 2004, and again in April 2011 through August 2012 serving in a Talent Management&nbsp;&amp; Organizational Development leadership role.
Ms.&nbsp;Evoli received her B.S. in Business Administration from California University of Pennsylvania and an M.S. in Human Resources / Organizational Development from Villanova University. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>RICHARD D. GORELICK</I> is Integra&#146;s Corporate Vice President, General Counsel, Administration and Secretary. Mr.&nbsp;Gorelick
was appointed Integra&#146;s Corporate Vice President in December 2012. He joined Integra as Vice President and General Counsel in 2000, and was appointed Senior Vice President and Corporate Secretary in 2006. Mr.&nbsp;Gorelick also chaired the
Human Resources Department from 2008 to 2011. In September 2011, Mr.&nbsp;Gorelick was given the additional responsibilities of Corporate Communications, Environmental, Health and Safety, Government Relations and Public Policy, and Risk Management,
and the Integra Foundation. Prior to joining Integra, he spent four and a half years at Aventis Behring LLC, a global leader in biologics (plasma proteins) as Associate General Counsel, where his practice focused on technology licensing, strategic
alliances, acquisitions and managing commercial litigation. Prior to that, Mr.&nbsp;Gorelick worked in the Business and Finance Section of Morgan, Lewis&nbsp;&amp; Bockius LLP, in Philadelphia, where his practice concentrated on transactions,
corporate reorganizations, creditors&#146; rights and secured transactions. Mr.&nbsp;Gorelick received his A.B. degree from Princeton University and a J.D. degree from the University of California at Berkeley School of Law. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>JOHN MOORADIAN</I> is Integra&#146;s Corporate Vice President, Global Operations and Supply Chain. His responsibilities include global
manufacturing and supply chain. Mr.&nbsp;Mooradian was appointed Integra&#146;s Corporate Vice President in December 2012. He joined Integra in September 2012 as Senior Vice President, Global Operations and Supply Chain. Before coming to Integra,
Mr.&nbsp;Mooradian spent 24 years at Abbott Laboratories in a series of leadership roles, including managing the Hematology and Point of Care businesses and, more recently, worldwide operations at Abbott Diagnostics Division, a $4&nbsp;billion
business with over 11,000 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
employees. Prior to Abbott, Mr.&nbsp;Mooradian held several positions at General Motors. Mr.&nbsp;Mooradian received a B.B.A. degree in Management from the University of Texas, Arlington.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>JUDITH E. O&#146;GRADY</I> is Integra&#146;s Corporate Vice President, Global Regulatory Affairs. She
was appointed Integra&#146;s Corporate Vice President in December 2012. In addition, Ms.&nbsp;O&#146;Grady was Corporate Vice President, Global Regulatory Affairs and Corporate Compliance Officer from December 2012 to June 2014, Senior Vice
President of Regulatory Affairs, and Corporate Compliance Officer from September 2012 to December 2012, and Senior Vice President, Regulatory Affairs, Quality Assurance, and Corporate Compliance Officer from 2007 to September 2012. Previously, she
was Vice President of Regulatory Affairs, Quality Assurance and Clinical Affairs. Ms.&nbsp;O&#146;Grady has worked in the areas of medical technology and collagen technology for over 25 years. Prior to joining Integra, Ms.&nbsp;O&#146;Grady worked
for <FONT STYLE="white-space:nowrap">Colla-Tec,</FONT> Inc., a Marion Merrell Dow Company. During her career she has held positions with Surgikos, a Johnson&nbsp;&amp; Johnson Company, and was on the faculty of Boston University College of Nursing
and Medical School. Ms.&nbsp;O&#146;Grady led the team that obtained the approval of the Food and Drug Administration (&#147;FDA&#148;) for INTEGRA<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> Dermal Regeneration Template, the first regenerative product approved by the FDA, and has led teams responsible for approvals of the Company&#146;s other regenerative
product lines as well as more than 600 FDA and international submissions. Ms.&nbsp;O&#146;Grady received a B.S. degree from Marquette University and M.S.N. in Nursing from Boston University. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>DAN REUVERS</I> is Integra&#146;s Corporate Vice President, President, Specialty Surgical Solutions. His responsibilities within
Specialty Surgical Solutions include leadership of sales, marketing, product development, regulatory affairs, quality assurance, Global Services and Repair and manufacturing worldwide He joined Integra in 2008 as Vice President of Marketing and
Product Development for Integra&#146;s surgical instruments business and was promoted to President of the acute surgical instruments business in June 2010. He was appointed President, Instruments in 2011, Corporate Vice President in December 2012,
and President, International in November 2013. Mr.&nbsp;Reuvers was President of Omni-Tract Surgical from September 2005 until December 2008, when the company was acquired by Integra. Mr.&nbsp;Reuvers has over 25 years of experience in the medical
technology field, including holding various executive level positions in sales, marketing and general management. He serves on the board of directors of Respirtech, Inc. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>JOSEPH VINHAIS</I> is Integra&#146;s Corporate Vice President, Global Quality Assurance. His responsibilities include strategic direction for corporate compliance and quality systems. Mr.&nbsp;Vinhais
was appointed Integra&#146;s Corporate Vice President in December 2012. Mr.&nbsp;Vinhais joined Integra in September 2012 as Senior Vice President, Global Quality Assurance, and was appointed Corporate Vice President in December 2012.
Mr.&nbsp;Vinhais has over 25 years of global quality experience in quality assurance, regulatory affairs, compliance, and operations execution. Prior to joining Integra, Mr.&nbsp;Vinhais was head of Quality Assurance, Regulatory Affairs, and
Sustainability at Philips Healthcare Imaging Systems, from 2009 to September 2012, where he was responsible for quality assurance and regulatory affairs for the Computed Tomography and Nuclear Medicine business. Prior to Philips, Mr.&nbsp;Vinhais
was General Manager of Quality Assurance&nbsp;&amp; Regulatory Affairs at General Electric Healthcare, from 2007 to 2009. Mr.&nbsp;Vinhais received a B.S. in Information Sciences and Systems from Central Connecticut State University, a certificate
in Medical Device Management from Worcester Polytechnic Institute, and a certificate in Regulatory Affairs and Compliance from Northeastern University. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_12"></A>PROPOSAL 2. RATIFICATION OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The firm of PricewaterhouseCoopers LLP served as our independent registered public accounting firm for
fiscal year 2016 and has been selected by the Audit Committee to serve in the same capacity for fiscal year 2017. The stockholders will be asked to ratify this appointment at the Meeting. The ratification of our independent registered public
accounting firm by the stockholders is not required by law or our Bylaws. We have traditionally submitted this matter to the stockholders and believe that it is good practice to continue to do so. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If stockholders fail to ratify the selection, the Audit Committee will reconsider whether to retain PricewaterhouseCoopers LLP. Even if
the selection is ratified, the Audit Committee in its discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if the Audit Committee determines that such a change would be in the
best interests of the Company and its stockholders. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During fiscal year 2016, PricewaterhouseCoopers LLP not only provided
audit services, but also rendered other services, including tax compliance and planning services. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets
forth the aggregate fees billed or expected to be billed by PricewaterhouseCoopers LLP and affiliated entities for audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services (as well as all <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;out-of-pocket&#148;</FONT></FONT> costs incurred in connection with these services) and are categorized as Audit Fees, <FONT STYLE="white-space:nowrap">Audit-Related</FONT> Fees, Tax Fees and All Other Fees. The
nature of the services provided in each such category is described following the table. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Actual Fees</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(In thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,914</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,030</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit-Related Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,923</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Audit and <FONT STYLE="white-space:nowrap">Audit-Related</FONT> Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,277</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">143</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Other Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,099</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,717</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,195</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The nature of the services provided in each of the categories listed above is described below: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Audit Fees</I>&nbsp;&#151;&nbsp;Consists of professional services rendered for the integrated audit of the consolidated financial
statements of the Company, quarterly reviews, statutory audits, comfort letters, consents and review of documents filed with the Securities and Exchange Commission. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Audit</I><I><FONT STYLE="white-space:nowrap">-Related</FONT> Fees</I>&nbsp;&#151;&nbsp;Consists of services related to the spine business carve out audit and accounting consultations in connection with
acquisitions and consultations concerning financial accounting and reporting standards. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Tax
Fees</I>&nbsp;&#151;&nbsp;Consists of tax compliance (review of corporate tax returns, assistance with tax audits and review of the tax treatment for certain expenses) and state, local and international tax planning and consultations with respect to
various domestic and international tax planning matters. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>All Other Fees</I>&nbsp;&#151;&nbsp;Consists of advisory services
and the licensing of accounting research software. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">No other fees were incurred to PricewaterhouseCoopers LLP during 2015 or
2016. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee approved all services and fees described above. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> of Audit and <FONT STYLE="white-space:nowrap">Non-Audit</FONT> Services </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Audit Committee Charter, the Audit Committee must <FONT STYLE="white-space:nowrap">pre-approve</FONT> all audit and <FONT
STYLE="white-space:nowrap">non-audit</FONT> services provided by the independent registered public accounting firm. The policy, as described below, sets forth the procedures and conditions for such
<FONT STYLE="white-space:nowrap">pre-approval</FONT> of such services. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Management submits requests for approval in writing to
the Audit Committee, which reviews such requests and approves or declines to approve the requests. The Audit Committee&#146;s <FONT STYLE="white-space:nowrap">pre-approval</FONT> of audit and <FONT STYLE="white-space:nowrap">non-audit</FONT>
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
services is not required if the engagement for the services is entered into pursuant to <FONT STYLE="white-space:nowrap">pre-approval</FONT> policies and procedures established by the Audit
Committee regarding the Company&#146;s engagement of the independent registered public accounting firm, provided that the policies and procedures are detailed as to the particular service, the Audit Committee is informed of each service provided and
such policies and procedures do not include delegation of the Audit Committee&#146;s responsibilities under the Exchange Act to the Company&#146;s management. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee may delegate to one or more designated members of the Audit Committee the authority to grant <FONT STYLE="white-space:nowrap">pre-approvals,</FONT> provided that such approvals are
presented to the Audit Committee at a subsequent meeting. If the Audit Committee elects to establish <FONT STYLE="white-space:nowrap">pre-approval</FONT> policies and procedures regarding <FONT STYLE="white-space:nowrap">non-audit</FONT> services,
the Audit Committee must be informed of each <FONT STYLE="white-space:nowrap">non-audit</FONT> service provided by the independent registered public accounting firm. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has determined that the rendering of the services other than audit services by PricewaterhouseCoopers LLP is compatible with maintaining PricewaterhouseCoopers LLP&#146;s independence.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Representatives of PricewaterhouseCoopers LLP are expected to be present at the Meeting and will be allowed to make a
statement. Additionally, they will be available to respond to appropriate questions from stockholders during the Meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Required Vote
for Approval and Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of the shares
present, in person or represented by proxy, at the Meeting and entitled to vote is required to ratify the appointment of PricewaterhouseCoopers LLP as the Company&#146;s independent registered public accounting firm for the fiscal year 2017.
Abstentions will not be voted and will have the effect of a vote against this proposal. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will not be counted in determining the number of shares necessary for approval and will have no effect
on the outcome of this proposal. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Audit Committee of the Board of Directors has adopted a resolution approving the
appointment of PricewaterhouseCoopers LLP. The Board of Directors hereby recommends that the stockholders of the Company vote &#147;FOR&#148; ratification of the appointment of PricewaterhouseCoopers LLP as the Company&#146;s independent registered
public accounting firm for fiscal year 2017. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_13"></A>PROPOSAL 3. APPROVAL OF THE COMPANY&#146;S 2018 PERFORMANCE
INCENTIVE COMPENSATION PLAN </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors is submitting for stockholder approval, in order to satisfy the
stockholder approval requirements of Section 162(m) of the Internal Revenue Code of 1986, as amended (&#147;Section 162(m)&#148;), the Company&#146;s 2018 Performance Incentive Compensation Plan (the &#147;Bonus Plan&#148;) under which participating
employees of the Company will be eligible to earn cash incentive payments based on the achievement of specified performance goals. On March&nbsp;29, 2017, the Board of Directors adopted the Bonus Plan, subject to and conditioned upon stockholder
approval, as recommended by the Compensation Committee. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The principal purpose of the Bonus Plan is to support the
Company&#146;s ability to offer incentive compensation to eligible employees by rewarding the achievement of corporate goals, division and major corporate functional goals and individual performance, all of which is consistent with and supportive of
the overall corporate objectives of the Company. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In general, Section 162(m) places a limit on the deductibility for federal
income tax purposes of the compensation paid to our Chief Executive Officer or any of our three other most highly compensated executive officers (other than our Chief Financial Officer) (&#147;covered employees&#148;). Under Section 162(m),
compensation paid to such persons in excess of $1&nbsp;million in a taxable year generally is not deductible. However, compensation that qualifies as &#147;performance-based&#148; under Section 162(m) does not count against the $1&nbsp;million
deduction limitation. One of the requirements of &#147;performance-based&#148; compensation for purposes of Section 162(m) is that the material terms of the performance goals under which compensation may be paid be disclosed to and approved by our
stockholders. For purposes of Section 162(m), the material terms include (a)&nbsp;the employees eligible to receive compensation, (b)&nbsp;a description of the business criteria on which the performance goals may be based and (c)&nbsp;the maximum
amount of compensation that can be paid to an employee under the performance goals. Each of these aspects of the Bonus Plan is discussed below, and stockholder approval of this Proposal 3 will be deemed to constitute approval of the material terms
of the performance goals under the Bonus Plan for purposes of the stockholder approval requirements of Section 162(m). </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholder approval of the material terms of the performance goals under the Bonus Plan is only one of several requirements under Section
162(m) that must be satisfied for amounts paid under the Bonus Plan to qualify for the &#147;performance-based&#148; compensation exemption under Section 162(m), and submission of the material terms of the Bonus Plan&#146;s performance goals for
stockholder approval should not be viewed as a guarantee that we will be able to deduct any or all compensation under the Bonus Plan. Nothing in this proposal precludes us or the Compensation Committee from making any payment that is not intended to
qualify for tax deductibility under Section 162(m). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If our stockholders approve the Bonus Plan pursuant to this Proposal 3,
the first performance period for which employees will be eligible to earn awards under the Bonus Plan will begin on January&nbsp;1, 2018. If our stockholders do not approve the Bonus Plan pursuant to this Proposal 3, then the Bonus Plan will not
become effective. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of the material terms of the Bonus Plan. The summary does not purport to be a
complete description of all the provisions of the Bonus Plan, a copy of which is attached to this proxy statement as Appendix A. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Description of the Bonus Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Plan Administration</I>. The Bonus Plan will be administered by a committee (the &#147;Committee&#148;) designated by the Board, consisting of at least two members, each of whom is an &#147;outside
director&#148; within the meaning of Section 162(m). The Compensation Committee currently is expected to administer the Bonus Plan. The Committee may delegate to a committee of one or more members of the Board or one or more officers of the Company
the authority to grant or amend bonuses or bonus opportunities, or to take other administrative actions, provided that in no event will an officer of the Company be delegated the authority to grant bonuses to, or amend bonus opportunities held by,
the following individuals: (a)&nbsp;individuals who are subject to Section&nbsp;16 of the Exchange Act, (b)&nbsp;Section 162(m) covered employees with respect to bonuses intended to constitute &#147;qualified
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
performance based compensation&#148; under Section 162(m), or (c)&nbsp;officers of the Company to whom authority has been delegated under the Bonus Plan. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Eligibility</I>. The Company or, solely with respect to Section 162(m) covered employees, the Compensation Committee, will determine
which employees will participate in the Bonus Plan. As of March&nbsp;31, 2017, we had approximately 1,876 United States employees and 215 <FONT STYLE="white-space:nowrap">non-United</FONT> States employees eligible to participate in the Bonus Plan
(assuming that each such employee remained employed on January&nbsp;1, 2018, the effective date of the Bonus Plan). Generally, all employees of the Company as of January&nbsp;1 of a performance period will be eligible to be selected to participate
in the Bonus Plan for the applicable performance period. In addition, employees who are newly hired after January&nbsp;1 of a performance period, but prior to October&nbsp;1 of such performance period, will be eligible to be selected to participate
in the Bonus Plan for such performance period. Any participant in the Bonus Plan who is promoted to a higher position may be assigned an increased target bonus if such promotion becomes effective on or prior to October&nbsp;1 of a performance period
(subject to the terms of the Bonus Plan). Except as otherwise provided in the Bonus Plan, any individual participating in the Bonus Plan during a performance period who ceases to be an employee during such performance period will cease to
participate in the Bonus Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Amendment or Termination</I>. The Board or the Compensation Committee may amend, modify, or
terminate the Bonus Plan, provided that no amendment of the Bonus Plan or with respect to a bonus opportunity may be made that would constitute a modification of the material terms of a &#147;performance goal&#148; (as described in Treasury
Regulation section <FONT STYLE="white-space:nowrap">1.162-27(e)(2)</FONT> or any successor thereto). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Performance
Period</I>. The first performance period for the Bonus Plan will be the period between January&nbsp;1, 2018 and December&nbsp;31, 2018. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Performance Goals</I>. Bonus awards will be subject to such terms and conditions as the Committee will establish, which will include the amount of the bonus to be paid based upon the attainment of one
or more performance goals, including threshold, target and maximum amounts. For any bonus that is intended to be &#147;qualified performance based compensation&#148; under Section 162(m), the Committee will establish the specific performance goals
within 90 days of the beginning of the performance period and the performance goal will be based on one or more of the following business criteria with respect to (i)&nbsp;Integra, (ii) Integra&#146;s worldwide operations, regional operations,
country specific operations and/or subsidiaries, business units, affiliates, corporations, divisions, groups, functions or employees and/or (iii)&nbsp;Integra&#146;s brands, groups of brands or specific brands: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Asset turnover; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Capacity utilization; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost improvements; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Costs or expenses; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Customer retention; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Customer satisfaction and/or growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Diversity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings before interest, taxes, depreciation and amortization; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted earnings before interest, taxes, depreciation and amortization; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted earnings per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Economic value or economic value added; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Employee engagement; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Environmental health and safety; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Financial and other capital-raising transactions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Free cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gross or net profit; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gross or net sales; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Implementation or completion of critical projects; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increase in customer base; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory turnover; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Market price appreciation of Shares; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Market share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mergers and acquisition integration; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income or adjusted net income; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating earnings; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating profit margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating profit; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Pre-tax</FONT> income; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Price per Share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Profitability growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Profitability; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Quality; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Recruiting and maintaining personnel; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regulatory body approval for commercialization of a product; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development achievements; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on capital; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on equity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on investment before or after the cost of capital; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on net assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on sales; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue (including gross revenue or net revenue); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales-related goals; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock price appreciation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stockholder return; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Working capital; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Year-end</FONT> cash. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The business criteria may be measured either in absolute terms or as compared to any incremental increase or decrease or as compared to results of other companies or to market performance indicators or
indices. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee, in its discretion, may determine whether any bonus is intended to be &#147;qualified performance based
compensation&#148; under Section 162(m) (&#147;QPBC&#148;), and may take such actions which it may deem necessary to ensure that such bonus will so qualify. The Committee, in its sole discretion, may grant bonus awards to eligible employees that are
based on the business criteria described above but that are not intended to be QPBC. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Target Award</I>. The amount that a
participant could earn if the targeted level of performance is achieved is expressed as a percentage of the participant&#146;s base salary or a fixed value. In no event will the target award for any participant exceed 165% of the participant&#146;s
base salary. Bonuses for executive officers intended to qualify under Section 162(m) will be determined by a <FONT STYLE="white-space:nowrap">pre-established,</FONT> objective formula, subject to negative discretion only for the final award amount.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Earning a Cash Award</I>. Under the Bonus Plan, a participant may earn an award for a performance period up to 200% of the
participant&#146;s target award based on the level of achievement of the performance cash goals established for that period and must be employed at the Company at the time of the award payment. An award may also be increased by up to 100% of the
amount that would otherwise be paid (subject to Chief Executive Officer&#146;s or designee approval) for a participant who is not an executive officer or a Section 162(m) covered employee or decreased by an amount equal to or less than the bonus
that would have otherwise been paid in the case of any participant, based on the assessment of the individual participant&#146;s performance for the applicable performance period. No award to an executive officer may exceed 200% of the
individual&#146;s target award or may be increased above the level of actual performance. Participants hired between February&nbsp;1 and September&nbsp;30 will be eligible for a <FONT STYLE="white-space:nowrap">pro-rated</FONT> target award.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Maximum Cash Award</I>. The maximum cash bonus award payable to any participant under the Bonus Plan with respect to any
calendar year is $3,000,000. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Payment of QPBC</I>. Unless otherwise provided by the Committee and only to the extent
otherwise permitted by Code Section 162(m), with respect to each Bonus that is intended to qualify as QPBC, (a)&nbsp;participant must be employed by the Company throughout the performance period and (b)&nbsp;the participant will be eligible to
receive payment of a bonus for the performance period only if and to the extent that the performance goals for such period are achieved, contingent on funding. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Limited Discretion</I>. The Committee will not have any discretion to increase a bonus opportunity intended to be QPBC-based upon the established terms of the bonus opportunity or to modify the
applicable performance goals (other than pursuant to automatic objectively determinable adjustments established at the time the performance goals were established), to the extent the existence or exercise of such discretion is inconsistent with the
requirements for QPBC. In determining the amount of any bonus that is intended to be QPBC, the Committee will have the right to reduce (but not to increase) the amount of the bonus that is derived solely based on the attainment of the applicable
performance goals, to take into account additional factors that the Committee may deem relevant to the assessment of individual or corporate performance. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder Approval</I>. No bonuses intended to be QPBC will be paid under the Bonus Plan unless and until the stockholders approve the Bonus Plan and the business criteria. So long as the Bonus Plan
will not have been previously terminated by the Company, to the extent the Company determines that a bonus under the Bonus Plan more than five years after the stockholders&#146; initial approval of the Bonus Plan will continue to be intended to be
QPBC, the Bonus Plan and the business criteria will be resubmitted for approval of the stockholders no later than the fifth year after it will have first been approved by the stockholders and every fifth year thereafter. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cancellation/Recovery</I>. All bonuses granted under the Bonus Plan will be subject to
the provisions of any clawback, repayment or recapture policy implemented by the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>New Plan Benefits </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Participation in the Bonus Plan will be determined by the Company or our Compensation Committee, as applicable, in the future and any
future cash awards under the Bonus Plan that may be paid to an individual or group will be determined upon the satisfaction of performance goals established by the Compensation Committee for the relevant fiscal year. At this time we cannot predict
participation in the Bonus Plan (as the first performance period under the Bonus Plan is expected to begin on January&nbsp;1, 2018), actual performance or the extent to which performance goals will be achieved. In addition, we cannot predict the
extent, if any, to which (i)&nbsp;the Compensation Committee will use its discretionary authority to reduce the amount of awards otherwise payable to a covered employee under the Bonus Plan or (ii)&nbsp;the administrator appointed to administer
awards for other participants will use his or her discretionary authority to increase or decrease awards otherwise payable to such participants. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The stockholders&#146; vote on the new Bonus Plan will have no effect on our employees&#146; cash annual bonus opportunities for 2017, which have been put in place under our Performance Incentive
Compensation Plan, as discussed with respect to our named executive officers in the Compensation Discussion and Analysis beginning at page 38. Please also refer to the Compensation Discussion and Analysis for information regarding the 2016 cash
annual bonuses actually paid to our named executive officers with respect to 2016. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Required Vote for Approval and Recommendation of the
Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of the shares present, in person or represented by
proxy, at the Meeting and entitled to vote on the proposal is required for approval of the Company&#146;s 2018 Performance Incentive Compensation Plan. Abstentions will have the effect of a vote against this proposal. Broker <FONT
STYLE="white-space:nowrap">non-votes</FONT> will not be counted in determining the number of shares necessary for approval and will have no effect on the outcome of this proposal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors recommends a vote &#147;FOR&#148; the approval of the Company&#146;s 2018 Performance Incentive Compensation Plan and the material terms of its performance goals as set forth in
this Proposal&nbsp;3, as disclosed in this proxy statement. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_14"></A>PROPOSAL 4. APPROVAL OF THE FOURTH AMENDED AND RESTATED 2003
EQUITY INCENTIVE PLAN </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors is submitting for stockholder approval our Fourth Amended and Restated 2003
Equity Incentive Plan (the &#147;Amended Plan&#148;). On March&nbsp;29, 2017, the Compensation Committee recommended that the Board of Directors adopt the Amended Plan, subject to stockholder approval and on that same date, the Board of Directors
adopted the Amended Plan, subject to stockholder approval. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Amended Plan restates in its entirety our Third Amended and
Restated 2003 Equity Incentive Plan, as amended (the &#147;Plan&#148;). In particular, the Amended Plan makes the following material changes to the original Plan: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increases the maximum number of shares of common stock which may be issued under the Plan by 1,700,000&nbsp;shares to a total of 14,700,000 shares.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Limits the number of shares of common stock which may be granted as incentive stock options (&#147;ISOs&#148;) under the Amended Plan at 14,700,000
shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Requires that the exercise price of a stock appreciation right granted under the Amended Plan must be not less than the fair market value of the shares
of common stock subject to the stock appreciation right on the date of grant (or, if greater, the par value per share). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prohibits the payment of dividends or dividend equivalents with respect to awards granted under the Amended Plan until the applicable vesting
conditions are satisfied and the award vests. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Permits net share tax withholding with respect to awards granted pursuant to the Amended Plan up to the maximum statutory withholding rates in the
applicable jurisdiction. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Extends the term for ten years through March&nbsp;29, 2027. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We are asking our stockholders to approve the Amended Plan because we believe it is integral to our continued growth and success. The purpose of the Amended Plan is to provide a means whereby we may grant
equity awards in order to attract and retain key employees and associates, and to motivate those people to exercise their best efforts on behalf of our Company and our affiliates. We believe that the equity-based awards to be issued under the
Amended Plan will motivate recipients to offer their maximum effort to the Company and help focus them on the creation of long-term value consistent with the interests of our stockholders. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In determining the number of shares to request for approval under the Amended Plan, our management team worked with Willis Towers Watson
(the Compensation Committee&#146;s independent compensation consultant) and the Compensation Committee to evaluate a number of factors including our recent share usage, anticipated share usage, and criteria expected to be utilized by institutional
proxy advisory firms in evaluating our proposal for the Amended Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the Amended Plan is approved, we intend to utilize
the shares authorized under the Amended Plan to continue our practice of incentivizing key employees and associates through the use of annual equity grants. We anticipate that the shares requested in connection with the approval of the Amended Plan
combined with the shares currently available for future awards under the Plan (which will be available for future awards under the Amended Plan) will last for approximately five years, based on our historic grant rates and the approximate current
stock price, but could last for a shorter period of time if actual practice does not match historic rates or our stock price changes materially. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We believe that we have demonstrated a commitment to sound equity compensation practices in recent years and we recognize that equity compensation awards dilute shareholder equity, so we have carefully
managed our equity incentive compensation. Our equity compensation practices are intended to be competitive and consistent with market practice, and we believe that grants of equity incentive awards are necessary to enable us to continue to attract
and retain top talent. If the Amended Plan is not approved, we believe our recruitment and retention capabilities will be adversely affected. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2016 awards covering 1,512,831 shares of our common stock were outstanding under the Plan, and only 1,076,548&nbsp;shares remained available for future issuance or the grant of
awards under the Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
The weighted average price of options outstanding as of December&nbsp;31, 2016 was $41.4693 and the weighted average remaining term was 3.4 years.</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the above, we are asking stockholders to approve the Amended Plan to satisfy the stockholder approval requirements of
Section&nbsp;162(m) of the Code (&#147;Section 162(m)&#148;), and to ensure we have the ability to grant &#147;incentive stock options&#148; under the Amended Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In general, Section&nbsp;162(m) places a limit on the deductibility for federal income tax purposes of the compensation paid to our Chief Executive Officer or any of our three other most highly
compensated executive officers (other than our Chief Financial Officer). Under Section&nbsp;162(m), compensation paid to such persons in excess of $1&nbsp;million in a taxable year generally is not deductible. However, compensation that qualifies as
&#147;performance-based&#148; under Section&nbsp;162(m) does not count against the $1&nbsp;million deduction limitation. One of the requirements of &#147;performance-based&#148; compensation for purposes of Section&nbsp;162(m) is that the material
terms of the plan under which compensation may be paid be disclosed to and approved by our stockholders. For purposes of Section&nbsp;162(m), the material terms include (a)&nbsp;the employees eligible to receive compensation, (b)&nbsp;a description
of the business criteria on which the performance goals may be based and (c)&nbsp;the maximum amount of compensation that can be paid to an employee under the performance goals. Each of these aspects of the Amended Plan is discussed below, and
stockholder approval of this Proposal 4 will be deemed to constitute approval of the material terms of the Amended Plan for purposes of the stockholder approval requirements of Section&nbsp;162(m). </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholder approval of the material terms of the performance goals of the Amended Plan is only one of several requirements under
Section&nbsp;162(m) that must be satisfied for amounts realized under the Amended Plan to qualify for the &#147;performance-based&#148; compensation exemption under Section&nbsp;162(m), and submission for stockholder approval of the material terms
of the performance goals of the Amended Plan should not be viewed as a guarantee that we will be able to deduct all compensation under the Amended Plan. Nothing in this proposal precludes us or the Compensation Committee from making any payment or
granting awards that do not qualify for tax deductibility under Section&nbsp;162(m). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder Approval</I>. If
stockholders do not approve the proposal in this Proposal 4, the Plan (not as amended and restated) will, however, remain in effect with respect to eligible individuals, including covered employees, and we may continue to grant awards under the Plan
(and not the Amended Plan) to such individuals, subject to the terms and conditions of the Plan. In addition, all previously granted awards will continue to be subject to the Plan. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The principal features of the Amended Plan are summarized below. That said, the summary is qualified in its entirety by reference to the
actual plan document, a copy of which is included as Appendix&nbsp;B. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.<I> Shares</I><I></I><I>&nbsp;Subject To
Awards</I><I>.</I>&nbsp;The total number of shares of common stock that may be issued or awarded under the Plan is 13,000,000 shares. If this Proposal&nbsp;4 is approved by our stockholders, then an additional 1,700,000&nbsp;shares will be available
for issuance under the Amended Plan (for a total of 14,700,000 shares), and the maximum number of shares of common stock that may be granted as ISOs will be 14,700,000 shares. If any award is forfeited, expires or otherwise terminates without having
been exercised in full, or if any award payable in cash or shares of common stock is paid in cash rather than shares, or if any shares are withheld for the payment of taxes with respect to an award, the number of shares of common stock as to which
such award was </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">not exercised or for which cash was paid or which were withheld, as applicable, will continue to be available for future awards
under the Amended Plan. In addition, the aggregate fair market value (determined at the time of grant) of shares of common stock with respect to which any ISOs are exercisable for the first time by any participant during a calendar year (under the
Amended Plan and under any other stock option plan of the Company or a Related Corporation (as defined in the Amended Plan)) may not exceed $100,000. </FONT></P>
<P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">On a post-split basis, as of December 31, 2016 awards covering 3,024,038 shares of our common stock were outstanding under the Plan, and only 2,154,696 shares remained
available for future issuance or the grant of awards under the Plan. The weighted average price of options outstanding as of December 31, 2016 was $20.7346 and the weighted average remaining term was 3.4 years. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The shares of common stock issued under the Amended Plan may be authorized but unissued
shares, treasury shares or reacquired shares, and the Company may purchase shares required for this purpose, from time to time, if it deems such purchase to be advisable. The Amended Plan provides that no employee may be granted awards under the
Amended Plan for more than 2,000,000&nbsp;shares in the aggregate during any calendar year. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.<I> Administration.</I>&nbsp;Our
Compensation Committee administers the Amended Plan. The Amended Plan requires that the Compensation Committee consists of not fewer than two directors of our Board of Directors who are appointed by the entire Board of Directors. Under the Amended
Plan, the Compensation Committee generally has the authority (i)&nbsp;to select the eligible individuals to be granted awards under the Amended Plan, (ii)&nbsp;to grant awards on behalf of the Company and (iii)&nbsp;to set the terms of such awards.
The Amended Plan prohibits the Compensation Committee, without shareholder approval, from reducing the exercise price of any option or stock appreciation right or canceling any option or stock appreciation right in exchange for cash, another award
or options or stock appreciation rights with an exercise price per share that is less than the exercise price of the original option or stock appreciation right. The Compensation Committee has delegated authority for making equity awards to <FONT
STYLE="white-space:nowrap">non-executive</FONT> officer employees under the Company&#146;s equity incentive plans to a Special Award Committee consisting of the Chief Executive Officer, Mr.&nbsp;Arduini. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.<I> Eligibility.</I>&nbsp;Officers, executives, managerial and <FONT STYLE="white-space:nowrap">non-managerial</FONT> employees of the
Company, a parent or subsidiary corporation (referred to herein as a &#147;Related Corporation&#148;) or an affiliate as well as <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, consultants and other service providers to the Company,
a Related Corporation or an affiliate are eligible to participate in the Amended Plan. Only eligible employees of the Company or a Related Corporation may receive ISOs under the Amended Plan. Other types of awards may be granted to all eligible
individuals. As of the date of this Proxy Statement, approximately 1,956&nbsp;employees and <FONT STYLE="white-space:nowrap">8&nbsp;non-employee</FONT> directors are eligible to receive equity awards under the Amended Plan. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.<I> Term Of Amended Plan.</I>&nbsp;The Amended Plan will expire on the tenth anniversary of the date on which the Board adopted the
Amended Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">5. <I>Awards</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Options.</I>&nbsp;The Amended Plan permits the Compensation Committee to grant options that qualify as ISOs under the Code and stock options that do not so qualify (&#147;nonqualified stock
options&#148; or &#147;NQSOs&#148;). An option gives the holder the right to purchase common stock in the future at an exercise price that is set on the date of grant. The per share exercise price of options granted under the Amended Plan may not be
less than the fair market value of a share of common stock on the date of grant (or, if greater, the par value per share). No ISO may be granted to a grantee who owns more than 10% of our stock unless the exercise price is at least 110% of the fair
market value at the time of grant (or, if greater, 110% of the par value per share). Notwithstanding whether an option is designated as an ISO, to the extent that the aggregate fair market value of the shares with respect to which such option is
exercisable for the first time by any participant during any calendar year exceeds $100,000, such excess will be treated as a nonqualified stock option. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Payment of the exercise price of an option may be made (i)&nbsp;in cash or by check (acceptable to the Compensation Committee), bank draft or money order payable to the order of the Company, (ii)&nbsp;in
shares of common stock previously acquired by the participant, subject to certain limitations under the Amended Plan to avoid negative accounting consequences, (iii)&nbsp;by delivery of a notice of exercise of the option to the Company and a broker,
with irrevocable instructions to the broker promptly to deliver to the Company the amount of sale or loan proceeds necessary to pay the exercise price of the option, or (iv)&nbsp;by any combination of the above. In addition to these methods, the
Amended Plan provides that, to the extent that the applicable award agreement so provides or the Compensation Committee otherwise determines, payment of the option exercise price may be made in shares of common stock issuable pursuant to the
exercise of an NQSO or otherwise withheld in a net settlement of an NQSO. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock options may be exercised during the period
specified in the award agreement, but in no event after the tenth anniversary of the date of grant. However, in the case of an ISO granted to a person who owns more than 10% of our stock on the date of grant, such term will not exceed 5&nbsp;years.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Appreciation Rights.</I>&nbsp;The Compensation Committee may grant stock appreciation rights, either alone or in
tandem with options, entitling the participant upon exercise to receive an amount in cash, shares of common </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
stock or a combination thereof (as determined by the Compensation Committee), measured by the increase since the date of grant in the value of the shares covered by such right. The exercise price
of a stock appreciation right granted under the Amended Plan may not be less than the fair market value of the shares of common stock subject to the stock appreciation right on the date of grant (or, if greater, the par value per share). </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock appreciation rights may be exercised during the period specified in the award agreement, but in no event after the tenth anniversary
of the date of grant </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Restricted Stock.</I>&nbsp;The Compensation Committee may grant shares of common stock to participants
either with or without any required payment by the participant, subject to such restrictions as the Compensation Committee may determine. Any such issuances of restricted stock under the Amended Plan without any required payment by the participant
are limited to the extent permitted by applicable law. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Performance Stock.</I>&nbsp;The Compensation Committee may grant
awards entitling a participant to receive shares of common stock without payment provided certain performance criteria are met. The business criteria selected by the Compensation Committee may be expressed in absolute terms or relative to the
performance of other companies or an index. In determining the performance criteria applicable to a grant of performance stock, the Compensation Committee may use one or more of the following criteria (the &#147;Performance Criteria&#148;). The
italicized Performance Criteria are not included in the original Plan: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">return on assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">return on net assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">asset turnover; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">return on equity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">return on capital; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">working capital; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">market price appreciation of shares; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">price per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">economic value or economic value added; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">total stockholder return; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">earnings before interest, taxes, depreciation and amortization; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">adjusted earnings before interest, taxes, depreciation and amortization; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">revenue (including gross revenue or net revenue); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">revenue growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">net income; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">adjusted net income; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">pre-tax</FONT> income; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">profitability; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">gross or net profit; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">profitability growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">operating profit; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">earnings per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">adjusted earnings per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">operating earnings; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">operating profit margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">net income margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">gross or net sales; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">return on sales; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">sales margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">sales-related goals; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">free cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">operating cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">year-end</FONT> cash; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">market share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">asset turnover; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">inventory turnover; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">sales growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cost improvements; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">costs or expenses; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">regulatory body approval for commercialization of a product; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">research and development achievements; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">implementation of critical projects; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">capacity utilization; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">mergers and acquisitions integration; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">financial and other capital-raising transactions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">increase in customer base; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">customer retention; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">customer satisfaction and/or growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">employee satisfaction; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">recruiting and maintaining personnel; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">environmental health and safety; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">diversity; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">quality. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Contract Stock.</I>&nbsp;The Compensation Committee may grant awards that entitle participants to receive shares of common stock, at a
future date specified in the award. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Dividends; Dividend Equivalent Rights.</I>&nbsp;The Compensation Committee may grant
awards that entitle the participant to receive a benefit in lieu of cash dividends that would have been payable on any or all shares of common stock subject to another award granted to the participant had such shares been outstanding. However, under
the Amended Plan, dividends or dividend equivalents may not be granted to participants in connection with grants of options or stock appreciation rights, and except to the extent otherwise provided in awards granted on or
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
prior to April&nbsp;1, 2009, dividends and dividend equivalents payable with respect to an award prior to the vesting of such award instead will be paid out to the participant only to the extent
that the applicable vesting conditions are subsequently satisfied and the award vests. Dividends and dividend equivalents payable with respect to the portion of an award that does not vest will be forfeited. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Payments</I>. The Compensation Committee may grant awards of fully vested shares of our common stock that may, but need not, be
made in lieu of base salary, bonus, fees or other cash compensation otherwise payable to any individual who is eligible to receive awards. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Other Incentive Awards</I>. The Compensation Committee may grant awards other than those enumerated in this summary that are denominated in, linked to or derived from shares of our common stock or
value metrics related to our shares, and may remain forfeitable unless and until specified conditions are met. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.<I>
Adjustments.</I>&nbsp;If there is any stock split, reverse split, stock dividend, or similar change in the capitalization of the Company, the Compensation Committee will make proportionate adjustments to any or all of the following in order to
reflect such change: (i)&nbsp;the maximum number of shares that may be delivered under the Amended Plan, (ii)&nbsp;the maximum number of shares with respect to which awards may be granted to any participant under the Amended Plan and (iii)&nbsp;the
number of shares issuable upon the exercise or vesting of outstanding awards under the Amended Plan (as well as the exercise price per share under outstanding options or stock appreciation rights). However, no adjustment can be made to an award that
would cause the award to fail to comply with Section&nbsp;409A of the Code. Nor can an adjustment be made to an award intended to qualify as &#147;performance-based compensation&#148; (as defined in Section&nbsp;162(m) of the Code) to the extent
that it would cause the award to fail to so qualify as performance-based compensation, unless the Compensation Committee determines that the award should not so qualify. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">7.<I> Change in Control.</I>&nbsp;In the event of certain corporate transactions (such as a merger, consolidation, acquisition of property or stock, separation, reorganization or liquidation), the Amended
Plan provides that each outstanding award will be assumed by the surviving or successor entity, provided that in the event of a proposed corporate transaction, the Compensation Committee may terminate all or a portion of any outstanding award and
give each participant the right to exercise such award, or arrange to have such surviving or acquiring entity or affiliate grant a replacement award, subject to certain conditions. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon a change in control, all outstanding options and all outstanding equity awards granted under the Plan prior to January&nbsp;1, 2013
will generally become vested, exercisable and payable, as applicable. With respect to awards granted on or after January&nbsp;1, 2013, in the event that a change in control occurs and the participant incurs a qualifying termination on or within
twelve months following the date of such change in control, each outstanding award held by a participant, other than any award subject to performance vesting, will become fully vested (and, as applicable, exercisable) upon such qualifying
termination. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.<I> Vesting of Options, Stock Appreciation Rights and Restricted Stock in the event of Death or
Disability.</I>&nbsp;Except as otherwise determined by the Compensation Committee, in the event of a participant&#146;s death or disability, a participant&#146;s restricted stock granted on or after May&nbsp;17, 2012, stock options and stock
appreciation rights (other than such awards granted to participants in France) will accelerate and vest in full. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.<I>
Transferability, Clawback.</I>&nbsp;With limited exceptions, including the laws of descent and distribution, awards under the Amended Plan are generally <FONT STYLE="white-space:nowrap">non-transferable</FONT> prior to vesting, and are exercisable
only by the participant. All awards will be subject to the provisions of any claw-back policy implemented by our company to the extent set forth in such claw-back policy and/or in the applicable award agreement. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.<I> Termination or Amendment.</I>&nbsp;The Board of Directors may from time to time suspend, terminate or amend the Amended Plan at any
time. However, stockholder approval will be required for any amendment to change the class of employees eligible to participate in the Amended Plan with respect to ISOs, to increase the maximum number of shares with respect to which ISOs may be
granted under the Amended Plan (except to the extent permitted by the Amended Plan in connection with a change in the Company&#146;s capitalization), to increase the maximum number of shares that may be issued or transferred under the Amended Plan,
to increase the individual employee award limit under the Amended Plan, to extend the term of the Amended Plan with respect to any ISOs granted under the Amended Plan, to reprice or regrant through cancellation or modify (except to the extent
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
permitted by the Amended Plan in connection with a change in the Company&#146;s capitalization) any award, if the effect would be to reduce the exercise price for the shares underlying such
award, or to cancel any option or stock appreciation right in exchange for cash or another award under the Amended Plan, when the exercise price per share of such option or stock appreciation right exceeds the fair market value of the underlying
share of common stock. In addition, no amendment may be made to the Amended Plan that would constitute a modification of the material terms of the &#147;performance goal(s)&#148; within the meaning of Section&nbsp;162(m) of the Code (to the extent
compliance with Section&nbsp;162(m) of the Code is desired). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.<I> Tax Withholding.</I>&nbsp;In general, the Compensation
Committee, in its discretion, may permit or require the participant to satisfy the Federal, state and/or local withholding tax in whole or in part in cash or by having the Company withhold shares otherwise issuable under an award or by remitting
already owned shares; provided, however, that the number of shares withheld will have a fair market value on the date of withholding no greater than the aggregate amount of such withholding tax based on the maximum individual statutory withholding
requirements for the applicable jurisdiction. The Amended Plan provides that the Compensation Committee, in its discretion, may permit or require the acceleration of the timing for the payment of the number of Shares needed to pay employment taxes
upon the date of the vesting of an Award, subject to the requirements of Section&nbsp;409A of the Code. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">12.<I> New Plan
Benefits.</I><I></I>&nbsp;In 2017, our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors will each receive a grant of restricted stock valued at $170,000 (or $220,000 for the Chairman). In addition, the $75,000 annual retainer payable
to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors may be paid, at the director&#146;s election, either in cash, restricted stock, or half in cash and half<B> </B>in restricted stock. At this time we cannot determine whether any
director will elect to receive all or a portion of his or her annual retainer fee in restricted stock. Therefore, except with respect to the automatic annual grants of restricted stock described above, each of which are shown in the table below, the
number of awards that our named executive officers, directors, other executive officers and other employees may receive under the Amended Plan will be determined in the discretion of our Compensation Committee in the future, and our Compensation
Committee has not made any determination to make future grants to any persons under the Amended Plan as of the date of this Proxy Statement. Therefore, it is not possible to determine the future benefits that will be received by these participants
under the Amended Plan, or the benefits that would have been received by such participants if the Amended Plan, as proposed to be amended, had been in effect in the year ended December&nbsp;31, 2016. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:64pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Dollar<BR>Value ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;
Shares/Units</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Covered&nbsp;by&nbsp;Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini,</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn G. Coleman</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, Chief Financial Officer and Principal Accounting Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert T. Davis</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President and President, Orthopedics and Tissue Technologies</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel L. Reuvers</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President and President, Specialty Surgical Solutions</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Vice President, General Counsel, Administration and Secretary</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All current executive officers as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All current directors who are not executive officers as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,580,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All employees, including all current officers who are not executive officers, as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">We cannot determine at this time what elections will be made by the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors with respect to their annual cash
retainer, and therefore this amount is not included in the table above. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The aggregate number of restricted shares to be granted to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as their annual equity award will depend on
the value of our common stock on the grant date. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">13. <I>Equity Awards Outstanding as of March&nbsp;31, 2017</I>. The following table sets
forth summary information concerning the number of shares of our common stock subject to option grants, restricted stock grants, contract stock grants and performance share grants made under the Plan to our named executive officers, directors and
employees as of March&nbsp;31, 2017. The price per share of our common stock as of such date is $42.09. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:103pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name/Category of Individuals</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;
Shares<BR>Underlying</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option&nbsp;Grants</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;
of<BR>Restricted</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares&nbsp;
of<BR>Contract</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number
of<BR>Performance</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Named Executive Officers</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter Arduini</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">903,633</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">466,892</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">218,639</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn Coleman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">154,814</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,564</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,583</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert Davis</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,488</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,785</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard Gorelick</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34,390</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel Reuvers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,990</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,480</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,362</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Directors</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Keith Bradley</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,658</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,428</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard E. Caruso</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,542</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,170</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stuart M. Essig</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">678,536</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,030</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Barbara B. Hill</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,686</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lloyd W. Howell, Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,686</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Donald E. Morel, Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,170</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Raymond G. Murphy</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,686</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christian S. Schade</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,316</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,170</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">James M. Sullivan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,316</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,170</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All current executive officers as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,214,684</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41,912</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">466,892</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">340,982</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All non-employee directors as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">849,368</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,196</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All employees, including current officers who are not executive officers, as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">158,693</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">456,283</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">116,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">14.<I> Material U.S. Federal Income Tax Consequences</I>.<I> </I>The following is a general summary under
current law of the principal United States federal income tax consequences related to awards under the Amended Plan. This summary deals with the general federal income tax principles that apply and is provided only for general information. Some
kinds of taxes, such as state, local and foreign income taxes and federal employment taxes, are not discussed. This summary is not intended as tax advice to participants, who should consult their own tax advisors. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options</I>. If an optionee is granted a nonqualified stock option under
the Amended Plan, the optionee should not have taxable income on the grant of the option. Generally, the optionee should recognize ordinary income at the time of exercise in an amount equal to the fair market value of the shares acquired on the date
of exercise, less the exercise price paid for the shares. The optionee&#146;s basis in the common stock for purposes of determining gain or loss on a subsequent sale or disposition of such shares generally will be the fair market value of our common
stock on the date the optionee exercises such option. Any subsequent gain or loss will be taxable as a long-term or short-term capital gain or loss. We or our subsidiaries or affiliates generally should be entitled to a federal income tax deduction
at the time and for the same amount as the optionee recognizes ordinary income. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Incentive Stock Options</I>. A participant
receiving ISOs should not recognize taxable income upon grant. Additionally, if applicable holding period requirements are met, the participant should not recognize taxable income at the time of exercise. However, the excess of the fair market value
of the shares of our common stock received over the option exercise price is an item of tax preference income potentially subject to the alternative minimum tax. If stock acquired upon exercise of an ISO is held for a minimum of two years from the
date of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
grant and one year from the date of exercise and otherwise satisfies the ISO requirements, the gain or loss (in an amount equal to the difference between the fair market value on the date of
disposition and the exercise price) upon disposition of the stock will be treated as a long-term capital gain or loss, and we will not be entitled to any deduction. If the holding period requirements are not met, the ISO will be treated as one that
does not meet the requirements of the Code for ISOs and the participant will recognize ordinary income at the time of the disposition equal to the excess of the amount realized over the exercise price, but not more than the excess of the fair market
value of the shares on the date the ISO is exercised over the exercise price, with any remaining gain or loss being treated as capital gain or capital loss. We are not entitled to a tax deduction upon either the exercise of an ISO or upon
disposition of the shares acquired pursuant to such exercise, except to the extent that the participant recognizes ordinary income on disposition of the shares. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Other Awards</I>. The current federal income tax consequences of other awards authorized under the Amended Plan generally follow certain basic patterns: stock appreciation rights are taxed and
deductible in substantially the same manner as NQSOs; restricted stock subject to a substantial risk of forfeiture results in income recognition equal to the excess of the fair market value over the price paid, if any, only at the time the
restrictions lapse (unless the recipient elects to accelerate recognition as of the date of grant through a Section 83(b) election); performance stock awards, contract stock awards, dividend equivalents, stock payments, and other incentive awards
are generally subject to tax at the time of payment. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Section 162(m) of the Code</I>. Section 162(m) of the Code denies a
deduction to any publicly-held corporation for compensation paid to &#147;covered employees&#148; in a taxable year to the extent that compensation paid to such covered employee exceeds $1,000,000. It is possible that compensation attributable to
awards under the Amended Plan, when combined with all other types of compensation received by a covered employee from us, may cause this limitation to be exceeded in any particular year. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Section 162(m) deduction limitation does not apply to &#147;qualified performance-based compensation.&#148; In order to qualify for
the exemption for qualified performance-based compensation, Section 162(m) requires, among other things, that: (i)&nbsp;the compensation be paid solely upon account of the attainment of one or more
<FONT STYLE="white-space:nowrap">pre-established</FONT> objective performance goals, (ii)&nbsp;the performance goals must be established by a compensation committee comprised of two or more &#147;outside directors,&#148; (iii) the material terms of
the performance goals under which the compensation is to be paid must be disclosed to and approved by the shareholders and (iv)&nbsp;the compensation committee of &#147;outside directors&#148; must certify that the performance goals have indeed been
met prior to payment. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section 162(m) contains a special rule for stock options and stock appreciation rights which provides
that stock options and stock appreciation rights will satisfy the &#147;qualified performance-based compensation&#148; exemption if (i)&nbsp;the awards are made by a compensation committee comprised of &#147;outside directors&#148;, (ii) the plan
sets the maximum number of shares that can be granted to any person within a specified period, and (iii)&nbsp;the compensation is based solely on an increase in the stock price after the grant date. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Amended Plan has been designed to permit our Compensation Committee to grant stock options, stock appreciation rights and other awards
which will qualify as &#147;qualified performance-based compensation.&#148; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the Amended Plan is approved by our
stockholders, our Compensation Committee may, but is not obligated to, grant awards under the Amended Plan that constitute &#147;qualified performance-based compensation&#148; under Section 162(m). </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Section 409A of the Code</I>. Certain types of awards under the Amended Plan may constitute, or provide for, a deferral of compensation
subject to Section 409A of the Code. Unless certain requirements set forth in Section 409A of the Code are complied with, holders of such awards may be taxed earlier than would otherwise be the case (e.g., at the time of vesting instead of the time
of payment) and may be subject to an additional 20% penalty tax (and, potentially, certain interest penalties and additional state taxes). To the extent applicable, the Amended Plan and awards granted under the Amended Plan are intended to be
structured and interpreted in a manner intended to either comply with or be exempt from Section 409A of the Code and the Department of Treasury regulations and other interpretive guidance that may be issued under Section 409A of the Code. To the
extent determined necessary or appropriate by the plan administrator, the Amended Plan and applicable award </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
agreements may be amended to further comply with Section 409A of the Code or to exempt the applicable awards from Section 409A of the Code. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Required Vote for Approval and Recommendation of the Board of Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of the shares present, in person or represented by proxy, at the Meeting and entitled to vote is required to approve and adopt the proposed Amended Plan.
Abstentions will have the effect of a vote against this proposal. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will not be counted in determining the number of shares necessary for approval and will have no effect on the outcome of this
proposal. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If our stockholders do not approve this proposal, the Plan will remain in full force without giving effect to the
proposed changes as contemplated by the Amended Plan, and the Company may continue to grant awards under the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The
Board of Directors has adopted a resolution approving the Fourth Amended and Restated 2003 Equity Incentive Plan and hereby recommends that the stockholders of the Company vote &#147;FOR&#148; the Fourth Amended and Restated 2003 Equity Incentive
Plan. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_15"></A>PROPOSAL 5. ADVISORY VOTE ON NAMED EXECUTIVE OFFICER
COMPENSATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are seeking our stockholders&#146; vote to approve, on a
<FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis, the compensation of our named executive officers (&#147;NEOs&#148;), as described in the &#147;Executive Compensation&#148; section of this proxy statement beginning on page 34. In
deciding how to vote on this proposal, the Board and the Compensation Committee (the &#147;Committee&#148;) invite you to consider the recent actions that we implemented to our executive compensation programs as stated below. In addition, we
summarize our compensation programs more fully in the Compensation Discussion and Analysis section of this proxy statement (the &#147;CD&amp;A&#148;). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At our annual meeting of stockholders held in May 2016, we submitted a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote to our stockholders to approve our executive compensation
(&#147;Say on Pay&#148;). Approximately 99% of the stockholders who voted on our Say on Pay proposal voted in favor of it. We attribute that broad support in part to our continued efforts to understand and address the feedback that we received from
our stockholders. Specifically, we have continued our investor outreach program that includes (i)&nbsp;engaging a <FONT STYLE="white-space:nowrap">third-party</FONT> firm to interview institutional investors to understand how investors perceive our
management team and strategy, including our executive compensation program; (ii)&nbsp;regular meetings with investors to discuss the Company&#146;s strategic plan and growth prospects; and (iii)&nbsp;individual, detailed meetings with stockholders
to obtain feedback. We have used the results of this program to help guide our thinking about our compensation programs. We will continue our outreach to stockholders and proxy advisors to sustain and, where appropriate, refine alignment on
executive compensation practices. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation awarded to our Chief Executive Officer (&#147;CEO&#148;) and other NEOs for
2016 recognizes the positive financial, operational and shareholder return performance of the Company. The Committee is mindful of its responsibility to align executive compensation with the overall performance of the Company, while taking into
consideration the need to provide market competitive compensation in order to recruit and retain highly skilled and experienced executives. The CD&amp;A provides a comprehensive discussion and rationale for the 2016 pay decisions made by the
Committee and the correlation to Company performance. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As described in the CD&amp;A, our executive compensation programs are
designed to attract, retain and motivate our NEOs, who are crucial to our long-term success. Under these programs, we provide our NEOs with appropriate objectives and incentives to achieve our business goals. In 2016, we implemented the following
compensation actions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Long-Term Equity Incentive Plan: The Company continued its practice of granting 50% of its annual equity awards to the CEO, CFO, and the other NEOs in
the form of performance stock units, 30% in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, and 20% in the form of restricted shares. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peer Group: As a result of continued consolidation in the medical device industry, the Company amended its peer group to remove several peers who have
been acquired and added new companies to the group in order to align itself with companies that are similar in size (revenue and market capitalization) and in the same industry as Integra and with whom Integra may compete for executive talent.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the actions stated above, we maintain and continuously review our existing compensation
practices through strong corporate governance practices, which feature the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Separation of the Chairman of the Board and the Chief Executive Officer; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Appointment of a Presiding Director; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An independent compensation consultant reporting directly to the Committee; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An annual risk assessment of our compensation practices; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Significant stock ownership guidelines that align director and executive officer interests with those of our stockholders;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An annual stockholder advisory vote on executive compensation; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An Insider Trading Policy that prohibits hedging and pledging of our securities. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that all of these features demonstrate our responsiveness to our stockholders,
our commitment to our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> philosophy and our goal of aligning management&#146;s interests with those of our stockholders to support the creation of
long-term value. Accordingly, we ask our stockholders to vote &#147;FOR&#148; the following advisory resolution at our 2017 Annual Meeting: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#147;RESOLVED, that the compensation paid to the Company&#146;s named executive officers, as disclosed pursuant to Item 402 of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> including the
Compensation Discussion and Analysis, compensation tables and narrative discussion of this Proxy Statement is hereby APPROVED by the stockholders of Integra.&#148; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Because the Say on Pay vote is advisory, it will not bind the Company, the Committee or our Board. That said, because we value the opinions of our stockholders, the Committee will review the voting
results and take them into consideration when making future decisions regarding executive compensation. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With regard to the
frequency of future votes on Say on Pay, the Board determined that it would submit a Say on Pay proposal to our stockholders annually. Therefore, we expect the next stockholder vote to approve the compensation of our named executive officers to
occur at the Company&#146;s 2018 annual meeting of stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Required Vote for Advisory Approval and Recommendation of the Board of
Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of the shares present, in person or represented by proxy, at
the Meeting and entitled to vote on the proposal is required for advisory approval of this proposal. Abstentions will have the effect of a vote against this proposal. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will not be counted in
determining the number of shares necessary for advisory approval and will have no effect on the outcome of this proposal. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors hereby recommends a vote &#147;FOR&#148; the advisory resolution set forth in this Proposal 5, approving the
compensation of our named executive officers, as disclosed in this proxy statement. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_16"></A>PROPOSAL NO. 6 ADVISORY VOTE ON THE FREQUENCY OF THE ADVISORY
VOTE ON NAMED EXECUTIVE OFFICER COMPENSATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As described in Proposal No.&nbsp;5, the Company&#146;s shareholders are
being provided the opportunity to cast an advisory vote to approve the compensation of the Company&#146;s named executive officers, that is, the Say on Pay vote. Section&nbsp;14A of the Securities Exchange Act of 1934 also affords stockholders the
opportunity to cast an advisory vote on how often the Company should include the Say on Pay vote in its proxy materials for future annual stockholder meetings (or other meetings of stockholders at which directors will be elected). Under this
Proposal No.&nbsp;6, stockholders may vote to have the Say on Pay vote every year, two years, or three years, or abstain from the vote. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Although the vote is <FONT STYLE="white-space:nowrap">non-binding,</FONT> the Board and the Compensation Committee value the opinions of the stockholders and will consider the outcome of the vote when
determining the frequency of the Say on Pay vote. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board has determined that an annual Say on Pay vote is the best approach
for the Company and its stockholders because the Board believes that a <FONT STYLE="white-space:nowrap">one-year</FONT> frequency provides the highest level of accountability and communication by and between the Board and the shareholders. An annual
Say on Pay vote enables stockholders to approve the compensation of the named executive officers with the most recent executive compensation information presented in the proxy statement for the annual meeting of stockholders. In addition, the Board
recognizes the importance of receiving regular, direct input from stockholders on important issues such as the Company&#146;s compensation philosophy, policies and practices as disclosed in the proxy statement every year. An annual vote is
consistent with Company policies of annually seeking input from, and engaging in discussions with, the stockholders on corporate governance matters and executive compensation philosophy, policies and practices. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the reasons stated above, the Board recommends a vote for a &#147;one year&#148; frequency for the Say on Pay vote. Please note that
stockholders are not voting to approve or disapprove the best approach determined by the Board with respect to this proposal noted above. Rather, stockholders may cast their vote on their preferred voting frequency by choosing the option of one
year, two years, or three years, or abstain from the vote. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This proposal requires the affirmative vote of a majority of those
shares present in person or represented by proxy and entitled to vote on this proposal. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will not be counted as votes cast &#147;FOR&#148; or &#147;AGAINST&#148; any frequency
choice and will have no effect on the outcome of this proposal. If none of the options receive a majority vote, the option that receives the highest number of votes cast will be considered to be the frequency selected by stockholders. However,
because this is only an advisory vote, the Board may decide that it is in the best interests of the stockholders and the Company to hold the Say on Pay vote more or less frequently than the option selected by the stockholders. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board recommends a vote for the frequency of &#147;ONE YEAR&#148; for the advisory vote on executive compensation beginning with
the 2017 Annual Meeting of Stockholders. Proxies solicited by the Board will be voted for the frequency of &#147;ONE YEAR&#148; unless a contrary vote is specified. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXECUTIVE COMPENSATION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_17"></A>Compensation Discussion and Analysis </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Summary </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This Compensation Discussion and Analysis
(&#147;CD&amp;A&#148;) describes our executive compensation program for 2016, which we have continued to refine through feedback from stockholders, continuing assessments of competitive practices, and alignment with our performance. We use this
program to attract, motivate and retain our named executive officers (&#147;NEOs&#148;) and other executives. In particular, we will explain how the Compensation Committee (the &#147;Committee&#148;) of the Board of Directors (the &#147;Board&#148;)
made 2016 compensation decisions for our 2016 NEOs: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini, our President and Chief Executive Officer (&#147;CEO&#148;); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn G. Coleman, our Corporate Vice President and Chief Financial Officer (&#147;CFO&#148;); </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert T. Davis, Jr., our Corporate Vice President, President&nbsp;&#151;&nbsp;Orthopedics and Tissue Technologies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick, our Corporate Vice President, General Counsel, Administration and Secretary; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel L. Reuvers, our Corporate Vice President, Specialty Surgical Solutions. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee establishes the philosophy, approves the design of, and administers our executive compensation programs. The report of the
Committee appears at the end of this section. In addition to the Company continuing its investor outreach program, the Committee has continued to evolve the core elements of its executive compensation programs, as follows: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Utilized a Performance Incentive Compensation Plan (the &#147;Bonus Plan&#148;) containing a formulaic funding mechanism (based on quantitative
metrics) for annual cash bonuses; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company continued its practice of granting 50% of its annual equity awards to the NEOs in the form of performance stock units and 30% in the form
of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Granted equity pursuant to the Long-Term Equity Incentive Plan that includes a double-trigger change in control provision and a clawback provision; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continued to implement stock retention requirements for executive officers and directors. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Listening to Our Stockholders </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">At our 2016 Annual Meeting, approximately 99% of the stockholders who voted on our 2016 Say on Pay proposal voted in favor of the proposal. We believe that this support resulted largely from the
continuous improvements that we have made and continue to make in our executive compensation programs and the effect that they have had on the performance of the Company. The Company has achieved strong results over the past few years, and we
believe that investors support our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> philosophy in growing the Company.&nbsp;The Company makes its directors available to institutional investors who
wish to discuss the Company&#146;s policies and practices, including with respect to executive compensation. Continuing our investor outreach efforts, we gained feedback with respect to our executive compensation programs over the course of the year
in a number of different settings. Integra&#146;s management team participated in twelve institutional investor conferences where we discussed our strategic plans and growth prospects, and met with approximately 400 institutional investors. In
December 2016, we held a Regenerative Technology Day to discuss our strategy,&nbsp;technology&nbsp;platform, and investment in regenerative medicine. These discussions often included Integra&#146;s executive compensation program. The Committee
considered the feedback obtained from our investor outreach program when making decisions relating to executive compensation for 2016. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of the stockholder outreach conducted during the past several years and the
Committee&#146;s own deliberations with the assistance of <FONT STYLE="white-space:nowrap">third-party</FONT> advisers, we continue to evolve the executive compensation programs. We continue these practices in 2017 in order to reinforce a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> culture. The table below provides a summary of (i)&nbsp;the program elements from 2016 and (ii)&nbsp;how we applied those elements in 2017 for performance
in 2017 and beyond. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Element</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017+</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Link between performance and compensation</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;All compensation decisions made in 2016 for 2015 performance reflect company-wide
performance against <FONT STYLE="white-space:nowrap">pre-established</FONT> metrics and goals and an assessment of each NEO&#146;s performance against goals established at the beginning of 2015.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Specific
financial objectives for funding the pool for cash incentives, and for each NEO&#146;s division or function, were established within the first 90 days of 2016.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;The Company continued its practice of granting 50% of its annual equity awards to
its NEOs in the form of performance stock units (PSUs), and 30% of such annual equity awards was in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;The restricted
stock units granted to the CEO in 2016 are deferred and will not be delivered until after the CEO&#146;s departure from the Company.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Because the Company met its 2015 financial metrics provided in the Performance
Incentive Compensation Plan (the &#147;Bonus Plan&#148;), the Company paid cash bonuses to the NEOs in 2016 for 2015 performance under the Bonus Plan.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px">
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Continuing current practices.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Because the
Company met its 2016 financial metrics provided in the Bonus Plan, the Company paid cash bonuses to the NEOs in 2017 for 2016 performance.</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Element</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017+</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Use of discretion</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;The Bonus Plan approved at the 2013 Annual Meeting provides the Committee with only
negative discretion to reduce (but not increase) cash incentive payments intended to constitute &#147;qualified performance-based compensation.&#148;</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;The Bonus Plan is designed to meet the requirements of Section 162(m) of the
Internal Revenue Code (&#147;Section 162(m)&#148;) to allow tax deductibility for payments intended to qualify as <FONT STYLE="white-space:nowrap">performance-based</FONT> compensation.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Includes a
clawback provision.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;The Company funded the overall annual cash incentive pool for 2015 performance
pursuant to the Bonus Plan at 147% of target.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.50em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Based on strong financial and other qualitative measures in 2015, the Company&#146;s NEOs earned cash bonuses for 2015 performance paid in March 2016 up to 150% of each
NEO&#146;s respective target. The Committee determined such cash bonuses based upon the strong individual performance of each of the NEOs, achievement of several critical business priorities ahead of expectations, successfully meeting or exceeding
strategic objectives, optimizing the Company&#146;s organizational structure, systems and processes, and meeting the objectives to enhance overall commitment to quality and regulatory compliance.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px">
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Continuing current practices.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;The Company
funded the overall annual cash incentive pool for 2016 performance pursuant to the Bonus Plan at 117% of target.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Based on strong financial and other qualitative measures of performance in 2016,
the Company&#146;s NEOs earned cash bonuses for 2016 performance paid in March 2017 up to 144% of each NEO&#146;s respective target. The Committee determined such cash bonuses based upon the strong individual performance of each of the NEOs,
achievement of several critical business priorities ahead of expectations, successfully meeting or exceeding strategic objectives, optimizing the Company&#146;s organizational structure, systems and processes, and meeting the objectives to enhance
overall commitment to quality and regulatory compliance.</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.50em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;Based on competitive practices, the Compensation Committee amended the Bonus Plan in February 2017 to fund cash bonuses for NEOs up to a maximum of 200% of target to more
closely align pay and performance. This Bonus Plan Amendment commences with 2017 performance, with such bonuses to be paid in March 2018.</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Element</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017+</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Performance-based</FONT>
stock grants</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50% of each NEO&#146;s 2016 equity grant (including the CEO and CFO) was in
the form of PSUs with annual vesting over three years contingent on achieving three-year cumulative revenue growth performance goals, measured during each fiscal year of the performance period; 30% of each NEO&#146;s 2016 equity grant (including the
CEO and CFO) was in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, which the Committee, Board and management view as performance-based equity.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
grant considered:</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.78em; text-indent:-0.78em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;2015 performance;</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.78em; text-indent:-0.78em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;Future potential and
retention needs; and</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.78em; text-indent:-0.78em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;Competitive market data.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
(i)&nbsp;third installment of the PSUs granted to the NEOs in 2013, (ii) second installment of the PSUs granted to the NEOs in 2014, and (iii)&nbsp;first installment of the PSUs granted to the NEOs in 2015, all vested 2016 at target because the 2015
performance goal, based on revenue growth, was met In addition, the first installment of the PSUs granted to the NEOs in 2013 that failed to vest in 2014 also vested at target based on the achievement of the
<FONT STYLE="white-space:nowrap">&#147;catch-up&#148;</FONT> revenue performance goal measured over the entire performance period.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px">
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing current practices.</FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
third installment of the PSUs granted to the NEOs in 2014 and the second installment of the PSUs granted to the NEOs in 2015 both vested at target in 2017 because the 2016 performance goal, based on revenue growth, was met. In addition, the first
installment of the PSUs granted to the NEOs in 2016 vested in 2017 at 150% of the target number of shares of performance stock eligible to vest because the 2016 performance goal, based on revenue growth, was achieved at the maximum
level.</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Element</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017+</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peer group</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integra&#146;s peer group focuses on the medical technology industry and considers the complexity of
Integra&#146;s business, competitors for executive talent, as well as relative size (revenue and market cap). The Committee reviewed compensation of our NEOs relative to our peers, and as a result of our review, we made the following changes to our
peer group in October 2016: (i) we removed Thoratec Corporation (acquired by St. Jude Medical), and Alere Inc. (acquired Abbott Laboratories), and (ii)&nbsp;added Steris, Cantel Medical Inc, and Align Technologies, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Will continue to focus on the medical technology industry, Integra&#146;s complexity,
competition for executive talent and relative size (revenue and market cap), making adjustments to the peer group as necessary given the aforementioned criteria. We will review compensation of our NEOs relative to our peers on an annual
basis.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Change In Control provisions for equity awards</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continue to utilize &#147;double trigger&#148; provisions implemented in 2013 for acceleration of equity
awards.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continuing current practice.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Compensation recoupment (&#147;clawback&#148;)
policy</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continue to utilize clawback policy implemented in 2013 that pertains to both the equity plans and Bonus
Plan.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continuing current practice.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Pre-clearance,</FONT>
Anti-hedging/pledging policy</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continue to mandate <FONT STYLE="white-space:nowrap">pre-clearance</FONT> requirements to a broader group of
executives. Continue to follow the anti-hedging/pledging policy that was implemented in 2013.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continuing current practice.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company will continue its outreach to stockholders on an
<FONT STYLE="white-space:nowrap">on-going</FONT> basis to sustain and, where appropriate, refine alignment on executive compensation practices. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Philosophy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Committee determines our executive compensation philosophy, which is to align each executive&#146;s compensation with Integra&#146;s short- and long-term performance. Accordingly, we have designed our executive compensation programs to enhance
Integra&#146;s ability to attract, retain and engage executives who are essential to Integra&#146;s continued growth and success, and reward them when they deliver strong performance. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We linked our 2016 annual cash incentive program to financial metrics&nbsp;&#151;&nbsp;including revenue, adjusted earnings before interest, taxes,
depreciation and amortization (&#147;EBITDA&#148;), and operating cash flow&nbsp;&#151;which we believe drive the profitability and growth of the Company and long-term shareholder return. Cash incentive awards for NEOs are linked to the achievement
of these financial metrics as well as performance of other objectives to advance the long-term strategy of the Company. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our long-term equity incentive awards are aligned with stockholder interests because they focus on performance&nbsp;&#151;&nbsp;for grants and
vesting&nbsp;&#151;&nbsp;as well as retention, and to facilitate long-term stock ownership. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to stock ownership requirements for executive officers, our CEO holds certain equity grants whose payment is deferred until after he leaves
the Company. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">All compensation actions also are considered in the context of appropriately managing risk. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Overall, we design our compensation programs to attract and retain executives capable of
(i)&nbsp;leading our Company, which is more complex and diversified in its business than other medical technology companies of comparable revenues, and (ii)&nbsp;growing our Company more rapidly than industry peers, consistent with our long-term
objective to become a <FONT STYLE="white-space:nowrap">multi-billion</FONT> dollar global, diversified, medical technology company. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In determining compensation for our NEOs for 2016, the Company made some decisions, such as targets, in advance, while the Company made others, such as the determination of annual cash bonus awards for
2016 under the Bonus Plan and the long-term equity incentive awards, after the performance period concluded and could be evaluated. As a result, the Committee considered elements of compensation for our NEOs at various times beginning in late 2015
and ending in early 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2016 Performance </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Integra made considerable changes and progress toward transforming the Company during 2016, as it advanced toward becoming a multi-billion dollar, global medical technology company. We outlined our
strategy in 2012 to optimize our structure, execute consistently and accelerate growth. Since then, we have made significant progress in each of these areas. We have addressed substantial challenges over the past three years, and we are now at an
exciting and pivotal point to accelerate growth. The following represent our key accomplishments in 2016: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">One-year</FONT> total return to stockholders for 2016 was 26.6% (compared to 13.0% for our peer group), and the
three-year total return to stockholders for 2014, 2015 and 2016 was 98.9% (compared to 68.4% for our peer group); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Demonstrated the strength of our underlying businesses and the success of our new product launches by improving our organic revenue growth profile
during 2016 and achieving full-year organic revenue growth of 9.0%, an increase from 6.7% in 2015; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integrated TEI Biosciences Inc., and TEI Medical Inc., broadening our current advanced wound care portfolio and expanding a dedicated wound care
channel focused on the outpatient clinic. This acquisition also enhanced our regenerative product pipeline with four new products from the PriMatrix<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> and SurgiMend<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> platforms that
are planned for introduction during 2017; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integrated the Salto
Talaris<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> ankle and the Futura&#153; toe that the Company had acquired from Tornier. These products further
diversify our lower extremity portfolio, and, when combined with the launch of our internally developed Cadence total ankle replacement product, drove growth and captured market share in the fast-growing ankle arthroplasty market;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integrated Tekmed, allowing us to build a direct presence in Italy and expand our European infrastructure, increasing our growth in Italy for both our
specialty surgical solutions and orthopedics and tissue technologies product lines; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Received FDA approval and began the U.S. market commercialization of Omnigraft&#153;, the only <FONT STYLE="white-space:nowrap">FDA-approved</FONT>
product that regenerates dermal tissue used in the treatment of diabetic foot ulcers. Omnigraft heals in fewer applications than other technologies&nbsp;&#151;&nbsp;a unique value proposition that results in lower costs to the payer and patient;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increased international sales double digits, resulting primarily from strength in our neurosurgery business and the contribution from the TEI and
Tekmed acquisitions; and, </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increased our borrowing capacity from $1.1&nbsp;billion to $1.5&nbsp;billion through an amendment to our credit facility and extended the term through
2021. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Performance </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our stock generated a three-year total return for stockholders of 98.9% from 2014 through 2016, compared to 68.4% for our peer group of companies and 28.9% for the NASDAQ Composite Index. For the year
ended December&nbsp;31, 2016, we ranked in the 71</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">st</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">
percentile of total returns for the three-year period of our peer group. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g14d64.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the full roster of members of our Peer Group, please refer to the section below entitled &#147;Our Peer Group and the Markets in Which We Compete.&#148;
</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2016 Performance Versus Financial Metrics </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In 2016, we exceeded our revenue, operating cash flow and EBITDA targets and essentially met our adjusted EBITDA target. These results reflect significant progress made during 2016 on a series of
strategic initiatives designed to help the Company grow. Our financial performance versus our targets is reflected below. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2016 Financial Performance Targets </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8px">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016&nbsp;Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016&nbsp;Results</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;Result&nbsp;as&nbsp;%&nbsp;of&nbsp;Target&nbsp;&nbsp;
</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Revenue</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">985&nbsp;Million</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">992.1&nbsp;Million</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">101</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Adjusted EBITDA</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">233.1&nbsp;Million</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">231.7 Million</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Operating Cash Flow</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125 Million</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">159.2 Million</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EBITDA</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">97.2 Million</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">188.0 Million</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">193</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">See &#147;Appendix C&nbsp;&#151;&nbsp;Reconciliations of <FONT STYLE="white-space:nowrap">Non-GAAP</FONT>
Financial Measures&#148; for a more detailed explanation of &#147;Adjusted EBITDA&#148; and &#147;EBITDA.&#148; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February
2016, the Committee established the threshold objective 162(m) goal (70% of prior year EBITDA) as well as the 2016 performance targets under the Bonus Plan, as illustrated in the chart above. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company used these metrics again for 2017 because they provide a sound basis to measure profitability and growth and because many
stockholders rely upon some or all of these metrics to evaluate the Company. Our strategy is to increase our profit margins over the long term by (i)&nbsp;growing in size, including by acquisition and new product introductions, (ii)&nbsp;optimizing
the business by consolidating manufacturing into centers of excellence, leveraging our new <FONT STYLE="white-space:nowrap">two-division</FONT> global structure, and implementing common quality and information systems, and (iii)&nbsp;developing and
recruiting leaders who effectively execute our most important programs and who can manage important functions in a complex global medical technology company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Linking Financial Performance to Pay in 2016 </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our strong financial performance against our metrics determined how we funded the 2016 pool for cash incentive payments for NEOs. The
following is a brief discussion on our performance against these metrics: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Revenues: </I>We increased reported revenues 12.4% to $992.1&nbsp;million last year, exceeding our 2016 goal of $985&nbsp;million;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Adjusted EBITDA</I>: Our adjusted EBITDA (see &#147;Appendix C&nbsp;&#151;&nbsp;Reconciliations of <FONT STYLE="white-space:nowrap">Non-GAAP</FONT>
Financial Measures&#148;), increased 18.5% during 2016 to $231.7&nbsp;million, which essentially met our target of $233.1&nbsp;million; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Operating</I> <I>Cash Flow: </I>We increased operating cash flow 36.0% during 2016 to $159.2&nbsp;million, which exceeded our target of $125
million*; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>EBITDA: </I>Our<I> </I>2016<I> </I>EBITDA (see &#147;Appendix C&nbsp;&#151;&nbsp;Reconciliations of <FONT STYLE="white-space:nowrap">Non-GAAP</FONT>
Financial Measures&#148;), was $188.0&nbsp;million, which increased from $138.8&nbsp;million EBITDA in the prior year and exceeded our target of 70% of prior year EBITDA, or $97.2&nbsp;million. The Company established this goal for purposes of tax
deductibility under Section 162(m) and establishing the minimum amount of profitability necessary to warrant payment of any bonuses to NEOs, such that if the Company did not meet or exceed this objective, the pool for cash incentive payments for
NEOs would not be funded. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To demonstrate our efforts to link pay for performance, it is important to note
that the third installment of the PSUs granted to the NEO&#146;s in 2014 and the second installment of the PSUs granted to the NEOs in 2015 vested at target in 2017 because the Company achieved its 2016 performance goal based on 3% revenue growth.
In addition, the first installment of the of the PSUs granted to the NEOs in 2016 vested in 2017 at 150% of the target number of shares of performance stock eligible to vest because the Company achieved the 2016 performance goal, based on revenue
growth, at the maximum level. Specifically, revenues increased from $882.7&nbsp;million in 2015 to $992.1&nbsp;million in 2016, an increase of 12.4%. For more information, please refer to the section below entitled &#147;Refined Long-Term Equity
Incentive Plan.&#148; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">*For periods prior to 2016, operating cash flow has been adjusted for FASB
<FONT STYLE="white-space:nowrap">2016-09.</FONT> Accordingly, when comparing operating cash flow to last years&#146; proxy, without the adjustment, we increased operating cash flow 49.2% during 2016. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Once the Committee determined the funding of the 2016 pool for cash incentive payments, the Committee considered
several additional factors in finalizing the awards to NEOs. The Company successfully met or exceeded its strategic objectives for 2016. Integra achieved its financial objectives (or essentially met them) and reported significant improvement on all
of its key financial metrics, including organic revenue growth, reported revenue growth, adjusted gross margin, adjusted EBITDA margin, operating cash flow and free cash flow conversion. Integra also met its goals of launching Omnigraft&#153; with a
comprehensive strategy to enter the outpatient advanced wound care market. The Company also met its objective to develop and launch new products across all areas of the business, with new products such as Omnigraft, the MAYFIELD<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> 2 surgical headrest for neurosurgery, Cadence&#153;, and the Finlock&#153; glenoid, generating revenue growth during
2016. In addition to accomplishing the outlined the objectives for 2016, the Company also met several critical priorities ahead of expectations. Overall, the Committee determined that the Company&#146;s performance exceeded its objectives for 2016
and awarded the NEO pool with cash incentive payments for 2016 that were funded above a 100% target payout. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Compensation for
2016 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2016, we continued to follow and implement our approach to executive compensation that we have evolved since 2012
based upon feedback from our stockholders in our enhanced investor outreach program. Specifically, starting in 2013, we transitioned to a new executive compensation program that improved the alignment of Integra&#146;s executive compensation with
metrics that drive total stockholder return and holds management accountable for the Company&#146;s financial performance and progress towards the Company&#146;s strategic objectives and goals. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Performance Incentive Compensation Plan (the &#147;Bonus Plan&#148;) </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee approved the Bonus Plan in January 2013, which the full Board then approved in February 2013, and the stockholders then
approved in May 2013, which remains in effect. The following are the highlights of the Bonus Plan: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Bonus Plan, cash bonuses may be paid based on the Company&#146;s achievement of performance goals that the Committee determined within the
first 90 days of the year. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighting of metrics to fund the incentive pool for 2016 performance pursuant to a formula that includes percentage weightings for revenue (40%),
adjusted EBITDA (30%), and operating cash flow (30%). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2016 performance, the 2016 NEOs were eligible for cash incentive payments only if the Company achieved its EBITDA goal of at least 70% of its prior
year EBITDA. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee has only negative discretion to reduce (and not increase) the amount of the bonus pool funded, and subsequently the awards to NEOs, which
are intended to comply with Section 162(m). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each NEO in the Bonus Plan has an established target bonus opportunity, with no minimum (that is, the actual payment could be 0%) and a cap at 150% of
his or her target (cap of 182% for the CEO, which is 200% of the CEO&#146;s base salary). In February 2017, the Committee approved an amendment to the Bonus Plan, commencing in performance year 2017, to increase the maximum payout percentage to 200%
of target (up from 150%) for NEOs, to better align pay and performance. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Bonus Plan is designed to allow awarding compensation that is intended to meet the requirements of Section 162(m) to allow tax deductibility.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes a clawback provision. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Determining Awards for 2016 Performance under the Bonus Plan </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee
established the following target awards for 2016 performance for our NEOs: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive Officer</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Title</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cash Incentive Plan Target<BR>as a % of
Base Salary</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CEO</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">110%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn G. Coleman</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">60%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert T. Davis, Jr.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CVP</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">50%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CVP</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">45%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel L. Reuvers</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CVP</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">40%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of our NEOs has a cash incentive guarantee. In 2016, no NEO may earn an award in excess of 150% of
his/her target, other than the CEO who may earn an award up to 182% of his target, which is 200% of his base salary. For performance year 2017, each NEO can earn a cash bonus award up to 200% of his/her target. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Bonus Plan provides a clear process for determining bonuses for NEOs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Threshold Objective for NEOs for 2016 Performance </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee
established a threshold objective for 2016 performance (70% of prior year EBITDA from continuing operations) for the 2016 NEOs based on the prior year&#146;s EBITDA, for the purposes of tax deductibility under Section 162(m), because the Committee
believes that this is the most complete single metric to assess the Company&#146;s performance. The Company achieved this goal in 2016 resulting in funding of the Bonus Plan as stated below. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon achievement of the EBITDA goal, the bonus for such NEOs is funded at the maximum (150% of their targets in 2016). Thereafter, the
Committee has the ability to exercise only negative discretion in order to determine the actual cash incentive payment for such NEOs based on the funding of the Company&#146;s annual cash incentive pool pursuant to the metrics set forth in the table
below and such NEO&#146;s performance. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cash Incentive Pool Funding Model for 2016 Performance </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Bonus Plan was designed to fund an overall pool based on financial metrics for all participants. The aggregate amount of the final
payments to all participants, including such NEOs, may not exceed the overall funded pool. The Company&#146;s pool funding model for 2016 performance was as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8px">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Performance Goals as a Percent of Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016 Performance Metric</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weight</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Below<BR>Threshold</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>THRESHOLD<BR>GOAL</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>TARGET<BR>GOAL</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>MAX<BR>GOAL</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>REVENUE</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">95.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">96</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">104</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADJUSTED EBITDA</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">93</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">107</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OPERATING CASH
FLOW</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Cash Incentive Pool Funding as % of
Target</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee approved these metrics for 2016 performance because they are key indicators as to the strength of the
business, and we believe that they drive stockholder returns over the long term. Because the Company&#146;s results exceeded the threshold goals for the performance metrics consisting of revenue, adjusted EBITDA and operating cash flow, the cash
incentive pool was funded for all eligible participants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Negative Discretion to Determine Final Payout for 2016 Performance
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee has negative discretion to reduce awards for each NEO for 2016 performance based on the following metrics:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">65% weight on financial and quantitative measures including revenue, operating cash flow and adjusted EBITDA, in addition to other division-specific
financial metrics. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">35% weight on qualitative measures including leadership objectives and strategic initiatives. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Determining Awards for 2017 Performance under the Bonus Plan </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Committee established the following target awards for 2017 performance for the following NEOs: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive Officer</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Title</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cash&nbsp;Incentive&nbsp;Plan&nbsp;Target<BR>as a % of Base
Salary</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CEO</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">110</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn G. Coleman*</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert T. Davis, Jr.*</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CVP</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CVP</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel L. Reuvers*</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">CVP</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*The</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">NEO&#146;s target award for 2017 performance increased from the prior year to reflect their promotions on December&nbsp;1, 2016. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of our NEOs has a cash incentive guarantee. None may earn an award in excess of 200% of his/her target for the 2017 performance year.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Bonus Plan provides a clear process for determining bonuses for NEOs. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Threshold Objective for NEOs for 2017 Performance </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Committee has established a threshold objective for 2017 performance of 70% of prior year Adjusted EBITDA for the NEOs. This threshold objective was modified to be based on Adjusted EBITDA as opposed
to the previous threshold objective of EBITDA for NEOs for 2017 performance. The definition of Adjusted EBITDA for bonus purposes is GAAP net (loss)/income from continuing operations, excluding: (i)&nbsp;depreciation and amortization,
(ii)&nbsp;other income (expense), net, (iii)&nbsp;interest income and expense, (iv)&nbsp;income taxes, and (v)&nbsp;those operating expenses also excluded from adjusted net income. If the goal is achieved, the bonus for each NEO will be funded at
the maximum (200% of his or her target). Thereafter, the Committee may exercise only </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
negative discretion in determining the actual cash incentive payment for each NEO, using only the funding of the Company&#146;s annual cash incentive pool pursuant to the metrics set forth in the
table below and each NEO&#146;s performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cash Incentive Pool Funding Model for 2017 Performance </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Bonus Plan funds an overall pool based on financial metrics for all participants. The aggregate amount of the final payments to all
participants, including the NEOs, may not exceed the overall funded pool. The Company&#146;s pool funding model for 2017 performance is shown below. The Committee approved these metrics for 2017 performance because they are key indicators as to the
strength of the business, and we believe they drive stockholder returns over the long term. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Performance Goals as a Percent of Target</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2017 Performance Metric</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weight</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Below<BR>Threshold</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>THRESHOLD<BR>GOAL</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>TARGET<BR>GOAL</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>MAX<BR>GOAL</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>REVENUE</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">95.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">96</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">104</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADJUSTED EBITDA</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">93</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">107</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OPERATING CASH FLOW</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84.9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Cash
Incentive Pool Funding as % of Target</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, the Committee approved a potential modifier on the funding of the pool for 2017 based on the
achievement of milestones related to the integration of certain acquisitions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Negative Discretion to Determine Final Payout for
2017</I><B> </B><I>Performance </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee has negative discretion to reduce awards for each NEO for 2017 performance
based on the following metrics: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">65% weight on financial and quantitative measures, including revenue, operating cash flow and adjusted EBITDA, and other division-specific financial
metrics. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">35% weight on qualitative measures, including leadership objectives and strategic initiatives. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Long-Term Equity Incentive Plan </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2016 Equity Grants </I></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We amended our equity plan effective January&nbsp;1, 2013 (applicable to awards granted on or after that date)&nbsp;(i) to revise the trigger for
accelerated vesting after a change in control from a &#147;single trigger&#148; (meaning that the accelerated vesting shall occur in connection with the change in control) to a &#147;double trigger&#148; (meaning that the accelerated vesting occurs
upon both the change in control and a qualifying termination of employment), and (ii)&nbsp;to add a &#147;clawback&#148; provision that requires under certain circumstances the return of compensation received on the basis of financial statements
that are subsequently restated. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2016 annual equity grant to each of our NEOs was based on their performance over the long term and, during 2015, each NEO&#146;s long-term
potential, retention considerations and information about the market for comparable executives. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In March 2016, Messrs. Coleman, Davis, Gorelick, and Reuvers received an annual equity grant consisting of 50% PSUs, 30%
<FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, and 20% restricted stock. The restricted stock awarded to the NEOs vests annually over three years. The PSUs vest annually over three years, contingent on achieving our revenue
growth goal. The <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options vest annually over four years (other than for Mr.&nbsp;Coleman, whose <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options vest annually over three
years). </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In March 2016 Mr.&nbsp;Arduini received an annual equity grant of 50% PSUs, 30% <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options,
and 20% restricted stock unit. For more information on Mr.&nbsp;Arduini&#146;s 2016 annual equity grant, please refer to section entitled Annual Review of Compensation. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In December 2016, Messrs. Coleman, Davis, and Reuvers were awarded additional equity compensation in the form of
<FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options to reflect their respective promotions and additional responsibilities. These <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option grants vest in full after three
years. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The PSUs granted in March 2016 will vest in annual installments (assuming the annual revenue growth performance goal is achieved each year) with a
three-year performance period beginning January&nbsp;1, 2016 and ending December&nbsp;31, 2018. The target revenue levels also increased for the 2016 PSU cycle from previous cycles to increase the rigor of the program and align with the
company&#146;s long-term business strategy and growth targets. Each NEO is eligible to vest in and receive a number of shares of the Company&#146;s common stock ranging from zero percent (0%) to <FONT STYLE="white-space:nowrap">one-hundred</FONT>
and fifty percent (150%)&nbsp;of the target number of shares of performance stock granted based on the Company&#146;s achievement of goals relating to the increase in the Company&#146;s annual revenue over the initial revenue target, defined as the
Company&#146;s revenue for the fiscal year ended December&nbsp;31, 2015, during each fiscal year of the performance period running from January&nbsp;1, 2016 through December&nbsp;31, 2018 as detailed below: </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8px">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Increase&nbsp;in&nbsp;Annual<BR>Revenue over the<BR>Baseline (Fiscal<BR>2015)
Revenue<BR>Level</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Performance<BR>Vesting&nbsp;Percentage</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2016
PERFORMANCE YEAR</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;&nbsp;3&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Threshold Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Target Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>&nbsp;11&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL"></FONT>%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2017
PERFORMANCE YEAR</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;&nbsp;6&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Threshold Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Target Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>&nbsp;22&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL"></FONT>%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018
PERFORMANCE YEAR</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;&nbsp;9&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Threshold Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Target Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>&nbsp;33&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:SYMBOL"></FONT>%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the increase in annual revenue over the initial revenue target for any performance year falls between the threshold level and the target level, then
the performance vesting percentage shall be determined by means of linear interpolation between the threshold level&#146;s and target level&#146;s performance vesting percentages specified above. If the increase in annual revenue over the initial
revenue target for any performance year falls between the target level and the maximum level, then the performance vesting percentage shall be determined by means of linear interpolation between the target level&#146;s and maximum level&#146;s
performance vesting percentages specified above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the performance goal with respect to a given fiscal year is not achieved at the target level or higher, and the Company achieves the <FONT
STYLE="white-space:nowrap">&#147;catch-up&#148;</FONT> goal defined as a target cumulative revenue growth rate goal over </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
the three-year performance period, then additional shares of performance stock will vest on the third anniversary of the grant date, as though the performance goal for such fiscal year was
achieved at the target level. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2017 Equity Grants </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our annual equity grants are intended to provide long-term incentive and performance-based compensation to our NEOs. Accordingly, the amount of the
2017 annual equity grant made to each of our NEOs is based on their performance over the long term and during 2016, each NEO&#146;s long-term potential and retention considerations, and information about market practices for comparable executives.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In March 2017, Messrs. Coleman, Davis, Gorelick, and Reuvers each received an annual equity grant consisting of 50% PSUs, 30% <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options, and 20% restricted stock. The restricted stock vests annually over three years. The PSUs vest annually over three years contingent on achieving our revenue growth goal. The <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options vest annually over four years (other than for Mr.&nbsp;Coleman whose <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options vest annually over three years). For information
on the CEO&#146;s 2017 annual equity award (50% PSUs, 30% <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, and 20% restricted stock units), please refer to the section below entitled &#147;Annual Review of Compensation.&#148;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The PSUs granted in March 2017 will vest in annual installments (assuming the annual revenue growth performance goal is achieved each year) with a
three-year performance period beginning January&nbsp;1, 2017 and ending December&nbsp;31, 2019. Each NEO is eligible to vest in and receive a number of shares of the Company&#146;s common stock ranging from fifty percent (50%) at threshold to <FONT
STYLE="white-space:nowrap">one-hundred</FONT> and fifty percent (150%) of the target number of shares of performance stock granted based on the Company&#146;s achievement of goals relating to the increase in the Company&#146;s annual revenue over
the initial revenue target, defined as the Company&#146;s revenue for the fiscal year ended December&nbsp;31, 2016 during each fiscal year of the performance period running from January&nbsp;1, 2017 through December&nbsp;31, 2019 as detailed below:
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8px">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Increase&nbsp;in&nbsp;Annual&nbsp;&nbsp;<BR>Revenue over the<BR>Baseline
(Fiscal<BR>2016) Revenue<BR>Level(%)</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Performance<BR>Vesting&nbsp;Percentage&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2017
PERFORMANCE YEAR</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;&nbsp;3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Threshold Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Target Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U></U>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>&gt;</U>&nbsp;11</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018
PERFORMANCE YEAR</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;&nbsp;6</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Threshold Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Target Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U></U>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>&gt;</U>&nbsp;22</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019
PERFORMANCE YEAR</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;&nbsp;9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Threshold Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Target Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Maximum Level</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U></U>&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>&gt;</U>&nbsp;33</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the increase in annual revenue over the initial revenue target for any performance year falls between the threshold level and the target level, then
the performance vesting percentage shall be determined by means </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
of linear interpolation between the threshold level&#146;s and target level&#146;s performance vesting percentages specified above. If the increase in annual revenue over the initial revenue
target for any performance year falls between the target level and the maximum level, then the performance vesting percentage shall be determined by means of linear interpolation between the target level&#146;s and maximum level&#146;s performance
vesting percentages specified above. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the performance goal with respect to a given fiscal year is not achieved at the target level or higher, and the Company achieves the <FONT
STYLE="white-space:nowrap">&#147;catch-up&#148;</FONT> goal defined as a target cumulative revenue growth rate goal over the three-year performance period, then additional shares of performance stock will vest on the third anniversary of the grant
date, as though the performance goal for such fiscal year was achieved at the target level. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>PSUs Metric and Goal Setting
Considerations </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue and revenue growth is a critical focus for the Company, and is therefore a metric used in our
awards of PSUs (revenue growth) as well as the metric used in the Bonus Plan (revenue). Profitable growth is a core component of our strategy.&nbsp;In our industry, the increasingly competitive and complex landscape, increasing global regulation,
and overall pricing pressure have driven an even stronger correlation between scale and profitability, as measured by revenue. These considerations drive our strategy and annual objectives. As a result, we believe that linking our equity grants to
revenues creates an appropriate way to measure and reward performance and drive profitable growth. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We annually review the
metrics (and related goal targets) used in our annual and long-term incentive programs to ensure that they remain aligned with Integra&#146;s strategic plan. The three-year annual revenue growth goal derives from a rigorous process that involves
input and discussions among the President and CEO, internal human resources and finance personnel, the Company&#146;s compensation consultants, the Committee, and the Committee&#146;s compensation consultants and legal advisors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Key Governance Features Relating to Executive Compensation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee has a number of corporate governance features related to executive compensation, which we summarize below. We believe that
these mechanisms assure the alignment of our executive compensation with the interests of stockholders. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Element</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Purpose</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Key Characteristics</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock ownership guidelines and retention requirements</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To align the long-term interests of NEOs with stockholders.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The CEO is required to own shares equal to 6x his annual salary; the CFO is required to own 2x his annual salary; other
NEOs are required to own 1x their annual salaries. All of our NEOs have met these requirements or are still within the initial five-year period from the commencement date of employment to still comply with these requirements. The NEOs are required
to hold stock received from the Company pursuant to the stock ownership guidelines.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Compensation recoupment (&#147;clawback&#148;) policy</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ensure that compensation is paid only upon proven results.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If a restatement of our financial statements is required to
correct a material error or inaccuracy due to the fraud or intentional misconduct of an NEO, the Committee can recoup from that NEO bonuses or equity awards awarded on or after January&nbsp;1, 2013 and cancel outstanding bonus or equity award
opportunities.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Anti-hedging/pledging policy</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ensure that equity compensation is an effective method to align the interests of NEOs and stockholders.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">No NEO may hedge or pledge our securities. Also, all NEOs must <FONT STYLE="white-space:nowrap">pre-clear</FONT> trades
involving Company stock with our Law Department.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">No <FONT STYLE="white-space:nowrap">&#147;gross-ups&#148;</FONT></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To reflect sound executive compensation governance practices, manage the cost of compensation to the Company,
and recognize that the burden for payment of taxes on income falls on employees.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">No NEO is eligible to receive any tax <FONT
STYLE="white-space:nowrap">gross-ups</FONT> on perquisites or excise taxes, such as Section 280G taxes in the event of a change of control.</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">52 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Element</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Purpose</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Key Characteristics</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;Double trigger&#148; change in control
arrangements</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To prevent undue gains in the event of a change in control.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our equity plans and equity grant agreements require a qualifying termination of
employment in addition to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> in order to accelerate vesting of equity awards granted on or after January&nbsp;1, 2013. In addition, all change in
control provisions in our employment and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> severance agreements for NEOs require a qualifying termination of employment in addition to a change in
control before triggering <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> benefits.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Annual equity awards</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To retain and attract highly qualified NEOs and tie their performance to the performance of our stock, thus aligning their interests with the
interests of our stockholders.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We include annual equity as a primary component of the long-term compensation of our NEOs.
In 2016 and 2017, the grant value of the annual equity awards was determined based on each NEO&#146;s performance, potential, and competitive market data. In March 2016, the CEO received an annual equity award of 50% PSUs, 30% <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options, and 20% restricted stock units. In March 2016, Messers. Coleman, Davis, Gorelick and Reuvers received an annual equity award of 50% PSUs, 30%
<FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, and 20% restricted stock. In March 2017, the CEO received an annual equity award of 50% PSUs, 30% <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, and 20%
restricted stock units. In March 2017, Messers. Coleman, Davis, Gorelick and Reuvers received an annual equity award of 50% PSUs, 30% <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, and 20% restricted stock.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bonus Plan</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To provide annual cash incentive opportunities based on the achievement of performance goals and satisfy Section 162(m) requirements for
awards intended to qualify as <FONT STYLE="white-space:nowrap">performance-based</FONT> compensation.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2013, we adopted (and stockholders approved) a
<FONT STYLE="white-space:nowrap">performance-based</FONT> cash incentive plan designed to allow the Committee to grant bonuses intended to be &#147;qualified <FONT STYLE="white-space:nowrap">performance-based</FONT> compensation&#148; under Section
162(m).</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">53 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" STYLE="BORDER:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Element</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Purpose</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Key Characteristics</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cap on annual cash incentives</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To achieve the appropriate balance between fixed and variable compensation.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">For performance year 2016, we limit the amount of any annual bonus awarded to any NEO to a
maximum of 150%, other than the CEO who has a maximum of 182% of his related target award. For performance year 2017, we limit the amount of any annual bonus awarded to any NEO to a maximum of 200% of the related target award.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">No minimums or guarantees</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To motivate our NEOs to perform under all circumstances.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our NEOs have no guarantees or minimums related to base salary increases, bonuses or
equity awards.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Few perquisites</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To focus NEOs on performance elements of compensation.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our NEOs participate in <FONT STYLE="white-space:nowrap">broad-based</FONT> <FONT
STYLE="white-space:nowrap">Company-sponsored</FONT> benefits programs on the same basis as other full-time employees, except for the Executive Physical Medical Exam Program noted below.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">No SERP</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To focus NEOs on performance elements of compensation and long-term value creation.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our NEOs participate in the same defined contribution retirement plan as other
employees.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Risk Management</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To conform to Integra&#146;s brand promise to limit uncertainty.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have a strong risk management approach involving a broad spectrum of departments with
specific responsibilities assigned to management, the Board and the Board&#146;s committees. We review how the Company assesses, addresses, and reports risk annually with the Board.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Independent Compensation Consultant</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To obtain objective input to decision making.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Committee uses the services of an independent compensation
consultant.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Physical Medical Exam Program</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">To strengthen a culture of health and ensure a holistic approach to our executive remuneration program.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The program, implemented in October 2013, provides payment for annual executive physical
medical exams for NEOs.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Process for Determining Compensation and its Components </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the beginning of 2016, we established performance objectives for each NEO along with variable pay target opportunities for cash
incentives and long-term equity incentives. In the first quarter of 2017, the Committee completed a formal performance review for performance year 2016 for the CEO and each other NEO. The Committee reviewed the performance of the CEO, and the
CEO&#146;s assessment of the NEOs, along with market data that the Company&#146;s compensation consultants compiled, to determine each element of compensation for performance year 2016. As a result of this work, the Company determined the following:
(i)&nbsp;base salary merit increases for 2017, (ii) annual cash incentives based on the cash bonus pool for 2016, paid in March 2017, (iii) long-term equity incentives (annual equity grants) as summarized above, and (iv)&nbsp;the CEO&#146;s
compensation in 2016 and 2017. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">54 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Components of Integra&#146;s Executive Compensation </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integra&#146;s executive compensation consists of fixed pay and variable pay, each of which includes cash and <FONT
STYLE="white-space:nowrap">non-cash</FONT> components. The chart below summarizes the various elements of Integra&#146;s executive compensation, and the narrative that follows describes the most important elements and their purposes in greater
detail. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g48j77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Total Compensation:</I> We consider total compensation for comparable roles at companies in medical
technology, healthcare and general industry, based on the data obtained from published salary surveys that we review, the proxy statements of the companies mentioned below and other materials that the Committee&#146;s compensation consultant
prepared relying upon such data. We use this data primarily to ensure that our executive compensation program as a whole is competitive. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We continue to emphasize variable pay rather than fixed pay, with target opportunities based on market practices and payments based on performance. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following charts are designed to demonstrate the various components of our NEOs&#146;
2016 compensation which place a particular emphasis on variable pay. We believe that these charts are helpful in demonstrating the components of our NEOs&#146; compensation aligned with our philosophy. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g92s40.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salaries:</I> We establish salaries for NEOs that reflect each executive&#146;s experience, expertise, and
compensation history as well as current competitive compensation data and internal comparisons. The Committee reviews base salaries of our NEOs annually, and considers approving increases as warranted by performance, market competitiveness and
affordability. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Cash Incentives:</I> As discussed above, the cash bonus pool for 2016 performance, paid in March 2017, was funded at 117%
overall based on the Company&#146;s performance against 2016 financial targets. Individual payment recommendations were based on performance (65% weighting on quantitative and 35% weighting on qualitative objectives) and the relevant NEO&#146;s
target opportunity. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Equity Incentives:</I> Our equity grants align NEOs with stockholder interests as we increasingly focus on
performance as well as retention, and facilitate long-term stock ownership. The main terms and features of our equity grants include the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Restricted Stock Awards: Annual vesting over three years. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Restricted Stock Units: Granted to the CEO with three-year vesting and deferral of payments until after departure. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Options: The CEO&#146;s <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options
vest as to <FONT STYLE="white-space:nowrap">one-third</FONT> of the shares on the first anniversary of the grant date and thereafter in monthly installments through the third anniversary of such grant date. In addition, all NEOs who received <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options as part of their respective annual equity grants will vest annually over four years, except for the CFO, whose <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options will
vest annually over three years. Also, the <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options granted to Messrs. Coleman, Davis, and Reuvers in in December 2016 vest in full after three years. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">2016 CEO Compensation Summary2016 Other NEOs Average Compensation Summary </FONT></P>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">56 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">PSUs: Annual vesting over three years contingent on achieving revenue growth goals, as detailed in the discussion above. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Equity Grant Practices </U></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition to describing the types of grants the Company provides, we believe that a discussion of our practices surrounding our grants is useful to underscore the procedures behind the grants. The
Committee considers the performance of the Company, potential performance of individuals over the short- and long-term and market considerations in determining the value and equity-type for annual equity awards. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of our practices: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee approves equity awards after it completes its annual review process for the individuals eligible to receive equity grants and bases its
decisions, at its discretion, on their short- and long-term performance, the Company&#146;s performance in the prior year, and the need to stay competitive in the market for executives. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Special Award Committee, consisting of our CEO, has authority (within specified limits) to approve
<FONT STYLE="white-space:nowrap">equity-based</FONT> awards to other managers, and typically approves annual awards during the first quarter, and throughout the year for strategic new hires, selected promotions, and key retention needs. We expect
these practices to continue. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect PSU grants intended to constitute &#147;qualified performance-based compensation&#148; to be made within the first 90 days of the year
consistent with the requirements of Section 162(m). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We make decisions to grant equity awards without regard to anticipated earnings or other major announcements by the Company.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We require all NEOs and substantially all U.S. based employees to have signed a <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement or,
where applicable law does not support <FONT STYLE="white-space:nowrap">non-competition</FONT> agreements, a confidentiality agreement that includes provisions regarding <FONT STYLE="white-space:nowrap">non-solicitation</FONT> and assignment of
inventions or an employment or severance agreement with <FONT STYLE="white-space:nowrap">non-competition</FONT> provisions, as a condition to, among other things, employment and, for those eligible, receiving an equity award.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The exercise price of our <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options is equal to the closing price of our common stock on the
NASDAQ Global Select Market on the date of grant. This practice with respect to setting stock option exercise prices is consistent with the terms of our equity incentive plans. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our 2003 Equity Incentive Plan provides that, without stockholder approval, no amendment may be made that would reprice outstanding awards.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Other Components of Integra&#146;s Executive Compensation </U></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Ownership Guidelines and Retention Requirements:</I> All of our NEOs have met their stock ownership guidelines and retention
requirements or are still within the initial five-year period from the commencement date of employment to still comply with such guidelines and retention requirements. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Benefits:</I> Our NEOs participate in our benefits offerings on the same basis as all other employees except for the Executive Physical Medical Exam Program that was established in October 2013 and was
formed in order to strengthen a culture of health and foster a holistic approach to our executive remuneration program. The program provides payment for annual physical medical exams for our NEOs. Each NEO is encouraged to complete an exam in 2017.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Perquisites:</I> We provide our NEOs with very few perquisites and other benefits not generally available to other
employees. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">See &#147;Annual Review of Compensation&#148; for additional information, including a description of the goals and
each executive&#146;s achievements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">57 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Our Peer Group and the Markets in Which We Compete </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As one of several factors in considering approval of Integra&#146;s compensation programs, the Committee compares Integra&#146;s
compensation programs and performance against those maintained by an approved peer group of companies. The compensation peer group, which is periodically reviewed and updated by the Committee, consists of companies that are similar in size (revenue
and market capitalization) and in the same industry as Integra and with whom Integra may compete for executive talent. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
selecting peer companies, the Committee evaluates the comparability of those companies&#146; in terms of complexity of products and manufacturing processes, number and variety of product lines, technical complexity, and global reach as well as
considering where Integra competes for executive talent and the size of the organizations in terms of revenue and market capitalization. In 2016, after reviewing all of the relevant criteria with Willis Towers Watson, the Committee&#146;s
compensation consultant, the Committee made the following changes to the Company&#146;s peer group from 2015: (i) removed Thoratec Corporation (acquired by St. Jude Medical) and Alere Inc. (acquired by Abbott Laboratories Inc.) and (ii)&nbsp;added
Steris, Cantel Medical Inc., and Align Technologies, Inc. The revised peer group consists of the following companies: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="BORDER:1px solid #000000; padding-left:8px; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Integra&#146;s Peer Group</B></FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Abiomed, Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Invacare Corporation</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Align Technologies, Inc.</FONT></P></TD>

<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Masimo Corporation</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cantel Medical, Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">NuVasive, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">C.R. Bard, Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Orthofix International</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CONMED Corporation</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">ResMed Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Edwards Lifesciences
Corporation</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Steris</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Haemonetics Corporation</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Teleflex Inc</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT
STYLE="white-space:nowrap">Hill-Rom</FONT> Holdings, Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Cooper Companies, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Hologic, Inc.</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Varian Medical Systems, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px">
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integer Holdings Corporation</FONT></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Wright Medical Group, Inc.</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intuitive Surgical, Inc.</FONT></P></TD>

<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Annual Review of Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We make decisions regarding NEO compensation (salary increases, bonus payments and equity grants) in connection with our annual performance review process. The 2017 annual equity grants are based on the
performance of the Company in 2016, the performance of individuals over the short and long term, market considerations, each respective executive&#146;s long-term potential, and the Committee&#146;s desire to provide adequate incentive to motivate
the executive&#146;s continued performance. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For fiscal year 2016, we completed our review process for our NEOs in February
2017 and made the equity awards in March 2017. Thus, pursuant to the SEC rules, the equity grants awarded to the NEOs in 2017 for 2016 performance do not appear in the Summary Compensation Table for 2016. The Company accounts for equity in
accordance with FASB ASC Topic 718. We anticipate that we will adhere to a similar timetable for the annual reviews of performance and compensation for our NEOs in future years. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following discussion sets forth the Committee&#146;s actions for 2016 and, to the extent already taken, for certain 2017 items. See
&#147;Compensation of Executive Officers&#148; and the tables and footnotes in that section for complete information. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Peter J. Arduini,
President and Chief Executive Officer </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the beginning of 2017, the Committee conducted a formal review of
Integra&#146;s performance and Mr.&nbsp;Arduini&#146;s 2016 performance with a focus on key financial and other quantitative metrics as well as important qualitative objectives. This assessment of performance in 2016 and over the long term, along
with a review of competitive compensation as well as his specific accomplishments as described below, served as the basis for decisions regarding Mr.&nbsp;Arduini&#146;s compensation. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">58 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Performance Highlights Include the Following: </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2016, under Mr.&nbsp;Arduini&#146;s leadership as President and CEO, Integra executed and delivered on key strategic, operational, and
talent management priorities. Mr.&nbsp;Arduini managed the business well, increased value for stockholders, improved the overall infrastructure of the Company, focused the Company&#146;s portfolio and resources on select markets, and defined plans
for and showed early results of an accelerating growth portfolio. The Committee considered the following accomplishments in rendering its assessment: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">One-year</FONT> total return to stockholders for 2016 was 26.6% (compared to 13.0% for our peer group), and three-year
total return to stockholders for 2014, 2015 and 2016 was 98.9% (compared to 68.4% for our peer group); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Demonstrated the strength of our underlying businesses and the success of our new product launches by improving our organic revenue growth profile
during 2016 and achieving full-year organic revenue growth of 9.0%, an acceleration from 6.7% in 2015; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integrated TEI Biosciences Inc., and TEI Medical Inc., broadening our current Advanced Wound Care portfolio and expanding a dedicated wound care
channel focused on the outpatient clinic. TEI also enhanced our regenerative product pipeline with four new products from the PriMatrix<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> and SurgiMend<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> platforms that
are planned for introduction during 2017; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integrated the Salto
Talaris<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> ankle and the Futura&#153; toe that the Company acquired from Tornier. The products further diversify
our lower extremity portfolio, and, when combined with the launch of our internally developed Cadence total ankle replacement, drove growth and captured market share in the fast-growing ankle arthroplasty market; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Integrated Tekmed, allowing us to build a direct presence in Italy and expand our European infrastructure, increasing our growth in Italy for both our
specialty surgical solutions and orthopedics and tissue technologies product lines; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Received FDA approval and began the U.S. market commercialization of Omnigraft&#153;, the only <FONT STYLE="white-space:nowrap">FDA-approved</FONT>
product that regenerates dermal tissue used in the treatment of diabetic foot ulcers. Omnigraft heals in fewer applications than other technologies&nbsp;&#151;&nbsp;a unique value proposition that results in lower costs to the payer and patient;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increased international sales double-digits primarily from strength in our neurosurgery business and contribution from the TEI and Tekmed acquisitions;
and, </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increased our borrowing capacity from $1.1&nbsp;billion to $1.5&nbsp;billion through an amended credit facility and extended the term through 2021.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee also considered his leadership and key talent hires made during 2016, including the role
changes for Messrs. Davis, Reuvers and Coleman, as well as his key achievements relating to strategy, employee development, and process improvement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Based on all of the above achievements, which enabled the Company to exceed (or essentially meet) its financial targets and position the Company for growth, the Committee approved compensation actions for
Mr.&nbsp;Arduini as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016: An increase in base salary of $25,780 or 3% to $885,109 effective April&nbsp;1, 2016 (Integra&#146;s global salary increase effective date) as a
result of Mr.&nbsp;Arduini&#146;s accomplishments. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017: An increase in base salary of $26,553 or 3% to $911,662 effective April&nbsp;1, 2017 (Integra&#146;s global salary increase effective date) as a
result of Mr.&nbsp;Arduini&#146;s accomplishments discussed above. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Annual Cash Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Arduini&#146;s employment agreement provides for a target bonus opportunity of 110% of base salary in 2016. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">59 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2015, the Committee determined to award Mr.&nbsp;Arduini a cash bonus of $1,389,535, approximately 147% of target, paid in March 2016 for 2015
performance pursuant to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2016, the Committee determined to award Mr.&nbsp;Arduini a cash bonus of $1,400,000, approximately 144% of his target, paid in March 2017 for 2016
performance pursuant to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Equity Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s philosophy is to tie a significant portion of annual equity awards to performance. The Committee and management consider <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options and PSUs as performance-based equity and the Committee granted Mr.&nbsp;Arduini 80% of his annual equity award in performance-based equity (50% PSUs and 30%
<FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016 Annual Grant: Based on Mr.&nbsp;Arduini&#146;s <FONT STYLE="white-space:nowrap">short-and</FONT> long-term performance taking 2015 into account,
retention, and market considerations, the Committee approved a grant of $4,500,000, which was granted in March 2016, allocated as follows: (i) 20% in the form of restricted stock units with annual vesting over three years and a deferral feature that
provides the award will be paid following the <FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of Mr.&nbsp;Arduini&#146;s termination; (ii) 30% in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options; and
(iii) 50% in the form of PSUs with annual vesting over a three-year performance period based on achieving revenue growth goals. The value of the March 2016 equity grant and resulting total direct compensation falls between the median and the 75th
percentile of the peer group and emphasizes the importance of aligning CEO compensation with stockholder interests and rewards Mr.&nbsp;Arduini for significant accomplishments the Company made under his leadership. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017 Annual Grant: Based on Mr.&nbsp;Arduini&#146;s short and long-term performance taking 2016 into account, retention, and market considerations, the
Committee approved a grant of $4,750,000, which was granted in March 2017, allocated as follows: (i) 20% in the form of restricted stock units (21,750 shares of restricted stock units) with annual vesting over three years and a deferral feature that
provides the award will be paid following the <FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of Mr.&nbsp;Arduini&#146;s termination; (ii) 30% in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options (84,071
shares of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options); and (iii) 50% in the form of PSUs (54,373 shares of PSUs at target) with annual vesting over a three-year performance period based on achieving revenue growth goals. The
value of the March 2017 equity grant and resulting total direct compensation falls between the median and the 75th percentile of the peer group and emphasizes the importance of aligning CEO compensation with stockholder interests and rewards
Mr.&nbsp;Arduini for significant continued accomplishments the Company made under his leadership. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The underlying shares for the restricted stock unit grants in 2016 and 2017 will be deferred and will be delivered to Mr.&nbsp;Arduini within the <FONT
STYLE="white-space:nowrap">30-day</FONT> period immediately following the <FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of his separation from service. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vesting of the following PSU grants occurred in 2016 and 2017 because the Company achieved the <FONT STYLE="white-space:nowrap">pre-established</FONT>
revenue growth performance goals which covers their respective performance periods in 2015 and 2016: </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSUs VESTING IN 2016 </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2013 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target (pursuant to achievement of
<FONT STYLE="white-space:nowrap">catch-up</FONT> performance goal) and third performance period vested at target; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Additional March 2013 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target (pursuant to achievement of
<FONT STYLE="white-space:nowrap">catch-up</FONT> performance goal with deferral feature similar to his grants of restricted stock units) and third performance period vested at target (with a deferral feature similar to his grants of restricted stock
units); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2014 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">60 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSUs VESTING IN 2017 </U></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2014 PSU grant&nbsp;&#151;&nbsp;third performance period vested at target; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2016 PSU grant&nbsp;&#151;&nbsp;first performance period vested at 150% of the target number of shares. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Mr.&nbsp;Arduini&#146;s Compensation for 2016 </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s overall approach to Mr.&nbsp;Arduini&#146;s compensation is consistent with the Company&#146;s compensation philosophy in rewarding his strong leadership and individual performance,
which is highlighted by his accomplishments as stated above, while, at the same time, providing Mr.&nbsp;Arduini with significant equity incentives so as to further ensure his alignment with the interests of the stockholders (a significant portion
of Mr.&nbsp;Arduini&#146;s compensation has a deferral feature pursuant to which Mr.&nbsp;Arduini will not receive the applicable shares of Integra stock until thirty days after the <FONT STYLE="white-space:nowrap">six-month</FONT> period following
his departure from the Company). The Committee determined that the Company exceeded its financial targets and was positioned for future growth under Mr.&nbsp;Arduini&#146;s leadership in 2016. Accordingly, in 2016 the Company awarded
Mr.&nbsp;Arduini a market competitive compensation package, substantially in the form of performance-based equity (80% of his annual equity award). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Arduini&#146;s reported total compensation increased from approximately $6.3&nbsp;million in 2015 to approximately $6.8&nbsp;million for 2016 performance, as illustrated in the table below. This
increase in total compensation primarily resulted from the Committee&#146;s wanting to ensure that Mr.&nbsp;Arduini&#146;s opportunity for total compensation remained competitive with the market and to recognize his performance and the
Company&#146;s performance in 2016. As a result, the Committee awarded him a $4.75&nbsp;million equity grant, which was granted in March 2017. Also, the Committee approved a cash bonus award of $1.4&nbsp;million at 144% of Mr.&nbsp;Arduini&#146;s
target bonus paid in March 2017, in alignment with the Company&#146;s achievement of its performance metrics. In addition, the Committee approved a 3% base salary increase for 2016. For 2015, 2016 and 2017, a substantial majority of his compensation
is at risk and dependent upon future performance (80% of his 2015, 2016 and 2017 equity grants are performance-based). The following chart outlines the breakdown of Mr.&nbsp;Arduini&#146;s compensation for 2015 and 2016 as well as his compensation
received in March 2017 for his 2016 performance. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g333443g10q46.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excluding an approximate $1.3&nbsp;million increase in fair value for his outstanding equity awards in connection with the Company&#146;s spin off.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Glenn G. Coleman, Corporate Vice President and Chief Financial Officer </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Coleman is the Corporate Vice President and Chief Financial Officer of the Company. In assessing his performance, the Committee
considered Mr.&nbsp;Coleman&#146;s performance against his objectives and overall contribution. In assessing Mr.&nbsp;Coleman&#146;s performance, the Committee considered his strong performance against
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">61 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
his objectives and overall contribution to the success in 2016.&nbsp;Highlights of his contributions include the following:&nbsp;1) the essential achievement of all key financial metrics for the
Company in 2016; 2) guiding the Company to achieve strong revenue growth and organic growth; and 3) leading the information technology function to achieve key milestones; and 4) expanding his responsibilities in December of 2016 to lead the
International business. Based on Mr.&nbsp;Coleman&#146;s accomplishments, as outlined above, the Committee&#146;s actions for 2016 include the following: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary </I></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016: An increase in base salary of $16,000 or 3.5% to $480,000 effective April&nbsp;1, 2016 (Integra&#146;s global salary increase effective date) to
reflect Mr.&nbsp;Coleman&#146;s performance in 2015. In recognition of his added responsibilities&nbsp;&#151;&nbsp;assuming oversight of the Company&#146;s international business&nbsp;&#151;&nbsp;Mr.&nbsp;Coleman received an increase in base salary
of $45,000 or 9.0% to $525,000, effective December&nbsp;1, 2016. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017: An increase in base salary of $15,750 or 2.65% to $540,000 effective April&nbsp;1, 2017 (Integra&#146;s global salary increase effective date) to
reflect Mr.&nbsp;Coleman&#146;s performance in 2016. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Annual Cash Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2015, the Committee determined to award Mr.&nbsp;Coleman a cash bonus of $348,000, approximately 150% of target, paid in March 2016 for 2015
performance pursuant to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2016, the Committee determined to award Mr.&nbsp;Coleman a cash bonus of $400,000, approximately 127% of target, paid in March 2017 for 2016
performance pursuant to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Equity Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016 Annual Grant: Based on Mr.&nbsp;Coleman&#146;s 2015 performance and market considerations, the Committee approved a grant of $700,000, which was
granted in March 2016, allocated as follows: (i)&nbsp;approximately 20% in the form of restricted stock with annual vesting over three years; (ii)&nbsp;approximately 30% in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock
options with annual vesting over three years; and (iii)&nbsp;approximately 50% in the form of PSUs with annual vesting over a three-year performance period based on the achievement of revenue growth goals. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016 Promotion Grant: In recognition of his added responsibilities in assuming oversight of the Company&#146;s international business, the Committee
approved an equity grant of $350,000, which was made December&nbsp;1, 2016, and provided in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, which vest in full after three years. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017 Annual Grant: Based on Mr.&nbsp;Coleman&#146;s 2016 performance and market considerations, the Committee approved a grant of $1,150,000, which was
granted in March 2017, allocated as follows: (i)&nbsp;approximately 20% in the form of restricted stock (5,266 shares of restricted stock) with annual vesting over three years; (ii)&nbsp;approximately 30% in the form of <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options (20,354 shares of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options) with annual vesting over three years; and (iii)&nbsp;approximately 50% in the form of PSUs (13,164
shares of PSUs at target) with annual vesting over a three-year performance period based on achieving revenue growth goals. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vesting of the following PSU grants occurred in 2016 and 2017 because the Company achieved the <FONT STYLE="white-space:nowrap">pre-established</FONT>
revenue growth performance goals which covers their respective performance periods in 2015 and 2016: </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSU
VESTING IN 2016 </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">May 2014 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSU VESTING IN 2017 </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">May 2014 PSU grant&nbsp;&#151;&nbsp;third performance period vested at target; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">62 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2016 PSU grant&nbsp;&#151;&nbsp;first performance period vested at 150% of the target number of shares. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Other</I>: Mr.&nbsp;Coleman does not have an employment agreement with the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Richard D. Gorelick, Corporate Vice President, General Counsel, Administration and Secretary </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Gorelick is the Corporate Vice President General Counsel, Administration and Secretary and manages the Law Department and
Environmental, Health and Safety functions. In assessing his performance, the Committee considered Mr.&nbsp;Gorelick&#146;s performance against his objectives and overall contribution, including leadership and his expertise in managing the global
legal function, managing litigation and employment law matters and continued development of members of the Law Department. Based on his contributions in these areas, the Committee approved the following compensation actions: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary: </I></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016: An increase in base salary of $10,000 or 2.7% to $387,188 effective April&nbsp;1, 2016 (Integra&#146;s global salary increase effective date) to
reflect Mr.&nbsp;Gorelick&#146;s performance in 2015. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017: An increase in base salary of $10,000 or 2.58% to $397,188 effective April&nbsp;1, 2017 (Integra&#146;s global salary increase effective date) to
reflect Mr.&nbsp;Gorelick&#146;s performance in 2016. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Annual Cash Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2015, the Committee determined to award Mr.&nbsp;Gorelick a cash bonus of $190,000, 144% of target, paid in March 2016 for 2015 performance
pursuant to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2016, the Committee determined to award Mr.&nbsp;Gorelick a cash bonus of $206,500, 118% of target, paid in March 2017 for 2016 performance
pursuant to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Equity Incentive: </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016 Annual Grant: Based on Mr.&nbsp;Gorelick&#146;s 2015 performance and market considerations, the Committee approved a grant of $264,000, which was
granted in March 2016, allocated as follows: (i)&nbsp;approximately 20% in the form of restricted stock with annual vesting over three years; (ii)&nbsp;approximately 30% in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock
options with annual vesting over four years; and (iii)&nbsp;approximately 50% in the form of PSUs, with annual vesting over a three-year performance period based on achieving revenue growth goals. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017 Annual Grant: Based on Mr.&nbsp;Gorelick&#146;s 2016 performance and market considerations, the Committee approved a grant of $315,000, which was
granted in March 2017, allocated as follows: (i)&nbsp;approximately 20% in the form of restricted stock (1,443 shares of restricted stock) with annual vesting over three years; (ii)&nbsp;approximately 30% in the form of <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options (5,576 shares of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options) with annual vesting over four years; and (iii)&nbsp;approximately 50% in the form of PSUs (3,606
shares of PSUs at target), with annual vesting over a three-year performance period based on the achievement of revenue growth goals. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vesting of the following PSU grants occurred in 2016 and 2017 because the Company achieved the <FONT STYLE="white-space:nowrap">pre-established</FONT>
revenue growth goals which covers their respective performance periods in 2015 and 2016: </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSU VESTING IN
2016 </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2013 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target (pursuant to achievement of
<FONT STYLE="white-space:nowrap">catch-up</FONT> performance goal) and third performance period vested at target; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2014 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">63 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSU VESTING IN 2017 </U></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2014 PSU grant&nbsp;&#151;&nbsp;third performance period vested at target; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2016 PSU grant&nbsp;&#151;&nbsp;first performance period vested at 150% of the target number of shares. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Robert T. Davis, Jr., Corporate Vice President and President&nbsp;&#151;&nbsp;Orthopedics and Tissue Technologies </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Davis was promoted to Corporate Vice President and President&nbsp;&#151;&nbsp;Orthopedics and Tissue Technologies on
December&nbsp;1, 2016. Previously Mr.&nbsp;Davis was Corporate Vice President and President&nbsp;&#151; Specialty Surgical Solutions. Mr.&nbsp;Davis made strong contributions as President of Specialty Surgical Solutions during the first eleven
months of 2016 before moving to his new role as President of Orthopedics and Tissue Technologies in December of 2016. His contributions included the following: 1) achieving strong revenue performance in 2016; 2) volume growth of the portfolio with
outstanding performance in instrument and Dural Repair franchises; 3) successfully launched the Mayfield 2 surgical headrest and strong planning for the launch of the next-generation ultrasonic aspirator; and 4) transitioned successfully into new
role and made an immediate impact as President, Orthopedics and Tissue Technologies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016: An increase in base salary of $14,000 or 3.6% to $401,500 effective April&nbsp;1, 2016 (Integra&#146;s global salary increase effective date) to
reflect Mr.&nbsp;Davis&#146; performance in 2015. In recognition of his added responsibilities in assuming oversight of the Company&#146;s Orthopedics and Tissue Technologies business, Mr.&nbsp;Davis received an increase in base salary of $28,500 or
7.0% to $430,000 effective December&nbsp;1, 2016. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017: An increase in base salary of $15,000 or 3.49% to $445,000, effective April&nbsp;1, 2017 (Integra&#146;s global salary increase effective date)
to reflect Mr.&nbsp;Davis&#146; performance in 2016. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Annual Cash Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2015, the Committee determined to award Mr.&nbsp;Davis a cash bonus of $232,500, 150% of target, paid in March 2016 for 2015 performance pursuant
to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2016, the Committee determined to award Mr.&nbsp;Davis a cash bonus of $300,000, 139% of target, paid in March 2017 for 2016 performance pursuant
to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Equity Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016 Annual Grant: Based on Mr.&nbsp;Davis&#146; 2015 performance and market considerations, the Committee approved a grant of $480,000, which was
granted in March 2016, allocated as follows: (i)&nbsp;approximately 20% in the form of restricted stock with annual vesting over three years; (ii)&nbsp;approximately 30% in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock
options with annual vesting over four years; and (iii)&nbsp;approximately 50% in the form of PSUs with annual vesting over a three-year performance period based on achieving revenue growth goals. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016 Promotion Grant: In recognition of his added responsibilities in assuming oversight of the Company&#146;s Orthopedics and Tissue Technologies
business, the Committee approved an equity grant of $250,000, which was made on December&nbsp;1, 2016, and provided in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, which vest in full after three years.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017 Annual Grant: Based on Mr.&nbsp;Davis&#146; 2016 performance and market considerations, the Committee approved a grant of $625,000, which was
granted in March 2017, allocated as follows: (i)&nbsp;approximately 20% in the form of restricted stock (2,862 shares of restricted stock) with annual vesting over three years; (ii)&nbsp;approximately 30% in the form of <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options (11,062 shares of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options) with annual vesting over four years; and (iii)&nbsp;approximately 50% in the form of PSUs (7,155
shares of PSUs at target), with annual vesting over a three-year performance period based on the achievement of revenue growth goals. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">64 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vesting of the following PSU grants occurred in 2015 and 2016 because the Company achieved the <FONT STYLE="white-space:nowrap">pre-established</FONT>
revenue growth goals which covers their respective performance periods in 2014 and 2015: </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSU VESTING IN
2016 </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2013 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target (pursuant to achievement of
<FONT STYLE="white-space:nowrap">catch-up</FONT> performance goal) and third performance period vested at target; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2014 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSU VESTING IN 2017 </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2014 PSU grant&nbsp;&#151;&nbsp;third performance period vested at target; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2016 PSU grant&nbsp;&#151;&nbsp;first performance period vested at 150% of the target number of shares. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Daniel L. Reuvers, Corporate Vice President and President&nbsp;&#151;&nbsp;Specialty Surgical Solutions </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Reuvers was promoted to Corporate Vice President and President&nbsp;&#151;&nbsp;Specialty Surgical Solutions on December&nbsp;1,
2016. Previously Mr.&nbsp;Reuvers was Corporate Vice President and President&nbsp;&#151;&nbsp;International. Mr.&nbsp;Reuvers achieved positive results against his objectives as President, International during the first eleven months of 2016 before
moving to his new role as President, Specialty Surgical Solutions in December of 2016.&nbsp;His contributions as President, International include the following: 1) achieved record organic growth for international markets; 2) developed and
implemented a strategic plan to address key growth markets through selling directly to customers; 3) achieved revenue metrics and showed improvements in specific markets year over year; and 4) transitioned successfully into his new role leading
Specialty Surgical Solutions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016: An increase in base salary of $10,000 or 3.15% to $327,000 effective April&nbsp;1, 2016 (Integra&#146;s global salary increase effective date) to
reflect Mr.&nbsp;Reuvers&#146; performance in 2015. In recognition of his added responsibilities in assuming oversight of the Company&#146;s Specialty Surgical Solutions business, Mr.&nbsp;Reuvers received an increase in base salary of $43,000 or
13.1% to $370,000 effective December&nbsp;1, 2016. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017: An increase in base salary of $8,000 or 2.16% to $378,000 effective April&nbsp;1, 2017 (Integra&#146;s global salary increase effective date) to
reflect Mr.&nbsp;Reuvers&#146; performance in 2016. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Annual Cash Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2015, the Committee determined to award Mr.&nbsp;Reuvers a cash bonus of $171,000, 142% of target, paid in March 2016 for 2015 performance pursuant
to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For 2016, the Committee determined to award Mr.&nbsp;Reuvers a cash bonus of $205,000, 138% of target, paid in March 2017 for 2016 performance pursuant
to the Bonus Plan. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Equity Incentive </I></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016 Annual Grant: Based on Mr.&nbsp;Reuvers&#146; 2015 performance and market considerations, the Committee approved a grant of $191,000, which was
granted in March 2016, allocated as follows: (i)&nbsp;approximately 20% in the form of restricted stock with annual vesting over three years; (ii)&nbsp;approximately 30% in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock
options with annual vesting over four years; and (iii)&nbsp;approximately 50% in the form of PSUs with annual vesting over a three-year performance period based on achieving revenue growth goals. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">65 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2016 Promotion Grant: In recognition of his added responsibilities in assuming oversight of the Company&#146;s Specialty Surgical Solutions business,
the Committee approved an equity grant of $150,000, which was made December&nbsp;1, 2016, and provided in the form of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, which vest in full after three years.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2017 Annual Grant: Based on Mr.&nbsp;Reuvers&#146; 2016 performance and market considerations, the Committee approved a grant of $375,000, which was
granted in March 2017, allocated as follows: (i)&nbsp;approximately 20% in the form of restricted stock (1,718 shares of restricted stock) with annual vesting over three years; (ii)&nbsp;approximately 30% in the form of <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options (6,638 shares of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options) with annual vesting over four years; and (iii)&nbsp;approximately 50% in the form of PSUs (4,293
shares of PSUs at target), with annual vesting over a three-year performance period based on the achievement of revenue growth goals. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vesting of the following PSU grants occurred in 2016 and 2017 because the Company achieved the <FONT STYLE="white-space:nowrap">pre-established</FONT>
revenue growth goals which covers their respective performance periods in 2015 and 2016: </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSU VESTING IN
2016 </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2013 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target (pursuant to achievement of
<FONT STYLE="white-space:nowrap">catch-up</FONT> performance goal) and third performance period vested at target; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2014 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;first performance period vested at target. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:7%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>PSU VESTING IN 2017 </U></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2014 PSU grant&nbsp;&#151;&nbsp;third performance period vested at target; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2015 PSU grant&nbsp;&#151;&nbsp;second performance period vested at target; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">March 2016 PSU grant&nbsp;&#151;&nbsp;first performance period vested at 150% of the target number of shares. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Oversight and Authority over Executive Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Role of the Compensation Committee and its Adviser </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee
oversees and provides strategic direction to management regarding Integra&#146;s compensation for NEOs. It determines the compensation of the CEO, and reviews and approves the compensation of the remaining NEOs. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each Committee member is an independent <FONT STYLE="white-space:nowrap">non-employee</FONT> director with experience in executive
compensation matters. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee retains Willis Towers Watson PLC as a consultant on executive compensation matters. Willis
Towers Watson provides market analyses and recommendations that inform the Committee&#146;s decisions, evaluates market data compiled by management&#146;s consultants, provides updates on market trends and the regulatory environment as it relates to
executive compensation, reviews various management proposals presented to the Committee related to executive compensation, and works with the Committee to validate and strengthen the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> relationship and alignment with stockholders. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the rules of the Securities and Exchange Commission (&#147;SEC&#148;), the Committee has reviewed the SEC&#146;s independence factors for compensation advisers and concluded that no conflict
of interest exists that would prevent Willis Towers Watson from independently representing the Committee. In 2016, Willis Towers Watson provided consulting services only to the Committee. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Willis Towers Watson periodically meets with the Committee chair and the Committee in executive session outside the presence of
management. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">66 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Committee met six times in 2016; the Committee also meets periodically in executive
sessions. The Committee&#146;s independent advisers participated in several of the Committee&#146;s meetings and, when requested by the Committee chair, in the preparatory meetings. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Role of Chief Executive Officer and Management in Executive Compensation </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our CEO provides significant input on the compensation for his direct reports and other NEOs&nbsp;&#151;&nbsp;beginning with an annual review of performance&nbsp;&#151;&nbsp;including merit increases,
cash incentive payments, and long-term equity incentive awards. In addition, he attends meetings of the Committee, except when the Committee meets in executive session without the CEO present, to discuss the CEO&#146;s performance and compensation.
As discussed under &#147;Annual Review of Compensation,&#148; the Committee approves the compensation of the NEOs, taking into consideration the recommendations of our CEO. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On an annual basis, management considers market competitiveness, business results, experience and individual performance in evaluating executive compensation. The Chief Human Resources Officer and members
of Integra&#146;s human resources organization, together with members of the finance and legal organizations, work with the CEO to assist the Committee in designing and developing compensation programs, to recommend changes to existing plans and
programs applicable to NEOs and other senior executives, to recommend financial and other targets to be achieved under those programs, to prepare analyses of financial data, peer comparisons and other briefing materials to assist the Committee in
making its decisions, to recommend compensation actions for NEOs other than the CEO and, ultimately, to implement the decisions of the Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Tax and Accounting Matters </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Tax </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section 162(m) limits the deductibility of compensation paid to the CEO and certain NEOs (other than the CFO) to $1,000,000 per year
unless the compensation qualifies as <FONT STYLE="white-space:nowrap">&#147;performance-based</FONT> compensation&#148; within the meaning of Section 162(m). Although the Company maintains plans that are intended to permit the award of deductible
compensation under Section 162(m), the Committee does not necessarily limit executive compensation to the amount deductible under that provision. Rather, it considers the available alternatives and acts with the intention of preserving the
deductibility of compensation to the extent reasonably practicable and consistent with its other compensation objectives. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Committee also endeavors to structure NEO compensation in a manner that is either compliant with, or exempt from, the application of Section 409A of the Internal Revenue Code, the provisions of which may impose additional taxes to employees.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Accounting </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We account for <FONT STYLE="white-space:nowrap">stock-based</FONT> compensation in accordance with FASB ASC Topic 718, which requires us to recognize compensation expense for <FONT
STYLE="white-space:nowrap">share-based</FONT> payments (including <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, restricted stock, restricted stock units, PSUs and other forms of equity compensation). The Committee regularly
considers the accounting implications of significant compensation decisions, especially in connection with decisions that relate to equity compensation awards. As accounting standards change, we may revise certain programs to appropriately align
accounting expenses of our equity awards with our overall executive compensation philosophy and objectives. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although the
Committee generally considers the tax and accounting implications of its compensation decisions, the primary drivers for determining the amount and form of executive compensation are the attraction, motivation and retention of executive talent
rather than the Internal Revenue Code or accounting requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Post-Employment Arrangements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 2016, we entered into <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT>
severance agreements with Messrs. Coleman, Gorelick, Davis, and Reuvers that expired January&nbsp;31, 2017 (the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Change-in-Control</FONT></FONT> Severance Agreements&#148;). The
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">67 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements provided for the payment of severance and other benefits to the executives
in the event of a &#147;qualifying termination,&#148; which means a termination of employment with the Company without &#147;cause&#148; or by the executive for &#147;good reason,&#148; in either case, on or within two years following a &#147;change
in control&#148; of the Company (each, as defined in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements). Thereafter, the Company entered into new
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> severance agreements in February 2017 for Messrs. Coleman, Gorelick, Davis, and Reuvers providing for the same payment of severance and other benefits
as stated in the expired <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements. These new
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> severance agreements do not provide for any excise tax <FONT STYLE="white-space:nowrap">gross-ups</FONT> and have double-trigger cash payments. These
new <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> severance agreements will expire in January 2018. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Details of the severance provisions are described in &#147;Potential Payments Upon Termination of Change in Control.&#148; See &#147;Employment Agreements and Severance Agreement Matters&#148; for
additional information. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Employment Agreement and Severance Agreement Matters </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Peter J. Arduini </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company initially determined to enter into an
employment agreement with Mr.&nbsp;Arduini in order to recruit him from a highly compensated, senior position at Baxter International, a global medical device company with almost $14&nbsp;billion in annual revenues in 2011, to induce him to relocate
his family, to provide some security commensurate with the risks undertaken in such a considerable career and geographic move, and to provide him with appropriate incentives to help the Company grow. The Company amended that agreement upon
Mr.&nbsp;Arduini&#146;s promotion to President and Chief Executive Officer to provide him with an appropriate blend of incentives and severance payments to reflect his greater responsibilities and address the risks undertaken with such a position.
The Company then amended and restated Mr.&nbsp;Arduini&#146;s employment agreement, as it was set to expire December&nbsp;31, 2014, for retention purposes as well as the desire to motivate Mr.&nbsp;Arduini to improve the Company&#146;s performance
and continue to position Integra for future growth. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The terms of the amended and restated employment agreement, effective June
2014, are described below. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On June&nbsp;16, 2014, the Company entered into the Second Amended and Restated Employment
Agreement with Mr.&nbsp;Arduini (the &#147;Arduini Agreement&#148;). The Arduini Agreement is effective June&nbsp;16, 2014, and amends and restates the Amended and Restated Employment Agreement between the Company and Mr.&nbsp;Arduini, dated
December&nbsp;20, 2011, that was scheduled to expire on December&nbsp;31, 2014. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless earlier terminated, the term of the
Arduini Agreement will terminate on December&nbsp;31, 2017. If a change in control of the Company were to occur prior to the expiration of the term, the employment period will instead continue through the later of December&nbsp;31, 2017, or the
second anniversary of the consummation of the change in control. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Arduini Agreement, Mr.&nbsp;Arduini is entitled to
receive an annual base salary of $834,300, and he remains eligible for an annual bonus opportunity targeted at 110% of his annual base salary. Mr.&nbsp;Arduini&#146;s bonus opportunity will range from 50% of his annual base salary (if threshold
performance goals are achieved) to a maximum of 200% of his annual base salary. On February&nbsp;15, 2017, the Compensation Committee (&#147;Committee&#148;) adopted the First Amendment (the &#147;First Amendment&#148;) to the Company&#146;s
Performance Incentive Compensation Plan (the &#147;Plan&#148;) which increases the maximum bonus opportunity for executive officers to 200% of such executive&#146;s target bonus under the Plan. In connection with approving the First Amendment, the
Committee also approved a revision to Mr.&nbsp;Arduini&#146;s employment agreement to clarify that his maximum bonus opportunity under the employment agreement is 200% of his target bonus (rather than 200% of his base salary). </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Arduini&#146;s base salary is subject to annual review and may be increased in the discretion of the Company. The Arduini
Agreement eliminates the target annual base salary increase that was provided in Mr.&nbsp;Arduini&#146;s prior employment agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Arduini Agreement provides that Mr.&nbsp;Arduini is eligible to receive a discretionary annual equity award, with the amount, form and mix of such award to be determined by the Committee in its
discretion after giving consideration to annual equity-based awards granted to chief executive officers in the Company&#146;s peer group. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">68 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
The Arduini Agreement also provides that each current and future equity award held by Mr.&nbsp;Arduini that provides for double trigger accelerated vesting will provide for accelerated vesting
upon a qualifying termination that occurs on or within 24 months following a change in control. In addition, Mr.&nbsp;Arduini&#146;s <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options will remain exercisable for up to two years
following a qualifying termination or such longer period of time provided in the applicable option agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Arduini
Agreement contains <FONT STYLE="white-space:nowrap">non-compete</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants that extend for 18 months following a termination of Mr.&nbsp;Arduini&#146;s employment (or 12 months in
the event of a termination due to the expiration of the employment term). Further, the Company will reimburse Mr.&nbsp;Arduini for up to $15,000 in legal fees and expenses incurred in connection with the drafting, review and negotiation of the
Arduini Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Arduini Agreement, if Mr.&nbsp;Arduini&#146;s employment is terminated outside the context of a
change in control by the Company other than &#147;cause,&#148; death or &#147;disability,&#148; or by Mr.&nbsp;Arduini for &#147;good reason&#148; (each, as defined in the Arduini Agreement), then, in addition to accrued amounts, Mr.&nbsp;Arduini
will be entitled to the following payments and benefits: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment equal to 2.99 times Mr.&nbsp;Arduini&#146;s annual base salary;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Company-subsidized healthcare continuation coverage for Mr.&nbsp;Arduini and his dependents for up to eighteen months after his termination date; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Company-paid life and disability insurance premiums for Mr.&nbsp;Arduini for up to eighteen months after his termination date.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If Mr.&nbsp;Arduini&#146;s employment is terminated by the Company within twenty-four months following a
change in control by the Company other than cause, death or disability, or by Mr.&nbsp;Arduini for good reason, then Mr.&nbsp;Arduini will be entitled to receive the same payments and benefits as in the
<FONT STYLE="white-space:nowrap">non-change</FONT> in control context, except: (i)&nbsp;the <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment will instead equal 2.99 times the sum of Mr.&nbsp;Arduini&#146;s annual base salary and target
bonus and (ii)&nbsp;Mr.&nbsp;Arduini will receive a <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of his annual bonus for the year of termination, determined based on actual performance. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If Mr.&nbsp;Arduini&#146;s employment is terminated due to his death, then his estate will receive (i)&nbsp;a lump sum cash payment equal
to Mr.&nbsp;Arduini&#146;s annual base salary, and (ii)&nbsp;Company-subsidized healthcare continuation coverage for up to twelve months after his termination date. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Arduini&#146;s right to receive the severance payments pursuant to the Arduini Agreement (other than upon his death) is contingent on Mr.&nbsp;Arduini&#146;s executing a general release of claims
against the Company (provided that the Company also executes a general release of claims against Mr.&nbsp;Arduini). In addition, to the extent that any payment or benefit received in connection with a change in control would be subject to an excise
tax under Section&nbsp;4999 of the Internal Revenue Code, such payments and/or benefits will be subject to a &#147;best pay cap&#148; reduction if such reduction would result in a greater net <FONT STYLE="white-space:nowrap">after-tax</FONT> benefit
to Mr.&nbsp;Arduini than receiving the full amount of such payments. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements for Other Executive Officers
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 2016, the Company entered into
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements with Messrs. Coleman, Gorelick, Davis, and Reuvers in order to keep such executives engaged both before and during any possible
impending deals or transactions, as well as the need for continuity in management after any potential change in control. Each <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreement
provides for the payment of severance and other benefits to the executives in the event of a &#147;qualifying termination,&#148; which means a termination of employment with the Company without &#147;cause&#148; or by the executive for &#147;good
reason,&#148; in either case, on or within two years following a &#147;change in control&#148; of the Company and so long as such change in control occurred by January&nbsp;31, 2017 (each, as defined in the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements). In the event of a qualifying termination, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements
provide for </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a lump sum payment equal to 1.5 times (or 2.0 times in the case of Mr.&nbsp;Coleman) the sum of the executive&#146;s annual base salary and target cash
bonus; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a lump sum payment equal to a pro rata portion of the executive&#146;s target cash bonus for the partial fiscal year in which the termination occurs;
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">69 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Company-subsidized COBRA premium payments for up to eighteen months following the termination date; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Company-paid outplacement services for up to twelve months following the termination date. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The executive&#146;s right to receive the severance payments and benefits described above is subject to his delivery and <FONT
STYLE="white-space:nowrap">non-revocation</FONT> of an effective general release of claims in favor of the Company. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements clarified that to the extent the executive has not yet received his short-term annual cash bonus for his prior year&#146;s performance
with the Company, the executive shall still receive such short-term annual cash bonus for prior year performance at the time <FONT STYLE="white-space:nowrap">non-terminated</FONT> employees receive such short-term annual cash bonus if such payment
is due. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, under the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements, to the extent that any change in control payment or benefit would be subject to an excise tax imposed in connection with
Section&nbsp;4999 of the Internal Revenue Code, such payments and/or benefits may be subject to a &#147;best pay cap&#148; reduction to the extent necessary so that the executive receives the greater of (i)&nbsp;the net amount of the change in
control payments and benefits reduced such that such payments and benefits will not be subject to the excise tax, or and (ii)&nbsp;the net amount of the change in control payments and benefits without such reduction. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The term of each <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreement
expired on January&nbsp;31, 2017. However, upon the occurrence of a change in control, the term would have automatically been extended until the two-year anniversary of the date on which the change in control occurred. In addition, if the executive
incurred a qualifying termination during the term of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreement, the term would automatically have been further extended until each
party&#146;s rights and obligations were fully satisfied. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">After the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Severance Agreements expired, the Company entered into new <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control</FONT></FONT> severance agreements in February
2017 for Messrs. Coleman, Gorelick, Davis, and Reuvers. The terms of these agreements are the same as the prior Change in Control Severance Agreements that expired January 2017. To clarify the new Change in Control Severance Agreements, a
&#147;qualifying termination&#148; may occur on or within two years following a &#147;change in control&#148; of the Company and so long as such change in control occurs by January&nbsp;31, 2018. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">70 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_18"></A>COMPENSATION COMMITTEE REPORT </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have reviewed and discussed with management the Compensation Discussion and Analysis prepared by management. Based on this review and
discussion, we have recommended to the Board of Directors that the Compensation Discussion and Analysis prepared by management be included in this Proxy Statement and incorporated into our 2016 Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K.</FONT> </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee of the</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Board of Directors</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>KEITH BRADLEY (CHAIR)</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>BARBARA B. HILL</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>DONALD E. MOREL, JR.</I></FONT></P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">71 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_19"></A>COMPENSATION OF EXECUTIVE OFFICERS </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Compensation Table </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth information regarding compensation paid to our President and Chief Executive Officer, our Chief Financial Officer, and each of our three other most highly compensated
executive officers based on total compensation earned during 2016. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">* The information in the following tables and footnotes pertaining to
equity and share price have not been adjusted pursuant to the two-for-one stock split, distributed on January 3, 2017, unless otherwise specified. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:59pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Position(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus(1)<BR>($)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards(2)<BR>($)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards(2)<BR>($)<BR>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive<BR>Plan<BR>Compensation(3)<BR>($)<BR>(g)
</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Change in<BR>Pension<BR>Value
and<BR>Nonqualified<BR>Deferred<BR>Compensation<BR>Earnings<BR>($)<BR>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation(4)<BR>($)<BR>(i)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>($)<BR>(j)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Peter J. Arduini</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">878,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,150,122</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,555,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,993,984</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">President and Chief</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2015</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">885,642</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,053,586</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,267,236</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,389,535</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,825</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,603,824</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Executive Officer and Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2014</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">827,758</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,450,031</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,050,017</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,126,907</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">23,295</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,478,008</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Glenn G. Coleman</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2016</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">481,600</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">490,078</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">591,986</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">400,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,950</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,973,614</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Corporate Vice President and</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2015</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">478,077</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">397,049</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">480,009</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">348,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7,825</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,710,960</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2014</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">287,308</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">980,051</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">420,010</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">190,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,127,369</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Robert T. Davis, Jr</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2016</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">400,465</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">336,082</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">415,946</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">300,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,945</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,463,438</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Corporate Vice President, President,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2015</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">391,635</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">297,961</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">60,505</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">232,500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,125</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">986,726</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Orthopedics and Tissue Technologies</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2014</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">344,673</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">278,089</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">175,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">104,598</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">902,360</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Daniel L. Reuvers</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2016</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">328,177</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">133,794</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">216,029</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">205,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">19,950</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">902,950</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Corporate Vice President, President, Specialty Surgical Solutions</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Richard D. Gorelick</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2016</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">384,727</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">184,887</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">91,273</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">206,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,950</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">876,837</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Corporate Vice President,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2015</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">388,734</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">188,767</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">228,066</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">190,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,125</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">999,692</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">General Counsel, Administration and Secretary</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2014</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">364,236</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">251,264</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">141,000</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">&#151;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4,125</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">760,625</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amount reported for Mr.&nbsp;Coleman represents a <FONT STYLE="white-space:nowrap">one-time</FONT> <FONT STYLE="white-space:nowrap">sign-on</FONT> hiring bonus.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This column reflects the aggregate grant date fair value computed in accordance with FASB ASC Topic 718, based on the closing price of the Company&#146;s common stock
on the grant dates in 2016, 2015, and 2014. In regards to the stock options, for a discussion of assumptions used to estimate fair value, please see Note 15, &#147;Stock-Based Compensation,&#148; to our consolidated financial statements included in
our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2016. Amounts in column (e)&nbsp;and (f) for each NEO include the incremental fair value of certain modifications made to outstanding equity
awards in connection with the <FONT STYLE="white-space:nowrap">spin-off</FONT> of the Company&#146;s orthobiologics and spine fusion hardware business (also referred to as the &#147;spine business&#148;). See &#147;&#151;&nbsp;Compensation
Discussion and Analysis &#151; Equity Treatment for NEOs pertaining to the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> of the Company&#146;s Spine Business&#148; for more information. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in column (g)&nbsp;reflect cash awards for 2016 , 2015 and 2014 earned pursuant to the terms of the Performance Incentive Compensation Plan. See
&#147;&#151;&nbsp;Compensation Discussion and Analysis &#151; Annual Review of Compensation&#148; for more information. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">72 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts reported in the <I>All Other Compensation</I> column for each NEO represents legal fees, relocation expenses, 401(k) employer matching contributions, and
executive physicals. No tax <FONT STYLE="white-space:nowrap">gross-ups</FONT> were paid on any of these components. The breakout of the components is shown in the following table below: </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>BREAKDOWN OF ALL OTHER COMPENSATION </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Legal&nbsp;Fees<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Relocation<BR>Expenses<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>401(k)<BR>Employer<BR>Matching<BR>Contribution<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive<BR>Physical<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Peter J. Arduini</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2016</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>6,625<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>2,950<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>9,575<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2015</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,825</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,395</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,295</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Glenn G. Coleman</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2016</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>7,000<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>2,950<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>9,950<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2015</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,825</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert T. Davis, Jr</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2016</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>7,000<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>3,945<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>10,945<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2015</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,473</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">104,598</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Daniel L. Reuvers</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2016</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>7,000<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>2,950<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>19,950<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Richard D. Gorelick</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2015</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>7,000<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>2,950<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>9,950<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2014</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">73 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Grants of Plan-Based Awards </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table presents information on annual incentive opportunities and equity awards granted under the Company&#146;s 2003 Equity Incentive Plan. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:17pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Award</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Type</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date of<BR>Board or<BR>Comp.<BR>Committee<BR>Action</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated Future Payouts<BR>Under <FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive Plan
Awards(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated Future Payouts<BR>Under Equity<BR>Incentive Plan Awards(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Stock<BR>Awards:<BR>Number&nbsp;of<BR>Shares of<BR>Stock
or<BR>Units(3)<BR>(#)<BR>(i)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Option<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Options<BR>(#)<BR>(j)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise<BR>or Base<BR>Price of<BR>Option<BR>Awards<BR>($/Sh)<BR>(k)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date<BR>Fair<BR>Value of<BR>Stock
and<BR>Option<BR>Awards(4)<BR>($)<BR>(l)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>($)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>($)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>(#)<BR>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>(#)<BR>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>(#)<BR>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Peter&nbsp;J.&nbsp;Arduini</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">PSU</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,263</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">51,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,250,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">RSU</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13,811</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">900,063</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock&nbsp;Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">64,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,555,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Bonus</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">442,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">973,620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,771,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Glenn&nbsp;G.&nbsp;Coleman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">PSU</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,685</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,371</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,056</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">350,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">RSA</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,149</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">140,050</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,053</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">241,976</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/16/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12,187</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">76.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">350,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Bonus</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">63,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">315,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">472,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Robert&nbsp;T.&nbsp;Davis,&nbsp;Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">PSU</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,683</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">240,021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">RSA</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">96,061</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,894</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">165,939</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/16/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8,705</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">76.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">250,008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Bonus</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">43,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">215,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">322,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Daniel&nbsp;L.&nbsp;Reuvers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">PSU</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">733</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,466</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">95,539</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">RSA</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">587</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">38,255</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,743</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">66,024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/16/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">76.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,005</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Bonus</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">29,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">148,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">222,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Richard&nbsp;D.&nbsp;Gorelick</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">PSU</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1,013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,026</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,039</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">132,034</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">RSA</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">811</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">52,853</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/14/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,792</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">91,273</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">Cash Bonus</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/1/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,847</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">174,235</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">261,352</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported in columns (c)&nbsp;through (e) represent potential cash payments pursuant to the Company&#146;s Performance Incentive Compensation Plan. The
&#147;Target&#148; is calculated by multiplying the officer&#146;s base salary by the executive&#146;s target award percentage established by the Compensation Committee and, for Mr.&nbsp;Arduini, provided in the applicable employment agreement. See
&#147;&#151;&nbsp;Compensation Discussion and Analysis &#151; Annual Review of Compensation&#148; for more information. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amount shown in this column represents shares of performance stock granted under the Company&#146;s 2003 Equity Incentive Plan. See &#147;&#151;&nbsp;Compensation
Discussion and Analysis &#151; Annual Review of Compensation&#148; for a description of the material terms of this performance stock award. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts shown in this column represent shares of restricted stock or contract stock/restricted stock units granted under the Company&#146;s 2003 Equity Incentive
Plan. See &#147;&#151;&nbsp;Compensation Discussion and Analysis &#151; Annual Review of Compensation&#148; for a description of the material terms of these restricted stock and contract stock/restricted unit awards. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This column reflects the aggregate grant date fair value computed in accordance with FASB ASC Topic 718 of the restricted stock, contract
stock/restricted stock units, performance stock and stock options granted to each NEO in 2016. For restricted stock and contract stock/restricted stock units, fair value is calculated using the closing price of the Company&#146;s common stock on the
grant date noted. For stock options, fair value is based on the fair value of the option on the grant date as estimated using the binomial distribution model. For a discussion of the assumptions used to
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">74 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
estimate fair value, please see Note 8, &#147;Stock-Based Compensation&#148; to our consolidated financial statements included in our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2016. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This grant of performance stock was made to the executive for his 2016 performance. Each NEO is eligible to vest in and receive a number of shares of the Company&#146;s
common stock ranging from 0% to 150% of the target number of shares of Performance Stock granted based on the Company&#146;s achievement of goals relating to the increase in the Company&#146;s annual revenue over the initial revenue target, defined
as the Company&#146;s revenue for the fiscal year ended December&nbsp;31, 2015, during each fiscal year of the performance period running from January&nbsp;1, 2016 through December&nbsp;31, 2018. See &#147;&#151;&nbsp;Compensation Discussion and
Analysis &#151; Long-Term Equity Incentive Plan&#148; for a description. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">75 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Outstanding Equity Awards At Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT>
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table presents information with respect to outstanding equity awards as of December&nbsp;31, 2016.
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:17pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)<BR>Exercisable<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Unexercisable<BR>(1)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)
</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B>
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of&nbsp;Shares or<BR>Units<BR>of&nbsp;Stock&nbsp;That<BR>Have Not<BR>Vested
(2)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market<BR>Value of<BR>Shares or<BR>Units of<BR>Stock</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>That Have<BR>Not Vested<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number&nbsp;of<BR>Unearned<BR>Shares,&nbsp;Units<BR>or
Other<BR>Rights That<BR>Have Not<BR>Vested(3)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(i)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Market or<BR>Payout<BR>Value
of<BR>Unearned<BR>Shares,&nbsp;Units<BR>or Other<BR>Rights</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>That Have<BR>Not Vested</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(j)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">175,794</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27.78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/01/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,138</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27.78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/01/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,893</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/22/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,282</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,935</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41.76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/06/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,315</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,799</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/23/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">64,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/14/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,352,877</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91,553</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,854,332</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn G. Coleman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,664</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,665</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38.82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">05/02/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,708</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/23/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,453</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63.37</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11/16/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,053</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/14/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,187</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/01/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,942</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">595,554</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,036</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,718,888</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert T. Davis, Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,349</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/23/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,894</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/14/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,705</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/01/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,277</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">366,924</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,329</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">714,545</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel. L. Reuvers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">302</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">908</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/23/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,743</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/14/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/01/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,329</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">199,805</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,942</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">338,184</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,090</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/23/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,162</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63.37</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11/16/2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,792</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">03/14/2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,903</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">249,048</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,131</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">440,188</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">76 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vesting information for each outstanding <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option award as of December&nbsp;31, 2016 for the Named Executive
Officers is described in the table below. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:43pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting Date</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise<BR>Price</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Peter&nbsp;J.&nbsp;Arduini</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Glenn&nbsp;G.&nbsp;Coleman</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Robert&nbsp;T.&nbsp;Davis&nbsp;Jr.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Daniel&nbsp;L.&nbsp;Reuvers</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Richard&nbsp;D.&nbsp;Gorelick</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" COLSPAN="24" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of Shares Underlying <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2017</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/6/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41.76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,317</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,723</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">685</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/23/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,708</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">302</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/2/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38.82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,332</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,317</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,723</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">686</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/23/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,792</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">303</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/2/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38.82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">11/16/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63.37</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,453</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,162</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,724</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">686</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/23/2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53.73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">303</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">364</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/1/2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,187</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,705</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2020</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2020</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,724</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">686</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Arduini&#146;s <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options vest as follows: one third of the shares vest on the first anniversary of
the grant date and thereafter in monthly installments through the third anniversary of such grant date. The 4,935 unexercisable <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options pursuant to Mr.&nbsp;Arduini&#146;s March&nbsp;6,
2014 <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option grant will vest monthly over the first three months of 2017. 23,039 of the 28,799 unexercisable <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options pursuant to
Mr.&nbsp;Arduini&#146;s March&nbsp;23, 2015 <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option grant will vest monthly throughout 2017. In addition, 21,541 of the 64,625 unexercisable
<FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options pursuant to Mr.&nbsp;Arduini&#146;s March&nbsp;14, 2016 grant will vest on March&nbsp;14, 2017, the first anniversary of such grant. Thereafter, 16,156 <FONT
STYLE="white-space:nowrap">non-qualified</FONT> stock options pursuant to Mr.&nbsp;Arduini&#146;s March&nbsp;14, 2016 grant will vest monthly for the remaining nine months of 2017. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Arduini&#146;s <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options vest as follows: one third of the shares vest on the first anniversary of
the grant date and thereafter in monthly installments through the third anniversary of such grant date. 5,760 of the 28,799 unexercisable <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options pursuant to Mr.&nbsp;Arduini&#146;s
March&nbsp;23, 2015 <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option grant will vest monthly over the first three months of 2018. 21,542 of the 64,625 unexercisable <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock
options pursuant to Mr.&nbsp;Arduini&#146;s March&nbsp;14, 2016 <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option grant will vest monthly throughout 2018. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Arduini&#146;s <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options vest as follows: one third of the shares vest on the first anniversary of
the grant date and thereafter in monthly installments through the third anniversary of such grant date. 5,386 of the 64,625 unexercisable <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options pursuant to Mr.&nbsp;Arduini&#146;s
March&nbsp;14, 2016 <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option grant will vest monthly over the first three months of 2019. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">77 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in columns (g)&nbsp;and (h) reflect the number and market values of the outstanding RSUs and RSAs as of December&nbsp;31, 2016 for the Named Executive
Officers. Scheduled vesting of such RSUs and RSAs and the number of shares underlying such awards is described in the table below. Please note that Mr.&nbsp;Arduini is the only Named Executive Officer with RSUs. </FONT></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:43pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting Date</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Peter&nbsp;J.&nbsp;Arduini</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Glenn&nbsp;G.&nbsp;Coleman</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Robert&nbsp;T.&nbsp;Davis&nbsp;Jr.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Daniel&nbsp;L.&nbsp;Reuvers</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Richard&nbsp;D.&nbsp;Gorelick</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" COLSPAN="20" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of Shares Underlying Outstanding RSUs and RSAs</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2017</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,604(a)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">709</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">486</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">193</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/23/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,294(a)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">473</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">506</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/24/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,027(a)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">782</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,064</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/2/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,604(a)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">709</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">486</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">194</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">268</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/23/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,294(a)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">602</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">825</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">487</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">522</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/2/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,804</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,603(a)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">731</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">276</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The terms of this RSU award provide that, subject to certain conditions, the shares will be delivered within 30 days following the first business day immediately
following the <FONT STYLE="white-space:nowrap">six-month</FONT> period after the date of Mr.&nbsp;Arduini&#146;s separation of service. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts in columns (i)&nbsp;and (j) reflect the number and market values of the outstanding performance stock as of December&nbsp;31, 2016 for the Named Executive
Officers. Scheduled vesting of all performance stock awards and the number of shares underlying such awards, subject to the satisfaction of the performance goals, is described in the table below. Payouts for the March&nbsp;14, 2016 grant are
calculated at 150% of target maximum level. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:43pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting Date</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Peter&nbsp;J.&nbsp;Arduini</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Glenn&nbsp;G.&nbsp;Coleman</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Robert&nbsp;T.&nbsp;Davis&nbsp;Jr.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Daniel&nbsp;L.&nbsp;Reuvers</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Richard&nbsp;D.&nbsp;Gorelick</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" COLSPAN="20" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of Shares Underlying Outstanding Performance Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2017</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,090</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,658</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,823</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,002</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/23/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,285</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">473</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">506</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/24/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,819</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">782</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,063</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/2/2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,508</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2018</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,091</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,658</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,823</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">726</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,004</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/23/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,659</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,503</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">825</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">487</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">522</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/2/2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,509</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2019</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/14/2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,609</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,741</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,880</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,034</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">78 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Option Exercises And Stock Vested </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table presents information on stock option exercises and stock award vesting during 2016. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:20pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Shares<BR>Acquired&nbsp;on&nbsp;Exercise<BR>(#)<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on Exercise(1)<BR>($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Shares<BR>Acquired&nbsp;on&nbsp;Vesting<BR>(#)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on Vesting<BR>($)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,178,417</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">63,565</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,098,974</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn G. Coleman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,352</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">585,155</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert T. Davis, Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">412,911</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel L. Reuvers.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">269,290</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">331,564</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value realized is calculated on the basis of the difference between the per share exercise price and the market price of the Company&#146;s common stock as reported by
the NASDAQ Global Select Market on the date of exercise, multiplied by the number of shares of common stock underlying the options exercised. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This includes the market value of the shares that are vested, but delivery is deferred. These awards are also shown in the
<FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Deferred Compensation Table as follows: (i) 4,118 shares of common stock underlying restricted stock units from an initial grant in March 2015 of 12,883 units (of which 177 units were withheld to
pay taxes), of which the first installment vested fully on the first anniversary of the grant date, based on the $64.81 closing price of our common stock on the vesting date, (ii) 4,821 shares of common stock underlying restricted stock units from
an initial grant in March 2014 of 15,083 units (of which 207 units were withheld to pay taxes), of which the second installment fully vested on the second anniversary of the grant date, based on the $64.37 closing price of our common stock on the
vesting date, (iii) 2,443 shares of common stock underlying restricted stock units from an initial grant in March 2013 of 7,644 units (of which 105 units were withheld to pay taxes), of which the third installment fully vested on the third
anniversary of the grant date, based on the $64.37 closing price of our common stock on the vesting date, (iv) 14,193 shares of common stock underlying performance stock units from an initial grant in March 2013 of 19,109 units (of which 607 units
were withheld to pay taxes), of which the first installment (pursuant to achievement of <FONT STYLE="white-space:nowrap">catch-up</FONT> performance goal, comprised of 6,989 units, of which 299 were withheld to pay taxes) and the third installment
(comprised of 7,204 units, of which 308 units were withheld to pay taxes) fully vested on the third anniversary of the grant date, based on $64.37 closing price of our common stock on the vesting date. Such deferred shares are deliverable within
thirty days following the first business day that occurs immediately following the <FONT STYLE="white-space:nowrap">six-month</FONT> period after the date of Mr.&nbsp;Arduini&#146;s separation from service from the Company. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Nonqualified Deferred Compensation in 2016 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:20pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive<BR>Contributions<BR>in&nbsp;Last&nbsp;Fiscal&nbsp;Year<BR>($)<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Registrant<BR>Contributions<BR>in&nbsp;Last&nbsp;Fiscal&nbsp;Year<BR>($)<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Aggregate<BR>Earnings&nbsp;(Losses)<BR>in&nbsp;Last&nbsp;Fiscal&nbsp;
Year<BR>($)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Aggregate<BR>Withdrawals/<BR>Distributions<BR>($)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Aggregate&nbsp;Balance<BR>at&nbsp;Last&nbsp;
Fiscal<BR><FONT STYLE="white-space:nowrap">Year-End</FONT><BR>($)<BR>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,648,075</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,991,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,607,765</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This represents the market value of: (i) 4,118 shares of common stock underlying restricted stock units from an initial grant in March 2015 of 12,883
units (of which 177 units were withheld to pay taxes), of which the first installment vested fully on the first anniversary of the grant date, based on the $64.81 closing price of our common stock on the vesting date, (ii) 4,821 shares of common
stock underlying restricted stock units from an initial grant in March 2014 of 15,083 units (of which 207 units were withheld to pay taxes), of which the second installment fully vested on the second anniversary of the grant date, based on the
$64.37 closing price of our common stock on the vesting date, (iii) 2,443 shares of common stock underlying restricted stock units from an initial grant in March 2013 of 7,644 units (of which 105 units were withheld
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">79 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
to pay taxes), of which the third installment fully vested on the third anniversary of the grant date, based on the $64.37 closing price of our common stock on the vesting date, (iv) 14,193
shares of common stock underlying performance stock units from an initial grant in March 2013 of 19,109 units (of which 607 units were withheld to pay taxes), of which the first installment (pursuant to achievement of
<FONT STYLE="white-space:nowrap">catch-up</FONT> performance goal, comprised of 6,989 units, of which 299 were withheld to pay taxes) and the third installment (comprised of 7,204 units, of which 308 units were withheld to pay taxes) fully vested on
the third anniversary of the grant date, based on $64.37 closing price of our common stock on the vesting date. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This represents the gain in the value of 216,899 shares of common stock underlying restricted stock units and deferred performance stock units through December&nbsp;31,
2016. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This represents the <FONT STYLE="white-space:nowrap">year-end</FONT> value of the 216,899 shares of common stock underlying restricted stock units and deferred
performance stock units through December&nbsp;31, 2016. All of these shares are deliverable within 30 days following the first business day that occurs immediately following the <FONT STYLE="white-space:nowrap">six-month</FONT> period after the date
of Mr.&nbsp;Arduini&#146;s separation from service from the Company. The aggregate balance shown is based on the $85.79 closing price of our common stock on December&nbsp;30, 2016. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Potential Payments Upon Termination or Change in Control </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As of December&nbsp;31, 2016, the Company has entered into agreements with each of its named executive officers, which provide certain payments and benefits upon any of several events of termination of
employment, including termination of employment in connection with a change in control. This section describes these payments and benefits, with amounts calculated based on the assumption that a named executive officer&#146;s termination of
employment with the Company occurred on December&nbsp;31, 2016. On December&nbsp;31, 2016, the Company&#146;s common stock had a closing sale price on the NASDAQ Global Select Market of $85.79. Actual amounts payable would vary based on the date of
the named executive officer&#146;s termination of employment and can only be finally determined at that time. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless specified
otherwise, the information in this section is based upon the terms of (i)&nbsp;the Second Amended and Restated Employment Agreement between the Company and Peter J. Arduini, dated as of June&nbsp;16, 2014 (the &#147;Arduini Agreement&#148;) and
(ii)&nbsp;individual Change in Control Severance Agreements, dated February&nbsp;1, 2016 , between the Company and Glenn Coleman, Robert Davis, Jr., Daniel L. Reuvers, and Richard Gorelick (collectively, the &#147;Change in Control Agreements&#148;)
(the Arduini Agreement and the Change in Control Agreements are collectively referred to in this section as the &#147;Agreements&#148;). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Payments Upon Termination By The Company Without Cause Or By The Executive For Good Reason Prior to a Change in Control </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Arduini Agreement provides for the following severance payments and benefits upon termination of employment by the Company without
&#147;Cause&#148; or by Mr.&nbsp;Arduini for &#147;Good Reason&#148; (as defined in the Arduini Agreement) before a change in control of the Company: (i)&nbsp;a lump sum cash severance payment equal to 2.99 times his annual base salary;
(ii)&nbsp;Company-subsidized healthcare continuation coverage for Mr.&nbsp;Arduini and his dependents for up to eighteen months after his termination date; and (iii)&nbsp;Company-paid life and disability insurance premiums for Mr.&nbsp;Arduini for
up to eighteen months after his termination date. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of the unvested equity awards held by Messrs. Arduini, Coleman, Davis,
Reuvers or Gorelick will vest upon such termination. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Payments Upon Termination For Cause Or By Executive Without Good
Reason </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Agreements do not provide the applicable named executive officers with any payments or other benefits in
the event of their termination of employment by the Company for cause or by the executive without good reason other than amounts accrued and owing, but not yet paid, as of the date of the executive&#146;s termination of employment. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A termination for cause under each Agreement would result from an executive&#146;s: (i)&nbsp;continued failure to perform the
executive&#146;s stated duties in all material respects for a specified period of time after receipt of written </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">80 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
notice of such failure; (ii)&nbsp;intentional and material breach of any provision of the Agreement which is not cured (if curable) within a specified period of time after receipt of written
notice of such breach; (iii)&nbsp;demonstrated personal dishonesty in connection with the executive&#146;s employment with the Company; (iv)&nbsp;breach of fiduciary duty in connection with the executive&#146;s employment with the Company;
(v)&nbsp;willful misconduct that is materially and demonstrably injurious to the Company or any of its subsidiaries; or (vi)&nbsp;conviction or plea of guilty or nolo contendere to a felony or to any other crime involving moral turpitude which
conviction or plea is materially and demonstrably injurious to the Company or any of its subsidiaries. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Payments Upon
Death </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only the Arduini Agreement provides severance payments and benefits upon death. If Mr.&nbsp;Arduini dies during
the term of his employment, then the Company will pay to his estate a lump sum payment equal to one times his annual base salary. In addition, the Company will pay his eligible beneficiaries the monthly premium for COBRA family coverage under the
Company&#146;s group health plan for a period of one year from the date of his death. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All of Mr.&nbsp;Arduini&#146;s unvested
equity awards will vest in the event of death other than the <FONT STYLE="white-space:nowrap">non-deferred</FONT> PSU grants in March of 2014, 2015 and 2016, which would remain outstanding and subject to the achievement of the respective performance
goals. All of Messrs. Coleman&#146;s, Davis&#146;, Reuver&#146;s, and Gorelick&#146;s unvested equity awards will vest in the event of death other than their respective outstanding PSU grants, which would remain outstanding and subject to the
achievement of the respective performance goals. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Payments Upon Disability </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">None of the Agreements provide for cash severance payments upon the executive&#146;s termination of employment on account of their
disability. In addition, each of the executive officers&#146; unvested equity awards will vest in the event of such executive officer&#146;s disability in the same manner as death as stated above. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Agreements, disability means the executive&#146;s inability to perform his duties by reason of any medically determinable
physical or mental impairment, which is expected to result in death or which has lasted or is expected to last for a continuous period of not less than six months. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Payments in Connection with a Change in Control </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Arduini
Agreement and Change in Control Agreements provide each of the applicable named executive officers with severance payments and benefits upon termination of their employment in connection with or following a change in control. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Arduini Agreement provides that, if Mr.&nbsp;Arduini&#146;s employment with the Company is terminated within twenty-four months
following a change in control by the Company other than cause, death, or disability, or by Mr.&nbsp;Arduini for good reason, then the Company will pay (i)&nbsp;a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment equal to a multiple of
2.99 times the sum of Mr.&nbsp;Arduini&#146;s base salary and target cash bonus as well as (ii)&nbsp;a <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of Mr.&nbsp;Arduini&#146;s annual bonus for the fiscal year in which the termination date
occurs, based on actual results for such year. In addition, the Company will pay Mr.&nbsp;Arduini for up to eighteen months after the termination date (i)&nbsp;Company-subsidized healthcare continuation coverage for Mr.&nbsp;Arduini and his
dependents and (ii)&nbsp;Company-paid life and disability insurance premiums for Mr.&nbsp;Arduini. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Change in Control
Agreements for Messrs. Coleman, Davis, Reuvers, and Gorelick provide that, if any applicable named executive officer&#146;s employment with the Company is terminated within twenty-four months following a change in control so long as such change of
control occurs before January&nbsp;31, 2017 by the Company without cause or by such named executive officer for good reason, then the Company will pay the following to such named executive officer: (i)&nbsp;a
<FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment equal to a multiple of 1.5 times the sum of the named executive officer&#146;s base salary and target cash bonus (or 2 times in the case of Mr.&nbsp;Coleman), (ii) a lump sum payment
equal to a pro rata portion of such named executive officer&#146;s target bonus for the partial fiscal year in which the termination occurs, (iii)&nbsp;the monthly premium for COBRA family coverage under the Company&#146;s group health plan for up
to eighteen months after the termination date, and (iv)&nbsp;Company paid outplacement services for up to twelve months following the termination date. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">81 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s equity plans provide for the acceleration of vesting and/or delivery of
all equity compensation awards granted since January&nbsp;1, 2013 for all of the named executive officers, if a change in control occurs and the named executive officers incurs a qualifying termination on or within twelve months (or on or within
twenty-four months pursuant to the Arduini Agreement) following the date of such change in control. For PSU award agreements granted in 2016 to NEOs, any outstanding shares shall vest if such NEO incurs (i)&nbsp;a qualifying termination or
(ii)&nbsp;a termination due to death or disability, in either case, on or following a change of control and prior to or on the last day of the performance period. The NEOs will receive payment of common stock underlying such grants of restricted
stock, stock options, and PSUs in such event. In addition, Mr.&nbsp;Arduini will receive deferred payment of common stock underlying such grants of restricted stock units on the date that represents six months after the date of his termination of
employment. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Agreements, a change in control would be deemed to have occurred: (i)&nbsp;if the beneficial ownership
of securities representing more than fifty percent of the combined voting power of the voting securities of the Company is acquired by any individual, entity or group; (ii)&nbsp;if the individuals who, as of the date of the Agreement, constitute the
Board of Directors cease for any reason during any period of at least twenty-four months to constitute at least a majority of the Board of Directors; (iii)&nbsp;upon consummation of a reorganization, merger or consolidation or sale or other
disposition of all or substantially all of the assets of the Company or the acquisition of assets or stock of another entity; or (iv)&nbsp;upon approval by the stockholders of a complete liquidation or dissolution of the Company. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Change in Control Agreements as well as the equity award agreements (except for the PSU award agreements granted in 2014 and
2015) for the NEOs, a qualifying termination would be deemed to have occurred for the following reasons: (i)&nbsp;if the Company terminates the individual without cause or (ii)&nbsp;if the individual, who is a party to an employment, severance or
applicable award agreement containing the definition of &#147;Good Reason,&#148; terminates his or her employment with the Company for good reason. Pursuant to Mr.&nbsp;Arduini&#146;s PSU award agreements granted in 2014 and 2015, a qualifying
termination would be deemed to have occurred: (i)&nbsp;if the Company terminates Mr.&nbsp;Arduini without cause, (ii)&nbsp;if Mr.&nbsp;Arduini terminates his employment with the Company for good reason, (iii)&nbsp;by reason of
Mr.&nbsp;Arduini&#146;s disability, or (iv)&nbsp;by reason of Mr.&nbsp;Arduini&#146;s death. In addition, for all other NEOs&#146; PSU award agreements granted in 2014 and 2015, a qualifying termination would be deemed to have occurred by reason of
such NEO&#146;s disability or death. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Restrictive Covenants And Other Conditions </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For each of the Agreements, the foregoing severance benefits are conditioned on each executive&#146;s execution of a mutual release. In
addition, for all of the applicable named executive officers, such benefits are consideration for the restrictive covenants set forth in their respective Agreements. Specifically, during the term of their employment with the Company and the <FONT
STYLE="white-space:nowrap">one-year</FONT> period thereafter, all of such named executive officers generally may not compete against the Company or solicit employees and customers of the Company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">82 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Summary of Potential Payments </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table summarizes the payments that would be made by the Company to the named executive officers upon the events discussed
above, assuming that each named executive officer&#146;s termination of employment with the Company occurred on December&nbsp;31, 2016 or a change in control of the Company occurred on December&nbsp;31, 2016, as applicable: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:86pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Termination<BR>Without&nbsp;Cause<BR>or With Good<BR>Reason&nbsp;(Before&nbsp;a</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Change In<BR>Control)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Death</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Disability</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Termination<BR>Without&nbsp;Cause,<BR>With&nbsp;Good&nbsp;Reason</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Death or Disability<BR>(&#147;Double trigger&#148;<BR>after a Change<BR>in Control)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Peter J. Arduini</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Severance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,646,476</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">885,109</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,957,599</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continued Health&nbsp;&amp; Other Benefits(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,931</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,086</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,931</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,473,151</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,473,151</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,473,151</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Other Grants(2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,352,877</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,352,877</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,214,857</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fees/Interest(3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,373</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,923</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,694,355</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,739,596</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,826,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,709,461</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Glenn G. Coleman</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Severance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,575,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continued Health&nbsp;&amp; Other Benefits(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,593</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,344,226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,344,226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,344,226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Other Grants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">595,554</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">595,554</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,160,039</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fees/Interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,939,780</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,939,780</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,101,858</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert T. Davis, Jr.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Severance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,182,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continued Health&nbsp;&amp; Other Benefits(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">295,286</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">295,286</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">295,286</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Other Grants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">366,924</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">366,924</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">975,492</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fees/Interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">662,210</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">662,210</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,466,487</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Daniel L. Reuvers</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Severance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">925,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continued Health&nbsp;&amp; Other Benefits(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,783</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">132,365</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">132,365</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">132,365</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Other Grants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">199,805</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">199,805</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">495,771</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fees/Interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">332,170</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">332,170</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,571,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Richard D. Gorelick</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash Severance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,016,369</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Continued Health&nbsp;&amp; Other Benefits(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,593</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">318,548</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">318,548</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">318,548</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceleration of Other Grants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">249,048</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">249,048</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">630,925</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fees/Interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">567,596</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">567,596</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,988,435</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">83 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company will pay Mr.&nbsp;Arduini the monthly premium cost of COBRA health insurance as well as the Company&#146;s monthly premium cost of the Company&#146;s life
and disability insurance plans for up to 18 months following Mr.&nbsp;Arduini&#146;s termination date. The Company will pay Messrs. Coleman, Davis, Reuvers, and Gorelick the difference between the monthly premium cost of COBRA health insurance and
such executives&#146; personal monthly health insurance contributions that were in effect prior to such executives&#146; termination for up to 18 months following such executives&#146; termination date. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">For information on vested and deferred restricted stock units, see the Nonqualified Deferred Compensation table. The value of vested awards is not included in this
table. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Mr.&nbsp;Arduini, the amount shown represents the interest on his severance payment (cash severance plus premium cost for health and other insurance benefits) if it
is required to be delayed for six months because of the application of section 409A of the Code, with such interest applied at the rate of 0.74% compounded monthly. </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company does not provide for any tax <FONT STYLE="white-space:nowrap">gross-up</FONT> payments. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_20"></A>DIRECTOR COMPENSATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors
believes that providing competitive compensation is necessary to attract and retain qualified <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. The key components of <FONT STYLE="white-space:nowrap">non-employee</FONT> director
compensation include an annual equity grant and an annual retainer. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation. </I>The compensation of directors during
2016 included the compensation payable during the period beginning with the Company&#146;s 2015 Annual Meeting of Stockholders on May&nbsp;22, 2015 and ending with the Company&#146;s 2016 Annual Meeting of Stockholders on May&nbsp;24, 2016.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As compensation for their service during the period beginning with the Company&#146;s 2015 Annual Meeting of Stockholders, <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors received an annual equity grant in the form of restricted stock with a fair market value on the date of grant of $155,000 (or $205,000 for the Chairman). Directors also received an annual
retainer of $75,000, payable in one of three ways, at their election: (1)&nbsp;in cash, (2)&nbsp;in restricted stock, or (3)&nbsp;one half in cash and one half in restricted stock. In addition, the Company paid the following separate annual cash
fees to certain directors as follows: (1) $15,000 for the Nominating and Corporate Governance Committee Chair, (2) $15,000 for the Compensation Committee Chair, (3) $15,000 for the Audit Committee Chair, (4) $15,000 for the Finance Committee Chair,
(5) $25,000 for the Presiding Director, and (6) $75,000 for the Chairman. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Effective as of the 2016 Annual Meeting of
Stockholders, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors received an annual equity grant in the form of restricted stock with a fair market value on the date of grant of $170,000 (increased from $155,000) (or $220,000 for the
Chairman (increased from $205,000)). Directors also received an annual retainer of $75,000, payable in one of three ways, at their election: (1)&nbsp;in cash, (2)&nbsp;in restricted stock, or (3)&nbsp;one half in cash and one half in restricted
stock. In addition, the Company paid the following separate annual cash fees to certain directors as follows: (1) $15,000 for the Nominating and Corporate Governance Committee Chair, (2) $15,000 for the Compensation Committee Chair, (3) $15,000 for
the Audit Committee Chair, (4) $15,000 for the Finance Committee Chair, (5) $25,000 for the Presiding Director and (6) $75,000 for the Chairman.&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Effective as of the 2017 Annual Meeting of Stockholders, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors will receive the same compensation they earned the prior year. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company pays reasonable travel and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses incurred by <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in connection with attendance at meetings to transact business of the Company or attendance at meetings of the Board of Directors or any committee thereof.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">84 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides details of the total compensation for <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors in 2016. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:29pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned&nbsp;or</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Paid in
Cash</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock&nbsp;
Awards(1)(2)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option&nbsp;
Awards(3)(4)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Keith Bradley</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">207,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">297,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard E. Caruso</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stuart M. Essig</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">295,096</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">370,096</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Barbara B. Hill</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,054</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,054</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lloyd W. Howell, Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,054</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,054</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Donald E. Morel, Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Raymond G. Murphy</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">245,054</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">297,554</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christian S. Schade</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">260,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">James M. Sullivan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">99,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">269,277</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This column reflects the aggregate grant date fair value computed in accordance with FASB ASC Topic 718, based on the closing price of the Company&#146;s common stock
on the grant date. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock awards outstanding as of December&nbsp;31, 2016 for each director consisted of restricted shares of common stock, as follows: Keith Bradley &#151; 1,428; Richard
E. Caruso &#151; 1,170; Stuart M. Essig &#151; 2,030; Barbara B. Hill &#151; 1,686; Lloyd W. Howell, Jr. &#151; 1,686; Donald E. Morel, Jr. &#151; 1,170; Raymond G. Murphy &#151; 1,686; Christian S. Schade &#151; 1,170 and James M. Sullivan &#151;
1,170. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This column, if applicable, reflects the aggregate grant date fair value computed in accordance with FASB ASC Topic 718, based on the fair value of the option on the
grant date as estimated using the binomial distribution model. For a discussion of assumptions used to estimate fair value, please see Note 8, &#147;Stock-Based Compensation,&#148; to our consolidated financial statements included in our Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2016. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The aggregate number of options held by each director as of December&nbsp;31, 2016 was as follows: Keith Bradley &#151; 7,829; Richard E. Caruso &#151; 46,271; Stuart
M. Essig &#151; 339,268; Barbara B. Hill &#151; 0; Lloyd W. Howell, Jr. &#151; 0; Donald E. Morel, Jr. &#151; 0; Raymond G. Murphy &#151; 2,619; Christian S. Schade &#151; 15,658 and James M. Sullivan &#151; 15,658. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_21"></A>EQUITY COMPENSATION PLAN INFORMATION </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table provides information as of December&nbsp;31, 2016 regarding existing compensation plans (including individual
compensation arrangements) under which equity securities of the Company are authorized for issuance: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:49pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan Category</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Securities&nbsp;to&nbsp;be</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Issued Upon Exercise of<BR>Outstanding Options,<BR>Warrants and Rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT><BR>Exercise Price
of<BR>Outstanding&nbsp;Options,<BR>Warrants and Rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Securities<BR>Remaining&nbsp;Available&nbsp;for<BR>Future Issuance
Under<BR>Equity&nbsp;Compensation&nbsp;Plans(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans approved by stockholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,501,498</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,119,479</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,501,498</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,119,479</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excludes securities to be issued upon the exercise of outstanding options, warrants and rights. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of (a) 10,289 shares of common stock underlying unvested Restricted Stock Units, (b) 38,464 shares of common stock underlying outstanding
unvested contract stock, (c) 212,102 shares of common stock underlying outstanding unvested options, (d) 194,579 shares underlying unvested Performance Stock Units, (e) 21,182 shares underlying vested and deferred Performance Stock Units, (f)
195,717 shares underlying vested and deferred contract stock and (g) 829,165 shares of common stock underlying outstanding vested options. Of these amounts, the following securities are issuable under the 2003 Plan: (a)
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">85 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
10,289 shares of common stock underlying Restricted Stock Units, (b) 194,579 shares of common stock underlying outstanding Performance Stock Units, (c) 21,182 shares underlying vested and
deferred Performance Stock Units, (d) 234,181 shares of common stock underlying contract stock and (e) 1,026,500 shares of common stock underlying outstanding options. Performance Stock Units granted in March 2016 are calculated at 150% of target.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excluding the Restricted Stock Units, performance stock and contract stock, the weighted average exercise price is $41.30. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of 1,030,903 shares of common stock which remain available for issuance under the Employee Stock Purchase Plan and 1,088,576 shares which remain available for
issuance under the other Approved Plans, including 1,076,548 shares under the 2003 Plan. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_22">
</A>COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Bradley, Ms.&nbsp;Hill and Dr.&nbsp;Morel are the
current members of the Compensation Committee. None of our compensation committee members currently serves, nor did they ever serve, as an officer or employee or former officer of the Company or had any relationship requiring disclosure herein
pursuant to Securities and Exchange Commission regulations. No executive officer of the Company served as a member of a compensation committee or a director of another entity under circumstances requiring disclosure under Securities and Exchange
Commission regulations. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_23"></A>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Review and Approval of Related Person Transactions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to a written policy, the Company reviews all transactions, arrangements or relationships (or any series of similar transactions, arrangements or relationships) in excess of $100,000 in which the
Company (including any of its subsidiaries) was, is or will be a participant and the amount involved exceeds $100,000, and in which any Related Person had, has or will have a direct or indirect interest. For purposes of the policy, a &#147;Related
Person&#148; means: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a) any person who is, or at any time since the beginning of the Company&#146;s last
fiscal year was, a director or executive officer of the Company or a nominee to become a director of the Company; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(b) any person who is known to be the beneficial owner of more than 5% of any class of the Company&#146;s voting securities; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c) any immediate family member of any of the foregoing persons; and </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d) any firm, corporation or other entity in which any of the foregoing persons is employed or is a partner or principal
or in a similar position or in which such person has a 5% or greater beneficial ownership interest. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the Company&#146;s
legal department determines that a proposed transaction is a transaction for which approval is required under applicable rules and regulations of the Securities and Exchange Commission, the proposed transaction shall be submitted to the Audit
Committee for consideration. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee will consider all of the relevant facts and circumstances available to the
Committee, including (if applicable) but not limited to, the benefits to the Company; the impact on a director&#146;s independence in the event the Related Person is a director, an immediate family member of a director or an entity in which a
director is a partner, shareholder or executive officer; the availability of other sources for comparable products or services; the terms of the transaction; and the terms available to unrelated third parties or to employees generally. No member of
the Audit Committee shall participate in any review, consideration or approval of any Related Person Transaction with respect to which such member or any of his or her immediate family members is the Related Person. The Audit Committee shall approve
only those Related Person Transactions that are in, or are not inconsistent with, the best interests of the Company and its stockholders, as the Audit Committee determines in good faith. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">86 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The policy provides that the above determination should be made at the next Audit Committee
meeting. In those instances in which the legal department, in consultation with the Chief Executive Officer or the Chief Financial Officer, determines that it is not practicable or desirable for the Company to wait until the next Audit Committee
meeting, the transaction shall be presented to the Chair of the Audit Committee (who will possess delegated authority to act between Audit Committee meetings). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Related Person Transactions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company leases its manufacturing facility
in Plainsboro, New Jersey from Plainsboro Associates, a New Jersey general partnership. Ocirne, Inc., a subsidiary of Provco Industries, owns a 50% interest in Plainsboro Associates. Provco Industries&#146; stockholders are trusts whose
beneficiaries include the children of Dr.&nbsp;Caruso, a director and a principal stockholder of the Company. Dr.&nbsp;Caruso is the President of Provco Industries. The Company paid $272,309 for rent of this facility for 2016. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company leased certain production equipment from Medicus Corporation. On January&nbsp;5, 2017 the Company purchased the leased
equipment from Medicus Corporation. The sole stockholder of Medicus is TRU ST PARTNERSHIP, L.P., a Pennsylvania general partnership, of which Dr.&nbsp;Caruso is a partner and the President. Under the terms sale, the Company paid for&nbsp;$375,000 to
Medicus Corporation for the equipment. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">87 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_24"></A>AUDIT COMMITTEE REPORT </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following report of the Audit Committee is required by the rules of the Securities and Exchange Commission to be included in this
Proxy Statement. This report shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, by virtue of any general statement in such filing incorporating this Proxy Statement by
reference, except to the extent that the Company specifically incorporates the information contained in this section by reference, and shall not otherwise be deemed filed under either the Securities Act or the Exchange Act. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The purpose of the Audit Committee is to oversee the Company&#146;s accounting and financial reporting process and the audits of the
Company&#146;s financial statements. The Audit Committee operates pursuant to a Charter that the Board amended and restated on July&nbsp;21, 2015, a copy of which is available on the Company&#146;s website. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As set forth in the Audit Committee Charter, management of the Company is responsible for the preparation, presentation and integrity of
the Company&#146;s financial statements, the Company&#146;s financial reporting process, accounting policies, internal audit function, internal controls over financial reporting and disclosure controls and procedures. The independent registered
public accounting firm is responsible for auditing the Company&#146;s financial statements and internal control over financial reporting and expressing an opinion as to the conformity of those audited financial statements with accounting principles
generally accepted in the United States of America and on the effectiveness of the Company&#146;s internal control over financial reporting. The Audit Committee&#146;s responsibility is to monitor and oversee the Company&#146;s financial reporting
process. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the performance of its oversight function, the Audit Committee has reviewed and discussed with management and the
independent registered public accounting firm the audited financial statements and management&#146;s assessment of the effectiveness of the Company&#146;s internal control over financial reporting and the independent registered public accounting
firm&#146;s evaluation of the Company&#146;s internal control over financial reporting as of December&nbsp;31, 2016. The Audit Committee has also discussed with the independent registered public accounting firm the matters required to be discussed
by the applicable requirements of the Public Company Accounting Oversight Board. Finally, the Audit Committee has received the written disclosures and the letter from the independent registered public accounting firm required by the applicable
requirements of the Public Company Accounting Oversight Board, as currently in effect, has discussed with the independent registered public accounting firm its independence in relation to the Company and has considered the compatibility of <FONT
STYLE="white-space:nowrap">non-audit</FONT> services with such independence. Management has represented to the Audit Committee that the Company&#146;s consolidated financial statements were prepared in accordance with accounting principles generally
accepted in the United States of America. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based upon the review and discussions referred to above, the Audit Committee
recommended to the Board of Directors that the audited financial statements of the Company for the fiscal year ended December&nbsp;31, 2016 be included in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for such
fiscal year, as filed with the Securities and Exchange Commission on February&nbsp;23, 2017. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee of the Board of Directors</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>RAYMOND G. MURPHY (CHAIR)</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>LLOYD W. HOWELL, JR.</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>CHRISTIAN S. SCHADE</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>JAMES M. SULLIVAN</I></FONT></P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">88 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_25"></A>PRINCIPAL STOCKHOLDERS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the beneficial ownership of common stock as of February&nbsp;28, 2017 by:
(a)&nbsp;each person or entity known to the Company to be the beneficial owner of more than five percent of the outstanding shares of common stock, based upon Company records or statements filed with the Securities and Exchange Commission;
(b)&nbsp;each of the Company&#146;s directors and nominees for directors; (c)&nbsp;each of the named executive officers; and (d)&nbsp;all executive officers, directors and nominees as a group. Except as otherwise indicated, each person has sole
voting power and sole investment power with respect to all shares beneficially owned by such person. Unless otherwise provided, the address of each individual listed below is c/o Integra LifeSciences Holdings Corporation, 311 Enterprise Drive,
Plainsboro, NJ 08536. The numbers in the table below reflect the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">two-for-one</FONT></FONT> stock split distributed on January&nbsp;3, 2017. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount and Nature of Beneficial Ownership</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:134pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Address of Beneficial Owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Shares&nbsp;Owned(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Right&nbsp;to&nbsp;Acquire(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent&nbsp;
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Class(3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peter J. Arduini</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43,168</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">783,132</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">826,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Keith Bradley, Ph.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,951</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,658</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,609</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard E. Caruso, Ph.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,167,220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,542</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,259,762</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stuart M. Essig, Ph.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,928,764</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">678,536</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,607,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Barbara B. Hill</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34,614</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34,614</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lloyd W. Howell, Jr</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,096</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,096</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Donald E. Morel, Jr., Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,568</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,568</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Raymond G. Murphy</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60,894</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,238</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66,132</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christian S. Schade</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,316</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,440</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">James M. Sullivan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,496</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,316</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">85,812</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Glenn G. Coleman</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,543</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84,571</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,164</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,654</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert T. Davis, Jr.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,336</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41,516</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel L. Reuvers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,576</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,539</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,115</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All directors, nominees for director and executive officers as a group (20 persons)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,557,778</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,740,851</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,298,629</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">FMR LLC, Abigail P. Johnson and Fidelity Small Cap Discovery Fund<BR>245 Summer Street<BR>Boston, MA 02210</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,573,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,573,524</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc.<BR>55 East 52nd Street<BR>New York, NY 10055</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,888,052</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,888,052</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Vanguard Group<BR>100 Vanguard Blvd.,<BR>Malvern, PA 19355</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,219,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,219,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Champlain Investment Partners, LLC<BR>180 Battery Street, Suite 400<BR>Burlington, VT 05401<BR></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,941,230</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,941,230</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:9px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:13%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents beneficial ownership of less than 1%. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excludes shares that may be acquired through stock option exercises, restricted stock units or performance stock. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares not outstanding but deemed beneficially owned by virtue of the right of an individual to acquire them within 60 days of February&nbsp;28, 2017 upon (i)&nbsp;the
exercise of an option or other convertible security as well as (ii)&nbsp;the vesting of performance stock are treated as outstanding for purposes of determining beneficial ownership and the percentage beneficially owned by such individual.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of February&nbsp;28, 2017, we had 75,855,822 shares of common stock outstanding. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">89 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Excludes outstanding Restricted Stock Units awarded to Mr.&nbsp;Arduini that vested but are not yet deliverable and do not give Mr.&nbsp;Arduini the right to acquire
any shares within 60 days of February&nbsp;28, 2017. Such Restricted Stock Units are deferred and shall be delivered to Mr.&nbsp;Arduini within 30 days following the first business day that occurs immediately following the <FONT
STYLE="white-space:nowrap">six-month</FONT> period after the date of his separation of service. Also excludes 43,578 outstanding PSUs awarded to Mr.&nbsp;Arduini in March 2013 that vested but are not yet deliverable and do not give Mr.&nbsp;Arduini
the right to acquire any shares within 60 days of February&nbsp;28, 2017. Such PSUs are deferred and shall be delivered to Mr.&nbsp;Arduini within 30 days following the first business day that occurs immediately following the <FONT
STYLE="white-space:nowrap">six-month</FONT> period after the date of his separation of service. The shares reported in the table above and in this footnote have been adjusted to reflect the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">2-for-1</FONT></FONT> stock split distributed on January&nbsp;3, 2017. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 11,982,410 shares held by Tru St Partnership, L.P., a Pennsylvania limited partnership (&#147;Tru St&#148;). Also includes 46,676 shares held by Provco Leasing
Corporation (&#147;Provco&#148;), of which Dr.&nbsp;Caruso is President and sole director and 146,292 shares held by The Uncommon Individual Foundation, of which Dr.&nbsp;Caruso is the Chief Executive Officer. Provco is the corporate general partner
of Tru St. Dr.&nbsp;Caruso may be deemed to have shared voting and dispositive power over the shares held by Tru St, Provco and The Uncommon Individual Foundation. Also includes 134,134 shares owned by Dr.&nbsp;Caruso. Dr.&nbsp;Caruso disclaims
beneficial ownership of the shares held by Tru St, Provco and The Uncommon Individual Foundation, except to the extent of his pecuniary interest therein. Dr.&nbsp;Caruso&#146;s address is c/o The Provco Group, LTD, 795 E. Lancaster Avenue, Suite
200, Villanova, PA 19085. The shares reported in the table above and in this footnote have been adjusted to reflect the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">2-for-1</FONT></FONT> stock split distributed on
January&nbsp;3, 2017. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">FMR LLC, a holding company of investment companies, and Abigail P. Johnson each report beneficially owning and having sole dispositive power over 10,573,524 shares of
which FMR LLC has sole voting power over 339,176 shares. Members of the Johnson family including Ms.&nbsp;Johnson, Director, Vice Chairman, Chief Executive Officer and President of FMR LLC, are the predominant owners, directly or through trusts, of
Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders&#146; voting agreement under which all Series B voting common
shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#146; voting agreement, members of the Johnson family
group may be deemed under the Investment Company Act of 1940 (the &#147;1940 Act&#148;) to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Ms.&nbsp;Johnson has the sole power to vote or direct the voting of the shares owned
directly by the various investment companies registered under the 1940 Act, which power resides with the funds&#146; boards of trustees. The foregoing information has been included solely in reliance upon, and without independent investigation of,
the disclosures contained in the Schedule 13G/A filed by FMR LLC with the Securities and Exchange Commission on February&nbsp;14, 2017. The shares reported in the table above and in this footnote have been adjusted to reflect the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">2-for-1</FONT></FONT> stock split distributed on January&nbsp;3, 2017. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc. has sole voting power of 6,734,774 shares and sole dispositive power over all of the 6,888,052 shares. The foregoing information has been included
solely in reliance upon, and without independent investigation of, the disclosures contained in the Schedule 13G/A filed by BlackRock, Inc. with the Securities and Exchange Commission on January&nbsp;25, 2017. The shares reported in the table above
and in this footnote have been adjusted to reflect the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">2-for-1</FONT></FONT> stock split distributed on January&nbsp;3, 2017. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Vanguard Group has sole voting power of 120,770 shares and sole dispositive power of 5,095,310 shares of the total 5,219,120 shares. Vanguard
Fiduciary Trust Company, a wholly-owned subsidiary of The Vanguard Group, is the beneficial owner of 116,322 shares as a result of its serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd., a wholly-owned
subsidiary of The Vanguard Group, is the beneficial owner of 11,936 shares as a result of its serving as investment manager of Australian investment offerings. The foregoing information has been included solely in reliance upon, and without
independent investigation of, the disclosures contained in the Schedule 13G filed by The Vanguard Group with the Securities and Exchange Commission on January&nbsp;25, 2017. The shares reported
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">90 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
in the table above and in this footnote have been adjusted to reflect the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">2-for-1</FONT></FONT> stock split distributed on
January&nbsp;3, 2017. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Champlain Investment Partners, LLC has sole voting power of 3,016,100 shares of the total 3,941,230 shares. The foregoing information has been included solely in
reliance upon, and without independent investigation of, the disclosures contained in the Schedule 13F filed by Champlain Investment Partners, LLC with the Securities and Exchange Commission on February&nbsp;13, 2017. The shares reported in the
table above and in this footnote have been adjusted to reflect the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">2-for-1</FONT></FONT> stock split distributed on January&nbsp;3, 2017. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_26"></A>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section 16(a) of the Exchange Act requires the Company&#146;s directors and executive officers, as well as persons beneficially owning
more than 10% of the Company&#146;s outstanding shares of common stock and certain other holders of such shares (collectively, &#147;Covered Persons&#148;), to file with the Securities and Exchange Commission, within specified time periods, initial
reports of ownership and subsequent reports of changes in ownership of common stock and other equity securities of the Company. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely upon the Company&#146;s review of copies of such reports furnished to it and upon representations of Covered Persons that no
other reports were required, to the Company&#146;s knowledge all of the Section 16(a) filing requirements applicable to Covered Persons were complied with during 2016 except for two transactions that were not reported on a timely basis by John
Mooradian. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_27"></A>STOCKHOLDER PROPOSALS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The deadline for stockholders to submit proposals pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act for
inclusion in the Company&#146;s proxy statement and form of proxy for the 2018 Annual Meeting of Stockholders is December&nbsp;18, 2017. Such proposals must be sent to: Integra LifeSciences Holdings Corporation, 311 Enterprise Drive, Plainsboro, New
Jersey 08536, Attention: Corporate Vice President, General Counsel, Administration and Secretary. The date after which notice of a stockholder proposal submitted outside of the processes of Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the
Exchange Act is considered untimely is December&nbsp;18, 2017. If notice of a stockholder proposal submitted outside of the processes of Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange is received by the Company after
December&nbsp;18, 2017, then the Company&#146;s proxy for the 2018 Annual Meeting of Stockholders may confer discretionary authority to vote on such matter without any discussion of such matter in the proxy statement for such annual meeting of
stockholders. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Bylaws require, among other things, that a stockholder may present a proposal at the 2018 Annual Meeting
that is not included in the proxy statement if proper written notice is received by our Corporate Vice President, General Counsel, Administration and Secretary at our principal executive offices between January&nbsp;24, 2018 and the close of
business on February&nbsp;23, 2018. The proposal must contain the specific information required by our Bylaws. You may obtain a copy of the Bylaws by writing to our Corporate Vice President, General Counsel, Administration and Secretary. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_28"></A>OTHER MATTERS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A copy of the Company&#146;s 2016 Annual Report to Stockholders is being mailed simultaneously herewith to stockholders but is not to be regarded as proxy solicitation material. In addition, our Code of
Conduct, which applies to all of the Company&#146;s directors and officers, and the charters for each of our Audit, Compensation, and Nominating and Corporate Governance Committees are accessible via our website at www.integralife.com through the
&#147;Investor Relations&#148; link under the heading &#147;Corporate Governance.&#148; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Company, upon request, will
furnish to record and beneficial holders of its common stock, free of charge, a copy of its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> (including financial statements and schedules, but without exhibits) for the fiscal year
ended December&nbsp;31, 2016 as filed with the Securities and Exchange Commission on February&nbsp;23, 2017. Copies of exhibits to the Form <FONT STYLE="white-space:nowrap">10-K</FONT> also will be furnished upon request
</B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">91 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>
and the payment of a reasonable fee. All requests should be directed to the investor relations department, at the offices of the Company set forth on page one of this Proxy Statement.
</B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By order of the Board of Directors, </FONT></P>
<P STYLE="font-size:48px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/&nbsp;&nbsp;&nbsp;&nbsp;R<SMALL>ICHARD</SMALL> D. G<SMALL>ORELICK</SMALL></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Richard D. Gorelick</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Corporate Vice President, General Counsel,</I></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Administration and Secretary</I></FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Plainsboro, New Jersey </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;17, 2017 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">92 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_29"></A>APPENDIX A </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Integra LifeSciences Holdings Corporation 2018 Performance Incentive Compensation Plan </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Article&nbsp;I </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Establishment, Purpose, and Effective Date </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This Integra LifeSciences
Holdings Corporation 2018 Performance Incentive Compensation Plan (the &#147;<I>Plan</I>&#148;) is established by Integra LifeSciences Holdings Corporation, a Delaware corporation (&#147;<I>Integra</I>&#148;), for the purpose of enhancing the
ability of Integra to offer incentive compensation to eligible employees by rewarding the achievement of corporate goals, division and major corporate function goals and individual performance which is consistent with and supportive of the overall
corporate objectives of Integra. More specifically, through this Plan, Integra intends to (i)&nbsp;reinforce strategically important financial and operational objectives; (ii)&nbsp;provide rewards based on achieving significant corporate,
departmental or division and individual goals and objectives; (iii)&nbsp;provide incentives that result in behavior that is consistent with increasing stockholder value and the success of Integra; and (iv)&nbsp;incorporate an incentive program in
the Integra overall compensation program to help attract, retain, and motivate key employees. The Plan is a plan for employees of Integra and its subsidiaries for Performance Periods beginning on or after January&nbsp;1, 2018 (the &#147;<I>Effective
Date</I>&#148;). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">It is Integra&#146;s intent that bonuses paid under this Plan may be, but shall not be required to be,
designed to be deductible without limit under Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended, and the regulations and interpretations promulgated thereunder (collectively, the &#147;<I>Code</I>&#148;). </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Article&nbsp;II Definitions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2.1</B><B><I> Board.</I></B> &#147;Board&#148; shall mean the Board of Directors of Integra. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2.2</B><B><I> Bonus.</I></B> &#147;Bonus&#148; shall mean a cash payment under this Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2.3</B><B><I> Bonus Opportunity</I></B>. &#147;Bonus Opportunity&#148; shall mean the opportunity to receive a Bonus, subject to all applicable terms and conditions. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.4</B><B><I> Business Criteria</I></B>. &#147;Business Criteria&#148; shall mean the Business Criteria set forth in
Section&nbsp;3.1(d) hereof on which the Performance Objectives may be based. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.5</B><B><I> Change in Control</I></B>.
&#147;Change in Control&#148; shall mean the occurrence of any of the following: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a) An acquisition (other
than directly from Integra) of any voting securities of Integra (&#147;<I>Voting Securities</I>&#148;) by any &#147;Person&#148; (as such term is used for purposes of Section&nbsp;13(d) or 14(d) of the Exchange Act) immediately after which such
Person has &#147;Beneficial Ownership&#148; (within the meaning of <FONT STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> promulgated under the Exchange Act) of 50&nbsp;percent or more of the combined voting power of all the then outstanding Voting
Securities, other than Integra, any trustee or other fiduciary holding securities under any employee benefit plan of Integra or an affiliate thereof, or any corporation owned, directly or indirectly, by the stockholders of Integra in substantially
the same proportions as their ownership of stock of Integra;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that any acquisition from Integra or any acquisition pursuant to a transaction which complies with paragraph&nbsp;(c)(i) and (ii)&nbsp;below
shall not be a Change in Control under this paragraph&nbsp;(a); </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b) The individuals who, as of January&nbsp;1,
2018, are members of the Board (the &#147;<I>Incumbent Board</I>&#148;) cease for any reason to constitute at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the Board;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that if the election, or
nomination for election by the stockholders, of any new director was approved by a vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the members of the Board who constitute Incumbent Board members, such new directors shall for
all purposes be considered as members of the Incumbent Board as of January&nbsp;1, 2018,<I>&nbsp;provided further</I>, however, that no individual shall be considered a member of the Incumbent
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Board if such individual initially assumed office as a result of either an actual or threatened &#147;Election Contest&#148; (as described in
<FONT STYLE="white-space:nowrap">Rule&nbsp;14a-11</FONT> promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board of Directors (a &#147;<I>Proxy
Contest</I>&#148;) including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(c) Consummation by Integra of a reorganization, merger, or consolidation or sale or other disposition of all or substantially all of the assets of Integra or the acquisition of assets or stock of another
entity (a &#147;<I>Business Combination</I>&#148;), unless immediately following such Business Combination: (i)&nbsp;more than 50&nbsp;percent of the combined voting power of the then outstanding voting securities entitled to vote generally in the
election of directors of (A)&nbsp;the corporation resulting from such Business Combination (the &#147;<I>Surviving Corporation</I>&#148;), or (B)&nbsp;if applicable, a corporation which as a result of such transaction owns Integra or all or
substantially all of Integra&#146;s assets either directly or through one or more subsidiaries (the &#147;<I>Parent Corporation</I>&#148;), is represented, directly or indirectly, by Integra Voting Securities outstanding immediately prior to such
Business Combination (or, if applicable, is represented by shares into which such Voting Securities were converted pursuant to such Business Combination), and such voting power among the holders thereof is in substantially the same proportions as
their ownership, immediately prior to such Business Combination, of Integra Voting Securities; and (ii)&nbsp;at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving
Corporation) were members of the Incumbent Board at the time of the execution of the initial agreement, or the action of the Board, providing for such Business Combination; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d) The approval by the stockholders of Integra of a complete liquidation or dissolution of Integra; or </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(e) Acceptance by the stockholders of Integra of shares in a share exchange if the stockholders of Integra immediately
before such share exchange do not own, directly or indirectly, immediately following such share exchange more than 50&nbsp;percent of the combined voting power of the outstanding Voting Securities of the corporation resulting from such share
exchange in substantially the same proportion as their ownership of the Voting Securities outstanding immediately before such share exchange. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding the foregoing, if a Change in Control constitutes a payment event with respect to any Bonus Opportunity which provides for the deferral of compensation and is subject to Code
Section&nbsp;409A, the transaction or event described in this Section&nbsp;2.5 with respect to such Bonus Opportunity must also constitute a &#147;change in control event,&#148; as defined in Treasury Regulation
<FONT STYLE="white-space:nowrap">&#167;&nbsp;1.409A-3(i)(5)</FONT> to the extent required by Code Section&nbsp;409A. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.6</B> <B><I>Company</I></B>. &#147;Company&#148; shall mean Integra and its subsidiaries. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.7</B><B><I> Covered Employee</I></B><B>.</B> &#147;Covered Employee&#148; shall mean any employee of the Company who is, or could
become, a &#147;covered employee&#148; within the meaning of Code Section&nbsp;162(m). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.8</B><B><I> Eligible
Employee</I></B>. &#147;Eligible Employee&#148; shall mean an employee of the Company. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.9</B><B><I> Exchange Act</I></B>.
&#147;Exchange Act&#148; shall mean the Securities Exchange Act of 1934, as amended. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.10</B><B><I> Outside
Director</I></B>. &#147;Outside Director&#148; shall have the meaning set forth in the regulations and rulings promulgated under Code Section&nbsp;162(m). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2.11</B><B><I> Participant</I></B>. &#147;Participant&#148; shall mean an Eligible Employee who has been selected to participate in the Plan by the Company or the Committee, as applicable, pursuant to
Section&nbsp;3.1(a) hereof. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.12</B><B><I> Performance Period</I></B>. &#147;Performance Period&#148; shall mean a period
for which Bonus Opportunities may be awarded. The first Performance Period under the Plan shall begin on January&nbsp;1, 2018 and end on December&nbsp;31, 2018. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2.13</B><B><I> QPBC</I></B>. &#147;QPBC&#148; shall mean &#147;qualified performance-based compensation&#148; within the meaning set forth in the regulations and rulings promulgated under Code
Section&nbsp;162(m). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.14</B><B><I> Target Bonus</I></B>. &#147;Target Bonus&#148; shall mean the target
amount, expressed as a percentage of a Participant&#146;s base salary or a fixed value, that the Participant may earn as a Bonus for an applicable Performance Period, provided that the target level of performance is achieved with respect to each
Performance Objective applicable to the Participant for such Performance Period, and subject to funding. Notwithstanding the foregoing, in no event shall a Participant&#146;s Target Bonus exceed 165% of his or her base salary as in effect as of the
final day of the applicable Performance Period. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Article&nbsp;III </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Eligibility and Benefits </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>3.1</B><B><I> Eligible Employees; Performance Objectives</I></B>. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(a) Subject to this Section&nbsp;3.1, the Company or, solely with respect to Eligible Employees who are also Covered Employees, the Committee, shall determine which Eligible Employees shall be
Participants in the Plan for a given Performance Period. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b) All Eligible Employees who are employed by the
Company as of January&nbsp;1 of a Performance Period and who are selected by the Company or the Committee, as applicable, to be Participants in the Plan shall participate in the Plan for such Performance Period. In addition, Eligible Employees who
are newly hired by the Company after January&nbsp;1 of a Performance Period, but prior to October&nbsp;1 of such Performance Period, and who are selected by the Company or the Committee, as applicable, to be Participants in the Plan shall
participate in the Plan for such Performance Period. An Eligible Employee who is hired by the Company on or after October&nbsp;1 of a Performance Period shall not participate in the Plan for such Performance Period. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c) A Participant who is participating in the Plan for a Performance Period and who is subsequently promoted to a higher
position may be assigned an increased Target Bonus if such promotion becomes effective prior to October&nbsp;1 of the Performance Period (subject to the terms of the Plan), but may not be assigned an increased Target Bonus if such promotion becomes
effective on or after October&nbsp;1 of the Performance Period. Except as otherwise provided in this Plan, any Eligible Employee participating in the Plan during a Performance Period who ceases to be an Eligible Employee during such Performance
Period shall cease to participate in the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d) Each Bonus Opportunity shall be subject to such terms and
conditions as the Committee shall establish, which shall include the amount of the Bonus to be paid based upon the attainment of one or more performance objectives (each, a &#147;<I>Performance Objective</I>&#148;). For any Bonus that is intended to
be QPBC, each Performance Objective under the corresponding Bonus Opportunity shall be based on one or more of the following business criteria (the &#147;<I>Business Criteria</I>&#148;) with respect to (i)&nbsp;Integra, (ii)&nbsp;Integra&#146;s
worldwide operations, regional operations, country specific operations and/or subsidiaries, business units, affiliates, corporations, divisions, groups, functions or employees and/or (iii)&nbsp;Integra&#146;s brands, groups of brands or specific
brands: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">1. Asset turnover; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">2. Capacity utilization; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">3. Cash flow; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">4. Cost improvements; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">5. Costs or expenses; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">6. Customer retention; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">7. Customer satisfaction and/or growth;
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">8. Diversity; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">9. Earnings before interest, taxes, depreciation and amortization; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10. Adjusted earnings before interest, taxes, depreciation and amortization;
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">11. Earnings per share; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">12. Adjusted earnings per share; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">13. Economic value or economic value added; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">14. Employee
engagement; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">15. Environmental health and safety; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">16. Financial and other capital-raising transactions; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">17. Free cash flow; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">18. Gross or net profit; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">19. Gross or net sales; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">20. Implementation or completion of critical projects; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">21. Increase in customer base; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">22. Inventory turnover; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">23. Market price appreciation of Shares;
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">24. Market share; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">25. Mergers and acquisition integration; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">26. Net income margin;
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">27. Net income or adjusted net income; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">28. Operating cash flow; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">29. Operating earnings; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">30. Operating profit margin; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">31. Operating profit; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">32. <FONT STYLE="white-space:nowrap">Pre-tax</FONT> income; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">33.
Price per Share; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">34. Profitability growth; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">35. Profitability; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">36. Quality; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">37. Recruiting and maintaining personnel;
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">38. Regulatory body approval for commercialization of a product; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">39. Research and development achievements; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">40. Return on assets; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">41. Return on capital; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">42. Return on equity; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">43. Return on investment before or after the cost of capital; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">44. Return on net assets; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">45. Return on sales; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">46. Revenue growth; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">47. Revenue (including gross revenue or net revenue); </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">48. Sales growth; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">49. Sales margin; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">50. Sales-related goals; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">51. Stock price appreciation; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">52. Total stockholder return; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">53. Working capital; and
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">54. <FONT STYLE="white-space:nowrap">Year-end</FONT> cash; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">any of which may be measured either in absolute terms or as compared to any incremental increase or decrease or as compared to results of
other companies or to market performance indicators or indices. For any Bonus that is not intended to be QPBC, the Performance Objectives under the corresponding Bonus Opportunity may be based upon any of the foregoing Business Criteria and/or upon
other standards, including, without limitation, individual performance goals and personal contributions to the Company&#146;s business. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>3.2</B><B><I> Determination of Bonus Opportunity</I></B>. Subject to the terms of the Plan (including the provisions applicable to QPBC set forth in Sections&nbsp;4.4 and 4.5 hereof), the Committee
shall have authority to determine the amount of the Bonus Opportunity granted to each Participant, including threshold, target and maximum amounts. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>3.3</B> <B><I>Determination of Bonus Amounts</I></B>. Subject to Section&nbsp;3.2 above, the Committee may, in the case of a Participant who is not an executive officer of the Company or a Covered
Employee, increase the amount of any Bonus that is not intended to be QPBC by up to 100% of the amount that would otherwise be paid based upon the established terms of the Bonus Opportunity, and, in the case of any Participant, may reduce the amount
of any Bonus paid by an amount equal to or less than the Bonus amount that would otherwise be paid, in each case, based on the Committee&#146;s assessment of the individual Participant&#146;s performance for the applicable Performance Period.
Notwithstanding the foregoing, in no event shall the amount of a Bonus for an executive officer exceed 200% of such executive officer&#146;s Target Bonus. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>3.4</B><B><I> Maximum Bonus</I></B>. The maximum Bonus payable to any Participant under the Plan with respect to any calendar year shall be $3,000,000. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Article&nbsp;IV </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Section&nbsp;162(m) Bonuses </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.1</B><B><I> QPBC</I></B>. The Committee,
in its discretion, may determine whether any Bonus is intended to be QPBC, and may take such actions which it may deem necessary to ensure that such Bonus will so qualify. The Committee, in its sole discretion, may grant Bonus Opportunities to
Eligible Employees that are based on Business Criteria but that do not satisfy the requirements of this Article&nbsp;IV and that are not intended to qualify as QPBC. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>4.2</B><B><I> Performance Objectives</I></B>. With respect to any Bonus that the Committee determines should be QPBC: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a) the Performance Objectives shall be established in writing by the Committee not later than 90&nbsp;days after the
commencement of the applicable Performance Period or any designated fiscal period or period of service (or such earlier time as may be required under Code Section&nbsp;162(m)) to which the Performance Objectives relate, provided that the outcome is
substantially uncertain at the time the Committee actually establishes the performance targets;<I>&nbsp;provided</I>,<I>&nbsp;further</I>, that in no event shall the Performance Objectives be established after 25% of the period of service (as
scheduled in good faith at the time the Performance Objectives are established) has elapsed; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b) within the period described in Section&nbsp;4.2(a) above, the Committee
shall, in writing, (i)&nbsp;designate the Participants to whom such Bonus Opportunity is awarded, (ii)&nbsp;select the Business Criteria applicable to the Performance Period, (iii)&nbsp;establish the Performance Objectives for the applicable
Business Criteria, and the Bonus Opportunity for such Performance Period based on the Business Criteria and (iv)&nbsp;specify the relationship between Business Criteria and the Performance Objectives and the amounts of the Bonus to be earned by each
Covered Employee for such Performance Period; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c) before the Bonus is paid to the applicable Participant, the
Committee must certify in writing (which may take the form of a certification in minutes of the Committee or a resolution) that the Performance Objectives and any other material terms were satisfied; and </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d) the Performance Objectives must be based on an objective formula or standard. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.3</B><B><I> Compliance with Code Section</I></B><B><I></I></B><B><I>&nbsp;162(m)</I></B>. Performance Objectives relating to a Bonus
intended to be QPBC shall be drafted and implemented in a manner consistent with Code Section&nbsp;162(m). Furthermore, notwithstanding any other provision of the Plan, Bonuses that are intended to be QPBC shall be subject to any additional
limitations set forth in Code Section&nbsp;162(m) or any regulations or rulings promulgated thereunder that are requirements for qualification as QPBC, and the Plan shall be deemed amended to the extent necessary to conform to such requirements.
With respect to any Bonus intended to be QPBC, the provisions of this Article&nbsp;IV shall control over any contrary provision contained in the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>4.4</B><B><I> Payment of QPBC</I></B>. Unless otherwise provided by the Committee and only to the extent otherwise permitted by Code Section&nbsp;162(m), with respect to each Bonus that is intended to
qualify as QPBC, (a)&nbsp;the Participant must be employed by the Company throughout the Performance Period and (b)&nbsp;the Participant shall be eligible to receive payment of the Bonus for the Performance Period only if and to the extent that the
Performance Objectives for such period are achieved, contingent on funding. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.5</B><B><I> Limited Discretion</I></B>. Once
a Bonus Opportunity is established pursuant to Section&nbsp;4.2 hereof for a Bonus that is intended to be QPBC, the Committee shall not have any discretion to increase it based upon the established terms of the Bonus Opportunity or to modify the
applicable Performance Objectives (other than pursuant to automatic objectively determinable adjustments established at the time the Performance Objectives were established), to the extent the existence or exercise of such discretion is inconsistent
with the requirements for QPBC. In determining the amount of any Bonus that is intended to be QPBC, the Committee shall have the right to reduce (but not to increase) the amount of the Bonus that is derived solely based on the attainment of the
applicable Performance Objectives, to take into account additional factors that the Committee may deem relevant to the assessment of individual or corporate performance. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>4.6</B><B><I> Stockholder Approval</I></B>. Notwithstanding any provision in the Plan to the contrary, no Bonuses intended to be QPBC shall be paid under the Plan unless and until the stockholders of
Integra approve the Plan and the Business Criteria as required by Code Section&nbsp;162(m). So long as the Plan shall not have been previously terminated by Integra, to the extent Integra determines that the Bonus relating to any Bonus Opportunity
established under the Plan more than five years after Integra stockholders&#146; initial approval of the Plan shall continue to be intended to be QPBC, the Plan and the Business Criteria shall be resubmitted for approval of the stockholders of
Integra no later than the fifth year after it shall have first been approved by the stockholders of Integra and every fifth year thereafter. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Article&nbsp;V </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Payment of Benefits </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.1</B><B><I> Form of Payment</I></B>. Bonuses under the Plan may be paid in cash or its equivalent, as determined by the Committee in
its sole discretion. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.2</B><B><I> Designation of Beneficiary/ Death</I></B>: In the event a Participant dies during a
Performance Period, the Company will pay the Participant&#146;s Bonus with respect to such Performance Period to the Participant&#146;s surviving spouse or, if the Participant does not have a surviving spouse, to the Participant&#146;s estate, in an
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
amount equal to the Participant&#146;s Target Bonus with respect to such Performance Period, <FONT STYLE="white-space:nowrap">pro-rated</FONT> to reflect the number of days during the Performance
Period during which the Participant was employed by the Company. Such Bonus shall be paid within 60 days following the Participant&#146;s termination of employment due to death. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.3</B><B><I> Payees under Legal Disability</I></B>. If the Committee reasonably believes that any payee is legally incapable of giving
a valid receipt and discharge for any payment due him or her, the Committee may have the payment (if any) made to the person (or persons or institution) whom it reasonably believes is caring for or supporting such payee. Any such payment shall be a
payment for the benefit of the payee and shall be a complete discharge of any liability under the Plan to the payee. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.4</B><B><I> Payment of Bonuses</I></B>. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(a) Unless otherwise directed by the Committee, each Bonus shall be paid no later than the fifteenth day of the third month following the end of the calendar year in which the Bonus is no longer subject
to a &#147;substantial risk of forfeiture&#148; (within the meaning of Code Section&nbsp;409A). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b) Subject to
Section&nbsp;5.2 hereof, unless otherwise specifically determined by the Committee or otherwise provided for in an employment or severance agreement with Integra, a Participant shall be eligible for payment of a Bonus under the Plan only if the
Participant is an active employee of Integra, or is on a medical, family or military leave of absence, on the date of payment. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(c) All payments under the Plan shall be directly deposited into the Participant&#146;s designated payroll deposit account, delivered in person or mailed to the last address of the Participant (or, in the
case of the death of the Participant, to that of his or her surviving spouse or, if there is no surviving spouse, to the address of his or her estate). Each Participant shall be responsible for furnishing Integra with his or her current address and
the address of his or her spouse, if any. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.5</B><B><I> No Entitlement to Bonuses</I></B>. Nothing contained in the Plan
shall confer upon any person any claim or right to a Bonus with respect to any year or Performance Period, and whether the Company pays a Participant a Bonus and the amount of any such Bonus shall be determined by the Company in its sole and
absolute discretion, subject to the terms and conditions of the Plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Article&nbsp;VI </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Plan Administration </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>6.1</B><B><I> Committee</I></B>. Authority to administer the Plan shall be vested in a committee (the &#147;Committee&#148;) designated by the Board, consisting of at least two members, all of whom are
Outside Directors; <I>provided</I>, that any action taken by the Committee shall be valid and effective, whether or not members of the Committee at the time of such action are later determined not to have satisfied the requirements for membership
set forth in this Section&nbsp;6.1 or otherwise provided in any charter of the Committee. As of the Effective Date, the Compensation Committee of the Board shall serve as the Committee. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.2</B><B><I> Administrative Powers</I></B>. The Committee shall have all powers necessary to administer the Plan. In addition to any
powers and authority conferred on the Committee elsewhere in the Plan or by law, the Committee shall have the following powers and discretionary authority: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(a) To designate agents to carry out responsibilities relating to the Plan; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(b) To administer, interpret, and answer all questions which may arise under this Plan; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(c) To establish rules and procedures for the conduct of its business and for the administration of the Plan; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(d) To select and engage consultants, accountants, attorneys or other professionals or experts to render service or advice with regard to any responsibility the Committee has under the Plan, and (with
Integra, its Board and its officers) to rely upon the advice or opinions of any such persons, to the extent permitted by law, being fully protected in acting and relying thereon in good faith; and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(e) To perform or cause to be performed such further acts as it may deem
necessary or appropriate in the administration of the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All determinations and actions by the Committee relating to the
Plan will be binding upon all parties, to the maximum extent permitted by law. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.3</B> <B><I>Delegation of
Authority</I></B>. To the extent permitted by applicable law, the Board or the Committee may from time to time delegate to a committee of one or more members of the Board or one or more officers of Integra the authority to grant or amend Bonuses or
Bonus Opportunities, or to take other administrative actions pursuant to this Article&nbsp;6;<I>&nbsp;provided</I>,<I>&nbsp;however</I>, that in no event shall an officer of Integra be delegated the authority to grant Bonuses to, or amend Bonus
Opportunities held by, the following individuals: (a)&nbsp;individuals who are subject to Section&nbsp;16 of the Exchange Act, (b)&nbsp;Covered Employees with respect to Bonuses intended to constitute QPBC, or (c)&nbsp;officers of Integra to whom
authority has been delegated hereunder;<I>&nbsp;provided further</I>, that any delegation of administrative authority shall only be permitted to the extent it is permissible under Code Section&nbsp;162(m) and other applicable law. Any delegation
hereunder shall be subject to the restrictions and limits that the Board or Committee specifies at the time of such delegation, and the Board may at any time rescind the authority so delegated or appoint a new delegate. At all times, the delegate
appointed under this Section&nbsp;6.3 shall serve in such capacity at the pleasure of the Board and the Committee. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.4</B><B><I> Indemnification</I></B>. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(a) To the maximum extent permitted by law, Integra shall indemnify each member of the Committee and of the Board against expenses (including any amount paid in settlement) reasonably incurred by him or
her in connection with any claims against him or her by reason of the performance of his or her duties under the Plan. This indemnity shall not apply if the individual: (i)&nbsp;acted fraudulently or in bad faith in the performance of his or her
duties; or (ii)&nbsp;fails to assist Integra in defending against the claim. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b) Integra shall have the right
to select counsel and to control the prosecution or defense of the suit. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c) Integra shall not be required to
indemnify any person for any amount incurred through settlement of any action unless Integra consents in writing to the settlement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Article&nbsp;VII </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Miscellaneous Matters </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.1</B><B><I> Amendment and Termination</I></B>. Integra reserves the right to amend, modify, or terminate the Plan at any time by
action of the Board or the Committee. Notwithstanding the foregoing, no amendment of the Plan or with respect to a Bonus Opportunity may be made that would constitute a modification of the material terms of a &#147;performance goal&#148; (as
described in Treasury Regulation <FONT STYLE="white-space:nowrap">section&nbsp;1.162-27(e)(2)</FONT> or any successor thereto). </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.2</B><B><I> Clawback</I></B>. Notwithstanding anything contained in the Plan to the contrary, to the extent allowed under applicable
law or regulatory filings or unless otherwise determined by the Committee, all Bonuses granted under the Plan and any related payments made under the Plan shall be subject to the provisions of any clawback, repayment or recapture policy implemented
by Integra, including any such policy adopted to comply with applicable law (including, without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act) or securities exchange listing standards and any rules or regulations
promulgated thereunder, to the extent set forth in such policy and/or in any notice or agreement relating to a Bonus or payment under the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>7.3</B><B><I> Benefits Not Alienable</I></B>. Benefits under the Plan may not be assigned or alienated, whether voluntarily or involuntarily. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.4</B><B><I> No Enlargement of Employee Rights</I></B>. Nothing contained in the Plan shall be deemed to give a participant the right
to be retained in the employ of the Company or to interfere with the right of the Company to discharge any Participant at any time. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.5</B><B><I> Governing Law</I></B>. The Plan shall be governed by, and construed in
accordance with, the laws of the State of Delaware. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.6</B> <B><I>Code
Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B><B>.</B> Integra intends that the Bonuses under the Plan shall be exempt from Code Section&nbsp;409A as short-term deferrals and shall not constitute &#147;deferred compensation&#148; within the
meaning of Code Section&nbsp;409A. The Plan shall be interpreted, construed and administered in accordance with the foregoing intent, so as to avoid the imposition of taxes and penalties on Participants pursuant to Code Section&nbsp;409A. Integra
shall have no liability to any Participant, any Participant&#146;s spouse or otherwise if the Plan or any amounts paid or payable hereunder are subject to the additional tax and penalties under Code Section&nbsp;409A. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A&nbsp;-&nbsp;9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_30"></A>APPENDIX B </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INTEGRA LIFESCIENCES HOLDINGS CORPORATION FOURTH AMENDED AND RESTATED 2003 EQUITY INCENTIVE PLAN </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(EFFECTIVE AS OF May&nbsp;23, 2017) </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">WHEREAS, Integra LifeSciences Holdings Corporation (the &#147;Company&#148;) desires to have the ability to award certain equity-based benefits to certain &#147;Key Employees&#148; and
&#147;Associates&#148; (as defined below); </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOW, THEREFORE, the Integra LifeSciences Holdings Corporation Fourth Amended and
Restated 2003 Equity Incentive Plan is hereby adopted under the following terms and conditions. This Plan amends and restates in its entirety the Integra LifeSciences Holdings Corporation Third Amended and Restated 2003 Equity Incentive Plan, as
amended, which was initially adopted by the Board on March&nbsp;29, 2017 and approved by the Company&#146;s stockholders as of May&nbsp;23, 2017. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>1)</I> <I>Purpose. </I>The Plan is intended to provide a means whereby the Company may grant ISOs to Key Employees and may grant NQSOs, Restricted Stock, Stock Appreciation Rights, Performance Stock,
Contract Stock, Dividend Equivalent Rights, Stock Payments and Other Incentive Awards to Key Employees and Associates. Thereby, the Company expects to attract and retain such Key Employees and Associates and to motivate them to exercise their best
efforts on behalf of the Company and any Related Corporations and Affiliates. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>2) Definitions</I> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Affiliate&#148;</I> shall mean an entity in which the Company or a Related Corporation has a 50&nbsp;percent or greater equity
interest<I>.</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Associate&#148; </I>shall mean a designated non-employee director, consultant or other person
providing services to the Company, a Related Corporation or an Affiliate. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Award&#148; </I>shall mean any award
granted under the Plan to a Participant pursuant to any terms and conditions established by the Committee in the Award Agreement. Awards granted under the Plan my include: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">1. Stock Options, both Incentive (ISOs) and <FONT STYLE="white-space:nowrap">Non-qualified</FONT> (NQSOs) per section 7.1; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">2. Stock Appreciation Rights per section 7.2; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">3. Restricted Stock per section
7.3; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">4. Performance Stock per section 7.4; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">5. Contract Stock per section 7.5; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">6. Dividend Equivalent Rights per section 7.6;
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">7. Stock Payments per section 7.7; and/or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">8. Other Incentive Awards per section 7.8. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Award Agreement&#148;
</I>shall mean the document issued, either in writing or an electronic medium, by the Committee to a participant evidencing the grant of an Award, as described in Section&nbsp;10.1. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Board&#148; </I>shall mean the Board of Directors of the Company. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<I>Cause</I>&#148; shall mean, with respect to any Participant, &#147;Cause&#148; as defined in such Participant&#146;s employment
agreement or severance agreement with the Company if such an agreement exists and contains a definition of Cause or, if no such agreement exists or such agreement does not contain a definition of Cause, then Cause shall mean (i)&nbsp;the
Participant&#146;s neglect of duties or responsibilities that he or she is required to perform for the Company or any willful failure by the Participant to obey a lawful direction of the Board or the Company; (ii)&nbsp;the Participant&#146;s
engaging in any act of dishonesty, fraud, embezzlement, misrepresentation or other act of moral turpitude; (iii)&nbsp;the Participant&#146;s knowing violation of any federal or state law or regulation applicable to the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 1
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Company&#146;s business; (iv)&nbsp;the Participant&#146;s material breach of any confidentiality, <FONT STYLE="white-space:nowrap">non-compete</FONT> agreement or invention assignment agreement
or any other material agreement between the Participant and the Company; (v)&nbsp;the Participant&#146;s conviction of, or plea of nolo contendere to, any felony or crime of moral turpitude which conviction or plea is materially and demonstrably
injurious to the Company or any of its subsidiaries; (vi)&nbsp;failure by the Participant to comply with the Company&#146;s material written policies or rules; or (vii)&nbsp;the Participant&#146;s act or omission in the course of his or her
employment which constitutes gross negligence or willful misconduct. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Change in Control&#148; </I>shall mean:
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">i)&nbsp;An acquisition (other than directly from the Company) of any voting securities of the Company (&#147;Voting
Securities&#148;) by any &#147;Person&#148; (as such term is used for purposes of section&nbsp;13(d) or 14(d) of the Exchange Act) immediately after which such Person has &#147;Beneficial Ownership&#148; (within the meaning of <FONT
STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> promulgated under the Exchange Act) of 50&nbsp;percent or more of the combined voting power of all the then outstanding Voting Securities, other than the Company, any trustee or other fiduciary
holding securities under any employee benefit plan of the Company or an affiliate thereof, or any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the
Company; provided, however, that any acquisition from the Company or any acquisition pursuant to a transaction which complies with paragraph (iii)(A) and (B)&nbsp;below shall not be a Change in Control under this paragraph (i); </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">ii)&nbsp;The individuals who, as of March&nbsp;1, 2003, are members of the Board (the &#147;Incumbent Board&#148;) cease for any reason to
constitute at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the Board; provided, however, that if the election, or nomination for election by the stockholders, of any new director was approved by a vote of at least <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the members of the Board who constitute Incumbent Board members, such new directors shall for all purposes be considered as members of the Incumbent Board as of March&nbsp;1, 2003, provided further,
however, that no individual shall be considered a member of the Incumbent Board if such individual initially assumed office as a result of either an actual or threatened &#147;Election Contest&#148; (as described in
<FONT STYLE="white-space:nowrap">Rule&nbsp;14a-11</FONT> promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board of Directors (a &#147;Proxy
Contest&#148;) including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">iii)&nbsp;consummation by the Company of a reorganization, merger, or consolidation or sale or other disposition of all or substantially
all of the assets of the Company or the acquisition of assets or stock of another entity (a &#147;Business Combination&#148;), unless immediately following such Business Combination: (A)&nbsp;more than 50&nbsp;percent of the combined voting power of
the then outstanding voting securities entitled to vote generally in the election of directors of (I)&nbsp;the corporation resulting from such Business Combination (the &#147;Surviving Corporation&#148;), or (II)&nbsp;if applicable, a corporation
which as a result of such transaction owns the Company or all or substantially all of the Company&#146;s assets either directly or through one or more subsidiaries (the &#147;Parent Corporation&#148;), is represented, directly or indirectly, by
Company Voting Securities outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination), and such voting power
among the holders thereof is in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the Company Voting Securities; and (B)&nbsp;at least a majority of the members of the board of directors of the
Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) were members of the Incumbent Board at the time of the execution of the initial agreement, or the action of the Board, providing for such Business Combination;
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">iv)&nbsp;approval by the stockholders of the Company of a complete liquidation or dissolution of the Company;&nbsp;or
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">v)&nbsp;acceptance by the stockholders of the Company of shares in a share exchange if the stockholders of the Company
immediately before such share exchange do not own, directly or indirectly, immediately following such share exchange more than 50&nbsp;percent of the combined voting power of the outstanding Voting Securities of the corporation resulting from such
share exchange in substantially the same proportion as their ownership of the Voting Securities outstanding immediately before such share exchange. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Code&#148; </I>shall mean the Internal Revenue Code of 1986, as amended. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 2
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<I>Committee&#148; </I>shall mean the Company&#146;s Compensation Committee of the
Board, which shall consist solely of not fewer than two directors of the Company who shall be appointed by, and serve at the pleasure of, the Board (taking into consideration the rules under section&nbsp;16(b) of the Exchange Act and the
requirements of section&nbsp;162(m) of the Code). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<I>Company&#148; </I>shall mean Integra LifeSciences Holdings
Corporation, a Delaware corporation. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Contract Date&#148; </I>shall mean the date specified in the Award Agreement on
which a Participant is entitled to receive Contract Stock. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<I>Contract Stock&#148; </I>shall mean an Award that entitles
the recipient to receive unrestricted Shares, without payment, as of a future date specified in the Award Agreement pursuant to section 7.5. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Disability&#148; </I>shall mean separation from service as a result of &#147;permanent and total disability,&#148; as defined in section 22(e)(3) of the Code. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Dividend Equivalent Right&#148; </I>shall mean an Award that a Participant could receive in lieu of a cash dividend that would
have been payable on any or all Shares subject to another Award granted to the Participant had such Shares been outstanding. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Exchange Act&#148; </I>shall mean the Securities Exchange Act of 1934, as amended. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Exercise Price&#148;</I> shall mean the price of a Share, as fixed by the Committee, which may be purchased under an Option or
with respect to which the amount of any payment pursuant to a Stock Appreciation Right is determined. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Fair Market
Value&#148; </I>shall mean the following, arrived at by a good faith determination of the Committee: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">i)&nbsp;if there are
sales of Shares on a national securities exchange or in an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the date of grant (or on such other date as value must be determined), then the
quoted closing price on such date;&nbsp;or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">ii)&nbsp;if there are no such sales of Shares on the date of grant (or on such
other date as value must be determined), then the quoted closing price on the last preceding date for which such quotation exists;&nbsp;or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">iii) if the Shares are not listed on an established securities exchange or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market system on the date of
grant, but the Shares are regularly quoted by a recognized securities dealer, then the mean of the high bid and low asked prices for such date or, if there are no high bid and low asked prices for a Share on such date, the high bid and low asked
prices for a Share on the last preceding date for which such information exists;&nbsp;or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">iv)&nbsp;if paragraphs
(i)&nbsp;through (iii)&nbsp;above are not applicable, then such other method of determining fair market value as shall be adopted by the Committee. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#147;<I>Good Reason</I>&#148; shall mean, with respect to any Participant, &#147;Good Reason&#148; as defined in an employment, severance or applicable award agreement between such Participant and the
Company if such an agreement exists and contains a definition of Good Reason or, if no such agreement exists or such agreement does not contain a definition of Good Reason, then Good Reason shall mean, without the express written consent of the
Participant, the occurrence of any of the following: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(i) a material diminution in the Participant&#146;s authority, duties or
responsibilities or the assignment of duties to the Participant that are materially inconsistent with the Participant&#146;s position with the Company; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(ii) a material reduction in the Participant&#146;s base salary; or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(iii) a
change in the geographic location at which the Participant must perform services to a location more than fifty miles from the location at which the Participant normally performs such services as of the date of grant of the award, provided, that the
Participant&#146;s resignation shall only constitute a resignation for Good Reason if (x)&nbsp;the Participant provides the Company with a notice of termination for Good Reason within thirty days after the initial existence of the facts or
circumstances constituting Good Reason, (y)&nbsp;the Company has failed to cure such facts or circumstances within thirty days after receipt of the notice of termination, and (z)&nbsp;the date of termination occurs no later than sixty days after the
initial occurrence of the facts or circumstances constituting Good Reason. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 3
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Incentive Stock Option (ISO)&#148; </I>shall mean an Option which, at the time such
Option is granted under the Plan, qualifies as an incentive stock option within the meaning of section&nbsp;422 of the Code, unless the Award Agreement states that the Option will not be treated as an ISO pursuant to section 7.1. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Key Employee&#148; </I>shall mean an officer, executive, or managerial or <FONT STYLE="white-space:nowrap">non-managerial</FONT>
employee of the Company, a Related Corporation, or an Affiliate. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><FONT STYLE="white-space:nowrap">&#147;Non-qualified</FONT> Stock Option (NQSO)&#148; </I>shall mean an Option that, at the time such
Option is granted to a Participant, does not meet the definition of an ISO, whether or not it is designated as a nonqualified stock option in the Award Agreement pursuant to section 7.1. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Option&#148; </I>is an Award entitling the Participant on exercise thereof to purchase Shares at a specified exercise price.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<I>Other Incentive Award</I>&#148; is an Award denominated in, linked to or derived from Shares or value metrics related
to Shares, granted pursuant to Section&nbsp;7.8 hereof. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Participant&#148; </I>shall mean a Key Employee or Associate
who has been granted an Award under the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Performance Stock&#148; </I>shall mean an Award that entitles the
recipient to receive Shares, without payment, following the attainment of designated Performance Goals pursuant to section 7.4. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Performance Goals&#148; </I>shall mean goals deemed by the Committee to be important to the success of the Company or any of its
Related Corporations or Affiliates. The Committee shall establish the specific measures for each such goal at the time an Award of Performance Stock is granted. In creating these measures, the Committee shall use one or more of the following
business criteria with respect to (A)&nbsp;the Company, any of its Related Corporations or Affiliates, (B)&nbsp;the Company&#146;s, a Related Corporation&#146;s or an Affiliate&#146;s worldwide operations, regional operations, country specific
operations and/or subsidiaries, business units, affiliates, corporations, divisions, groups, functions or employees and/or (C)&nbsp;the Company&#146;s, a Related Corporation&#146;s or an Affiliate&#146;s brands, groups of brands or specific brands:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Asset turnover; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Capacity utilization; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cost improvements; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Costs or expenses; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Customer retention; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Customer satisfaction and/or growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Diversity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings before interest, taxes, depreciation and amortization; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted earnings before interest, taxes, depreciation and amortization; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Earnings per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adjusted earnings per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Economic value or economic value added; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Employee satisfaction; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Environmental health and safety; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Financial and other capital-raising transactions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Free cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gross or net profit; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 4
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gross or net sales; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Implementation or completion of critical projects; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Increase in customer base; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inventory turnover; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Market price appreciation of Shares; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Market share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mergers and acquisition integration; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net income or adjusted net income; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating cash flow; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating earnings; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating profit margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operating profit; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Pre-tax</FONT> income; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Price per Share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Profitability growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Profitability; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Quality; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Recruiting and maintaining personnel; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regulatory body approval for commercialization of a product; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development achievements; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on capital; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on equity; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on investment before or after the cost of capital; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on net assets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Return on sales; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Revenue (including gross revenue or net revenue); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales growth; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales margin; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sales-related goals; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock price appreciation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total stockholder return; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Working capital; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="white-space:nowrap">Year-end</FONT> cash; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 5
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The business criteria may be expressed in absolute terms or as compared to any incremental
increase or decrease or as compared to results of other companies or to market performance indicators or indices. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Plan&#148; </I>shall mean the Integra LifeSciences Holdings Corporation Fourth Amended and Restated 2003 Equity Incentive Plan,
as set forth herein and as it may be amended from time to time. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<I>Qualifying Termination</I>&#148; shall mean a
termination of a Participant&#146;s service (i)&nbsp;by the Company without Cause or (ii)&nbsp;by the Participant for Good Reason as defined here or in an employment, severance, or applicable award agreement that contains a definition of Good
Reason. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Related Corporation&#148; </I>shall mean either a &#147;subsidiary corporation&#148; of the Company (if any),
as defined in section&nbsp;424(f) of the Code, or the &#147;parent corporation&#148; of the Company (if any), as defined in section&nbsp;424(e) of the Code. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Restricted Stock&#148; </I>shall mean an Award that grants the recipient Shares at no cost but subject to whatever restrictions are determined by the Committee pursuant to section 7.3.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Securities Act&#148; </I>shall mean the Securities Act of 1933, as amended. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Shares&#148; </I>shall mean shares of common stock of the Company. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>&#147;Stock Appreciation Right&#148; </I>shall mean an Award entitling the recipient on exercise to receive an amount, in cash or
Shares or a combination thereof (such form to be determined by the Committee), determined in whole or in part by reference to appreciation in Share value pursuant to section 7.2. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;<I>Stock Payment</I>&#148; shall mean a payment in the form of Shares awarded under Section&nbsp;7.7 hereof. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">3. <I>Administration</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">a)&nbsp;The Plan shall be administered by the Committee. Each member of the Committee, while serving as such, shall be deemed to be acting in his or her capacity as a director of the Company. Acts
approved by a majority of the members of the Committee at which a quorum is present, or acts without a meeting reduced to or approved in writing by a majority of the members of the Committee, shall be the valid acts of the Committee. Any authority
of the Committee may be delegated either by the Committee or the Board to a committee of the Board or any other Plan administrator, but only to the extent such delegation complies with the requirements of section 162(m) of the Code, <FONT
STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> promulgated under the Exchange Act or as required by any other applicable rule or regulation. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">b)&nbsp;The Committee shall have the authority: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">i)&nbsp;to select the Key
Employees and Associates to be granted Awards under the Plan and to grant such Awards at such time or times as it may choose; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">ii)&nbsp;to determine the type and size of each Award, including the number of Shares subject to the Award; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">iii)&nbsp;to determine the terms and conditions of each Award; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">iv)&nbsp;to amend an existing Award in whole or in part (including the extension of the exercise period for any NQSO), subject to the requirements set forth in subsection (c)&nbsp;below, and except that,
without the consent of the Participant holding the Award, the Committee shall not take any action under this clause if such action would adversely affect the rights of such Participant; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">v)&nbsp;to adopt, amend and rescind rules and regulations for the administration of the Plan; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">vi)&nbsp;to interpret the Plan and decide any questions and settle any controversies that may arise in connection with it;&nbsp;and
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">vii)&nbsp;to adopt such modifications, amendments, procedures, <FONT STYLE="white-space:nowrap">sub-plans</FONT> and the like,
which may be inconsistent with the provisions of the Plan, as may be necessary to comply with the laws and regulations of other countries in which the Company and its Related Corporations and Affiliates operate in order to assure the viability of
Awards granted under the Plan to individuals in such other countries. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Such determinations and actions of the Committee, and
all other determinations and actions of the Committee made or taken under authority granted by any provision of the Plan, shall be conclusive and shall bind </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 6
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
all parties. Nothing in this subsection&nbsp;(b) shall be construed as limiting the power of the Board or the Committee to make the adjustments described in Sections&nbsp;8.3 and 8.4. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">c) Except as provided in Sections 8.3 or 8.4, the terms of outstanding Awards may not be amended to reduce the exercise price of
outstanding Options or Stock Appreciation Rights or cancel outstanding Options or Stock Appreciation Rights in exchange for cash, other Awards or Options or Stock Appreciation Rights with an exercise price that is less than the exercise price of the
original Options or Stock Appreciation Rights without stockholder approval. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">4. <I>Effective Date and Term of Plan</I>
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a)<I>&nbsp;Effective Date. </I>This Fourth Amended and Restated 2003 Equity Incentive Plan, having been adopted by the Board
on March&nbsp;29, 2017, is subject to the approval of the stockholders of the Company in accordance with Section&nbsp;9(b), and shall become effective on the date on which such approval is obtained. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">b)<I>&nbsp;Term of Plan. </I>No Awards may be granted or awarded during any period of suspension or after termination
of the Plan, and in no event may any Award be granted under the Plan after the tenth (10</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">) anniversary of the date of its adoption (the &#147;Expiration Date&#148;). Any Awards that are outstanding on the Expiration Date, or the date of termination of the Plan (if earlier), shall remain in
force according to the terms of the Plan and the applicable Award Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>5. </I><I>Shares Subject to the Plan. </I>The
aggregate number of Shares that may be delivered under the Plan is 14,700,000. The maximum number of Shares which may be granted as ISOs is 14,700,000. Further, no Key Employee shall receive Awards for more than 1,000,000&nbsp;Shares in the
aggregate during any calendar year under the Plan. However, the limits in the preceding sentences shall be subject to the adjustment described in Sections&nbsp;8.3 and 8.4. Shares delivered under the Plan may be authorized but unissued Shares,
treasury Shares or reacquired Shares, and the Company may purchase Shares required for this purpose, from time to time, if it deems such purchase to be advisable. Any Shares still subject to an Option which expires or otherwise terminates for any
reason whatsoever (including, without limitation, the surrender thereof) without having been exercised in full, any Shares that are still subject to an Award that is forfeited, any Shares withheld for the payment of taxes with respect to an Award,
and the Shares subject to an Award which is payable in Shares or cash and that is satisfied in cash rather than in Shares shall continue to be available for Awards under the Plan. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>6. Eligibility. </I>The class of individuals who shall be eligible to receive Awards under the Plan shall be the Key Employees
(including any directors of the Company who are also officers or Key Employees) and the Associates. More than one Award may be granted to a Key Employee or Associate under the Plan. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">7. <I>Types of Awards</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">7.1 <I>Options</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a)<I>&nbsp;Kinds of Options. </I>Both ISOs and NQSOs may be
granted by the Committee under the Plan. However, ISOs may only be granted to Key Employees of the Company or of a Related Corporation. NQSOs may be granted to both Key Employees and Associates. Once an ISO has been granted, no action by the
Committee that would cause the Option to lose its status as an ISO under the Code will be effective without the consent of the Participant holding the Option. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">b)<I>&nbsp;$100,000 Limit. </I>The aggregate Fair Market Value of the Shares with respect to which ISOs are exercisable for the first time by a Key Employee during any calendar year (counting ISOs under
this Plan and under any other stock option plan of the Company or a Related Corporation) shall not exceed $100,000. If an Option intended as an ISO is granted to a Key Employee and the Option may not be treated in whole or in part as an ISO pursuant
to the $100,000 limit, the Option shall be treated as an ISO to the extent it may be so treated under the limit and as an NQSO as to the remainder. For purposes of determining whether an ISO would cause the limit to be exceeded, ISOs shall be taken
into account in the order granted. The annual limits set forth above for ISOs shall not apply to NQSOs. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 7
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">c)<I>&nbsp;Exercise Price. </I>The exercise price of an Option shall be determined by the
Committee, subject to the following: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">i)&nbsp;The exercise price of an ISO shall not be less than the greater of
(A)&nbsp;100&nbsp;percent (110&nbsp;percent in the case of an ISO granted to a Participant who owns more than 10&nbsp;percent of the total combined voting power of all classes of stock of the Company or any Subsidiary, as defined in Code
Section&nbsp;424) of the Fair Market Value of the Shares subject to the Option, determined as of the time the Option is granted, or (B)&nbsp;the par value per Share. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">ii)&nbsp;The exercise price of an NQSO shall not be less than the greater of (A)&nbsp;100&nbsp;percent of the Fair Market Value of the Shares subject to the Option, determined as of the time the Option is
granted, or (B)&nbsp;the par value per Share. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">d)<I>&nbsp;Term of Options. </I>The term of each Option may not be more than
10&nbsp;years (five years, in the case of an ISO granted to a Participant who owns more than 10&nbsp;percent of the total combined voting power of all classes of stock of the Company or any Subsidiary, as defined in Code Section&nbsp;424) from the
date the Option was granted, or such earlier date as may be specified in the Award Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">e)<I>&nbsp;Exercise of Options.
</I>An Option shall become exercisable at such time or times (but not less than 1 year from the date of grant), and on such conditions, as the Committee may specify. The Committee may at any time and from time to time accelerate the time at which
all or any part of the Option may be exercised. Any exercise of an Option must be in writing, signed by the proper person, and delivered or mailed to the Company or initiated and executed in any other form that is approved by the Company or a
designated third-party administrator, accompanied by (i)&nbsp;any other documents required by the Committee and (ii)&nbsp;payment in full in accordance with subsection&nbsp;(f) below for the number of Shares for which the Option is exercised (except
that, in the case of an exercise arrangement approved by the Committee and described in subsection (f)(iii) or subsection (f)(iv) below, payment may be made as soon as practicable after the exercise) or in any other format that is approved by the
Company or a designated third-party administrator. Only full shares shall be issued under the Plan, and any fractional share that might otherwise be issuable upon exercise of an Option granted hereunder shall be forfeited. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">f)<I>&nbsp;Payment for Shares. </I>Shares purchased on the exercise of an Option shall be paid for as follows: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">i)&nbsp;in cash or by check (acceptable to the Committee), bank draft, or money order payable to the order of the Company; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">ii)&nbsp;in Shares previously acquired by the Participant; provided, however, that if such Shares were acquired through the exercise of an
NQSO and are used to pay the Option price of an ISO, or if such Shares were acquired through the exercise of an ISO or an NQSO and are used to pay the Option price of an NQSO, such Shares have been held by the Participant for such period of time, if
any, as required to avoid negative accounting consequences; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">iii)&nbsp;by delivering a properly executed notice of exercise of
the Option to the Company and a broker, with irrevocable instructions to the broker promptly to deliver to the Company the amount of sale or loan proceeds necessary to pay the exercise price of the Option;&nbsp;or </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">iv) to the extent that the applicable Award Agreement so provides or the Committee otherwise determines, in Shares issuable pursuant to
the exercise of an NQSO or otherwise withheld in a net settlement of an NQSO; or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">v)&nbsp;by any combination of the
above-listed forms of payment. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event the Option price is paid, in whole or in part, with Shares, the portion of the
Option price so paid shall be equal to the Fair Market Value on the date of exercise of the Option of the Shares surrendered or withheld in payment of such Option price. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">7.2. <I>Stock Appreciation Rights</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a)<I>&nbsp;Grant of Stock Appreciation
Rights. </I>Stock Appreciation Rights may be granted to a Key Employee or Associate by the Committee. Stock Appreciation Rights may be granted in tandem with, or independently of, Options granted under the Plan. A Stock Appreciation Right granted in
tandem with an Option that is not an ISO may be granted either at or after the time the Option is granted. A Stock Appreciation Right granted in tandem </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 8
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
with an ISO may be granted only at the time the ISO is granted. The exercise price of a Stock Appreciation Right shall not be less than the greater of (A)&nbsp;100&nbsp;percent of the Fair Market
Value of the Shares subject to the Stock Appreciation Right, determined as of the time the Stock Appreciation Right is granted, or (B)&nbsp;the par value per Share. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">b)<I>&nbsp;Nature of Stock Appreciation Rights. </I>A Stock Appreciation Right entitles the Participant to receive, with respect to each Share as to which the Stock Appreciation Right is exercised, the
excess of the Share&#146;s Fair Market Value on the date of exercise over its Fair Market Value on the date the Stock Appreciation Right was granted. Such excess shall be paid in cash, Shares, or a combination thereof, as determined by the
Committee. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">c)<I>&nbsp;Rules</I><I></I><I>&nbsp;Applicable to Tandem Awards. </I>When Stock Appreciation Rights are granted in
tandem with Options, the number of Stock Appreciation Rights granted to a Participant that shall be exercisable during a specified period shall not exceed the number of Shares that the Participant may purchase upon the exercise of the related Option
during such period. Upon the exercise of an Option, the Stock Appreciation Right relating to the Shares covered by such Option will terminate. Upon the exercise of a Stock Appreciation Right, the related Option will terminate to the extent of an
equal number of Shares. The Stock Appreciation Right will be exercisable only at such time or times, and to the extent, that the related Option is exercisable and will be exercisable in accordance with the procedure required for exercise of the
related Option. The Stock Appreciation Right will be transferable only when the related Option is transferable, and under the same conditions. A Stock Appreciation Right granted in tandem with an ISO may be exercised only when the Fair Market Value
of the Shares subject to the ISO exceeds the exercise price of such ISO. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">d)<I>&nbsp;Exercise of Independent Stock Appreciation
Rights. </I>A Stock Appreciation Right not granted in tandem with an Option shall become exercisable at such time or times, and on such conditions, as the Committee may specify in the Award Agreement. The Committee may at any time accelerate the
time at which all or any part of the Stock Appreciation Right may be exercised. Any exercise of an independent Stock Appreciation Right must be in writing, signed by the proper person, and delivered or mailed to the Company, accompanied by any other
documents required by the Committee. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">e)<I>&nbsp;Term of Stock Appreciation Rights. </I>The term of each Stock Appreciation
Right may not be more than 10&nbsp;years from the date the Stock Appreciation Right was granted, or such earlier date as may be specified in the Award Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">7.3. <I>Restricted Stock</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a)<I>&nbsp;General Requirements. </I>Restricted
Stock may be issued or transferred to a Key Employee or Associate (for no cash consideration), to the extent permitted by applicable law. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">b)<I>&nbsp;Rights as a Stockholder. </I>Unless the Committee determines otherwise, a Key Employee or Associate who receives Restricted Stock shall have certain rights of a stockholder with respect to the
Restricted Stock, including voting and dividend rights, subject to the restrictions described in subsection&nbsp;(c) below and any other conditions imposed by the Committee at the time of grant. Unless the Committee determines otherwise,
certificates evidencing shares of Restricted Stock will remain in the possession of the Company until such Shares are free of all restrictions under the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">c)<I>&nbsp;Restrictions. </I>Except as otherwise specifically provided by the Plan, Restricted Stock may not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of, and if the
Participant ceases to provide services to any of the Company and its Related Corporations and Affiliates for any reason, must be forfeited to the Company. These restrictions will lapse at such time or times, and on such conditions, as the Committee
may specify in the Award Agreement (but no less than 1 year from the date of grant). Upon the lapse of all restrictions, the Shares will cease to be Restricted Stock for purposes of the Plan. The Committee may at any time accelerate the time at
which the restrictions on all or any part of the Shares will lapse. d)<I>&nbsp;Notice of Tax Election. </I>Any Participant making an election under section&nbsp;83(b) of the Code for the immediate recognition of income attributable to an Award of
Restricted Stock must provide a copy thereof to the Company within 10&nbsp;days of the filing of such election with the Internal Revenue Service. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">7.4. <I>Performance Stock; Performance Goals</I> </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 9
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a)<I>&nbsp;Grant. </I>The Committee may grant Performance Stock to any Key Employee or
Associate, conditioned upon the meeting of designated Performance Goals. The Committee shall determine the number of Shares of Performance Stock to be granted. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">b)<I>&nbsp;Performance Period and Performance Goals. </I>When Performance Stock is granted, the Committee shall establish the performance period during which performance shall be measured, the Performance
Goals, and such other conditions of the Award as the Committee deems appropriate. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">c)<I>&nbsp;Delivery of Performance Stock.
</I>At the end of each performance period, the Committee shall determine to what extent the Performance Goals and other conditions of the Award have been met and the number of Shares, if any, to be delivered with respect to the Award. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.5<I>. Contract Stock</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">a)<I>&nbsp;Grant. </I>The Committee may grant Contract Stock to any Key Employee or Associate, conditioned upon the Participant&#146;s continued provision of services to the Company and its Related
Corporations and Affiliates through the vesting date(s) specified in the Award Agreement. The Committee shall determine the number of Shares of Contract Stock to be granted. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">b)<I>&nbsp;Contract Date. </I>When Contract Stock is granted, the Committee shall establish the Contract Date on which the Contract Stock shall be delivered to the Participant. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">c)<I>&nbsp;Delivery of Contract Stock. </I>To the extent that the Participant has satisfied the vesting conditions as of the Contract
Date, the Committee shall cause the Contract Stock to be delivered to the Participant in accordance with the terms of the Award Agreement. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">7.6. <I>Dividend Equivalent Rights. </I>The Committee may provide for payment to a Key Employee or Associate of Dividend Equivalent Rights, either currently or in the future, or for the investment of such
Dividend Equivalent Rights on behalf of the Participant; provided, however, that (i)&nbsp;Dividends or Dividend Equivalent Rights may not be granted to Participants in connection with grants of Options or Stock Appreciation Rights and
(ii)&nbsp;except to the extent otherwise provided in Award Agreements entered into prior to April&nbsp;1, 2009, (a) any dividends payable with respect to an Award prior to vesting of such Award instead shall be paid out to the Participant only to
the extent that the applicable vesting conditions are subsequently satisfied and the Award vests, and any dividends payable with respect to the portion of an Award that does not vest shall be forfeited, and (b)&nbsp;Dividend Equivalent Right
payments with respect to an Award shall be paid out to the Participant only to the extent that the applicable vesting conditions are subsequently satisfied and the Award vests, and Dividend Equivalent Right payments with respect to the portion of an
Award that does not vest shall be forfeited. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.7 <I>Stock Payments</I>.<I> </I>The Committee is authorized to make one or more
Stock Payments to any Key Employee or Associate. The number or value of Shares of any Stock Payment shall be determined by the Committee and may be based upon one or more Performance Goals or any other specific criteria, including service to the
Company or any Related Corporation, determined by the Committee. Stock Payments may, but are not required to be made in lieu of base salary, bonus, fees or other cash compensation otherwise payable to such Key Employee or Associate. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.8 <I>Other Incentive Awards</I>.<I> </I>The Committee is authorized to grant Other Incentive Awards to any Key Employee or Associate,
which Awards may cover Shares or the right to purchase or receive Shares or have a value derived from the value of, or an exercise or conversion privilege at a price related to, or that are otherwise payable in or based on, Shares, shareholder value
or shareholder return, in each case, on a specified date or dates or over any period or periods determined by the Committee. Other Incentive Awards may be linked to any one or more of the Performance Goals or other specific performance criteria
determined appropriate by the Committee. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">8. <I>Events Affecting Outstanding Awards</I> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.1. <I>Termination of Service (Other Than by Death or Disability).</I> If a Participant ceases to provide services to the Company and its
Related Corporations and Affiliates for any reason other than death or Disability, as the case may be, the following shall apply: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">a)&nbsp;Except as otherwise determined by the Committee, all Options and Stock Appreciation Rights held by the Participant that were not exercisable immediately prior to the Participant&#146;s termination
of service shall terminate </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 10
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
at that time. Any Options or Stock Appreciation Rights that were exercisable immediately prior to the termination of service will continue to be exercisable for six months (or for such longer
period as the Committee may determine), and shall thereupon terminate, unless the Award Agreement provides by its terms for immediate termination or for termination in less than six months in the event of termination of service. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In no event, however, shall an Option or Stock Appreciation Right remain exercisable beyond the latest date on which it could have been
exercised without regard to this Section. For purposes of this subsection (a), a termination of service shall not be deemed to have resulted by reason of a sick leave or other bona fide leave of absence approved for purposes of the Plan by the
Committee. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">b)&nbsp;Except as otherwise determined by the Committee, all Restricted Stock held by the Participant at the time
of the termination of service must be transferred to the Company (and, in the event the certificates representing such Restricted Stock are held by the Company, such Restricted Stock shall be so transferred without any further action by the
Participant), in accordance with Section&nbsp;7.3. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">c)&nbsp;Except as otherwise determined by the Committee, all Performance
Stock, Other Incentive Awards, Contract Stock, and Dividend Equivalent Rights to which the Participant was not irrevocably entitled prior to the termination of service shall be forfeited and the Awards canceled as of the date of such termination of
service. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.2. <I>Death or Disability. </I>If a Participant dies or incurs a Disability, the following shall apply: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a)&nbsp;Except as otherwise determined by the Committee, all Options and Stock Appreciation Rights held by the Participant immediately
prior to death or Disability, as the case may be, to the extent then exercisable, may be exercised by the Participant or by the Participant&#146;s legal representative (in the case of Disability), or by the Participant&#146;s executor or
administrator or by the person or persons to whom the Option or Stock Appreciation Right is transferred by will or the laws of descent and distribution, at any time within the <FONT STYLE="white-space:nowrap">one-year</FONT> period ending with the
first anniversary of the Participant&#146;s death or Disability (or such shorter or longer period as the Committee may determine), and shall thereupon terminate. In no event, however, shall an Option or Stock Appreciation Right remain exercisable
beyond the latest date on which it could have been exercised without regard to this Section. Notwithstanding the foregoing, except as otherwise determined by the Committee, in the event of a Participant&#146;s death or Disability, all outstanding
Options and Stock Appreciation Rights held by a Participant (other than Participants in France) immediately prior to such death or Disability shall vest and become exercisable in full. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">b)&nbsp;Except as otherwise determined by the Committee, all Restricted Stock held by the Participant at the date of death or Disability,
as the case may be, must be transferred to the Company (and, in the event the certificates representing such Restricted Stock are held by the Company, such Restricted Stock shall be so transferred without any further action by the Participant), in
accordance with Section&nbsp;7.3. Notwithstanding the foregoing, except as otherwise determined by the Committee, in the event of a Participant&#146;s death or Disability, all restrictions on such Participant&#146;s Restricted Stock granted on or
after May&nbsp;17, 2012 (other than Restricted Stock granted to Participants in France) shall lapse and such Restricted Stock shall become vested Shares. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">c)&nbsp;Except as otherwise determined by the Committee, all Performance Stock, Other Incentive Awards, Contract Stock, and Dividend Equivalent Rights to which the Participant was not irrevocably entitled
prior to death or Disability, as the case may be, shall be forfeited and the Awards canceled as of the date of death or Disability. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">8.3. <I>Capital Adjustments. </I>The maximum number of Shares that may be delivered under the Plan, and the maximum number of Shares with respect to which Awards may be granted to any Key Employee or
Associate under the Plan, both as stated in Section&nbsp;5, and the number of Shares issuable upon the exercise or vesting of outstanding Awards under the Plan (as well as the exercise price per Share under outstanding Options or Stock Appreciation
Rights), shall be proportionately adjusted, as may be deemed appropriate by the Committee, to reflect any increase or decrease in the number of issued Shares resulting from a subdivision (share-split), consolidation (reverse split), stock dividend,
or similar change in the capitalization of the Company. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.4. <I>Certain Corporate Transactions</I> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a)&nbsp;In the event of a corporate transaction (as, for example, a merger, consolidation, acquisition of property or stock, separation,
reorganization, or liquidation), each outstanding Award shall be assumed by the surviving or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 11
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
successor entity; provided, however, that in the event of a proposed corporate transaction, the Committee may terminate all or a portion of any outstanding Award, effective upon the closing of
the corporate transaction, if it determines that such termination is in the best interests of the Company. If the Committee decides to terminate outstanding Options or Stock Appreciation Rights, the Committee shall give each Participant holding an
Option or Stock Appreciation Right to be terminated not less than seven days&#146; notice prior to any such termination, and any Option or Stock Appreciation Right that is to be so terminated may be exercised (if and only to the extent that it is
then exercisable) up to, and including the date immediately preceding such termination. Further, subject to Section&nbsp;8.6 below, the Committee, in its discretion, may (i)&nbsp;accelerate, in whole or in part, the date on which any or all Options
and Stock Appreciation Rights become exercisable, (ii)&nbsp;remove the restrictions from outstanding Restricted Stock, (iii)&nbsp;cause the delivery of any Performance Stock, even if the associated Performance Goals have not been met,
(iv)&nbsp;cause the delivery of any Contract Stock, even if the Contract Date has not been reached, and/or Other Incentive Awards; and/or (v)&nbsp;cause the payment of any Dividend Equivalent Rights. The Committee also may, in its discretion, change
the terms of any outstanding Award to reflect any such corporate transaction, provided that, in the case of ISOs, such change would not constitute a &#147;modification&#148; under section&nbsp;424(h) of the Code, unless the Participant consents to
the change. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">b)&nbsp;With respect to an outstanding Award held by a Participant who, following the corporate transaction, will
be employed by or otherwise providing services to an entity which is a surviving or acquiring entity in such transaction or an affiliate of such an entity, the Committee may, in lieu of the action described in subsection&nbsp;(a) above, arrange to
have such surviving or acquiring entity or affiliate grant to the Participant a replacement award which, in the judgment of the Committee, is substantially equivalent to the Award. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.5<I>.</I><I></I><I>&nbsp;Change in Control</I>.<I> </I>Notwithstanding any other provision of this Plan and subject to Section&nbsp;8.6
below: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a) To the extent allowed under applicable law or regulatory filings or unless otherwise determined by the Committee, in
the event that a Change in Control occurs and the Participant incurs a Qualifying Termination on or within twelve (12)&nbsp;months following the date of such Change in Control, each outstanding Award held by a Participant, other than any Award
subject to performance-vesting, shall become fully vested (and, as applicable, exercisable) and all forfeiture restrictions thereon shall lapse upon such Qualifying Termination.&#148; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">b) Notwithstanding the foregoing, if a Change in Control constitutes a payment event with respect to any Award which provides for the
deferral of compensation and is subject to section 409A of the Code, the Change in Control with respect to such Award must also constitute a &#147;change in control event,&#148; as defined in Treasury Regulation &#167;
<FONT STYLE="white-space:nowrap">1.409A-3(i)(5)</FONT> to the extent required by section 409A. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.6.
<I>Section</I><I></I><I>&nbsp;162(m); Section</I><I></I><I>&nbsp;409A. </I>With respect to Awards which are intended to qualify as &#147;performance-based compensation&#148; as described in section 162(m)(4)(C) of the Code, no adjustment or action
described in this Section&nbsp;8 or in any other provision of the Plan shall be authorized to the extent that such adjustment or action would cause such Award to fail to so qualify as performance-based compensation, unless the Committee determines
that the Award should not so qualify. No action shall be taken under this Section&nbsp;8 which shall cause an Award to fail to comply with section 409A of the Code or the Treasury Regulations thereunder, to the extent applicable to such Award.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">9. <I>Amendment or Termination of the Plan</I> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">a)<I>&nbsp;In General. </I>The Board, pursuant to a written resolution, may from time to time suspend or terminate the Plan or amend it and, except as provided in Section&nbsp;3(b)(iv), 7.1(a), and
8.4(a), the Committee may amend any outstanding Awards in any respect whatsoever; except that, without the approval of the stockholders (given in the manner set forth in subsection&nbsp;(b) below): </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">i)&nbsp;no amendment may be made that would: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(A)&nbsp;change the class of employees eligible to participate in the Plan with respect to ISOs; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(B)&nbsp;except as permitted under Section&nbsp;8.3, increase the maximum number of Shares with respect to which ISOs may be granted under the Plan; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(C)&nbsp;increase the limits imposed in Section&nbsp;5 on the maximum number of Shares which may be issued or transferred under the Plan
or increase the individual Key Employee award limit set forth in Section&nbsp;5; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 12
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(D)&nbsp;extend the duration of the Plan under Section&nbsp;4(b) with respect to any ISOs
granted hereunder;&nbsp;or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(E)&nbsp;reprice or regrant through cancellation, or modify (except in connection with a change in
the Company&#146;s capitalization) any Award, if the effect would be to reduce the exercise price for the shares underlying such Award; provided, however, with the approval of the Company&#146;s stockholders, the Committee may (i)&nbsp;reduce the
exercise price per share of any outstanding Option or Stock Appreciation Right granted under the Plan, or (ii)&nbsp;cancel any Option or Stock Appreciation Right in exchange for cash or another Award when the Option or Stock Appreciation Right
exercise price per share exceeds the Fair Market Value of the underlying Shares. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">ii)&nbsp;no amendment may be made that would
constitute a modification of the material terms of the &#147;performance goal(s)&#148; within the meaning of Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;&nbsp;1.162-27(e)(4)(vi)</FONT> or any successor thereto (to the extent compliance with
section&nbsp;162(m) of the Code is desired). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding the foregoing, no such suspension, termination or amendment shall
materially impair the rights of any Participant holding an outstanding Award without the consent of such Participant. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">b)<I>&nbsp;Manner of Stockholder Approval. </I>The approval of stockholders must be effected by a majority of the votes cast (including
abstentions, to the extent abstentions are counted as voting under applicable state law) in a separate vote at a duly held stockholders&#146; meeting at which a quorum representing a majority of all outstanding voting stock is, either in person or
by proxy, present and voting on the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10. <I>Miscellaneous</I> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.1. <I>Documentation of Awards. </I>Awards shall be evidenced by such written Award Agreements, if any, as may be prescribed by the
Committee from time to time. Such instruments may be in the form of agreements to be executed by both the Participant and the Company, or certificates, letters, or similar instruments, which need not be executed by the Participant but acceptance of
which will evidence agreement to the terms thereof. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.2. <I>Rights as a Stockholder. </I>Except as specifically provided by
the Plan or an Award Agreement, the receipt of an Award shall not give a Participant rights as a stockholder; instead, the Participant shall obtain such rights, subject to any limitations imposed by the Plan or the Award Agreement, upon the actual
receipt of Shares. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.3. <I>Conditions on Delivery of Shares. </I>The Company shall not deliver any Shares pursuant to the
Plan or remove restrictions from Shares previously delivered under the Plan (i)&nbsp;until all conditions of the Award have been satisfied or removed, (ii)&nbsp;until all applicable Federal and state laws and regulations have been complied with, and
(iii)&nbsp;if the outstanding Shares are at the time of such delivery listed on any stock exchange, until the Shares to be delivered have been listed or authorized to be listed on such exchange. If an Award is exercised by the Participant&#146;s
legal representative, the Company will be under no obligation to deliver Shares pursuant to such exercise until the Company is satisfied as to the authority of such representative. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.4. <I>Registration and Listing of Shares. </I>If the Company shall deem it necessary to register under the Securities Act or any other
applicable statute any Shares purchased under this Plan, or to qualify any such Shares for an exemption from any such statutes, the Company shall take such action at its own expense. If Shares are listed on any national securities exchange at the
time any Shares are purchased hereunder, the Company shall make prompt application for the listing on such national securities exchange of such Shares, at its own expense. Purchases and grants of Shares hereunder shall be postponed as necessary
pending any such action. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.5. <I>Compliance with Rule</I><I></I><I><FONT STYLE="white-space:nowrap">&nbsp;16b-3.</FONT></I>
All elections and transactions under this Plan by persons subject to <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3,</FONT> promulgated under section&nbsp;16(b) of the Exchange Act, or any successor to such Rule, are intended to comply with at
least one of the exemptive conditions under such Rule. The Committee shall establish such administrative guidelines to facilitate compliance with at least one such exemptive condition under <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> as
the Committee may deem necessary or appropriate. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.6.<I>&nbsp;Tax Withholding</I> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">a) <I>Obligation to Withhold. </I>The Company shall withhold from any cash payment made pursuant to an Award an amount sufficient to
satisfy all Federal, state, and local withholding tax requirements (the &#147;Withholding Requirements&#148;). In the case of an Award pursuant to which Shares may be delivered, the Committee may require that the Participant or other appropriate
person remit to the Company an amount sufficient to satisfy the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 13
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Withholding Requirements, or make other arrangements satisfactory to the Committee with regard to the Withholding Requirements, prior to the delivery of any Shares. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">b) <I>Election to Withhold Shares. </I>The Committee, in its discretion, may permit or require the Participant to satisfy the federal,
state, and/or local withholding tax, in whole or in part, by having the Company withhold Shares otherwise issuable under an Award (or by surrendering Shares to the Company); provided, however, that the number of Shares withheld shall have a Fair
Market Value on the date of withholding no greater than the aggregate amount of such liabilities based on the maximum individual statutory Withholding Requirements for the applicable jurisdiction. In addition, the Committee, in its discretion, may
permit or require the acceleration of the timing for the payment of the number of Shares needed to pay employment taxes upon the date of the vesting of an Award; provided, however, that the Company may limit the number of Shares used for this
purpose to the extent necessary to avoid adverse accounting consequences. Shares shall be valued, for purposes of this subsection (b), at their fair market value (determined as of the date an amount is includible in income by the Participant (the
&#147;Determination Date&#148;), rather than the date of grant). Notwithstanding the foregoing, in no event shall any Participant be permitted to elect such accelerated payment to the extent that it would result in a violation of Treasury Regulation
&#167; <FONT STYLE="white-space:nowrap">1.409A-3(j)</FONT> (including, without limitation, Treasury Regulation &#167; <FONT STYLE="white-space:nowrap">1.409A-3(j)(4)(i)).</FONT> The Committee shall adopt such withholding rules as it deems necessary
to carry out the provisions of this Section. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.7. <I>Transferability of Awards. </I>No ISO may be transferred other than by
will or by the laws of descent and distribution. No other Award may be transferred, except to the extent permitted in the applicable Award Agreement. During a Participant&#146;s lifetime, an Award requiring exercise may be exercised only by the
Participant (or, in the event of the Participant&#146;s incapacity, by the person or persons legally appointed to act on the Participant&#146;s behalf). Notwithstanding the foregoing, any transfer of an Award otherwise permitted by this
Section&nbsp;10.7 shall be made only to a &#147;family member&#148; of the Participant within the meaning of the instructions to Form <FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statement under the Securities Act (a &#147;Permitted
Transferee&#148;). Notwithstanding the foregoing, in no event may an Award be transferable for consideration absent stockholder approval. Notwithstanding the foregoing, the Committee, in its sole discretion, may determine to permit a Participant or
a Permitted Transferee of such Participant to transfer an Award other than an ISO (unless such ISO is to become a <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option) to any one or more Permitted Transferees of such Participant,
subject to the following terms and conditions: (a)&nbsp;an Award transferred to a Permitted Transferee shall not be assignable or transferable by the Permitted Transferee (other than to another Permitted Transferee of the applicable Participant)
other than by will or the laws of descent and distribution; (b)&nbsp;an Award transferred to a Permitted Transferee shall continue to be subject to all the terms and conditions of the Award as applicable to the original Participant (other than the
ability to further transfer the Award); and (c)&nbsp;the Participant (or transferring Permitted Transferee) and the Permitted Transferee shall execute any and all documents requested by the Committee, including without limitation, documents to
(i)&nbsp;confirm the status of the transferee as a Permitted Transferee, (ii)&nbsp;satisfy any requirements for an exemption for the transfer under applicable federal, state and foreign securities laws and (iii)&nbsp;evidence the transfer. In
addition, and further notwithstanding the foregoing hereof, the Committee, in its sole discretion, may determine to permit a Participant to transfer ISOs to a trust that constitutes a Permitted Transferee if, under Section&nbsp;671 of the Code and
applicable state law, the Participant is considered the sole beneficial owner of the ISO while it is held in the trust. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.8.
<I>Registration. </I>If the Participant is married at the time Shares are delivered and if the Participant so requests at such time, the certificate or certificates for such Shares shall be registered in the name of the Participant and the
Participant&#146;s spouse, jointly, with right of survivorship. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.9. <I>Acquisitions. </I>Notwithstanding any other provision
of this Plan, Awards may be granted hereunder (without reducing the share limit in the first sentence of Section&nbsp;5) in substitution for awards held by directors, key employees, and associates of other corporations who are about to, or have,
become Key Employees or Associates as a result of a merger, consolidation, acquisition of assets, or similar transaction by the Company or a Related Corporation or (in the case of Awards other than ISOs) an Affiliate. The terms of the substitute
Awards so granted may vary from the terms set forth in this Plan to such extent as the Committee may deem appropriate to conform, in whole or in part, to the provisions of the awards in substitution for which they are granted. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 14
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.10. <I>Employment Rights. </I>Neither the adoption of the Plan nor the grant of Awards
will confer upon any person any right to continued employment by the Company or any of its Related Corporations or Affiliates or affect in any way the right of any of the foregoing to terminate an employment relationship at any time. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.11. <I>Indemnification of Board and Committee. </I>Without limiting any other rights of indemnification that they may have from the
Company or any of its Related Corporations or Affiliates, the members of the Board and the members of the Committee shall be indemnified by the Company against all costs and expenses reasonably incurred by them in connection with any claim, action,
suit or proceeding to which they or any of them may be a party by reason of any action taken or failure to act under, or in connection with, the Plan or any Award granted thereunder, and against all amounts paid by them in settlement thereof
(provided such settlement is approved by legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except a judgment based upon a finding of willful misconduct or recklessness on
their part. Upon the making or institution of any such claim, action, suit or proceeding, the Board or Committee member shall notify the Company in writing, giving the Company an opportunity, at its own expense, to handle and defend the same before
such Board or Committee member undertakes to handle it on his or her own behalf. The provisions of this Section shall not give members of the Board or the Committee greater rights than they would have under the Company&#146;s <FONT
STYLE="white-space:nowrap">by-laws</FONT> or Delaware law. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.12. <I>Application of Funds. </I>Any cash proceeds received by
the Company from the sale of Shares pursuant to Awards granted under the Plan shall be added to the general funds of the Company. Any Shares received in payment for additional Shares upon exercise of an Option shall become treasury stock.
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.13. <I>Governing Law. </I>The Plan shall be governed by the applicable Code provisions to the maximum extent possible.
Otherwise, the laws of the State of Delaware (without reference to the principles of conflict of laws) shall govern the operation of, and the rights of Participants under, the Plan and Awards granted hereunder. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.14. <I>Clawback, Repayment or Recapture Policy</I>. Notwithstanding anything contained in the Plan to the contrary, to the extent
allowed under applicable law or regulatory filings or unless otherwise determined by the Committee, all Awards granted under the Plan on or after January&nbsp;1, 2013, and any related payments made under the Plan after such date, shall be subject to
the provisions of any clawback, repayment or recapture policy implemented by the Company, including any such policy adopted to comply with applicable law (including without limitation the Dodd-Frank Wall Street Reform and Consumer Protection Act) or
securities exchange listing standards and any rules or regulations promulgated thereunder, to the extent set forth in such policy and/or in any notice or agreement relating to an Award or payment under the Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B - 15
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc333443_31"></A>APPENDIX C </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Reconciliations of <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Reconciliations of GAAP Net Income to EBITDA and Adjusted EBITDA </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><I>($ in thousands)</I></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2015</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>GAAP net income</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6,851</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>74,564</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> adjustments</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Depreciation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intangible asset amortization expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,235</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41,502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other (income) expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4,588</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">(845</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Interest (income) expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,504</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,779</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Income tax (benefit) expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,842</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Subtotal of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustments</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>131,989</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>113,441</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EBITDA</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>138,840</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>188,005</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Global ERP implementation charges</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,585</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Structural optimization charges</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,130</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,794</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Certain employee severance charges</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,642</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,446</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acquisition-related charges</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,814</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,898</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Post-spin SeaSpine separation-related charges</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustments</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>188,751</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>157,164</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Adjusted EBITDA</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>195,602</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>$</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>231,728</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">C&nbsp;-&nbsp;1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:120px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="28%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g333443g94x94.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Printed&nbsp;with</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Inks&nbsp;containing<BR>Soy and/or<BR>Vegetable
oils</FONT></P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="font-size:96pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:96pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-size:10pt">0</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-size:15pt">&#11035;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="97%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY CARD</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTEGRA LIFESCIENCES HOLDINGS CORPORATION</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>311 ENTERPRISE DRIVE</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLAINSBORO, NEW JERSEY 08536</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY - Annual Meeting of Stockholders - Tuesday, May&nbsp;23, 2017</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF
DIRECTORS</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">The undersigned hereby appoints Peter
J. Arduini and Glenn G. Coleman as proxies, each with the power to appoint his substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side hereof, all the shares of Common Stock of Integra LifeSciences Holdings
Corporation (the &#147;Company&#148;) held of record by the undersigned on March&nbsp;31, 2017 at the Annual Meeting of Stockholders to be held on Tuesday, May&nbsp;23, 2017 or at any adjournment or postponement thereof.</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman"><B>THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER
DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO DIRECTION IS MADE ON THIS PROXY WHEN PROPERLY EXECUTED, THIS PROXY WILL BE VOTED IN FAVOR OF PROPOSALS 2, 3, 4, AND 5; FOR &#147;1 YEAR&#148; ON PROPOSAL 6; FOR ALL NOMINEES LISTED FOR ELECTION
OF DIRECTORS UNDER PROPOSAL 1; AND IN ACCORDANCE WITH THE PROXIES&#146; JUDGMENT UPON OTHER MATTERS PROPERLY COMING BEFORE THE MEETING AND ANY ADJOURNMENT OR POSTPONEMENT THEREOF.</B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Continued and to be signed on the reverse side.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"><FONT STYLE="font-size:15pt">&#11035;</FONT><FONT STYLE="font-size:10pt">&nbsp;&nbsp;1.1</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-size:10pt">14475</FONT> &nbsp;&nbsp;<FONT STYLE="font-size:15pt">&#11035;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>ANNUAL MEETING OF STOCKHOLDERS OF </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>INTEGRA LIFESCIENCES HOLDINGS CORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>May&nbsp;23, 2017 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><U>NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIAL</U></B>:<B> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">The Notice of Meeting, proxy statement and proxy card </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">are available at http://investor.integralife.com/financials.cfm </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><U>Your vote is very important to us. </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Please sign, date and mail </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">your
proxy card in the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">envelope provided as soon </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">as possible. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="font-family:Times New Roman; font-size:12pt"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#105;</FONT></FONT><FONT STYLE="font-family:Times New Roman; font-size:8pt">&nbsp;&nbsp;Please detach along perforated line and mail in the envelope
provided.&nbsp;&nbsp;<B></B></FONT><FONT STYLE="font-family:Times New Roman; font-size:12pt"><FONT STYLE="FONT-FAMILY:'WINGDINGS 3'">&#105;</FONT></FONT><FONT STYLE="font-family:Times New Roman; font-size:8pt"> </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><FONT STYLE="font-size:14pt">&#11035;</FONT>
&nbsp;&nbsp;00033333333333334000&nbsp;&nbsp;&nbsp;&nbsp;6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">052317</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; ALL THE NOMINEES LISTED,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&#147;FOR&#148; PROPOSALS 2, 3, 4 AND 5, AND &#147;1 YEAR&#148; ON PROPOSAL 6.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE&nbsp;&nbsp;</B><FONT
STYLE="font-size:12pt"><B><FONT STYLE="font-size:8pt">&#9746;<B></B><B></B></FONT></B></FONT></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ROWSPAN="10"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">In their discretion, the Proxies are authorized, to the
extent permitted by the rules of the Securities and Exchange Commission, to vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">1.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">The Election of Directors:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">FOR</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">AGAINST</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">ABSTAIN</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Peter J. Arduini</P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Keith Bradley</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stuart M. Essig</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Barbara B. Hill</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lloyd W. Howell,
Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Donald E. Morel,
Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Raymond G.
Murphy</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Christian S.
Schade</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;James M.
Sullivan</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">2.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">The Proposal to ratify the appointment of PricewaterhouseCoopers LLP as
the Company&#146;s independent registered public accounting firm for the fiscal year 2017;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">3.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">The proposal to approve the Company&#146;s 2018 Performance Incentive
Compensation Plan.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">4.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">The proposal to approve the Fourth Amended and Restated 2003 Equity
Incentive Plan.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">5.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">A non-binding resolution to approve the compensation of our named
executive officers.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">6.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">A non-binding proposal on the frequency of the advisory vote on the
compensation of our named executive officers.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">1&nbsp;YEAR</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">2&nbsp;YEARS</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">3 YEARS</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">ABSTAIN</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the
registered name(s) on the account may not be submitted via this method.</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#9744;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="11" VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Signature&nbsp;of&nbsp;Stockholder&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Date:&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Signature&nbsp;of&nbsp;Stockholder&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Date:&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><FONT SIZE="1">&nbsp;</FONT></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:14pt">&#11035;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:8pt"><B>Note:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please
give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:14pt">&#11035;</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g333443g10q46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g10q46.jpg
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MM HD)C8E-#E#8G)X@8*2M;@H16-QA)&3Q/_$ !@! 0$! 0$
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MS$SEQ"!1QGD\S<W))7NO<AM$RLB@*M:J"XJ!+*33E.Y-RFDMUT9N,S<Q@R,
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M=&T /Q!&TS(P0O\ XM??W\/FQ=1ZKP(M53NIGR^;CB%!^V80>=%>W I_V'X
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M8<J^ES8;$W!<>4V1U173HN<7- XD/;>KVSF,Z):8:<>AD&TUQO3TDB1'P\O
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M^)4M='X^<CE#R][16+]=6!V6+ZZ(R?,:]U%RJIV:Z4]/TPDL8=44=?2_-UV
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M&_C\($?>_P [KC:=7J795$9*0WC?QXKK98J^H:F(*(GILH4.JZ$1D1>P_!L
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M_%:0P9!84W70R$QFT:OX]00BV6EY'3;<KF$A8UM-.Y)E>J8U$$SG$7*,-VK
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M0H]!75/LQ28#9NQ'KM!V(?W1PM[[VVRZ1Q:1C:59X'6WVIJ:4_X.E.#//NX
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MYF79?VK5_N)-G_<Z/]@_1>ZO^0_.[U;X/_G,QLO[5J_W";/^YT?[!^B]U?\
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MM).+7@>GCJE1X/N>'-Z^"[G?[WW?>[H.[NQCR]T9M_D_[6>UHU.YU.(P!@#
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ME6<3J, 8 P!@'GY[:O\ 56X>_O>\J_XR<5<W8QY>Z,V_R?\ :SVM&GW.IQ&
M, 8 P!@# & , H\A_P @/G^IW/\ Y(_(\'P?8'M+HG]1"F_WJJ\_BBT9P/02
MK@# & , UA=KS^LR=OWVZ._E-CV:L?F7/LR/!\'V/-IG8X# & , 8 P!@# &
M , ]*79$_K*(Q^^I?O\ +--<X/%\7W.ZP7!=C9MD*, 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8!KGY_?L3?P\_F;G3T\^7N<_4RY^QEG6[8L>N/M?M#<_
M.<67N=01! CDC*G8E;NQ*54.;B279M2R=FD,=4K4)@PJ4Q#XPO#4::6$"YM6
M)]F$#P\7Q?<W9P7!&(L<[-"G$\6C )5)+ 660VS^$VI(9E )B_4[&W271>T8
M=<;DSLU55BMC%9,$%?)S#TJD38"**Y(5M2?)5,I76&,R:&0UM._?SJL:W_%<
M5:4< V6W6=\0WI:\YEA5FL2-3>$6C".&16&SNRRZA?:8,G;=LF)'RN.^(0][
M1)VEF;Y$6W>/P>"NZ],I6))*&3BS112]X4QCIFSE>.SYBDE<)B_R:Y[:>91;
M;7+HI>SZ)+6" 5OU]-8U44,>(([MK=7B9KBS7J(TK%F!(XP=+'GM,F?9VN+<
M=/4C3.C,)/\ &[A_,Y';EG!5JN #P;>=GRZ6)K';XOY:H)'D$/CT!G[M!7:9
MNM?FA&"+&3%H30@N6MC4G,:9&VGR<BNH(XR(!JT,K#)PF,%%'G\Y<(*,[]G7
M%)'M]=)%>5SO$TFL#FM.V'.3BZM2O4RI.P8C64,D]:GHT%;IF)B)5M]2Q9V3
MRR.-39+T$E6RAR0.Z9$]%-+<$]YX/YV-AY999)99)0 EE% "666#6@@ 6 .@
M@ $.O,$(0ZT$.M>;6M:UK!")%,3BTDM24F2*-1]_&DK^N@)1O3,W.HTP#9':
M8C0IQ+DQ^R0F[+!LP)>PZ'L -BUO8==-2TE#B]]D9A-N5-R[LN/R6UEZ.H)Z
MHQ_V?DEU>K+"HM$/);67HZ@GJC'_ &?B75ZL0J+1'E9YV-#4Q\V^3K:RMC>S
MMQ,MK,1*!K1)F]$4([CI2IIHBTJ0HD@ C31B,,V$O6QF"$,746][WTL8/C[(
MQZBAV8^W_P!6C%C-G,8 P!@# & , 8 P"5*&0(7/D!QZ;W)&E<$"OD!2)*I$
MN3DJTBDD5HQ3O%*$R@!A)Q8NFNH# "#O[^LS:_*^7=&['YEPM?VL]?/DMK+T
M=03U1C_L_.4NKU9TA46B'DMK+T=03U1C_L_$NKU8A46B'DMK+T=03U1C_L_$
MNKU8A46B'DMK+T=03U1C_L_$NKU8A46B'DMK+T=03U1C_L_$NKU8A46B-"W;
M(1:,1JUN(WO<CC"P>.U[RE\<]Q&AO:O&_%I)Q:\7\9\13D>'\!X<_P #X7O^
M"\,;W.[X0?7=AMN]S=[HEM)6+E'XK/:T:F\Z'$8 P!@# & , 8 P"CR'_(#Y
M_J=S_P"2/R/!\'V![$Z-K&MCJ4IXTVO8.::;5M?&&&&1-A&888.)M AC&,2#
M8AC&+>Q"$+>Q"%O>][WO><9=7J=X5%H2EY+:R]'4$]48_P"S\2ZO5B%1:(>2
MVLO1U!/5&/\ L_$NKU8A46B'DMK+T=03U1C_ +/Q+J]6(5%HAY+:R]'4$]48
M_P"S\2ZO5B%1:(UI=K+!(.Q\/W)R98;%&=Q)MJD@DKVN.M#>M*"=93 4:$I4
MD1DGEA-*&,LS03-:&6(0!=0BWK>K+;M*6\^S(TDG"6#/._G4XC & , 8 P!@
M# & , ]$_9.0.#O?#6/.3U#(H[N)]IWP$]>Z1UH<%IVB;BF9)6C52M&:>9HH
MH "B]#,WH!8 @#T"'6M<6VFX;Q9V232E+!&R;R6UEZ.H)ZHQ_P!GY)=7JRPJ
M+1#R6UEZ.H)ZHQ_V?B75ZL0J+1%Z)4J9$F3HT:<A(C2$%)4B1*460F2IB"PE
M$)TY!00%$D$E "6446$)9980@ '0=:UJ%(WNTZ3)Z8MU1"O=;WY$5A/CHE[@
ME*#WSWS%11V&P^XI"0!BHYV]U0I/<XI,68H,6>! 2 1FPAV*L5.$FB/LT)+R
MQ=.4)".SE?,11!!TC8I[L&]$?(L$*!*"GRN QT1!UNI@1XF2>#-?0MH&XP#L
M8CVZZ)")(!5W=6MF[9YX^YE.TYVHRBZRJT,G(=R$Y3DTQQ?:XQ%+SU,6CCS5
M2"7$6-QHO!<_V=R/;":S9IU7]I2B;Q-H75W&]-;L[NJ^X'4Y"POC^N=WQ'.E
MY%;3"//&3<*7AC57*<M^[H4VQ^3G-6LV]$*1M;\H,M28'L,0)CU%.8I/#SVF
MP[])+CD2:/%Y*?,G=[J:N(9,W 3E'Y K2-)\GFR1N;8FX(QQ42[XU11U\*\F
M^<(K8OSC+2,M4N[\[JW26\''YDL?C-=%]01RLR"V);U)!OV52*'09DJ%=%H:
M=73C+G E&Z.4N]PH6J=Y MW"%[:I"$%B\L;GP<8[RRS+.YTERBRX?'64F-L3
M'9,4K&%%NU;7+8C^Q0)5RJINK(_:R.52"OVJ#6 D6<:WVPK;LE>NOFPWQN?"
MVA>M;XJFB5CH4XMV?1I9-Q&5]RN]CLR>P.?K0\RA>RJ%;NQ1]NY,OS2P[X^K
M%"N1^0BTZFCE218#RB<BA#5\@HC,[ ?3%J!O\9=&B'(%5=HFS;+)G9[$N[=5
M?EDRA<N5'(5CLKD(?1B^_99*)-QVLH$*W&8WR ;&2AIG%*.?Y%%E\'TH3*>+
MUU!LN7MK)%4C*B:%5ZQ.RI?M8VN4BC[4<UUV*HNFJS5]^J[<RH2_D%S+:G2<
M>3N*3J;FLK3* ,;').-$^9&DZNFWCXT3.'W<1)!M,7)EUK2&WU8(V[<>6=>U
M2?:9T70U/!XT_P &>Y(XA"[7\[U&Y9[J-%U5G,^0.^8["<:GM*3\?)[1]=-;
MM:4FI2;P=<KLF*R[E:I:HR]0%_8XT&L$3E'#V]TFEA>]U(4N=H_5#*>W1YKM
M6*&J NC?.5+N/>I2"YGS0CTSD:>/H9@HAS3<<S?QH9+6TBEJN71=^YCM<(31
MQHDBY4 UAB+31#T_2V/@8TQGN>@:F&3)5(8>S.S0^B7=%K%_6[F6A*>07.04
M'BRJ),KNAG+X]SD-B)YEQKO5'&JAFS2V+3816;,9!Z<M"06I5;NZ%&@>+0C#
M(Y(G9%'S"FBT8NX6'#2FT6%NURK>\=SCA3O6C/>=BACDAZ57-F!O=I9=3FD'
M7]'.;G):ZA]#<YZF@4/):@Z;G]SGI]S\:I'/9\2A''C7.;1^(%.$ 9C$^WH;
MJ%W'#.)E7Z,YF:S^=4+(112-U[([(4S61\C7B.RJ7PF2M!;)Y&+NON1DEV"H
M>U:5/%T')> '43#*?;2-,;2PC<99((DUD1ML0MC,$*L8=8PX7SCEO+H;IORP
MF_$B7OLU!*S)/Y7ZA)<P5=!;CK^Y2: .D5-K[^2,C!+ZGIR;FS9!&U]O$1I9
M5D86R0F, :&2#R217.R&.BH+IY534WQ[3/8MN!63R1:2%>H3!KC9JLA,1Y=S
MX\M\A=^6=8EP.];L_'$^FXO%Q<J'!JL:(JYLNGMOMK#!W<23<R>:W4*X<O;8
MWIQ4FA&]3=2%C3EA4IT8N_GP]-34O%&GI,FB:JP75?I=14T]TK2;6*YZ<8X@
MR*S9)"ZL=&,3U6,QL56<K:JUBSBXJ8HFDK6C):&!\(?0A77X])FDX7>^[-?B
M LM!15\G2W#()S(YPS7A?C$:NGL)/A*\,9:[;EJ>!A8P"86%#)HDJ@VHZZQR
M5L@75C<$#B%"W.ZDILVG2B/V7:_J0?S^_8F_AY_,W.GIY\O<Y>IES]C)5AG"
M>LN*K+9"MBD<H2U_Q];9LIC,.;?=F72)/%:Y)?3F*+,_AD^G61.Q: 2!D;MJ
M"-+7)0F3;.*T;WPXM8OBS=G!<$02DYPHD4/X]2=_CL#=_+W9K1633NM;PKB<
M)5CA)+(9*_;'&N2T+CI?:**,E2!-++0"S)VY3 8FQRQX6D*C6DEM60U#OW;G
M\624XR5&\^=<+H-[L$Z5P66N5:5&:!FLVQV14QG:CLR65"^W:V1M%%%:Y*[O
M9:F&-;*F4O"<U.G22*=1!N*3K4/OI=HL"3?S?' LY_[08B)+K'CTGH^7()?1
M33,IO?;(CED1<D4!JZ#P^G)^[S1D>2U)!<X6'1&[&)<WQM"C;#U2Z(6(U^Z)
M9S/&S)>$8;\-6O8D.]>;4-H&2RTF60Z2+:XJ])7IENV8VK&C:2#N%KG2)+!6
MY-&3U);W)/"K&-N)D:I"%,6R F43.1@? #DFHT"4\2+W[M$B8L*7LDAH2<H)
M_7-<S>])]""I5"UAS11%>PRL)M))HT/1*_W-?Y.4FMF.QI% R]HCELP:94C+
M?@QQN:Y2^"[.]7_SX-D1)Q2@DH\D83"3RP'%&!_2F%&!T,L8?_1$$6A:_%O!
MDBT<BC[':<K ]OK.SC4U_7(DX71S1-XCPER*U-&")"K/)V:$O8P:'L&A:#L0
M="Z=[774-I0IO?9&92;EQ<N[+H\H$#^6T1]9&;^VY(='HRRJK5#R@0/Y;1'U
MD9O[;B'1Z,2JK5'E/YX.3<[<WN3RYJ7HG)$;+*R"6L;U1"Q*8(OCG2A9F@*$
MQAA0]EF!$ >@CWL(P["+IO6]9TL8/C[(QZF-G_C_ .K1BKFSF, 8 P!@# &
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MO *\F3)T:<A(D()2I$I)29*E3% (3IDY  E$D$$E!"62226$)91180@+ $(
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M)+"6#6]\<:3WO>@ T$.NN][WOIKS[WUWG6QAS]D<_4QL_P#'_P!6C$W-G,8
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M9MMRP81HWN.QYT9UH=:%W#-I%QW@3@F$'=P\HPL/)J6\,7FEW.RN23G!9.G
MSM\I,=^+I]]%-H_4[)#W:KR)6_1^!Y28[\73[Z*;1^IV(>[5>1*WZ/P7NE4E
MK$R964$\!2H@E24!4E4H5(2SRPF@"I1+24ZQ&>$(M:.2JR"%*<S0BCR2S0#
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M]V<F\:9>N4J# )*2I4J%*F1(DY"1&C3DI4B1,4 A,E2IRPDD)TY!00EDD$%
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MHF\N V%(4LA=$ZD#K$<2.+R9B:8P1Q_J(J/,3X?(VEG# X[X@C>5+8TLBA8
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M , 8 P!@# & , 8 P#7/S^_8F_AY_,W.GIY\O<Y^IES]C,REOU'*F_>S@?\
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M1QQU?V) [.+"EET<.41Z5)F=6K.;R)(PJ#V9\*3A<VLXU"J(&(1E[8 P!@#
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M_/[]B;^'G\S<Z>GGR]SGZF7/V-4C+_D9I_U8@_Y4K.AS*G@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
0 ([GW_Y3_P#SO_\ CP#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g333443g14d64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g14d64.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 1@"! ,!$0 "$0$#$0'_Q  ?  $  @,  P$! 0          !P@&"0H#
M! 4" 0O_Q !2$   !00  P0'!08"!0D&!P " P0%!@ !!P@)$1(3%!48(3$X
M05=WE@H646&S(B,R4G*T<8$7)&)S@B4G,S1"572ALBA#8Y&3PS4Y1)2CL;;_
MQ  8 0$! 0$!                 0(#!/_$ #01 0 ! @((!@(" @,  P$
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M_D.;;];\9&V08BLEJ9$@R[F)K>3YP#[Q1N-,<?P["HX3)YX]2)0-QB[W(FU
MV*0V+$]O[FM2-[2UNCN$Y;=4133;VC5\OB:<\<31/=;+S?@6!/.3\:9;D;6:
M]P*&9TQ\=CU7DEH(1J'(Q9!7 IU?65V&)L2J7-(W*G)O=W-O3+%;6WK24"\:
M4315$7T3&J9B8FTY3;5_37AHKQT%>S?%ASWKE+5TJ3X1?3&S&^I\0:L5&M)B
M&0Q\+J\365Y;=SU"Q[;'-W3,ZI(B4N"\+  A.B3L[(WJ%BY2M-546HIJWZ<6
MF,XM;]Z]*T<U^T?<-Z%S"2L@5.P$P@$-F(X)*-@8+A1XD6!VF1$J@(U*?[Y
M<DSHYD%'&!$F4,L;<@/*49"Z/^+HEB)0I'E5Y1?*\7_"-MZMJ\G)>+/P8HIA
M;-\Q1:_[&-,RD\GCD-E;HB@&68VN0(W:*NSXT)3R4$@0G-BQ,L;#%R<SD0>
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M@F\I4O+"@2*6JX#27<399U3-B],N:%:@MY;7)O2"/#JJTZ(OJO,1?X37E;C
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MUJ$[<ZW7-\H:'9,W%K#=&'Q+TX,.B;51?1J[Y;W29M9Q6]:-)8;@U7L$3/\
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MOGHKMPDF%FM]FBXHBWPQ%=8Z W/5N*H2<H1ZQ0R:W0(3.8>;<-QF>&&)RSD
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M5]R^A]GJ2IT&Q/&U;T9):9"AX@LN2HTA  EITR<B<YG())(*!:P"BRR2BRP
M &P0@+ &UN0;6L/$U>'_ *0Z=Z.10*!0*!0*!0*!0*!0*!0*!0<ZO$Z]IPSY
M?Q/]5WKU^#L<9<:]J>'U#<WJ![,&#?EU'_[:O/XFW5\NE&S''[E8^L-% H%
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MK&,73U"O>X?*E$"@TXNT"FL+B<O%'W +LPBE$=9Y!=D= 7!<#DT7=D:N[:X
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M3IMAT5;YM(4I"%_F*&/-"25/B)*6C)3(WB0IT9;NYI4Y3>@*(3K59Y)1:%&
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MD;]/!P$M>03+CP-*V-MK9 '-:ZB=#4Q-RT[2YN28Z>7IJC%&&G75/3V^4_\
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MOXG^J[UZ_!V.,N->U/#ZAN;U ]F#!ORZC_\ ;5Y_$VZOETHV8X_<K'UAHH%
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M:A,1:^&VGWU:<^CZVXF[&>-7W;+D98=FY3-)9K&PX@6/WWSA^HF-(E/'F?N
MY:I;)LUNIE\OY1->X<Z(65F.UQQ_B.-Q,IJ/*=IA*I6W2XYH+$7MHUS[\M-M
MTZYF?9T/485OV+_<J-?G#_N_9#'G[7\OC#7*XUZ_]N[W8O\ /KY>^M4_]O\
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M@4"@4'HJ&ML6&&&JVY"J--(+2FF*$B<\PQ,4?944G,&:6(0R"U-K*"R17N6
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MC7M3P^H;F]0/9@P;\NH__;5Y_$VZOETHV8X_<K'UAHH% H% H% H% H% H%
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M!ZNQ,+EK4R#)4@!^\-2'!+4DE\S#B@ M<5,-67[^C%3FG2.;8:MS (1139+
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M+6)PQ@PP6.2MCM&(ZGC+8Y'B:I&]ORN5GEJF+S;5,W_%]5],7OJ;2*,O&<4
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MWNAY45*%&C9-=XM&C7?O^OVL4:;S.^_?SHGE[NA0DDE.24G3E%D$$%@)(()
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M:M/SN;9*,JW8U_<;%;,I/592CP@^\O\ QL3?V3K_ ,_NUT\__A\O=6IV:?\
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M<NR\SW%^=PA-!:_X6$'\;5N=BF<JJHY4SU9_[3[Q$_C0GEU9H^X &I>VMG6
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MUMB @M*@;FY*0A0(DI(; *3)$:8LI.F(*#:P2R22P%@#:U@AM;T5EI[M H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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G]N3:X>W(">2(P'K#8P%[_P 5J]'A_P"--JM$WG1+G5-YF8[T/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g333443g17u52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g17u52.jpg
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M$0'_Q  5  $!                   )"O_$ !X0  $$ P$! 0
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* M; T(&)Z7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g333443g25b38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g25b38.jpg
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g333443g48j77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g48j77.jpg
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M5EEB8W&AHM35XO R-#AS=Y.5M=,C)$)'5'*!L<'A"B4F)S,H-W:S@K;Q_\0
M& $! 0$! 0                $" P3_Q  Z$0 ! @,%!0<# P4!  ,!   !
M !$"(3$205%AH7&!D='P Q,B,E*QP6*2X2-"HE-RTN+Q@C-#LL+_V@ , P$
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M6<2) *7=+!WKE@^W:M"M\LG;EKJNT64:OT$%&)!EXDD/<.ASELZ6/!Z#]_\
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M;WSVC@9+.L.!CHBXF)648K!AK(E('K#8("9%B<0IJ/BKV(V3/X-7[UV%!JH
M9G#W.H0BY'1^+IDBQ4\VW!BHVX1886(L-1S3O:5:;F\R#&M0=MTWFL.6X!GQ
M+0BQKUY5 X&>E)]_*XFZCHMN)DT7]>&[)S78)RG):YL^'?\ VUB-B0B)QQ&1
M5I,1H<#!U(A$6L10VB\JBBQ%AJ.:=[B\J< #>#,@\7G0^,5W/F;L:Z%#5['B
MJML(#HG'9!9>K*1=IRF#QWA)!>.I6O"I3PDY#M!Y?;D,S91N/Z$<-<,B:Q1+
MPICKY7LL18>W-.]G27S:=\*2VY+:PW#.Q&UUU[9^A6LX'%XV[BKQO7-=:K)
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M+19!:7,PZX=N>;!0<XAA%XC*1,R)>0Z1Q98BPU'-9':,#*M)\.&\' 5523/
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M%W &=<O^JP@,8B"6(# M5ZEC@H'(<_1L;=BP;V'+66_4B>%%91213>:PV36
MUHQ:]E0$.=MF;EOD;(8LS<9AX\P;0LDQY4(?LJ_(1@L*E)&6C@^PO<_M^'6^
M[>;L'D(JM::8R>9IF*#^89SJ*RJP4F6:[WQ7*P:C1Q4JT--L2.$V%;-\WO0^
MPXT,)[CB9 =F1UM$U,AWD;B,OA[,D;4EHG0[IM% P1'#;.DR/C:%# SSF'W@
M0PQ>Q-Y>[%92?<V2E9S:\X^3@#J8#*L4EDC;[QL@Q#/FE=5O1M*6Q.B!90^1
MV0,2+=U:#]E&!XMN-;/LMA8XDH.2\OD6@DAY.!H&!^4$#B$NSM<6<Q1 3%*#
MBO=*.<S>.>1;H5-,S:4NLZ:U36'8SYJ>*3"15H7L<3/'1.(11G)9['0PO%62
MDDP),HG)D'#!4*F;VC94@L,9+1]-[#.N^Y+&8H"7D [-.AJ+U'\H[H>_Q#CT
MEA=+RA'.!#'U)J6"3'QQ5W*W585=<+J/2:--U7)V.ZBX99NC9TLNIEQF61HR
M$W:-V2HTT]6CAJUSSPDG=XQ#-IR<AP:7+)/^Z)QB*##2$FA4P-RT9*)2R: (
MD*25>%HD/G=FUR#E3,:B7.N]QN]BP!M5I!;151[O)I)&3B@80*D2 \?+6(G@
M-X]Y:C!.[-QEG*;")OM+[B%ND*YR#Y7/()!2=46+"5)<Y>AGQV9BC48"BY.@
M=GP!D$8.I+'@>""Y9:!;$A; UF*2PN'E49< 8D8>(3%A$;:+CPD/CU^6FR&!
M@3:!:X3<,#=D<QFK&782QO3-MZ^'M]=6,]U]W;[,5*X^!]_K07-<^N*W=Q.'
M]3T77%:2J <MU3L*B@:.%7P#C'84AC[H@%8-AKI008%(.$"3%1=NHHT>I:X0
M<M_ 6TV[V^N,\8R\41S7I@[*)@7AF!^X8D^Q5@7?_P 0+P@U;+>+KWF>OOE/
M;75)+B5:6N^V=L9U[^-EV**6,:]_PMO"4U]K&>]W\][&<K?=18P_<%HO *[(
MI?J?)VXH6PE J+3OD,])AQ\XCSV)2ILW:UO7PE30Q'2'_/1:^SD<ONDBO]<H
MVW17Q]8KKUZ!Y8/[?DKRQAHH@;C=-="?+-/?T\_194.<B8F:L_C[>E;191AK
M)K#IRSH/'-R"^6X_4[+82; B-GSC717*+/! @WRY6PFIE-#P]\:;^#X.8:'8
M582T4)- 0>!5#LT1RZUG@1676[,B<)%(L!IR4Q.V9L")DV#&P;'/V%,W43&/
M'#1H?LJN9%$0P:(1Z)G!\)D8A\!K=6L \>A<K<9:)\LB:7EL\!A*5>MJ!I0A
M\" ;I!\C4EGOO D.(5C<-Q\6 C.VSIYY8TTMRC;%,MG1V:P+LJ(599]49RH'
M8:JA)1"'DQKZLU[,(P]RW%$@]D38TQ?),RJ&72-#D3J2)49B.3J6A#'(!@(A
M<9D&_(EM@VK26''[ED&AV2+.Q"Y*RVN7P=JR*7E:",)<Q-3AX;@R+%<0*,L6
M#4DKR54!S#,B%M!LN:IM.WA\F&N,K)[3Q-2>V3,<\?\ N%,4!- U?*'>V#>/
M2XKNQ^N"\?.5:+A<C*;(F3; *6@3]?BL7O9*Z+0;FT:SE!UA*V&9:?;2)+>'
M#I\!S')6=GX=D@55C; H2#JM"/06N4SB,WQQIA6&*"X"\&0PB 8MLHWNO%M4
M/+!J$$,6!YXI+Q<(U SM\>Y)62<4LJ;N74:TFE@Q $U/QQW7HTX'8G24*C8&
M8P%LS*.$PBK6O!3;!]X\34VS,\Q,-U)6U \Q*;>$"5P-7.)8TO*VVKZ)Y+QZ
MM.1:,BENVEJV#Q^-5O6DKS89TS(PDC'VQS'E%;*.YB_V>'6"D3AEQU,/:%LD
MB[L0_$$6C4B33"-BI&@%B]2-7BYA9,4+PM01.0S!F@>6T'HK&3KC=R-&K3E>
MJ[;G3 81(271@WD]_6S(U=X+M.^-DI0 #EI++'B@"1$HW$N0<;'REF6#&P>9
MRT::2L2)<(N <:*>]I[&OOGLR5$4,G NI"!-HG)D'G9E3)8V <8KWTM&OY=,
MI?,E +L?!-+#)#^05A)'B$=@3[FR:BT(+N 9D<\.L1KZY>/RNR&3!MN]S$)*
MSD$FF6='LAFP"*3[YX6F%7O"&*%BS/-O"*FPY$I4B^&D!BQU%<K!U=:10_*I
ML1G^\1JT;F>1[D_, "+QO%X[2.LAAX&".M< W<A5,06RG<@.>40DG,P!=ZEB
MS@#VQ9([ACQ,S;[6SHS%[&:MJ!W $B2QAO-J9.^'%I2DK[T20GXR!1N'VJ.:
M,IE%8[%PA RVD9F0L)821C0QT7?C"$L+'9@0[/=+[#R1"0') _>D6[MPJ?+J
M>.=[:#WAFZT7.)G>&A)N9IRI*=PP4V^6Z?"T_"ZJRHSNIWIFG+:QC.G?S6<\
MQ[OOQ8KCHBYZ\3^[@\0:EHFNJSE<!Y;*G85%Q$=*/X]QCL*11YT_#,6XUUN(
M,BD'"!%DHLW44:/4M-4'#?P%=-N]OKC/&,O%$<UZH.RBLCRX^87S5CM__B!N
M#VFFVVL YFJ;:ZYSA/3B1:N-]\XQ[6NN5!Z:>-L^YCP]]->_[NV,>WUE:[J+
M&'[@H?XE\K*ZY=\I^3UO5B&L,!&=H+3,9PPM*#E:^D_EXHI93QRMZGS&?+/(
M-TBK;5N]_P#Q+JZ.$]?KD-^O1"? -OL %YHX3#$06QD7O."M[R3Q*27'6_!T
M#T*KSA_2MILH8C''#YI(5I6Z@QU".I 70Q30DV,J%U&>@MP/WT>HOLH*--M5
M]4\XAH=A4A\T+TM!WVJBIOBMR6+2407$V&K"(DA+3)<'7,8O:6NFU5Z/&U+M
MD30R5RRIY,]GSIT_@MC2E84^%17LYW81"+-R;H)*I>^URT0I3!W:E^[EB.@C
M@#N+19G,(G6YY5%]SU ";\/9W$R$3GJ\@CIXHRC<7#6LPD=RV<#0M/;68SHH
M4CKZ9KL2KT0!R]D<%-!V6@[R N_AJ$$>"QL:-.W>5F*1>E9F<SS4MNXG]+ %
MBP#M??Q>JV2O^*-C/PP)W8-G^KE0A8D.+GB8FXK4?,BE11[BLUKI.%,2.BX_
M<OX-Y9>2EX1<Z-7<X"ZZ2F6$5I \7CJ%#WXZ6>?-4]H [!I&1 \QC?\ _-SR
MHHMF/$'E5I6>D+BEH!,%'<12VVDYF\;;;FQ-TK4W5T+3G#,T8CLP;N69&S(]
M-)01<JQ[:9*/S0HK$C$.,2&8JK1HJ;)N7>\\=*5*".!YRG2R"\+DM47%A-L;
ME+Q3C!=#8PL=&RUK(1YN<V-*;'@Y>W[/%#;*"%K\ELXKJ++%]!QC:,,HG6\C
M8"]V0@:F)<JQQG7#I!W!W:A1I2(MT[ZS=LI2T-R@CAOP !8$CP@$YS!OO>LE
MGJ.X^WS!;P3G\YL)V0BV@75IV.RM^52\2F.S7<(C(Z!J@9M7V\E.L8O)@ALV
MSFQJR<FB[S.):^%:R&?SE@W 1.Y9L'/712**"S9 F]6 O,Y&4I,V5P4>"^,5
M]*69(Y;94\C[&K3,STD\V!";ELO0:4CP67V*=T4RT>@V!$<S<Q:2@AIH:;GQ
MH9EH)7C#? R#A@0O("*]FVG%Y<6W#?;<+-")LWE$B6Y7 5Q6QT]QHNZ*V/2<
MJL211^;YKAR"(DIV]MBQ9 >W&->*:%)O8:-AYN.X!DTU++V.V'F:$3;(R\1E
M!AZLUR;.R'5X .6V^@^0ZACA(B #/<PK;M.[O1@WP%HY_B-R&6=372(2X+"!
M!FQ[DF1MM'+@FVJEPAK*Y2"+HC@HV,,5^6C5:.X9 495%G304*F >7/ID:#E
MMD 1P\_7C13;,UK-VR]IYE!'#)P\@)@>%H6J[D$SN(;%EY<<0>23$45T3G8R
M1OC<-+A$=#-VV$&+1^=NZ]@<7@5I/)S$Z\!D)F8IIY&Y$,CK=Y'PS@T+DFDI
M4=C90*0;. $0>AWF]I[MQP5MPOO?R@R=S"SRM2G/W4IU70-_A+P8S0_>S.85
M2)FT\3>1]M+Y0]<O(K&%)0ZIN,K!,MM0K Y'9E;-HHV,OVJNN0&5S3(ISN5U
M%N68*L7=Y3E[?G9-U#'#980L2!-A>PBS8B$-F2HQG7&F\-99)5X++J[B00==
MDZO!T7;7'.8\<9IS*?P&=I%90&WB1Z.C6JT?C$OB[ALV:-G^4&RFC&;L8U*Y
M8+;QHGDS.3+:\_:AX*B(-,%[(A\H8L")8U'(L%HI&H[D"JTC'()()-,R\FBO
M%TGK;\<L"ZI/$8O(0ML&I3>%AACB8@I6\Q#3Z J@M286Q)5 VI2.Q^-,(H+E
MCIR/"#7BE?Y9AVJ9YR9YY[+:A-HF36O"1""?"P%7#%Z S=R%+?'[B_;D"L.I
MI'8,R'S(K6S\RZ-BS5RF)P1$LYC5?J.(3H$GFKH4NHXFDQC:V7PB1^/P43;O
MYDI(MI:K(13H!$X=NG#[_<D[)%&"(K,G^EGF)$N: F<L,%K2])\BY60F;@<^
M$13U1V1R&2>A)?=%G(2&TX:KRR'R6%2!M&\AG(2',:]J\ Z!PL=HA-X5)(O9
M+1I( : 8DY&N#172F:DSF^[#8EJ$-?X89B$>$V9AWFYF:&3;)-XTU9><*L^.
MQJPYK)#T/K2K8H<DSI\9FI<7(K\( 7]9H8CTQD(6,(3:&B:@##R!X4R#H"&=
MCFD9"[:H2CRI-I0[@&X3K,TORPO68HH2"PF2U!Y:YL;6BTCV.5P&IHP,B>R
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M/_UAT8X'@4MPXZ'DGKQU)]T^O_EA'_ZPZ,<#P*6X<=#R3UXZD^Z?7_RPC_\
M6'1C@>!2W#CH>2>O'4GW3Z_^6$?_ *PZ,<#P*6X<=#R3UXZD^Z?7_P L(_\
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M&&0Q:=GI>SC3NUC4E(Q)$YR6L*QY@^LAXK,LLK(7EM2R6&Q?+(R'MU1D>#E
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M0NY P+G60XQ'5+(BTS1%BMAQEI&S4B:.(T%%1#.KL,8M4O/C9:I./N@BA8S
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M)V13AB7);%&A<:-\I8RE;E"F+C.A1C*M63#"[G Q)I'EMS"8NU]*2P-[8J^
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MA1_[K*S_ #G6_P!->CGT#[2B>LA1_P"ZRL_SG6_TUZ.?0/M*)ZR%'_NLK/\
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MJ:^XLP-?:Z9;O$%-UD>H=;TM1>@];EEO*4_X'S?^_2R/4-.:6CZ3KR6)(R<
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M_9HN*+P'CUWI%/1<>F4,VGY>200 G!9-5EF3L*>-%#E1H&G!]E&*^/A2(J#
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MO=,H6PK=]8KJFK>9:,0JLRUC9,6P%R$K 486K.W$BCHUZ[2>R9PP%I;"S38
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MAU4*<5:8L?CWRGY-P*T>1EA<GY/M!J;,YLZSAPD=)LCWA.R&[:/^3!=MV6&
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MR:-Q7+?DX<$R^(E$X(6<18.%!%V357L-L 46<*[3@V=[8J&.$F@8?2+HP?\
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MYQ(5LJ$#18-8$UJQGN&9D#C)1<E)9#+@C6(RQ[&I'&2TC))34*&SOJWVP\.
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MR$7\G[H;0JG?[W_V0OG7_H_9*5/\+VOL==NS\A_N'L5RCKN^2K&=J_O_ /\
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MQTH @H24NH\["E458@LU9NV:C$\S )]8-D2:@+5PQV<%T![2)IAGJT(F2 7
MG,D.]=CK;AUE\1HYN:'ET#F[YI,68*2&LXO.QVS<[15\6W+:_2E]@%A;M5&2
M,["C<[EB;$R16ROOLB'W)R6).X2X.5Q?[$T.+*-&>#_M$HH806&QAR+K.U*O
MQZ"#E;!@\EGX"+P0_3E4,0Y-E9L=V QQK%U ]3P"0C)>TS)Y%!,+<BEYVQ)'
M-5 P;!X"L0=CA]>X2%V0T KL SK?\*16J$!S:-V,R&D/*TL\5#MK6QPFE".U
M@I!3-C*S!H3(&=X46NH 7D;"8G8W69!DH+C20\?(6JY&F ?;,:+.6F0["(L)
M(S$+JG6RY>$BK'<X-0,GG<2M#O*.S,SV9-.^8\TC>[46^U>QXG6_ZK4%H!(P
MY6+F9V;? I62MW4&/&1N9V]6Q(O7C@RZ9QE.+N')&=;.@%>)I Q"\A;Z+#\+
M)@GG5#84)]S3\44,48O$VH(:L#=-Z5YJ.U91P2DK^&O6<0L;>/3:&2HD$EH/
M'(6.#B#8&5@\"91X:P"O1C^1.K'4Y+LHVR['9D$).\<LX:<4<F@X(.*DI";-
MF,+KW>JOZ@>8<$ @V3B9W2LO.E:36PRB6<.00&6S.-Q>PC1R'Q";30L' .^0
M<;39[1D4]C1:!V$0:+(AX@RE!+CEF/&8C-TTH\</0Y,N="$R!AJ^.I<'-]TI
MG=?5KT%MP'$R*V#6\7F44FN+"BW*27=QAL"<)-38B0DAMBQVI-A]MQQ*SV0I
MPXC]QRB)UCN,ET0:L-HF,9V+*W_J9LP6;$"90WE.R[0T4BK=5^W2XM.>/6U\
M% (P)76I>&^$$N#60F"[-BH_+3?A9LO&'349/4VAYJ"=N9,E)>0L*EB,93K&
MQEH'-06FI 7-YLE:(87)(>@8C:CPQ9I%)H//N9*6CHIDR2SN>H-"V9P3]3WN
MA(=X7!N#2,_+DLJ(M3AE*G0N(R6/%80>]<"8QJ/!'NEI@C8@C(^0X%0<=?O&
M"0E] GDZO*I(R0B62#D<Z:&HSJW .TA";_==*C-N.,MCD40]Y6H8&[TD[P!$
M7N:J]M?YX+VF6C,*AT8E3[><UJW.!XV^#WV CB\%DU;2:L TW*@S>!H *6D]
M3!3T, V4;8L)6]BF!D>;273M>.,'[PD[=HN9\*2=">T$R1(U\)+N"TIU+V:9
M2*NZ)A,< RLI+PRI4<\/;F'9X6@<)[QTT9,IQ1LM(GX-PX68Y.LQ\.%"QKYN
MFW\A'KE4$DN^3=;[ZZZX+#DAMEP>5SKRVZ[TS4]GX[^GMUY-<?X7OQLEU14;
M0HKX< ?\D:B_]',2_P!Q,.N/:>>+:NT'E&_W*N1UA:7#.6+81Y[<C<YSC'A5
M/2'>[_?^P<M7WOX^O0/)#U="N!J=I]U*OENOPM/-M\_11/+=?A:>;;Y^B)Y;
MK\+3S;?/T1/+=?A:>;;Y^B)Y;K\+3S;?/T1/+=?A:>;;Y^B)Y;K\+3S;?/T1
M4KOZ170M<<'B]4N9SCQL">GT$H^M"6D(:2-G9<!8=J66I*%$##^-I1-Y)FKL
M3&-GY!PP<D%6(O>3I19\RA>7XUZU9;A9B2V$W>8- ,P)ZJ)JVC'-DV;C0ZU)
MU-@X)U.HZZLAX :UJ T;M6=?WVO),P8TUF,W,NH,5GVU(L6K/6,1$LD)1&N&
MXE@[=6/EI (L3G3 NV]K@RI,#2 H6=S?"SR =K5YVF3QE7M8\RJSJ.*UK!TI
MI%S$?@8H2BHU,4NK"A8EUQS8;EF8U%9=R^=7"ARI=E3;R1EAST&3C^3"SZ0D
MQ3H2Q5 $"56QRPH[XYSHM&* DF1G>(G\U<+-B[&Y33.H'RR1+62Y@]CV8NQ%
M@+&1J]FK(:SV;%R<;IRHU*A[5[4$Z/%5I!<#>RE9$Y*+L<$L+.6DB4;0]8*V
MS2\V?*DY;,>J+(,$G N>OJ+M_P"6^)K$"AG,Z0VT3:F'MAQ"JSLX>9+.$Y#5
MCET(C(^8335GK&#+,BY)Z#C</<Q;730=!XV6%L=&:3MZ7FS(S)57';+&G5V:
M/ U(26P-6%=[WD&= 66-40YSYABZ2KFP_7/VC-7-TR[(G2"D%3CZ5=U>C;39
M8$H1&.R-S.I\C;+N-.6#R+Q?RE['=LS8=%VR0K$G/&6&_?7*FZOV;W-.MIW<
MV9^EF>^LGFKC<?7]GMH"P#VYH>>2IDJ:>8D)X=%A2KX.1FDOTC -PQC4ZG*F
M3,<B#&.X)/GY!;<BR*!G3PF_E&TJ9A]#-8B9Y-L#X"<P*EZ4;!B9T\MU^%IY
MMOGZ+*>6Z_"T\VWS]$3RW7X6GFV^?HB>6Z_"T\VWS]$3RW7X6GFV^?HB>6Z_
M"T\VWS]$3RW7X6GFV^?HBC&MEL+=T(I_.,XSX- 6?CVL9^S.ZZ]_H?)%U<51
M4;1[KN+UYUW7'_D\OY/W0&A5._WO_LK>N.__ !DJJ^]G_P NNW9^2+^X>RY1
MUW?)4P=J?O\ ^7^QUI850+?X\/['LHI938[%7NJXNBFB4!G$:7D,)D*M.EN1
M;Y9G,F:3Y#M$:1]?EJ:C^-&JF8U-(''Y&JV,:I:,$X0\ZY;'YK<,3!F]4P9^
M*S399WNTE464]S=D!6"R:OQ5F5VF-ED>9#B9<A4Z&YA$VC1D>I=J48/,&7)E
M@"B*$;R0B$9$R 2]T&2-_'B,K4:"M5C>;.SA.C<B)B];':M-B^WZB>)>9TG*
MW1#C4F>K:*UT?ESI5H%Y'3Z^"CX&[DD6(OVLVM:S[,UC@XU'#PJ0A7K#UPD!
MBAQ@624=;"EUO)DD7^6J6FID7]^:YVF+M^T0XT %X8T=E7UGW/[+*9PPFO/
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M9MLF#[.)#)*:')&6$)C02*,'9F2R!,*[8F#3K=\(% VK]@W5<.WSS5LGNR
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M3V6=O?%(LO\ VZ)_H'1H?5H43V6=O?%(LO\ VZ)_H'1H?5H43V6=O?%(LO\
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MD'S4D#4ES4<%7[,&%@*S-6##("=[9KR$6//\$:DNE;,3[-L29\HG41%/&](
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MU6BM'Y'- ,7Q&M#>C^;M;4V*O&_'9UAS3])B='+M)KJU??<0VXIG.98D>/1
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M71-Q6SG1FWJRME]C@'37Q[AF2:M")YU*F6'@1\GB;KA>9W7:*>!S(,\33BH
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MUTUUQC777777&,:ZXQKKC'>QC&.N!+DG%=@&#+>-]?#TWTS[F^NVOX6,X_\
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M9B1?'P>J(87$K\2BDO@7_DD43_HVA_\ _KX_KGVGGBVKK!3</>)6Y<?XNO\
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M"2Y;<+8AQUI578I_DO)[4G<^K=*.@4"]7@U'TJE XR1)0PDYFZS,W1#Z'O\
M1EKB1 9M7.2,IE3ELX\9%223$&AL4\L\NTT)_MAD*M)S3-FZ"P80 #-B94=A
MYMX,AC540KONBMOQBF(2\FC"%VA8JT%CKPLV(2Y*+3<^;E/%QARC0LEU&HQ
MV8H#2Z#TTWI!$HP!.E6<I;-55BQHKNN,=9=A,0GWF'>E+MMZV>S!)9P)W.)1
M62')K)_A=C@A,SD,)S(]QNL@R-99.:A-W^X;4OY,GVEJ)W?Z:/=QN'GCL,MG
MFFCK9MXO*^FJN=M<=&& X+BLIVG_  FWG4^;HPP' (HNO$CX5*V_KXS;/A5=
M8&.]WU/;[\3+8^SCO=&& X(I%X _Y(U%_P"CF)?[B8=<^T\\6U=H/*-_N5<C
MK"TN1D7<^3\_.4_[^HJ"^SWO\$_;_P![/O\ 7H >"%^I0KB202Q:9]U;?M/^
M_A_V.HPP' *.<3Q*=I_W\/\ L=&& X!'.)XE.T_[^'_8Z,,!P".<3Q*=I_W\
M/^QT88#@$<XGB4[3_OX?]CHPP' (YQ/$IVG_ '\/^QT88#@$<XGB4[3_ +^'
M_8Z,,!P".<3Q*=I_W\/^QT88#@$<XGB4[3_OX?\ 8Z,,!P".<3Q*=I_W\/\
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M.EO'#6[9Y"%5&[B&(6."(.%B0YK(=EPNV[^VB]*TGK3"<G4[L  F(T<A@2)
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>[_?ZYQ]I:D!*=VSE>'6H834RRY];<%T=ZYKHO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g333443g72r19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g72r19.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0J^4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              0P   +L    & &< -P R
M '( ,0 Y     0                         !              "[
M0P                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     ""$    !    <    "@
M  %0   T@   " 4 &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  H ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
M @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1
M Q$ /P#U5)8]?U@<_P"K[^L_9P"S=^@]33VO]'^>]/\ M?S2M='ZM1U7$&14
M-CVG9=23)8\?28>/[#TE-Y)9=/5\C(NZG11BA]W3G-94SU(]4N;O$N<S]!_X
M(JAZ_P!:&8, ]);]J=6;FU_:F_0!],NW^CM^FDIWTECYO6L_"Q,2RW!;]KS+
MO0&-ZPAKG;_3_3^EM=OVM_-5GI^5U6^QXSL!N&QH!8X7BTN)/T=K*V;=J2F^
MDL:SK]]V5;B](PG9[L=Q9?<7MJI:X<UMM>'^I8W\[8Q6NG9O4;[+*L[ .&6
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MW?\ DE?ZW]8\7J[JVY6%8S[,YX8:LAHG<0UV[?C6?N+>_P"872/]/D_Y[/\
MTBH)8Q.1(<7(,O,YLDN7F)0'#_5KT_UO[K__T?54E\JI)*?JI)?*J22GZJ5;
M-Q/M3&-WFO:720)D.992[_S[N7R\DDMGP\)XOE?I;]@XY;>TV/<W(:YKVN]P
M&[US[&/EK?=D[T:_I;+K=WJ%E):T>DP;8+#[=EC2US/9^ZOF-)#1A'W>M*KZ
M_P!;_P!"?I9G1&M+"ZXV.8YC_4>T%Y+&.IVN>"W]%[_6KKV_HKDU70**64-J
MM>QU&R+!M#GBHO-3+W1^DK_2>]G_ !?\VOFI)+1']&\+U_>O^L_3 Z)C;Y>X
MVMW-?LL <T.:[=N8'SL]1FRNS;^Y_75O#Q68F.VACG/#9E[B2XDF9<YTN7RX
MDD*7X_9XO17%1\Z?;_K)T?H_130YM%N2<ESR=UQ9MV[7:;:W?Z1=ATK,?G=.
MQLQ[0Q]];7N:W4 D=I7S DFQ^8UMX-;E.'[QF]KA]FHUP</S?UOTOWW_V0 X
M0DE-!"$      %4    ! 0    \ 00!D &\ 8@!E "  4 !H &\ = !O ',
M: !O '     3 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P "  -@ N
M #     ! #A"24T$!@      !P (  $  0$ _^X #D%D;V)E &1      ?_;
M (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$! 0$! @(! @(# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\
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MX1XEQC(V195])VR9:JNZ_0*N@A(6F4:D.= )%=)PY9L(:&\R02>9=K) J)%
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MSLP:VI2MS\:K6:U+)DE(!O9)XS]Q&) T>$.FXC<>5Z,;MX]%4@EZUDEAW41
M1S2'(T-:J-Q))712  4 *4 *4H !2@     ;   '@  &L"NO1&*BQE"S@QK
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MBG59=T^R7M"62CI_LGKE1LD73K <R)HDKI.996J::QY8HR995P[6*FBV4-N
M8A>6Q8)!*,F4FN/ $ ]G&I IQKV+8;?JUT[N]*BUNVW/$_2WV4UT) R6G)MY
MH[:8TY>82-GECA$! G?(X-9$XKV&/)7%4A+5Z!3/DAK-6:'F;"RBY;!F<8-]
M%P4"_=QDC+W!O-8Z8*4&.\\R.1!:=".(\W(+<52J)B>1=PES6^_F()Q8\8#M
M-6^[ZZ5[%DM^I^TKB\TW3VNU-E]=0R3-CDTO5(G1Q1/<Q\ER);-AM&9FD,==
M<D2>Z8R\.:3BK'F7@*5@*]9H>7R/.1-GL"E5BO0< \@)V3)8 KM=N#.,F(&(
MQ>\GJVO-U&UQ\K%C(MFI):,<>:9&70(HH2@O[9S6O:YY:3048\XT!Q ;45!!
M%:5&(J%M,'6SI[=Z=IVJ65YJ=Q9W5P8(^5I.KROYW)AN&LDBCL72PF6WN(;B
M#G,C%Q _FP&2-KG#:D;FC&$RK84(FW,9%:IY+;8=L:;-M).#1.27:4.JC5G7
M;9&V<]$\UZUB]35,R@E.J4R:@$S"XA=G#7URORGP=AA\H\%RVUWOM6]?J4=G
MK$<K[/5&Z=,&M>>7>N$9$#J-\WWV.KA6-I)!>"UP&NS\O>/@TUO?F-WD)ZJN
M:I9;P1]5*#DBX.T:I3;)'U*VS#V$JU1F)V.0K$[*(I/R.&R:K1+K75*5!)54
MF+XZUY8E$A+,I. << :$T )P)Q[N/!<:=UDZ<_H6/<,&NR7&DNLYKK/;VE[<
MN%O;3,M[B1T4%O)*P02R-;*'L:Z-N:1X$;'N;]Z"Y*8<L,G!03*Q33&Q69Q6
MF\#5K+C_ "+3K;)!;V=MD*^\0JEMJ<)8@B7D?0YEP=Z9L5FV0C'"BZJ9$S&U
M9MW XM:'$/-* M<#C6F! -,#CPP*W&PZG[+U*ZL+"#4IX]2NG0"*">TO+:X?
M\0VX?"X6]Q;Q3<MS+2Y>92P1L9!(Z1S6M)60QN$,4Q&1'>5XZEQK:_O4Y BL
M^5:0/V3R_3ZN[81:KQ2%BY*7Z1\V[;-DG+KK/W5#]P_5JLQI2N"Y]1<&')C[
M1_('Z[<K?V[GM=8W?]KNORCOLE?G,ZH_O,ZB?KV__P W*K /9/\ MSP'U;9$
M^;FFMRT#_P"BW_P<O1'U&?W]:?\ JR\_J-79)KG:^U::(O_6[^-$31$T1-$3
M1$T1-$31$T11TR7@-QD&T76=;W=>OQ^1,+.\)VV'+7FDH=>#5&\JLY6*DEI!
MJ>-DFCJ\K',!DETU2H$+L7<1UI9K8ROD<)*!\>0BG9CB/:NM=T=/9-QZKKFH
M1ZZZVMM2T-VF7$?);(3$?BBV2-Y>TL>UUTXFK7AP:!A4E:X>\&<025D&]2"!
MGF0V^3L;Y$AKLJT)ZK"ML>6C#EH3J[=L5R6.<M)5QB$J /%DCO6#>9D4VITR
M.G!%\1TZ!S^:1]]SM<#W92TT]>7CQ%33B5QF?H+LVZU,Z_<QE^Y&ZK97D=T6
M_?(FV<^G3B -KD<V0Z<&\QS3+$RYN6Q.:V:0/W%7<'Q5=L..;"C.2#E;',?E
MV/9-U6[8B4D3+EFA+-(J.CD'J2-$+PA4D )X*$.(F\0#6=MNUKXGYC5H=]T0
M?DHN:Z;L2TTW4MM:BR_D<_38]08T$-H\:A/%.\N[N68@UM.())Q6*SG''UC+
MPY&+?9-G6GUXI>3IZA$@XI;U*^4"I*4VO2#2T*&"0C(52*2:'>,>PL9==D0R
M:Z!5%B*4=:YI^;S#D+@XB@XM%!CW4I4>'9BMHONFGQN\CN4;@E9I<E_;7TMH
M(HSGN[2W-M"]LY]]D1C$9DBRN+G1-+7QASP[4B7M_P"-F*PO(6VVR!?'Q9CN
MCG/&A&^GEO&++)B^UU/,+>%>MWD6C;U97#\"$FAVS,Y-%@D58G5UG4P?HR(8
MM>X'(T>MI:0ZG?5HKV&BX>SZN^V+=YGL=8O+>X.DV=K5F3)\5836,]OJ(B<'
M,%P9-.M.>VACG;$T/%<SG;$DN,TA9\@4K*%WOD3:+I5:9/TIS)*8ZC6**C*>
M?/W*K^LH$G7"M4D46CX6PJ=UZ*J0#U>)O#*;0OECFDD!D:TCR]_=CA\JY)==
M+KG5=Q:'NO7=P0W>N6EC-;%YLV-!;*][B^ <TFW>&NR5S2YFUKQ7APUQ%J>$
MJK7:55[)+KUVM9 KN26#5ZT:'<_$$5CQK1)HBTAU&>.6-B7;#)="QU3LEE3-
MT#@T(W016]DRW8V-CSE#@[UY<I]O'PX#"BILGHYI&Q=)TW0]*U.9VFVNHPWK
M&N:TNYT=FVUEJ_S.;,6\ZCBXQ.<8XR(6QL9\;&7"VK8M?NI*(OMUE'=BGJ)>
M+T,\Y))HVK(]/N$_=I&Z().5%?AQ>W2]H>^=9M!!J '3$I>M/J-6&P9"26R.
M))!->UP)-?"I)J!@M%M;HAI.U+B6ZL]PWTLUS<6MU=<UP>)[VVN9;E]R XGD
MFXDGEYL<?N8M(%6U/J0?!O'M9&QJ0-CL$:>W\:W?'>QMT$VOI3]5[7ZQ5W>3
MTHG?RK*Z24+4(]%Z*>R+PK1$5 ZTQ.>&Z=$S/E>1FAR'V 9O30"O?18+#H-M
MS2SJ;M/U.XB-YMAVCS !O+>70P0.OA'Y6W+XK>%LN7W9!&PN]YI)WL.$ZN?*
M6-,L+ DO8\98ONN+XM16.9'6=L+E)8\?^J*OQ(+ML[ADJ,X0;D3'H[4R[ =N
MH0-J?AV<Z*?^FQA;[<OV*?*5V!]!M*.Z]K[O?1VIZ5I5S8QDL;5S+E]F_F%_
MF:Z,6KV, PRW,W?CN76=<U57.>_;;X)QU2S3FR7X^(6*VL*[D;*<GYK*>:8]
MM.V)K&3-M>^81B\AMFS%"3DR&ZRMTDR)%.()E*   ;/<Z5IP9<7#K6KP'.\S
M\3B?G+RCU"^K)T"MM'WQOF\Z<MN=8CMKR_?FO]38V69K)+AU0R\:UH>\&H8T
M!H/N@  +GJPGS\Q+QUO3?)6&^$F-:==6L;(Q"$U],6=;!T1TLF1*0;^G6FX3
MD2;S"9 #K% 3DV^28!UQBWU*"UD$L&GL;)2E<SSQ])(7SEV-]8;9_377X]S[
M*Z%Z99:XR)\8E_2.JS49(*/&2>XECQ XEE1V$+M;US]?<A-$7__7[^-$31$T
M1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%I+DQ]G#D#]265O["3VM
I/=_V2Z_)N^P5P7JC^[/J)^HK_P#RDJ_/;UUDOSF+])'7:J_3:FB+_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g333443g88f37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g88f37.jpg
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5C0$1HA(QB-^J#)NU+E*9<ZW[/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g333443g92s40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g92s40.jpg
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M&_$821-LMJ)J?<&Y-&&N+5&&H0$0YS1I]KR%BII#I[)<EVU"EL?2R%*+T@(
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MI"1!Y.LOBZDGZ?LE9,&Z)IBT8R.*R-6T-\&B<?3S>RE;06WHG"P9D-<Z.Z%
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M">!V<5 $ZE4=HU(GV$O;U8TR6R3I;OOG-0]-? _HJR^/N7>/+"MVUY-&N3[
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M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"O\
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M%+Y!&IF7%O !X[.-#SS*;&_KO25JO5@)CM^O=35U\5J:CT9>_EM$[,S,]J[
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MDE3][:O5!@4YP23IG,O8Q%N3-LL+CG?+O^<TH5;5,0J"-#CD33K33'!Q4O\
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MTZQZRH)I8H/< 0N8,)#N(IZ(<TJ87[<DWX# 8# 8# 8# 8# 8# 8# 8# 8#
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M@[V0EZA]CY[XH3@$2A?FT9NU <W1+W>'Z=='UOJ:.%S.EWG\.E%XCG@Y]/\
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M[WO>][WY[W\][W\][WO\.][PKMD?<F/6Y]:]>6ER2_.FRXKTG CI5#T)YWJ
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M6Q:$(*-\;4SDG />M:^V I2$!FO(.]#"+6PAWK>M>&S%LO&7'H[RYDK)LBF
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M^+R_'%M5&Q@L>_8+7"=/RHOS^6SFQ-&&] />OQ[T!V<@ZWO\&A;\O[6_+O\
M0F^J]TGK_AS^IRGSYQ:&Y+!(5,BME2J*1^0:]/H"8ZM2)8H*UY>7F0J-)$I3
MBUKY!&0:6,.OP"UGH[,O*.><<%?'CCRK35Q;Q#EDLKE[3"&:B<(L_*M:2GC
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M(0A"V+>]YV'@P& P.T5P$_G2'DJHU"D>QJ&Y#(6 >][\_22Q2U^;$ -;_P"
M&Q,B#K7XO+TZ^6L\?U?[]7E]Y*[:/[9Y^ZXV<VC 8# K)>?]7M[C!85]D]3T
M%-F X?XQMB[DSI9]4I__ +ICE%V91O6_EZDH=_AUK"SGX?F+-X0P& P& P&
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M"TKG+8%#8D6K4K>JVNT8C3+%1*8PLI0:$>>SC_;MX?.YJ:I>:ORD"DM0<!8
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M=.%Y8=_+?LA3B0I2Q>7XM#TE]H'_ )0!A%KY;UGC^K_\FKR]H[:/[5XLYM&
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MI3VA!W^,[0>AQA 'R\]DC4"\_(&];+ROI]\_A9S"& P& P& P& P& P& P&
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M4.][,#K7H^CJXZ;>^?F1SUSGZ_AI5ST.;'I;)$,,BDFF#H4K/;(I'GJ2.)"
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M@Z%R?2!AI,*U(/6AH'-#S_%JH:WE"/[:=X0+PF>1FQAT6^VWCUOK]EG\(8#
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MI^BY*Z)43!L,AW87(D7MQM>]-,UE">^(%,J=G=IRYT:X0="9R_5O&Y ,Q"Q
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MI*J)*4)E*<T!R=0G. $PD\@XL0BS232Q!,*-+$(!@!!$$6P[UO#+S8# _(P
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M;4L<8S,(RY,TPA[R^15]9W=:$JX%#^X.S@<1HZVL::1Y"X4E(B[>89M(0'+
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MFSW7TCET,D('B/OYA#8^/%6P=6)^BAD7GS.%H.31R8LR5W>B' LN/Y9EOF.
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MQ:B,4C44<4$^6R3V&MH:T'%>7EY>S-;V5.,'EY:\O2+7X-?\,"6P  4 !98
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MAWN3:2=SRWC?&I>G,)BEEPJ7US/&)#)X//8P_0R8QIS ,QMD$6D[6J97]D<
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M5#5B.+"F"F"7[42D1^Q:*"0$K6S=G;'HO1>O7L7I^>!Y];\_GKYZW\];U^/
M8# 8# 8# 8# 8# K)R1_=5*/TE^T_P#./?&%O'RGM%F\(8# 8# 8# 8# 8#
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MNJE'Z2_:?^<>^,+>/E/:+-X0P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P*Q\3_ .#7DS]&FB_W81?"WC?&^[UYY,;Q>+Q,J:II
M+5,-0,]4LEB.[O8E92^R5;FK?Y?)HT0VMI$:N"J26A.A)C@E)QRD3T:M-6Z
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MQ4=R=77/2[1U=RFY?@9*1[1-T$E-R3^7UXRE/SSM]6C9(5('I<PM1Y3@,\2
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MD2@25J1*'=>0V-I)YP"S1!&M<%2=(1K0-^HXT =^7GYX%1?]*KX=?YW=._\
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M^4]HLWA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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6@,!@,!@,!@,!@,!@,!@,!@,!@,#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g333443g94x94.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g94x94.jpg
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M P$  P$!            "@<("08#! 4""__$ #80  $$ @$" 0H& @(# 0
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ML./U^S<SPL+D\)0CTA-F!<JP'!;A\Y8K/'7AD<94+G<*-WQ4=?VA*+5G#'D
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M.YW,YU&HJ\DT3,1.NU+-,6O(K/C\'C,E@9P*T&ST]=$[*DCQUD?L..N%X^E
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M7 1FRFDD16ALN&V! 9?!9G*:YL*O9T)9$Q;&60>=0HJ%DD>+XB#1H*\Y:/\
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#9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g333443g95p98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g333443g95p98.jpg
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"_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
